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This project was concerned with investigating the electrophilic cyclisation reactions of 3-
phenylpenta-1,4-diyn-3-ols possessing either an ortho-N-linked- or an ortho-S-linked- sulfonamide 
function. Cyclisations of both series of sulfonamides meditated by alkynophilic initiators [e.g. I2, ICl, 
AgOAc or In(OTf)3] provided access to novel functionalised heterocycles. 
Thus, addition of methyl 2-(arenesulfonamido)benzoates to alkynyllithium reagents furnished 3-[(2-
arenesulfonamido)phenyl]penta-1,4-diyn-3-ols in which the alkyne termini possess identical 
substituents. Dialkynols having unsymmetrical alkyne terminal groups have been obtained from the 
addition of an alkynyllithium reagent or HC≡CMgBr to 3-aryl-1-(2-tosylamidophenyl)prop-2-yn-1-
ones. The ortho-S-linked sulfonamides have been accessed directly from N-substituted saccharins 
that readily add alkynyllithiums to provide 3-(2-sulfamoylphenyl)penta-1,4-diyn-3-ols in good yields. 
 
Desilylation (5M NaOH in MeOH) of 1,5-bis(trimethylsilyl)-3-(2-tosylamidophenyl)penta-1,4-diyn-3-ol 
also triggered cyclisation via a 5-exo-dig pathway and gave a quantitative yield of 3-ethynyl-2-
methylene-1-tosylindolin-3-ol. However, when both silyl functions were replaced with either a 
propyl- or a phenyl- group, cyclisation to the 1-tosylindolin-3-ol did not occur with base. A 
quantitative yield of 3-(phenylethynyl)-1-tosyl-1H-indol-2-yl(1-phenyl)methanol was obtained from 
treatment of 1,5-diphenyl-3-(2-tosylamidophenyl)penta-1,4-diyn-3-ol with AgOAc in MeCN. The 
analogous reaction with 6-(2-tosylamidophenyl)undeca-4,7-diyn-6-ol, provided 1-[3-(pent-1-yn-1-yl]-
1-tosyl-1H-indol-2-yl)butan-1-ol, together with smaller amounts of (E)-2-but-1-en-1-yl-3-pentyn-1-yl-
1-tosyl-1H-indole and 4-pentyn-1-yl-2-propylquinoline. It was found that when 3-(2-
tosylamidophenyl)penta-1,4-diyn-3-ols possessed bulky groups on the alkyne units, the reaction 
followed an alternative course giving access to the (Z)-2-benzylidene-, (Z)-2-(2,2-
dimethylpropylidene)- and (Z)-2-(trimethylsilylmethylene)- derivatives of 3-alkynyl-1-tosylindolin-3-
ols. Mechanisms to account for these outcomes have been proposed. Contrasting behavior was 
observed from the In(OTf)3-mediated cyclisation of 1,5-diphenyl-3-(2-tosylaminophenyl)penta-1,4-
diyn-3-ol, which promoted an unexpected and remarkable cascade pathway leading to 2,4-diphenyl-
1-tosyl-4,5-dihydrofuro[2,3-c]quinoline, albeit in moderate yield.  
 
Attempted iodocyclisation (ICl in MeCN) of 1,5-diphenyl-3-[2-(N-methylsulfamoyl)phenyl]penta-1,4-
diyn-3-ol resulted only in cyclodehydration to give the novel 3,3-bis(phenylethynyl)-2-methyl-1,2-
benzisothiazole 1,1-dioxide. However, application of these conditions to 1,5-diphenyl-3-[2-(N-p-
tolylsulfamoyl)phenyl]penta-1,4-diyn-3-ol provided a novel derivative of the unusual 1,2-
benzisothiazolo[2,3-a]quinoline system that was characterised by X-ray crystallography; the 
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corresponding 2-aryl-3,3-di(alkynyl)-1,2-benzisothiazole 1,1-dioxide was also formed. The latter also 
underwent iodocyclisation to give the 1,2-benzisothiazolo[2,3-a]quinolines. It was established that 
the 3,3-di(alkynyl)-1,2-benzisothiazole 1,1-dioxides could be generated most efficiently by treatment 
of the 3-[2-(sulfamoyl)phenyl]penta-1,4-diyn-3-ols with In(OTf)3 in DCM.  
 
Iodocyclisation (ICl in MeCN) of 3-(2-tosylamidophenyl)penta-1,4-diyn-3-ols having symmetrical 
alkyne substituents afforded novel 4-alkynyl-3-iodoquinolines. However, the unsymmetrically-
substituted pentadiynols cyclised less efficiently to give, in some cases, mixtures of regioisomeric 3-
iodoquinolines. The cyclisation of 1-(4-methoxyphenyl)-5-phenyl-3-(2-tosylamidophenyl)penta-1,4-
diyn-3-ol regiospecifically generated 3-iodo-2-(4-methoxyphenyl)-4-(phenylethynyl)quinoline, as 
anticipated. 
Silver-catalysed cyclisation (AgOAc in MeCN) of 3-[2-(N-arylsulfamoyl)phenyl]penta-1,4-diyn-3-ols 
proceeds stereoselectively to (Z)-3-alkylidene-4-alkynyl-2-aryl- and (Z)-4-alkynyl-2-aryl-3-arylidene-
1,2-benzothiazin-4-ol 1,1-dioxides via a 6-endo-dig pathway in good to excellent yields, constituting 
a new approach to this ring system. Two of the pentadiynols also furnished 1,2-benzothiazepine 1,1-
dioxides derived via a 7-endo-dig ring closure. Mechanisms for the formation of these novel 
compounds are proposed. 
With a range of heterocycles to hand some were subjected to functionalisation or annulation 
reactions. Of note is the Pd-mediated domino-amination-hydroamination of 4-alkynyl-3-
iodoquinolines with a range of primary amines. This approach was exploited to access novel 2,3,4-
trisubstituted pyrrolo[2,3-c]quinolines, analogues of the biologically active Marinoquinolines. 
However, in some instances the hydroamination step was suppressed and the major or exclusive 
product was a 4-alkynyl-3-amino-2-arylquinoline.  
Suzuki-Miyaura couplings to 4-alkynyl-2-iodo-3-arylquinolines and efforts to effect iodocyclisations 
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Table 8.2 Bond lengths and angles for 6-Iodo-2-methyl-5-phenyl-6a-(phenylethynyl)-
6aH-1,2-benzisothiazolo[2,3-a]quinoline 11,11-dioxide 2.66-3 370 
Table 8.3 Crystal data for 2-(6-Hydroxyundeca-4,7-diyn-6-yl)-N-(p-
tolyl)benzenesulfonamide 2.23Bb 371 
Table 8.5 Bond lengths and angles for 2-(6-Hydroxyundeca-4,7-diyn-6-yl)-N-(p-
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Chapter 1 Introduction 
1.1 Natural Occurrence, Applications and Synthesis of Quinolines  
Bark from the Cinchona tree (Cinchona officinalis) has been known to exhibit anti-malarial 
activity since around 1600. Pure cinchonine and quinine were first isolated from the bark of 
Cinchona officinalis in 1820 by Pelletier and Caventou. Quinoline was first isolated by Runge 
(1834) from coal tar, later Gerhardt (1842) isolated quinoline from cinchonine [67MI1]. 
Within the natural world quinolines are a very important class of heterocycle. The quinoline 
skeleton is ubiquitous in natural products especially, alkaloids [10MI1], as well as 
pharmaceuticals [10COB347], electrically conducting materials, dyes and agrochemicals. 
Some examples of important quinoline-containing compounds are shown in Figure 1.1.  







Figure 1.1 Quinoline derivative examples  
Consequently, much attention has been paid to the synthesis of quinoline derivatives. There 
are a plethora of ways by which the quinoline ring can be constructed. Some classical 
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examples being; Conrad-Limpach-Knorr, Combes, Friedländer, Gould-Jacobs and Skraup 
syntheses (Scheme 1.1). All of the important routes rely upon construction of the 
heterocyclic ring onto a benzene (aniline) derivative [03MI1, 10MI2]. With extensive reviews 
relating to quinoline synthesis, structure and reactivity available in all the editions of 
Comprehensive Heterocyclic Chemistry [synthesis: 84CHEC-I(2)395, 96CHEC-II(5)167, 
08CHEC-III(7)217; structure: 84CHEC-I(2)99, 96CHEC-II(5)1, 08CHEC-III(7)1; reactivity: 
84CHEC-I(2)165, 84CHEC-I(2)315, 96CHEC-II(5)37, 96CHEC-II(5)91, 08CHEC-III(7)41, 08CHEC-
III(7)101]. Reviews in the literature are also summarised yearly (1991 – present) in Progress 
in Heterocyclic Chemistry.  
 
Scheme 1.1 
1.2 Natural Occurrence, Applications and Synthesis of Indoles 
Indole and its derivatives are prevalent throughout both the plant and animal kingdom and 
indoles is therefore classed as a privileged structure [10COB347], some examples include; 
dyes like indigo, amino acids (tryptophan), hormones (indole-3-acetic acid), and skatole (3-
methylindole) which is found in citrus oils and widely used within fragrances. Possibly the 
most useful application of the Fischer indole synthesis is its use in the synthesis of the 
neurotransmitter serotonin, and its derivatives which act as agonists of serotonin. 
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Derivatives of serotonin have been used as pharmaceuticals, for example Sumatriptan is 
used to treat migraines. A few more examples of important indoles are shown in Figure 1.2 
below. Extensive reviews relating to indole synthesis, structure and reactivity have been 
summarised in Comprehensive Heterocyclic Chemistry [synthesis: 84CHEC-I(4)313, 96CHEC-
II(2)119, 08CHEC-III(3)269; structure: 84CHEC-I(4)155, 96CHEC-II(2)1, 08CHEC-III(3)1; 
reactivity: 84CHEC-I(4)39, 84CHEC-I(4)201, 96CHEC-II(2)39, 08CHEC-III(3)45]. Developments 




   




Figure 1.2 Indole derivative examples 
The Fischer indole synthesis has been the most important method for the preparation of 
substituted indoles since its discovery in 1883. Fischer and Jourdan treated pyruvic acid 1-
methylphenylhydrazone with alcoholic hydrogen chloride, which resulted in the formation 
of 1-methylindole-2-carboxylic acid [1883MI2241]. The general reaction conditions for the 
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Fischer indole synthesis involve the heating of arylhydrazines with an α-methylene ketone 
or an aliphatic aldehyde in the presence of an acid (Scheme 1.2) [06CRV2875].  
Another widely used application of the Fischer indole synthesis is in the synthesis of the so-
called Fischer base (1,3,3-trimethyl-2-methyleneindoline) (1.1, Scheme 1.2), which has been 
utilised extensively in industry for the synthesis of cyanine dyes and photochromic 
compounds [16JST426, 17DP481, 17JMC5111]. Fischer base is obtained via the reaction of 
PhNHNH2 with 3-methylbutan-2-one followed by alkylation of the resulting 2,3,3-trimethyl-
3H-indole. Alternatively indolisation of 3-methylbutan-2-one with PhN(Me)NH2 affords the 
product directly. 
 
Scheme 1.2  
There are a plethora of indole syntheses that allow access to variously substituted 
derivatives, a selection of examples are provided by the Bartoli indole synthesis, the 
Bischler-Mӧhlau indole synthesis, Hegedus, Larock, Gassman and the Madelung synthesis 







1.3 Heterocycles via Electrophilic Cyclisations 
Both alkenes and alkynes possessing a pendant nucleophilic function can, providing the 
necessary stereochemical requirements are fulfilled, cyclise upon treatment with an 
electrophilic initiator. This process has been developed as a means to access a wide range of 
heterocycles and application to functionalised alkynes has been extensively exploited. The 
most useful electrophilic initiators are selected from halogen or positive halogen sources. Of 
these elemental iodine or iodine-containing reagents have been widely employed i.e. I2, NIS, 
ICl or, less commonly, bis(pyridine)iodonium tetrafluoroborate (IPy2BF4, Barluenga’s 
reagent). The uses of these reagents in electrophilic cyclisations leading to novel 
heterocyclic compounds has been reviewed [11CRV2937, 15S1961, 16OBC7639]. Some 
examples of these iodocyclisation reactions are shown in Scheme 1.4. Electrophilic 
iodocyclisation reactions have been used for the construction of highly functionalized 
pyrroles, indoles, furans, thiophenes, selenophenes, pyridines, quinolines, benzo[b] furans 
and the review literature details many examples [11CRV2937, 15S1961, 16CC853, 
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16OBC7639]. Additional examples relating to the construction of indoles [17OL6744], 
quinolines [17JOC4625] and quinoline annulation to generate thieno[2,3-b]quinolines 
[18OBC245] are noteworthy. 
All the reactions depicted in Scheme 1.4 proceed via initial iodination of the triple bond to 
generate a bridged iodonium ion. Subsequent attack by an adjacent nucleophile facilitates 
cyclisation, most commonly via a 5-exo-dig or 6-endo-dig pathway. These mechanisms are 
considered in more detail in the following chapters. 
These electrophilic cyclisations often proceed with incorporation of an iodo-substituent into 
the ring. Thus, heterocycles with an iodine substituent allows for further structural 
modifications and access to structurally complex compounds. In addition, the halogen atom 
can sometimes enhance the bioactivity [10T1177].  
 
Scheme 1.4 
Metal-containing Lewis acid catalysts are developing as powerful reagents to effect the 
cyclisation of alkynes, as many can be used in tandem reactions to both couple a terminal 
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alkyne to the starting material in situ and then to induce cyclisation (in most cases a domino 
oxidative cross-coupling electrophilic cyclisation) Scheme 1.5 [08CRV3174, 11CC12855, 
11CRV1780, 13CC7549, 13OBC1456]. For example, silver(I) was employed to catalyse the A3 
reaction of 4-imidazolecarboxaldehyde, phenylacetylene and a secondary amine to obtain 
alkyne 1.2, the pyrrole 1.3 and ketone 1.4 (A, Scheme 1.5) [11CC12855]. Another silver-
mediated oxidative cross-coupling and cyclisation reaction made use of a β-enamino ester 
and arylacetylenes affording substituted pyrroles 1.5 (B, Scheme 1.5) in varying yields (37 – 
84%) [13CC7549]. Tsuchimoto and co-workers employed In(III) to activate phenylindole 
derivatives to addition of propargyl ethers, subsequent in situ cyclisation afforded 6-methyl-
7H-benzo[c]carbazoles 1.6 and 1.6’ (C, Scheme 1.5) [13OBC1456]. 
 
Scheme 1.5  
A range of alkynol substrates and solvents are tolerated (Scheme 1.6) for the metal-
catalysed cyclisation, reviews of catalytic activation have been published [16CC853, 
18MI31129]. Metal containing Lewis acid catalysts most relevant to the present project, 
which have also been reviewed are; Ag(I) [15CSR8124], In(III) [03S633, 07S1, 04T1959] Au(I) 
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and Au(III) [07CC333]. The mechanisms of the reactions shown in Scheme 1.6 will be 
discussed in subsequent chapters in the context of results from the present study. 
 
Scheme 1.6 
1.4 Electrophilic Cyclisations for the Synthesis of Indoles and Fused-Ring 
Derivatives  
1.4.1 From 1-(2-Aminophenyl)- or 1-[2-(Alk)oxyphenyl]-prop-2-yn-1-ol Derivatives 
Chan and co-workers used a gold(I) catalyst to cyclise the propargylic alcohol 1.7 and effect 
iodination with NIS in acetone to produce 1H-indole-2-carbaldehydes. It was found that by 
keeping the mixture at a low temperature (-40 °C) the reaction could be halted at the 




Scheme 1.7  
Subsequent work showed that when R1 ≠ H in 1-(2-anilinyl)prop-2-yn-1-ols 1.8, treatment 
with molecular iodine affords a mixture of 3-iodoquinolinium salts and 2-acyl-1H-indoles 
(Scheme 1.8) [06OL243, 11OL2598]. When the alkynols (1.8) were treated with NIS the  
course of the reaction is controlled by the nature of the R group, and two routes can 
operate. When NIS was used to trigger the cyclisation of the nitrogen nucleophile to the 
alkyne, intermediate A was formed. Thus, if R ≠ H then A was susceptible to an hydroxyl 
group shift followed by alkyl migration and oxidation to afford 3-(diiodomethyl)indolin-2-
ones. However in A R = H a 1,2-hydride shift and oxidation of the secondary carbinol centre 
resulted in formation of 2-(iodomethylene)indolin-3-one (Scheme 1.8) [13CEJ1978]. 
 
Scheme 1.8  
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In a further extension of the reactions in Scheme 1.8, it was found that when non-distilled 
solvents were used the yield of indole-2-carbaldehyde was increased. This led to the 
optimisation of solvents in which H2O – acetone (6:1 v/v) and 2.15 equiv. of NIS was used, 
affording the highest yields of 1.9 (Scheme 1.9) [13T7471]. 
 
Scheme 1.9 
A suggested mechanism for the formation of indole-2-carbaldehyde 1.9 involves an initial 
iodocyclisation to the 2-(iodomethylene)-indolin-3-ol 1.10. Co-ordination to the alcohol by 
another molecule of NIS facilitates dehydration, nucleophilic substitution of the activated 
species by H2O generating 1.11, the loss of HI then generates 1.9 (Scheme 1.10). 
 







Chan et al. found that Ag(I) salts catalysed the cyclisation of 1-[(2-tosylamido)aryl]but-2-yne-




A suggested mechanism for the formation 1.13 is via allene 1.14. Silver(I) co-ordination of 
the alcohol promotes the deprotonation of 1.15, followed by elimination of [Ag]-OH which 






1-[2-(Tosylamino)phenyl]prop-2-yn-1-ols 1.16 were cyclised (5-exo-dig) upon treatment with 
AgOAc in acetonitrile, when R1 = H a Fischer base-like structure was produced (Scheme 1.2, 
1.1). (Z)-2-Methylene-1-sulfonylindolin-3-ols 1.17 were also obtained from a range of alkyl 
and/or aryl substituents (Scheme 1.13). However when the nitrogen protecting group was 
replaced with an acetyl or a Boc function, the cyclisation did not proceed and resulted only 
in quantitative recovery of starting material [12JOC7166]. 
 
Scheme 1.13 
Ramasastry and co-workers used silver(I) acetate along with other Lewis acids and Brønsted 
acids in a relay system, via 1.18, to generate cyclopenta[b]indoles 1.19 – when a protic acid 
was used (CSA, p-TsOH or TfOH). However, in the presence of Bi(OTf)3 the intermediate 3-
vinylindolin-3-ol 1.18 underwent rearrangement with concomitant aromatisation to afford 
indole 1.20. Treatment of the latter with Pd(OAc)2 promoted oxidative cyclisation to the 






Reddy et al. used silver(I) carbonate to cyclise 2-hydroxyphenyl propargyl alcohols to the 
dihydrobenzofuran-3-ol e.g. 1.22, which was then subjected to treatment with TMSN3 to 
afford 2-(α-azidobenzyl)benzofuran (A, Scheme 1.15). It was found that this and related 
reactions also proceeded in a one-pot sequence to give moderate to high yields of products 
(52 – 92 %) [16OBC4077]. Another example of silver(I) catalysis for the cyclisation of 
propargylic alcohols is provided by the ynone-terminated example from Chan and co-
workers (B, Scheme 1.15). When the substituent on the amine function was a tosyl group, 
only the allene 1.23 was obtained. However, when the N-allyl-protected propargylamines 
was employed the reaction proceeded to the spirocycle 1.24 in high yields [14OL4110]. 
 
Scheme 1.15 
Shi and co-workers treated 1-[2-(tosylamino)phenyl]prop-2-yn-1-ol 1.25 with a gold(I) – 
iron(II) catalyst system to effect cyclisation to 1.26 and 1.27. However, there was no 
concern with obtaining good yields of indolines 1.26, as they were intermediates in the 
synthesis of indole aldehydes 1.27 (Scheme 1.16). When only the gold(I) catalyst was used 
only a 13% yield of 1.26 was obtained. None of the indole-2-carbaldehyde 1.27 was formed. 
This observation was attributed to a slow protodeauration step. However, in the presence 





Ramasastry and Dhiman treated 1-(N-tosylaminophenyl)prop-2-yn-1-ols with a gold(I) 
catalyst in the presence of base, followed by addition of a 1,3-dicarbonyl and triflic acid in a 
two-step, one pot synthesis of cyclopenta[b]indoles. Indoline 1.28 could be isolated when 
gold(I) and base was used alone. However, TfOH did not facilitate the cyclisation in the 
absence of AuCl (Scheme 1.17) [15CC557]. 
 
Scheme 1.17 
Another example of gold catalysis for the cyclisation of aryl propargyl alcohols is provided by 
Chan and co-workers (Scheme 1.18). They found that either indole or acyclic structures 
could be obtained by varying the reaction conditions. Thus gold(I) chloride and an AgOTf co-
catalyst with 20 mol % HMPA and CaSO4 in toluene gave tetracycle 1.29, in excellent yield 
(94%). However, if DMAP was employed instead of HMPA the Meyer-Schuster product 1.30 
was obtained in a high yield (87%). It was found that indoline 1.31 could be transformed 
into 1.29 by using the same catalyst and solvent system but discarding the HMPA. Indole 




Scheme 1.18   
Silver(I) was employed to cyclise the enynol 1.33, via indoline 1.34, to afford the β-carboline 
1.35 in good to high yields (67 – 81%). However, with AuCl and K2CO3 1.33 gave the 6-exo-
trig product 1.36 exclusively (Scheme 1.19) [16AGE7737]. 
 
Scheme 1.19 
A copper(I) species promotes the tandem cyclisation-condensation reaction of 3-(2-
aminophenyl)prop-2-yn-1-ols with acetylacetone to indole 1.37. The reaction which can also 
be conducted in a stepwise manner, affords indoline 1.38 in the absence of the diketone. 
However, access to 1.37 by the stepwise procedure is less efficient than the one-pot 





Wang and co-workers showed that alkynols 1.39 in the presence of boron trifluoride 
etherate, cyclised to the corresponding spiro(indenebenzosultams) 1.40 (Scheme 1.21). 
Interestingly, it was found that at low temperature, or after a short reaction time, the 
Meyer-Schuster product 1.41 could be isolated in a 94% yield. It was also found that when 1 
equiv. of NIS was added to the reaction mixture, the iodospiro(indenebenzosultams) 1.42 
were obtained [15OL242]. 
 
Scheme 1.21 
1.4.2 From (2-Aminophenyl)acetylene Derivatives 
Larock et al. showed that N,N-disubstituted-2-(p-tolylethynyl)anilines undergo facile 
iodocyclisations to indoles, in which a range of substituents on the alkyne are tolerated 





Thieno[2,3-b]quinolines were synthesised in high yields (61 – 91%) from 3-alkynyl-2-
(methylthio)quinolines via a 5-endo-dig cyclisation initiated by a positive iodine source 
(Scheme 1.23). It was found that the efficiency of the cyclisation was highly dependent on 
the nature of the iodinating reagent. However, the reaction tolerated a variety of functional 
groups once the optimised conditions were established [18OBC245]. 
 
Scheme 1.23 
Muñiz and Fra used a hypervalent iodine reagent to activate the triple bond of an alkynyl 
sulfonamide to nucleophilic attack from the sulfonamide nitrogen. Subsequent nucleophilic 
attack of the aromatic ring and re-aromatisation ensued to afford the tetracycle 1.43 






1.5 Formation of Six-Membered Rings and Benzologues  
1.5.1 From 1-(2-Aminophenyl)- or 1-[2-(Alk)oxyphenyl]-prop-2-yn-1-ol Derivatives 
Ali et al. found molecular iodine promoted the cyclisation of 1-[2-(tosylamino)phenyl]prop-
2-yn-1-ols, to 3-iodoquinolines. If nitromethane was employed as the solvent, yields were 
poor. However, when replaced with methanol, moderate to excellent yields (40 – 99%) of 
the 3-iodoquinoline could be obtained 1.44 (Scheme 1.25) [11OL2598]. 
 
Scheme 1.25 
Kumer et al. exploited the iodocyclisation of N-unsubstituted 1-(2-aminophenyl)propynols 
to prepare quinolines. The amino function was not protected because the enhanced 
nucleophilicity and diminished bulk of the amino group was envisaged to increase the 
reaction rates. It was found that cyclisation to the 3-iodoquinoline could be achieved under 
mild conditions. Furthermore the 2,4-disubstituted quinolines were also easily obtained via 
a Brønsted acid catalysed cyclisation (Scheme 1.26) [12MI3986]. 
 
Scheme 1.26 
When either the secondary or tertiary 1-(2-aminophenyl)alk-2-yn-1-ols 1.45 were subjected 
to iodocyclisation conditions, the outcome could be manipulated by choice of solvent 
(Scheme 1.27). In dichloromethane or acetonitrile, the 6-endo-dig product was obtained. 
Yet when either ethanol or methanol was used a 2-acylindole derived from a 5-exo-dig 
pathway was generated [06OL243]. These results lead to the conclusion that it is the protic 
nature of the solvent that is the key factor in controlling the outcome of the reaction. This 
observation is contrary to the results of Ali – that in MeOH the 6-endo-dig pathway is 
favoured (Scheme 1.25) [11OL2598]. However, the substrates used by Hessian and Flynn 
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possessed a 2-dimethylamino group whereas Ali used 2-tosylamido compounds; clearly the 
tosyl group will greatly affect the nucleophilicity of the nitrogen. 
 
Scheme 1.27  
The alkynol formed from the addition of LiC≡COEt to 2-aminobenzaldehyde or 2-
aminophenyl ketones could not be isolated, as cyclisation ensued on work up with aq. NH4Cl 
to afford 2-ethoxy-4-quinolines in good yields (Scheme 1.28) [12EJO5803]. 
 
Scheme 1.28 
Yamamoto and co-workers used a range of Lewis acids and Brønsted acids (e.g. I2, Br2, TfOH, 
TFA and HNTf2) to cyclise 1-azido-2-(2-propynyl)benzenes (1.46) to afford 3-unsubstituted 
quinolines E = H and 3-haloquinolines E = Br, I (A, Scheme 1.29). It was also found that with 
some catalysts a small amount of 3-phenyl-4H-[1,2,3]triazolo[1,5-a]indole 1.47 was also 
obtained [10JOC1266]. 3-Iodoquinolines were synthesised from 2-aminobenzophenones 
and an acetylene in a single pot reaction (B, Scheme 1.29). The intermediary of the phenyl 





3-Iodocoumarins can be accessed easily by the cyclisation of ethoxyalkyne diols in moderate 
to high yields (A, Scheme 1.30) [13JOC5878]. Laing et al. found that iodination occurred 
twice upon cyclisation of alkynols 1.49 to afford 3,4-diiodochromenes when molecular 
iodine was used; with either IBr or with ICl both halogens added to the chromene. A range 
of chromanones could be synthesised when a Brønsted acid was used to catalyse the 







1.5.2 From N-Arylpropargylamines 
Larock reported that iodine was an excellent electrophilic initiator for the cyclisation of N-(2-
alkynyl)anilines [05OL763]. Iodine monochloride produced slightly lower yields but at faster 
reaction rates (Scheme 1.31), which is not surprising as it is a harder electrophile than 
molecular iodine [07CSR354]. It was found that the iodocyclisation tolerated a variety of 
substituents. However, the presence of electron withdrawing groups were found to also 
produce side products, including a 3,6-diiodoquinoline derivative when R = 4-MeCOC6H4 
[05OL763]. Larock also reported that N-propargyltriflamides could be cyclised to 3-
iodoquinolines in moderate yields (Scheme 1.31) [10T1177]. 
 
Scheme 1.31 
Zhang et al. achieved good yields (64 – 81%) of 3-iodo-2,4-diarylquinolines (1.50) from N-
phenyl propargylamines and NIS in 1,4-dioxane; together with trace amounts of the 3,6-
diiodo-2,4-diphenylquinolines (Scheme 1.32). In MeOH the product distribution was 
reversed, suggesting that the solvent promotes p-iodination of the aromatic ring prior to 
cyclisation. Zhang et al. also proposed that the cyclisation proceeds via a radical pathway, 
however no evidence in support of this assertion was presented [17OBC6901]. 




3-Iodochromenes have been synthesised in a one pot reaction, involving in situ O-arylation 
of a propargylic alcohol with diphenyliodonium triflate [13S183] and subsequent 
iodocyclisation under Lewis acid catalysis (A, Scheme 1.33). Yields could be improved by 
addition of DCM [16OL944]. Togo and co-workers went on to adapt the method to 
synthesise 3-iodoquinolines from N-tosylproparylamines (B, Scheme 1.33). The 
dihydroquinoline was isolated before removal of the tosyl group (B, step iii, Scheme 1.33). 
However, removal of the tosyl function (NaOH in MeOH) could also be achieved without 
isolation of the intermediate [17JOC11727]. 
 
Scheme 1.33  
1.5.3 From 1-Arylprop-2-ynone Derivatives 
Hessian and Flynn reported that regioselectivity from the iodocyclisation of 2-[2-
(substituted)phenyl]alkyl-3-yn-2-ones was achievable. Thus, either the 5-exo-dig or 6-endo-
dig cyclisation route could be controlled by the appropriate choice of starting material. 
When 1-[(2-alkylthio)phenyl]alk-2-yn-1-ones were subjected to iodocyclisation conditions 
they underwent exclusive 5-exo-dig ring closure (A, Scheme 1.34). However, the analogous 
1-[2-(dimethylamino)phenyl]prop-2-yn-1-ones were highly selective for the 6-endo-dig 
pathway (B, Scheme 1.34). These pathways were unaffected by variations of the iodine 




Scheme 1.34  
Larock and co-workers published a route to access 3-iodo(thio)chromones and 3-iodo-4-
quinolones from an ICl-induced electrophilic cyclisation (6-endo-dig) of 1-(aryl)propyn-1-
ones. The starting alkynones were synthesised from a Sonogashira coupling of a 2-
substituted benzoyl chloride and a terminal acetylene, which allowed access to a variety of 
compounds with different substituents by utilising this approach. Cyclisations of the 
alkynones ensue under mild conditions affording fair to excellent yields (45 – 99%) of 
products (Scheme 1.35) [06JOC1626]. 
 
Scheme 1.35 
Derivatives of 1-[2-(BocNH)phenyl]prop-2-yn-1-ones cyclise upon heating with acid, over a 
prolonged time (four days) to give 4-quinolones from which the Boc group has been cleaved 
(A, Scheme 1.36). When the temperature was increased, several side products were also 
formed [09TL6494]. Moreover, 4-quinolones have been synthesised from ynones by a 
gold(I)-mediated cyclisation. Helaja and co-workers obtained a range of 2-substiuted 





The highly alkynophilic gold(I) species [Ph3PAu]SbF6 (generated in situ) was used to cyclise 
ynones 1.51 to indenochromen-4-ones (A, Scheme 1.37), the substrate scope was extended 
to generate indenoquinoline-4-ones 1.52 (B, Scheme 1.37). It was proposed that activation 
of the triple bond by the gold(I) species is assisted by hydrogen bonding of the hydroxyl 
group to the carbonyl function. In the case of the amino substrate, a protecting group was 
needed to change the electron density of the amino group so allowing better hydrogen 
bonding with the ynone carbonyl function [16CC11516]. Although not involving direct 
electrophilic activation of the triple bond, Zhu and co-workers developed a radical process 
to cyclise 2-azidoaryl propynones 1.53 to obtain 2-aryl-3-tosylquinolin-4(1H)-one derivatives 
(C, Scheme 1.37). Attack of the ynone by the electrophilic radical TolSO2• has been invoked 





1.5.4 From ortho-Substituted Phenylacetylenes 
Larock demonstrated that the substituents played an essential role in determining the 
nature of the final product when 2-(1-alkynyl)benzylic alcohols were iodocyclised with 
molecular iodine and an inorganic base (NaHCO3, K2CO3, KHCO3 or NaH) in acetonitrile 
(Scheme 1.38) [10JOC897]. When the triple bond was substituted with a 3-thienyl-, a 1-
cyclohexenyl- or an n-butyl-group the 6-endo-dig product was generated. Furthermore, 
when the starting material possessed either electron withdrawing or electron donating 
groups meta to the hydroxyalkyl group, the 6-endo-dig product was formed. However, with 
increasing steric hindrance in the substrate, complex reaction mixtures were produced. If 




Pal et al. took advantage of the alkyne moiety in 2-sulfamoylphenylacetylenes 1.54 to form 
2H-1,2-benzothiazine 1,1-dioxides 1.55, using a silver(I) catalyst such as AgSbF6 [07JOC8547] 
or AgNO3 [12TL6577] (Scheme 1.39). The reaction tolerated both alkyl and aryl substituents 
on the alkyne moiety [07JOC8547, 12TL6577]. However, the choice of solvent for each 
silver(I) catalyst was different, when AgSbF6 was employed with DMF the yield of 2H-1,2-






1,2-Benzothiazine 1,1-dioxides could be obtained from the Lewis acid-catalysed cyclisation 
of 1.56 with phenyltrifluoromethanesulfanylamide (A, Scheme 1.40). It was found that when 
R1 was an alkyl group the 5-exo-dig product 1.57 was obtained; the cyclisation pathway 
could be controlled by the nature of the R group, if electron-withdrawing groups (Cl and CF3) 
were used then the 6-endo-dig product was obtained selectively [13CC8647]. 2-
Bromobenzenesulfonamides can be coupled with a range of acetylenes via a Sonogashira 
reaction to synthesise 1,2-benzothiazine 1,1-dioxides (B, Scheme 1.40). Intermediate 1.58 
was isolated to establish how the reaction proceeds. Alkynes 1.58 could be activated by 
complexation with copper(I) in a separate step demonstrating that Cu(I) promotes the 6-
endo-dig cyclisation (Scheme 1.40) [15JOC3940]. 
 
 





1.6 Seven-Membered Rings via Electrophilic Cyclisations 
Within the literature there are very few examples of electrophilic cyclisations of substrates 
leading to seven-membered carbocyclic or heterocyclic rings. However some examples are 
discussed below. 
Chen and co-workers found that the iodocyclisations of alkynone 1.59 could operate via two 
pathways, to give either the 7-endo-dig 1.60 or the 6-endo-dig 1.61 product (Scheme 1.41). 
It was found that the substituents on the distal phenyl ring can control the cyclisation 
pathway. If a strong electron-donating group is present in the para position the 6-endo-dig 
(1.61) pathway is favoured, if this group is removed then the 7-endo-dig product (1.60) 
predominates [13CEJ9795, 14JOC3452]. 
 
Scheme 1.41  
Palladium(0) generated in situ has been utilised in the synthesis of polycyclic sultams by a 
novel tandem reaction. The ArPdBr species generated from 1-bromo-2-
(cyclopropylidenemethyl)benzenes 1.62 undergoes carbopalladation with 2-
alkynylbenzenesulfonamides 1.63 and rearrangement to a cyclopropyl-PdBr species 
(Scheme 1.42). The latter is intercepted by the sulfonamide function from which the product 
results with reductive elimination of Pd(0). However, it was expected that the cyclopropane 






Alkylation of the sulfonamide 1.64 in the presence of potassium carbonate in MeCN was 
found to facilitate the cyclisation to isothiazole 1.65 albeit in low yields (9%, Scheme 1.42). 
Use of the base without allyl bromide provided the isothiazole in high yields (78%) 
[09T3180]. Cobalt(0) was used to cyclise 1.66 in a Pauson-Khand reaction, affording the 
tricyclic sultam 1.67 (Scheme 1.43) [09T3180]. 
 
Scheme 1.43  
1,2-Benzothiazepine 1,1-dioxide derivatives 1.68 were afforded in good to excellent yields 
(56 – 99%) from a Pd(II) catalysed reaction of 1-(2-alkynyl)benzenesulfonamide and 2-
alkynylvinyl bromide (Scheme 1.44). Wu and co-workers suggest that the reaction proceeds 
via intermediate A, which after intramolecular insertion of a triple bond affords 
intermediate B. The latter then undergoes a C-N coupling to afford the 1,2-benzothiazepine 





1.7 Aims of the Project  
There is a remarkable gap in the literature in that no systematic study of the electrophilic cyclisation 
of dialkynols, specifically derivatives of 3-arylpenta-1,4-diyn-3-ols possessing a nucleophilic ortho 
substituent have been reported.  
The objective of the present study was to redress this deficiency and to:  
(i) Synthesise a range of 3-phenylpenta-1,4-diyn-3-ols having an ortho-N-linked 
sulfonamide function via addition of alkynyllithiums to methyl 2-
(arenesulfonamido)benzoates. The compounds so obtained will have symmetrical 
terminating groups on the alkyne moieties. 
(ii) Synthesise a range of 3-[2-(arenesulfonamido)phenyl]penta-1,4-diyn-3-ols having 
electronically and sterically dissimilar alkyne terminal groups via addition of 
alkynyllithiums or alkynyl-Grignard reagents to 1-[(2-arenesulfonamido)phenyl]prop-2-
yn-1-ones. 
(iii) Investigate the reactivity of N-substituted saccharins towards alkynyllithium reagents to 
access novel 3-(2-sulfamoylphenyl)penta-1,4-diyn-3-ols. These S-linked sulfonamides, 
isomeric to those prepared initially in (i) have effectively a chain-extension to the 
nucleophilic centre. 
The compounds obtained from (i) – (iii) above will then be treated with a variety of 
electrophilic/alkynophilic activators [e.g. TsOH, I2, ICl, Ag(I) and In(III) salts] as the subsequent 
cyclisations are anticipated to generate novel alkyne-linked heterocyclic rings, which would not be 




















Chapter 2 Synthesis of 3-Arylpenta-1,4-diyn-3-ols 
2.1 3-[2-(Arenesulfonamido)phenyl]-penta-1,4-diyn-3-ols 
Many routes already exist to synthesise propargylic alcohols, such as 1-aryl- and 1,1-diaryl-
prop-2-yn-1-ols. Generally these involve the reaction of aryl aldehydes or aryl ketones 
(possessing either an aryl or alkyl substituent) with an alkynyllithium or alkynylmagnesium 
halide. Various groups on the phenyl ring are tolerated in this reaction, including alkyl, 
amino, hydroxy, halogens and methoxy groups (Scheme 2.1) [13OL5222, 14OL5246, 
14SC1924, 15AGE13711, 15OL5796, 17JOC11659, 18OL3202, 19AGE8898]. 
 
Scheme 2.1  
Other alkynyl organometallic reagents have been employed to generate secondary and 
tertiary propargylic alcohols [15MI201], for example alkynylzincs generated in situ from a 
dialkylzinc reagent (Me2Zn or Et2Zn). These reactions have been developed to provide 
enantioselective routes to alkynols, in the presence of a chiral auxiliary. Niwa and Soai 
varied the chiral auxiliary to optimise the ee and yields achieved, the β-amino alcohol ligand 
Y (A, Scheme 2.2) was found to be the most efficient with 99% yield and 34% ee (where R = 
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R1 = Ph) [90J(P1)937]. Cozzi described additions of zinc alkynides to various ketones with the 
use of a modified salen ligand (L) affording enantioselectively tertiary alcohols (B, Scheme 
2.2) [03AGE2895]. 
 
Scheme 2.2  
There are also numerous examples of dialkynols, some of which have been known for 
decades, of particular interest are 3-phenylpenta-1,4-diyn-3-ols 2.1. Routes to these include 
the reaction of alkynyllithiums or alkynylmagnesium halides with aryl benzoates or aroyl 
chlorides (Scheme 2.3) [1921CB2520, 71JOC749, 13OL5222, 18MI78]. 
 
Scheme 2.3  
However, to date there is only one example of a fully characterised 3-(2-p-
tosylamidophenyl)penta-1,4-diyn-3-ol derivative 2.2 that was reported by Chan and co-
workers (Scheme 2.4) [12CEJ6133]. No experimental details of how they obtained the 1-[(2-
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tosylamido)aryl]but-2-yne-1,4-diol 2.3 from X were provided. We envisage that alcohol X 




As described in Section 1.3, alkynes and to a lesser extent alkynols have been used 
extensively in electrophilic cyclisations to access a diverse array of heterocycles with a range 
of substituents. The use of alkynes and propargylamines to synthesise heterocycles has 
been reviewed [14COSII(4)412, 15SL1305, 16MI49730, 19AHC(127)1]. Therefore it is 
surprising that only one example of a 3-(2-p-tosylamidophenyl)penta-1,4-diyn-3-ol 
derivative has been described so far (2.2, Scheme 2.4). The latter was cyclised with a silver(I) 
salt to a 2,3-alkynylindole (Scheme 1.11) [12CEJ6133]. Previous work carried out by the 
group [16UP1] has shown that the synthesis of 3-(2-p-tosylamidophenyl)penta-1,4-diyn-3-
ols can be carried out with ease.  
Initially, the requisite 2-sulfonamido-benzoates were prepared by sulfonylation of methyl 2-
aminobenzoate. Thus, a solution of the ester in DCM or CHCl3 containing pyridine, was 
treated with the relevant sulfonyl chloride, and the mixture was stirred at room 
temperature overnight (Scheme 2.5). After an aqueous work up the products 2.4a – 2.4d 
(Table 2.1) were obtained in good to excellent yields, following recrystallisation from 
methanol. All compounds synthesised in this way were characterised by their IR, 1H NMR 




Scheme 2.5  
Entry R Solvent  Ester  Yield (%) 
1 Me DCM 2.4a 81 
2 OMe CHCl3 2.4b 62 
3 NO2 DCM 2.4c 71 
4 H DCM 2.4d 70 
Table 2.1 Yields of esters 2.4a – 2.4d 
Varying the nature of the R group on the phenylsulfonyl function will change the 
nucleophilicity of the sulfonamide nitrogen in 2.4. The nitro group being electron 
withdrawing will render the sulfonamide less nucleophilic, and therefore cyclisations with 
this substrate were predicted to be slower than the others. In contrast the methoxy group, 
which is electron donating, should enhance the nucleophilicity of the nitrogen centre thus 
promoting a more efficient cyclisation when the alkyne is exposed to an electrophile. 
With the sulfonamides 2.4 to hand, their reactivity towards alkynyllithiums to afford 
dialkynols was explored, to date only the phenyl and n-butyl substituted 4-methylphenyl 
sulfonamido compounds 2.5a and 2.5c (R1 = Ph or C4H9) have been synthesised by the 
author [16UP1].  n-Butyllithium (3.5 equiv.) was added dropwise to a cold (-78 °C) solution 
of the appropriate acetylene (3.5 equiv.), to ensure complete reaction, in anhydrous THF. 
Excess alkynyllithium is needed to compensate for the deprotonation of the sulfonamide. A 
solution of the methyl 2-(arylsulfonamido)benzoate (1.0 equiv.) in anhydrous THF was 
added dropwise to the warm (-5 °C to 5 °C) solution of the alkynyllithium compound. After 
stirring for 1 h or until complete by TLC, the mixture was quenched with aqueous NH4Cl and 
diluted with ethyl acetate (Scheme 2.6). Purification of crude products either by 
recrystallisation or by flash column chromatography afforded the corresponding dialkynols 





Entry Ester R R1 Dialkynol Yield 
(%) 
Quaternary carbons  
δC (ppm) 
α              β               γ 
1 2.4a Me Ph 2.5a 80 66.27 87.01 86.87 
2 2.4a Me C3H7 2.5b 78 65.36 87.79 79.40 
3 2.4a Me 4-MeOC6H4 2.5c 90 66.27 86.85 86.00 
4 2.4a Me C4H9 2.5d 89 65.36 87.79 79.40 
5 2.4a Me TMS 2.5e 39 65.33 102.21 92.62 
6 2.4a Me CH2OMe 2.5f 0 – – – 
7a 2.4a Me Me 2.5g 16 65.40 83.56 78.31 
8 2.4a Me OEt 2.5h 0 – – – 
9 2.4a Me CH2OH 2.5i 0 – – – 
10 2.4a Me t-Bu 2.5j 79 64.98 95.54 78.00 
11 2.4a Me (CH3)C=CH2 2.5k 65 65.89 87.88 85.92 
12b 2.4a Me H 2.5l 0 – – – 
13 2.4b OMe Ph 2.6a 70 66.27 87.09 86.82 
14 2.4b OMe C3H7 2.6b 73 65.35 87.77 79.44 
15 2.4c NO2 Ph 2.7a 10 67.53 92.19 82.23 
16 2.4c NO2 C3H7 2.7b 11 64.96 86.19 80.18 
17 2.4d H Ph 2.8a 65 66.28 86.96 86.94 
18 2.4d H C3H7 2.8b 0 – – – 
Table 2.2 Yields of dialkynols 2.5 – 2.8. a = From 1-bromopropene and excess LDA, b = reaction with 
ethynylmagnesium bromide in warm (40 °C) THF  
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All of the dialkynol compounds 2.5 – 2.8 showed two characteristic signals in their 13C NMR 
spectra (β, γ, Table 2.2) corresponding to the acetylenic carbons. These are similar to the 
shifts reported by Komatsu et al. for the dialkynol 1,3,5-triphenylpenta-1,4-diyn-3-ol 2.9, in 
which the acetylenic carbons resonate at δC 89.1 (β) and 84.9 (γ) ppm and the quaternary 
benzylic C-OH carbon (α) resonated at δC 65.7 ppm [88TL5157]. The disappearance of the 
ester methyl protons in the 1H NMR spectra further confirmed the formation of the 
dialkynols, as did the appearance of a singlet for the OH proton between δH 2.90 and 4.11 
ppm. 
 
The nitrophenylsulfonamides (entries 15 and 16, Table 2.2) provided the poorest yields of 
products presumably due to side reactions of the nitro group with the organolithium 
reagent. Nitro arenes are known to undergo ortho lithiation, [82ACR300] other side 
reactions can occur also with Grignard reagents and nitro groups [12OL5618]. 
Attempts to synthesise the terminal alkyne analogue 2.5l R1 = H (entry 12, Table 2.2) 
involved addition of ethynylmagnesium bromide to 2.4a in warm (40 °C) anhydrous THF 
followed by heating under reflux. Unfortunately, the crude material obtained following 
aqueous work-up was a complex mixture which afforded no identifiable products. 
Compound 2.8b (entry 18, Table 2.2) was shown by 1H NMR to be approximately 50% pure, 
unfortunately attempts at purification were thwarted, as it co-eluted with unreacted 
starting material. Methyl 2-(p-tosylamido)benzoate 2.4a was reacted with LiC≡CCH2OMe, 
derived from methyl propargyl ether or with the dianion LiC≡CCH2OLi derived from 
propargyl alcohol (entries 6 and 9 respectively, Table 2.2). Unfortunately, both acetylides 
failed to react and in each case only starting material was recovered. Evidently double 
addition of these acetylides to the ester function was not favoured. Formation of the 2-
hydroxy-2-(3-methoxyprop-1-yn-1-yl)-cyclohexane-1-carboxylate 2.10 (A, Scheme 2.7) by 
preferential addition of the (3-methoxyprop-1-yn-1-yl)magnesium chloride to the ketone 
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moiety has been reported [17OL4980]. In a similar manner the dianion LiC≡CCH2OLi reacted 
smoothly with the steroidal ketone 2.11 (B, Scheme 2.7) [08BAC1987]. 
 
Scheme 2.7  
Prop-1-yn-1-yllithium was generated in situ from treatment of 1-bromopropene with excess 
LDA in THF [92SC2997], as shown in Scheme 2.8. Addition of the ester 2.4a to the 
propynyllitium solution afforded dialkynol 2.5g in only 16% yield (entry 7, Table 2.2), this is 
the lowest yield achieved from acetylide addition to ester 2.4a (Table 2.2). 
 
Scheme 2.8 
Ethoxyethynyllithium generated in situ from chloroacetaldehyde diethyl acetal and LDA 
(Scheme 2.9) [87JOC2332, 05MI254], also failed to provide the corresponding ethoxyalkynol 
2.5h (entry 8, Table 2.2). Only a complex black mixture was obtained from the reaction, this 
could have been due to the unfavourable double addition to an ester moiety or the 





Regrettably, lithiation of commercially available ethoxyacetylene (solution in hexanes) was 
also unsuccessful in affording the desired alkynol 2.5h. Many reactions have been reported 
with effective addition of ethoxyacetylene to ketones and aldehydes [06JA15106, 
07JOC9736, 08JA13528, 12EJO5803, 12SL1675, 14AGE10747, 14OL1176]. 
Acyl chlorides are more reactive than esters towards nucleophiles due to the electron 
withdrawing chlorine, which in-turn makes the sp2 carbon of the carbonyl group more 
electrophilic. Therefore a suitable acyl chloride may provide an alternative starting material 
for the dialkynols which could not be accessed from 2.4a. 2-(Tosylamido)benzoyl chloride 
2.13 was synthesised from N-tosylanthranilic acid as shown in Scheme 2.10 [11T5564]. 
 
Scheme 2.10  
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2-(Tosylamido)benzoyl chloride was used in the reactions that had either failed or had 
provided some of the lower yielding products from ester 2.4a. Thus, reaction of the benzoyl 
chloride 2.13 with excess lithium (trimethylsilyl)acetylide provided dialkynol 2.5e in a 
substantially better yield (65%, Scheme 2.11) than from methyl N-tosylanthranilate 2.4a 
(39%, entry 5, Table 2.2). It was thought that the acid chloride would react smoothly with 
the dianion LiC≡CCH2OLi, derived from propargyl alcohol at the terminal carbon anion to 
afford the desired dialkynol 2.5i. However, the only product obtained from the reaction was 




The 13C NMR signals of 2.14 showed the presence of an ester carbonyl rather than the 
quaternary sp3 centre from a tertiary alcohol. Hradil previously reported the propargyl ester 
2.15 (Figure 2.1), prepared from isatoic anhydride and HC≡CHCH2ONa, for which the NMR 




Figure 2.1 NMR (1H and 13C) comparison of 2.14 (CDCl3) and 2.15 (DMSO-d6) 
Ynones exemplified by structure 2.16 provide an interesting set of compounds, as they have 
been shown to cyclise in the presence of an iodine electrophile. Larock demonstrated that 
1-(2-methoxyphenyl)prop-2-yn-1-ones having either a 3-alkyl- or a 3-aryl- substituent 
cyclised easily to 3-iodochromones with ICl to give mostly high yields (44 – 99%) (Scheme 
2.12). They also reported the synthesis of 3-iodothiochromones and 3-iodoquinolin-4-ones 
via this procedure, again in high yields (Scheme 2.12) [06JOC1626]. 
 
Scheme 2.12 
There are a plethora of routes to synthesise ynones and some of the more useful pathways 
are shown in Scheme 2.13 [19CRV11110]. A large number of examples provided are by the 
C-H bond insertion of a metal to a terminal alkyne and the subsequent coupling reaction 
with an acyl chloride (A, Scheme 2.13) [56JA1675, 82JOC2549, 75JOC131, 11AGE10448]. 
Other examples include; organometallic (alkynylmetal) addition to a Weinreb amide (B, 
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Scheme 2.13) [81TL3815], alkynyl Grignard reagent addition to an acid anhydride (C, 
Scheme 2.13) [36JA1861], oxidation of a secondary propargyl alcohol (D, Scheme 2.13) 
[15MI107] or the Pd-mediated carbonylative coupling of a terminal acetylene and an aryl 
halide (E, Scheme 2.13) [03OL3057]. 
 
Scheme 2.13 
Cyclisations of 1-[2-tosylamidophenyl]propynones 2.17 could offer a simple route to 
synthesise 3-iodo-1-tosyl-4-quinolones 2.18 of which there are currently no examples. 
Furthermore, it was envisaged that addition of a lithium acetylide would provide an entry to 





Initially access to the ynones 2.17 utilised the Weinreb amide 2.20 (2-amino-N-methoxy-N-
methylbenzamide) that was synthesised by acylation of N,O-dimethylhydroxylamine with 
isatoic anhydride in aqueous EtOH under basic conditions. Following work-up, flash column 
chromatography provided the Weinreb amide 2.20 in 50% yield (Scheme 2.15) [14CC12293]. 
The 1H NMR spectrum of 2.20 showed the appearance of two singlets corresponding to the 
methyl protons, indicating that isatoic anhydride unit was no longer intact. Subsequent N-
sulfonylation of the Weinreb amide (2.20) was accomplished by treatment with TsCl in 
refluxing pyridine (Scheme 2.15). Following an acidic aqueous workup, the crude material 
was purified by flash column chromatography and trituration of the resulting oil with ether 
to afford the tosylated amide 2.21 in 81% yield [16JOC2930]. 
 
Scheme 2.15 
The 1-arylpropynones 2.17 were synthesised simply by treatment of Weinreb amide 2.21 
with an excess of alkynyllithium in THF at -78 °C to 0 °C for 1 h (Scheme 2.16). After this time 
the mixture was quenched with aqueous NH4Cl. Isolation via EtOAc gave an orange oil which 
crystallised on trituration with ether. This crude product was washed with cold ether to 








Entry  R1 Ynone  Yield (%) 
1 Ph 2.17A 55 
2 C3H7 2.17B 66 
3 4-MeOC6H4 2.17C 66 
Table 2.3 Yields of ynones 2.17 
The 1H NMR spectra of ynones 2.17 matched those reported by Ramasastry et al. 
[16AGE7737]. The ynone R1 = C3H7 (2.17B) is a novel compound and so was further 
confirmed by HRMS, that exhibited a molecular ion [M+H]+ at m/z 342.1148 corresponding 
to C19H19NO3S. 
1-(2-Tosylamidophenyl)propynones 2.17 were the primary starting materials for the 
unsymmetrical dialkynols (2.19). The latter were obtained by two methods with the majority 
being synthesised by simple treatment with an excess of an alkynyllithium in THF for 1 h 
(Method A, Scheme 2.17). After this time the mixture was quenched with aqueous NH4Cl. 
Isolation via EtOAc gave the crude product which was purified either by recrystallisation or 
by flash column chromatography, to afford the novel compounds in Table 2.4 in generally 
high yields. Excess ethynylmagnesium bromide (0.5 M in THF) was added to a warm solution 
of 2.19 in anhydrous THF and refluxed until complete by TLC (Method B, Scheme 2.17). After 
this time the mixture was allowed to cool and quenched with aqueous NH4Cl, isolation via 
EtOAc gave the crude product, which was purified by flash column chromatography, to 











1 2.17A Ph C3H7 A 2.19Ab 86 
2 2.17A Ph 4-MeOC6H4 A 2.19Ac 86 
3 2.17A Ph CH2OMe A 2.19Af 73 
4a 2.17A Ph Me  A 2.19Ag 28  
5 2.17A Ph t-Bu  A 2.19Aj 88  
6 2.17A Ph (CH3)C=CH2 A 2.19Ak 76 
7 2.17A Ph H B 2.19Ai 65 
8 2.17B C3H7 H B 2.19Bi 64 
9 2.17C 4-MeOC6H4 C3H7 A 2.19Cb 74 
10 2.17C 4-MeOC6H4 CH2OMe A 2.19Cf 73 
11 2.17C 4-MeOC6H4 H B 2.19Ci 64 
Table 2.4 Yields of unsymmetrical dialkynols 2.19. a = From 2-bromopropene and excess LDA 
 
All the compounds 2.19 (Table 2.4) exhibited four carbon signals in the range δC 60 – 89 
ppm corresponding to the acetylenic carbons and the quaternary C-OH signal between δC 65 
– 66 ppm. Of particular note was that some of the acetylides which did not react with the 
ester 2.4a added smoothly to the ynones 2.17 (entry 3, 7, 8, 10 and 11, Table 2.4); (3-
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methoxyprop-1-yn-1-yl)lithium (entry 3 and 10 Table 2.4) and ethynylmagnsium bromide 
(entry 7, 8, and 11 Table 2.4) provided good yields of products. No doubt smooth addition of 
the acetylide and Grignard reagent was facilitated by the less conjugated, less hindered 
carbonyl group in the ynone 2.17 compared to that in the ester 2.4a. The ready formation of 




To date there are few aryl (di)alkynols in which the aryl ring is substituted with a primary, 
secondary or tertiary sulfamoyl group i.e. -SO2NH2, -SO2NHR or -SO2NR2 respectively. The 
majority of known compounds have the alkyne moiety bonded to the same aromatic ring as 
the sulfonamide function e.g. 2.22 (via Csp – Csp2 bond), rather than as a tertiary propargylic 
alcohol function (via Csp – Csp3 – Csp2 linkages) e.g. 2.23. 
 
Compounds of the general structure 2.5 – 2.8 represent N-linked sulfonamides as described 
previously (Section 2.1). Isomeric to these are the S-linked sulfonamides 2.23 (2-






Pal et al. employed a Sonogashira cross-coupling to 2-iodo-N-methylbenzenesulfonamides, 
to give a range of 2-alkynyl benzenesulfonamides in high yields A, Scheme 2.18 
[07JOC8547]. Wang and co-workers also utilised a Sonogashira coupling to synthesise a 
range of propargylic alcohols B, Scheme 2.18 [15OL242]. 
 
Scheme 2.18 
2-Sulfamoylphenyl dialkynols could be potentially synthesised by the ring opening of o-
sulfobenzoic anhydride with MeOH and subsequent halogenation with PCl5 [06JA11693] to 
obtain methyl 2-(chlorosulfonyl) benzoate. Subsequent reaction with an aromatic amine and 
DMAP would afford ester 2.24 [WO9912916]. Nucleophilic addition to the ester moiety 







A drawback to this approach is the number of steps to provide dialkynol 2.23, as well as the 
cost of o-sulfobenzoic anhydride (£10.00 per g, Fluorochem). The anhydride can also be 
synthesised from saccharin, via hydrolysis-dehydration with H2SO4 [11SC1101]. However this 
process will add an extra step in the sequence. A more direct route to the corresponding 
1,5-disubstituted-3-[2-(N-arlysulfamoyl)phenyl]penta-1,4-diyn-3-ols 2.23 would involve 
addition of an alkynyllithium to an N-substituted saccharin derivative 2.25 (Scheme 2.20). 
 
Scheme 2.20 
Surprisingly the reaction of organometallic reagents to saccharin derivatives has received 
almost no attention [03T7445, 10CME65]. The only report for many decades related to the 
reaction of N-phenylsaccharin with Grignard reagents (MeMgI, EtMgBr and PhMgBr) to 
afford the tertiary alcohol, from an addition, ring cleavage addition sequence as shown in 
Scheme 2.21 [52JCS1339]. 
 
Scheme 2.21 
However, more recently, the reaction of saccharin with excess PhMgBr has been reported. 
The crude reaction mixture was subjected to treatment with acid (TsOH) to afford the 






Earlier work by Oppolzer described the preparation of 3-alkyl-1,2-benzisothiazole 1,1-
dioxides from reaction of saccharin with either methyllithium [90TL4117] or with t-BuLi 
[91TL4893] in THF at low temperature. No tertiary alcohols were observed from these 
reactions. 
Initially a series of substituted saccharins were synthesised by either N-alkylation or N-
arylation. For example, iodomethane was added dropwise to a solution of sodium saccharin 
in DMF, the mixture was stirred at 100 °C overnight (Method A, Scheme 2.23). After this 
time the reaction mixture was allowed to cool, quenched with water and the resultant 
precipitate was collected to afford 2.25A in a 63% yield [15CEJ5532].  
For N-aryl saccharins a Chan-Lam-(Evans) coupling of saccharin with arylboronic acids in the 
presence of Cu(OAc)2 and pyridine (Method B, Scheme 2.23) was employed to afford 2.25B 











Entry Method R Product  Yield (%) 
1 A Me 2.25A 63  
2 B Tolyl 2.25B 95  
3 B 3-MeC6H4 2.25C 59  
4 B 2-MeOC6H4 2.25D 48  
5 B 3-MeOC6H4 2.25E 82  
6 B 2-thienyl 2.25F 0 
7 B 3-thienyl 2.25G 65  
8 B 2-naphthyl 2.25H 87  
Table 2.5 Yields of N-substituted saccharins 2.25A – H 
A proposed catalytic pathway for the Chan-Lam-(Evans) coupling reaction of saccharin and 
arylboronic acids is shown in Scheme 2.24 [17JA4769, 17OBC801]. First saccharin is 
deprotonated by pyridine, followed by complexation with the Cu(II) to give species X. 
Subsequent transmetallation with the arylboronic acid leads to the transfer of the aryl group 
from the boronic acid to the Cu(II) species and concomitant oxidation generated the 
copper(III) intermediate (Y). Reductive elimination of the N-substituted saccharin and 
sequential oxidation and ligand exchange regenerates the Cu(OAc)2. 
The pathway depicted in Scheme 2.24 is based upon the stabilities of intermediates in 





The constitution of all of the N-substituted saccharins 2.25 were confirmed by comparison 
of their m.p., 1H and 13C NMR spectra to those in the literature [15CEJ5532, 17SL2000]. The 
N-substituted saccharins 2.25 are all known compounds, with 2.25A, B and E – H (entries 1, 
2, 5, 7 and 8, Table 2.5) being synthesised via a Chan-Lam coupling of the relevant aryl 
boronic acid and saccharin [15CEJ5532]. However, compounds 2.25C – D (entries 3 and 4, 
Table 2.5) were prepared previously by a Pd-catalysed carbonylative cyclisation of N-aryl-2-
iodobenzenesulfonamides [17SL2000]. Use of the Chan-Lam coupling therefore represents a 
new route to these N-aryl saccharins.  
Attempted N-arylation of saccharin with thiophene-2-boronic acid gave none of the desired 
product 2.25F (entry 6, Table 2.5). No doubt this failure stems from the propensity of 
thiophene-2-boronic acid to undergo protodeboronation under a variety of conditions 
[10JA14073]. On the other hand, coupling of thiophene-3-boronic acid to saccharin afforded 
2.25G in 65% yield with a m.p. 170 – 172 °C (literature m.p. 173 – 175 °C) [15CEJ5332]. 2-(2-
Thienyl)saccharin 2.25F is a known compound but was prepared via an oxidative 
(Selectfluor) copper-catalysed (CuCl) amination reaction of thiophene with saccharin 





With a series of N-substituted saccharins (2.25) now available their reactivity towards a 
variety of alkynyllithiums was investigated. Thus, n-butyllithium (2.3 equiv.) was added 
slowly to a cold (-78 °C) solution of the appropriate acetylene (2.3 equiv.) in anhydrous THF. 
A solution of the saccharin derivative 2.25 (1.0 equiv.) in anhydrous THF was added slowly 
to the cold (-5 °C to 5 °C) lithium acetylide solution. After stirring for 1 h the mixture was 
then quenched with aqueous NH4Cl and diluted with EtOAc (Scheme 2.26). Purification of 
crude products either by recrystallisation or by flash column chromatography afforded the 
















R R1 Dialkynol Yield (%) Quaternary carbons  
δc (ppm) 
α              β               γ 
1 2.25A Me Ph 2.23Aa 98 67.02 88.54 86.61 
2 2.25A Me C3H7 2.23Ab 97 66.29 87.23 81.04 
3 2.25A Me TMS 2.23Ae 68 66.30 92.14 87.10 
4 2.25B Tolyl Ph 2.23Ba 80 67.05 88.80 86.92 
5 2.25B Tolyl C3H7 2.23Bb 76 66.28 87.62 81.44 
6 2.25B Tolyl 4-MeOC6H4 2.23Bc 93 67.06 87.78 86.92 
7 2.25B Tolyl TMS 2.23Be 63 66.83 105.25 93.09 
8 2.25B Tolyl CH2OMe 2.23Bf 66 65.72 85.84 82.84 
9 2.25B Tolyl OEt 2.23Bh 0      –   –   –   
10 2.25B Tolyl CH2OH 2.23Bi 0 –   –   –   
11 2.25C 3-MeC6H4 Ph 2.23Ca 94 67.08 88.82 86.90 
12 2.25C 3-MeC6H4 C3H7 2.23Cb 84 66.31 87.59 81.46 
13 2.25D 2-MeOC6H4 Ph 2.23Da 59 66.41 89.63 85.31 
14 2.25D 2-MeOC6H4 C3H7 2.23Db 74 66.15 87.17 80.88 
15 2.25D 2-MeOC6H4 TMS 2.23De 62 66.32 104.00 91.87 
16 2.25E 3-MeOC6H4 Ph 2.23Ea 84 67.08 88.78 86.90 
17 2.25E 3-MeOC6H4 C3H7 2.23Eb 74 66.33 87.62 81.43 
18 2.25G 3-thienyl Ph 2.23Ga 42 67.05 88.66 86.87 
19 2.25G 3-thienyl C3H7 2.23Gb 69 66.31 87.57 81.30 
20 2.25H 2-naphthyl Ph 2.23Ha 98 67.16 88.85 86.96 
21 2.25H 2-naphthyl C3H7 2.23Hb 89 66.40 87.68 81.40 
Table 2.6 Yields of reversed sulfonamide dialkynols 2.23  
68 
 
The formation of the reversed sulfonamides 2.23Aa – Hb can be rationalised as shown in 
Scheme 2.27. Initial nucleophilic addition of a lithium acetylide unit to the amide carbonyl 
group results in ring opening to afford ynone 2.26, which possess a sulfonamide-stabilised 
anion. Facile addition of the second lithium acetylide species will then take place. Finally, an 




All reversed sulfonamides 2.23Aa – Hb showed two characteristic signals in their 13C NMR 
spectra (β, γ, Table 2.6) corresponding to the acetylenic carbons, which are similar to that 
seen for the dialkynols 2.5 – 2.8 (Table 2.2). Of note is the downfield shift of the β carbon in 
the TMS substituted compounds 2.23Ae, 2.23Be and 2.23De (entries 3, 7 and 15, Table 2.6). 
Trimethyl(phenylethynyl)silane has been reported to have similar 13C shifts (Scheme 2.28) to 
those seen in the TMS substituted reversed sulfonamides 2.23Ae, 2.23Be and 2.23De, this 
deshielding of the β-carbon has been attributed to the resonance form shown in Scheme 





Interestingly these sulfamoyl-substituted dialkynols or reversed sulfonamides (2.23Aa – Hb) 
have very different 1H NMR spectra to those of the 2-tosylamido dialkynols 2.5 – 2.8 derived 
from the N-tosyl anthranilate. The 1H NMR spectra in Figure 2.2 (2.5a and 2.23Ba) are 
illustrative of the striking difference between the two species. The most deshielded proton 
in 2.5a gives rise to the apparent doublet at δH 7.91 ppm (black star, red spectrum, Figure 
2.2) whereas in the reversed sulfonamide 2.23Ba the same signal is substantially deshielded 
and absorbs at δH 8.44 ppm (black star, blue spectrum, Figure 2.2). In both cases the low 
field signal originates from the 2-H proton i.e. ortho to the dialkynylmethanol moiety. The 
assignments of both these (black stars) signals was established from consideration of the 2D 
NMR spectra (1H – 1H COSY, HSQC and HMBC) of both compounds. 
 
Figure 2.2 400 MHz 1H NMR spectral comparison of 2.5a and 2.23Ba in CDCl3 
The HMBC spectrum of 2.5a provided definitive confirmation that the apparent doublet at 
δH 7.91 ppm (black star, red spectrum, Figure 2.2) corresponds to 2-H because of a 
correlation (3J coupling) with the quaternary sp3 C-OH at δC 66.27 ppm (Figure 2.3). The 1H – 
1H COSY spectrum (Figure 2.3) of 2.5a enabled identification of the tosyl group protons. 
Thus, the two-proton doublet at δH 7.79 ppm (red spectrum, pink star, Figure 2.2) can be 
assigned to the protons ortho to the sulfone function. The COSY exhibits a cross peak 
between the doublet (δH 7.79 ppm) and the partially overlapped doublet at δH 7.01 ppm. 
The latter signal is coupled to the methyl protons (δH 2.28 ppm) and consequently 









In the 1H NMR spectrum of the reversed sulfonamide 2-(N-tolylsulfamoyl)dialkynol 2.23Ba, 
the doublet at δH 6.90 ppm (blue spectrum, pink star, Figure 2.2) corresponds to the two 
tolyl ring protons ortho to the NH function. The 1H – 1H COSY spectrum (Figure 2.4) revealed 
the Ar-H protons ortho to the Ar-Me group absorb at δH 6.97 ppm, confirming the 
assignment of the pink starred signal (blue spectrum, Figure 2.2). 
Most striking in the 1H NMR spectrum of 2.23Ba (blue spectrum, Figure 2.2) is the low field 
doublet of doublets at δH 8.45 ppm (black star, blue spectrum, Figure 2.2). At first it was 
thought the signal corresponded to the 5-H proton (ortho to the electron withdrawing 
sulfamoyl group, -SO2NHTolyl). However this was dismissed by examination of the HMBC 
spectrum (Figure 2.4) which revealed an interaction (3J) between the 2-H proton and the 
quaternary sp3 carbon C-OH (δC 67.05 ppm). The pronounced downfield shift of the 2-H in 
2.23Ba (black star, blue spectrum, Figure 2.2) is most unusual and is observed throughout 
the reversed sulfonamide series 2.23Aa – Hb. Presumably this deshielding originated from 
the proximity of the 2-H to one of the anisotropic alkyne units. Protons situated above 
alkene or alkyne moieties are known to experience deshielding and the origins of this have 





















Interestingly the X-ray crystal structure of 2.23Bb (Figure 2.5) revealed that the 2-H proton 
is located (in the crystal) near one of the alkyne functions. Of course, it must be recognised 





Figure 2.5 X-Ray crystal structure of 2-(6-hydroxyundeca-4,7-diyn-6-yl)-N-(p-
tolyl)benzenesulfonamide 2.23Bb 
Lithium ethoxyacetylide and the dianion LiC≡CCH2OLi, from propargyl alcohol both failed to 
react with N-(p-tolyl)saccharin (entry 9 and 10, Table 2.6). In the case of the ethoxyacetylide 
entry 10 (Table 2.6) a very complex mixture was obtained, whereas with the dianion (entry 
10, Table 2.6) only starting material was recovered. These observations support the 
previous findings that the double addition of these lithium acetylides (LiC≡CCH2OLi and 






2.3 Base-Mediated 5-Exo-Dig Cyclisation of 3-[2-(Tosylamido)phenyl]penta-
1,4-diyn-3-ols 
As the addition of ethynylmagnesium bromide to ester 2.4a, did not yield any tractable 
products (entry 12, Table 2.2), attempts to access the parent dialkynol 2.5l (R1 = H) then 
focused on removal of the TMS groups from dialkynol 2.5e, which was envisaged to proceed 
straightforwardly (Scheme 2.29).  
 
Scheme 2.29 
Thus, 1,5-bis(trimethylsilyl)-3-[2-(tosylamido)phenyl]penta-1,4-diyn-3-ol was stirred in cold 
MeOH with the slow addition of aqueous 5M NaOH (2 equiv.). After dilution with water and 
isolation via EtOAc, attempts to purify the mixture by column chromatography produced 
numerous decomposition products and only one identifiable fraction was isolated in a very 
low yield (2%). The 1H NMR spectrum (Figure 2.6) of this material showed the presence of 
an alkene moiety, due to the appearance of two doublets (2J = 2.0 Hz) each integrating for 
one proton at δH 5.90 and 5.47 ppm (Figure 2.6). 
After careful examination of both 1D and 2D NMR spectra (1H – 1H COSY, HSQC and HMBC) 
the unknown product was characterised as 3-ethynyl-2-methylene-1-tosyl-2,3-dihydroindol-






Figure 2.6 400 MHz 1H NMR spectrum of 2.27 in CDCl3 
The doublets at δH 5.92 and 5.48 ppm have similar shifts to those reported by Chan and co-
workers, for a related indoline (2.28, Scheme 2.30), prepared by Ag(I)-mediated cyclisation 




Initially it was thought that the formation of 2.27 could be due to the acidity of the silica 
used in flash column chromatography, and can be rationalised by protonation of one of the 
alkyne units to give the vinylic carbocation 2.29, which is susceptible to attack from the 
sulfonamido group, with cyclisation to afford 3-ethynyl-2-methylene-1-tosyl-2,3-
dihydroindol-3-ol 2.27 (Scheme 2.31). No improvement in yield was observed if the reaction 
mixture (crude desilylation) was acidified (AcOH) or heated with AcOH. Unfortunately 
attempts to further purify the material from acidic reactions was unsuccessful, producing a 






As acid did not promote cyclisation of the expected terminal dialkynol 2.5l to 2.27 as 
anticipated, it was thought that the cyclisation must occur during removal of the TMS 
groups. Removal of the TMS groups from 2.5e was again attempted, but a large excess of 
aqueous 5M NaOH (28.3 equiv.) was used. After an aqueous workup the 1H NMR spectrum 
showed that crude material was indeed the desired 1-tosylindoline 2.27, moreover the 
conversion was quantitative. Consequently, the cyclisation is base catalysed.  
It is not known whether the cyclisation proceeds with initial desilylation (pathway A, 
Scheme 2.32) or if this step follows formation of the indoline ring (pathway B, Scheme 2.32). 
Therefore, the proposed mechanisms for both the TMS protected dialkynol and the 
deprotected dialkynol are shown in Scheme 2.32. In both cases the sulfonamide nitrogen 
will be deprotonated under basic conditions and can then undergo nucleophilic attack on 





This novel base-mediated indoline ring synthesis was investigated further. Replacement of 
the alkyne terminal groups was explored (Scheme 2.33). Thus, 2.5a and 2.5b were subjected 
to basic conditions to investigate whether internal alkynes would also cyclise. Unfortunately 
only starting material was recovered from these reactions, suggesting that either the 
presence of a silyl moiety or a terminal alkyne group is a necessary prerequisite. 
 
Scheme 2.33 
Literature examples of purely base-mediated cyclisations onto pendant alkynes are scarce, 
and of relevance is the 5-exo-dig cyclisation of 2-alkynylanilines to afford mostly indoles 
(Scheme 2.34). Knochel and co-workers synthesised a variety of indoles and related ring-
fused derivatives, it was found the reaction worked with a range of bases but KH or KOtBu 
were used in varying ratios (A, Scheme 2.34) [00AGE2488]. Sodium hydroxide was used to 
promote the base-mediated cyclisation of 2-alkynylanilines affording a range of indoles in 
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high yields (74 – 91%) (B, Scheme 2.34). However the conditions used were rather harsh 
[08SL3006, 11JOC3416]. Sanz et al. also observed the deprotection of the silyl groups when 
o-trimethylsilylethynylanilides were used (C, Scheme 2.34), affording 2-unsubstituted 4-
halo-1H-indoles (R = H). They did not allude to the point of the desilylation step in the 










With this novel pathway to indoline 2.27 it was envisioned that previously synthesised 
unsymmetrical dialkynols 2.19Ai, 2.19Bi and 2.19Ci may also undergo this base mediated 5-
exo-dig cyclisation, Scheme 2.35.  
 
Scheme 2.35 
In order to verify this proposal, a range of other TMS-substituted unsymmetrical dialkynols 
2.19Ae, 2.19Be and 2.19Ce (Scheme 2.33) were synthesised by addition of Li-C≡C-TMS to 
the appropriate ynone 2.17A – C. The TMS-dialkynols were obtained in excellent yields as 
oils; examination of the crude products’ 1H NMR spectra revealed trace amounts of the 
indolin-3-ols. Consequently, the dialkynols 2.19Ae, 2.19Be and 2.19Ce were not purified 
further and carried forward directly for the base-catalysed cyclisations. The desilyldialkynols 
(Scheme 2.17, Table 2.4, page 59) were prepared by addition of ethynylmagnesium bromide 






Base-mediated cyclisations of the unsymmetrical dialkynols 2.19Ai – 2.19Ci and 2.19Ae – 












1 TMS 2.5e 0.25 28.3 2.27 100 102.41 
2 Ph 2.19Ae 24 11.2 2.30A 76 
99.70 
3 Ph 2.19Ai 1 59.5 2.30A 70* 
4 C3H7 2.19Be 24 10.1 2.30B 62 
101.77 
5 C3H7 2.19Bi 0.5 5.0 2.30B 91 
6 4-MeOC6H4 2.19Ce 24 22.9 2.30C 40 
102.07 
7 4-MeOC6H4 2.19Ci 24 60.4 2.30C 77 
Table 2.7 Yields of the base mediated cyclisation to 2.27 and 2.30. *By 1H NMR 
Table 2.7 indicates that in some cases a large excess of base was used to effect the ring 
closure. Generally, sufficient aqueous 5M NaOH was added to a methanolic solution of the 
dialkynol until TLC indicated that formation of the product had commenced or was 
complete. 
The quantitative yield achieved from entry 1 (Table 2.7) in comparison to the other entries 
may indicate that the TMS group exerts a stabilising influence upon the cyclisation 
intermediate (anion), by the α-effect of the silyl group [93JOC1778, 94JA8304]. However this 
was not the case with the other silyl dialkynols and in general the terminal alkyne 
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derivatives produced better yields, with exception of 2.19Ai (entry 3, Table 2.7). This 
difference is probably due to the difficulties in purification of the indoline 2.30A from this 
substrate compared with the reaction of its TMS analogue 2.19Ae (entry 2, Table 2.7).  
All 2-methyleneindolines 2.27 and 2.30A – C showed two characteristic doublets in the 
region of δH 5.80 – 5.90 ppm and 5.41 – 5.47 ppm with a geminal coupling of 2J = 2.0 – 1.7 
Hz, corresponding to the alkene protons.  
It is noteworthy that the 3-alkynyl-2-methylene-1-tosylindolin-3-ols 2.27 and 2.30A – C are 
all novel compounds and thus represent the ‘missing’ examples in the series below (Scheme 
2.38). Chan et al. synthesised the 3-phenyl- and 3-methyl- substituted indolin-3-ols from 
alkynols with the use of Ag(I) catalysis [12JOC7166]; the phenyl analogue (R = Ph) was also 
obtained in a poor yield with a Au(I) catalyst (A, Scheme 2.38) [15JA8912]. Ramasastry and 
co-workers could not access the 3-allylindoline 2.31 (R = H) but the benzylidene indolinol (R 






2.4 Silver(I) Catalysed 5-Exo-Dig Cyclisation of 3-[2-(Tosylamido)phenyl]  
penta-1,4-diyn-3-ols 
Many cyclisations of alkynes reported in the literature use silver(I) salts due to their affinity 
for triple bonds, the exploitation of this affinity has been reviewed numerous times 
[08CRV3174, 15CSR8124, 19AHC(127)1, 19MI1]. Silver has the electronic configuration 
[Kr]4d105s1. The alkynophilicity of Ag(I) can be explained by invoking σ-overlap of a vacant 
orbital on the metal with the C≡C π-system (M ← L) with simultaneous, but weaker, back-
donation from a silver 4d orbital to an alkyne π* orbital (M → L). Overall, the decrease in the 
electron density in the triple bond (with a decrease in bond order) renders it susceptible to 
nucleophilic attack. Detailed discussion of the nature of alkyne-metal π-complexation for 
silver and related metals is available. The Dewar-Chatt-Duncanson (DCD) and 
Metallacyclopropene models have been used to rationalise Ag(I)-alkyne interactions with an 
alkyne (Scheme 2.39) [14MI134, 15CSR8124, 19MI1]. Alkynophilicity has also been 




Some examples in which silver(I) salts have been used to catalyse the cyclisation of alkynes 
to various heterocycles are shown in Scheme 2.40. 4-Hydroxyquinoline2(1H)-ones can be 
synthesised by the Ag(I) catalysed intramolecular rearrangement of 4-alkylidene-3,1-
benzoxazin-2-ones generated in situ form 2-alkynylanilines in the presence of CO2 (A, 
Scheme 2.40) [13OL3710]. Hao et al. accessed pyrrolo[1,2-a]indoles from the silver(I) 
catalysed reaction of a variety of propargyl alcohols and 3,5-disubstitued indoles in varying 
yields (32 – 96%). It was found that the reaction pathway proceeded via two different 
routes, for secondary alcohols C2-propargylation followed by 5-endo-dig cyclisation, whilst 
with tertiary alcohols a C2-allenylation was followed by a 5-endo-trig cyclisation (B, Scheme 
2.40) [10ASC3215]. 3-Substituted-1,2-benzothiazines were obtained from the Ag(I) 
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mediated cyclisations of o-(1-alkynyl)benzenesulfonamides in high yields 75 – 80% (C, 
Scheme 2.40) [12TL6577]. 
 
Scheme 2.40 
A selection of conditions were evaluated with dialkynol 2.5a to investigate its reactivity 
towards silver(I) and its potential for cyclisation, by activating the alkyne unit towards 




Reactions of the dialkynol 2.5a with either AgOTf 5 mol % in PhMe (i), or with AgOTf 10 mol 
% in DCM (ii), provided only a complex mixture of products (i, Scheme 2.41) or recovery of 
starting material (ii, Scheme 2.41) respectively. On the other hand, AgOAc (5 mol %) in 
MeCN (iii, Scheme 2.41) resulted in a more successful outcome and provided a quantitative 
yield of the novel indole 2.32a as a brown oil. The structure of 2.32a was established from 
its NMR spectra, which is discussed on page 90 (Figure 2.10). Treatment of 2.5a with AgNO3 
on silica (5 mol %) in MeCN (vi, Scheme 2.41) followed a different course to give (Z)-2-
benzylidene-3-(phenylethynyl)-1-tosylindolin-3-ol 2.33a in a quantitative yield. The 
constitution of the indol-3-ol 2.33a was established principally from its 1H spectrum which 
exhibited broadened doublets at δH 7.86 and 7.54 ppm corresponding to the 4-H and 7-H 
protons respectively (Figure 2.7). The signals for these protons were assigned from the 
HMBC spectrum. The 7-H proton exhibits an interaction with the 7a carbon. The benzylidene 
proton (blue star, Figure 2.7) absorbs at δH 6.99 ppm, however it overlaps with the tolyl ring 
protons. 
 
Figure 2.7 400 MHz 1H NMR spectrum of (Z)-2-benzylidene-3-(phenylethynyl)-1-tosylindolin-3-ol 
2.33a in CDCl3 
Confirmation of the stereochemistry of (Z)-2-benzylidene-3-(phenylethynyl)-1-tosylindolin-
3-ol 2.33a was established by the NOESY spectrum. Figure 2.8 shows the energy minimised 
Chem3D structure of 2.33a and its likely conformation. This structure reveals that the p-tolyl 
group is by virtue of attachment to the tetrahedral sulfone unit, inclined towards the C-3 
phenylethynyl group. There is a through-space interaction of the phenylethynyl group ortho-
85 
 
protons and the methine proton (blue star, interaction Z, Figure 2.8). Another means by 
which the NOESY spectrum confirmed the (Z)-stereochemistry was the absence of a 
through-space interaction of the phenyl groups from the benzylidene moiety and the 




Figure 2.8 Chem 3D structure, NOESY and COSY spectra of 2.33a 
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Chan and co-workers also found that when 1-[2-(tosylamino)phenyl]prop-2-yn-1-ol was 
treated with AgOAc in MeCN, 2-benzylidene-3-phenyl-1-tosylindolin-3-ol was obtained as 
the (Z)-stereoisomer exclusively (Scheme 2.42) [12JOC7166].  
 
Scheme 2.42 
It was of interest to investigate the course of the Ag-mediated dialkynol cyclisation when 
the terminal phenyl group in 2.5a was replaced by alkyl groups. Thus, 6-(2-p-
tosylamidophenyl)undeca-4,7-diyn-6-ol 2.5b was subjected to the treatment with AgNO3 on 
silica (Scheme 2.43).  
 
Scheme 2.43 
Unfortunately these conditions provided only a small amount of 4-(pent-1-yn-1-yl)-2-
propylquinoline 2.35b (6%). Formation of the latter is likely promoted by the Brønsted 
acidity of the silica rather than the Ag(I) salt (Scheme 2.44). The cyclisation of unsubstituted 
1-(2-aminophenyl)propynols with PPTS to afford 2,4-disubstitued quinolines was also found 
to occur by Kumar et al. (page 33, Scheme 1.26). Consequently, AgNO3 was not used for any 
further cyclisations.  
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The 1H NMR spectrum of 2.35b (Figure 2.9) exhibits a one proton singlet at δH 7.36 ppm 
corresponding to the C-3 position. Other features of 4-alkynylquinoline spectra are 
discussed in more detail in Section 3.1. 
 
Figure 2.9 400 MHz 1H NMR spectrum of 2.35b in CDCl3 
The formation of 2.35b from 2.5b and AgNO3-silica is outlined in the proposed mechanism 
below (Scheme 2.44). In a Meyer-Schuster type reaction, initial loss of water generates the 
propargylic/allenic carbocation 2.36 that is susceptible to attack from water to afford an 
enone. Cyclisation by attack of the sulfonamide nitrogen ensues. Aromatisation by 
elimination of water and subsequently TsOH affords quinoline 2.35b.  
 
Scheme 2.44 
Due to the failure of AgNO3-silica to promote efficient cyclisations of the dialkynols 2.5a – b, 
attention shifted to the use of AgOAc in refluxing MeCN, which proved effective for 
cyclisation of 2.5a to the benzylic alcohol 2.32a (iii, Scheme 2.41). Thus dialkynols 2.5a – k 
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were subjected to AgOAc in refluxing MeCN (Scheme 2.45). The results of these reactions 
are collated in Table 2.8.  
 
Scheme 2.45 
Entry R1 Dialkynol  Time (h) Indole  Yield (%) 
1 Ph 2.5a 19 2.32a 100 
2 C3H7 2.5b 1.5 2.32ba 62a 
3 4-MeOC6H4 2.5c 21 2.32c 0 
4 TMS 2.5e 19 2.32eb 0b 
5 Me 2.5g 21 2.32g 0 
6 t-Bu 2.5j 21 2.32jc 0c 
7 (CH3)C=CH2 2.5k 21 2.32k 0 
Table 2.8 Yields from the AgOAc cyclisations of 2.5a – k to 2.32a – k. a, b and c other products were 
isolated 
Whilst the dilakynol 2.5a provided the indole 2.32a quantitatively and 2.5b also gave the 
corresponding indole (62%) other products were isolated from this and some of the other 
substrates (entries 4 and 6) and these are discussed subsequently. 
The 1H spectrum of 2.32a (Figure 2.10) exhibited a doublet at δH 6.95 ppm integrating for 
one proton with a geminal coupling constant of 2J = 7.1 Hz, corresponding to the benzylic 
proton. The 1H – 1H COSY showed an interaction of the benzylic proton and the OH proton 














































































Resonances for the benzylic and OH protons (δH 6.95 and 5.19 ppm, 2J = 7.1 Hz) in 2.32a are 
different to those reported (δH 6.30 and 4.72 ppm, 2J = 11.84 Hz) by Chan et al. for 2.37 
(Scheme 2.46) [12JOC7166]. On the other hand, the benzylic CH(OH) carbon resonance (13C 
NMR) is nearly identical; δC 68.4 ppm for 2.32a and δC 68.6 ppm for 2.37. The downfield 
shift of the CH proton (benzylic) in the 1H spectrum of 2.32a is probably due to the 
anisotropic deshielding effect of the adjacent triple bond.  
 
Scheme 2.46 
A reasonable mechanism for the formation of indoles 2.32a – b is shown in Scheme 2.47. 
Coordination of silver(I) to the triple bond will form the π-complex (metallacyclopropenium 
ion) which is susceptible to attack by the nucleophilic sulfonamide function and will cyclise 
accordingly, via a 5-exo-dig pathway. Following protodeargenation (loss of silver by attack of 
a proton) and protonation of the alcohol, dehydration (E1) will lead to the carbocation 2.38. 
Subsequent hydration of the alkene moiety and aromatisation will afford the corresponding 





Flash column chromatography of the crude material from the reaction of 6-(2-p-
tosylamidophenyl)undeca-4,7-diyn-6-ol 2.5b with AgOAc afforded three products (fractions 
A, B and C in order of increasing polarity). The lowest yielding being 8% (fraction B), which 
was readily identified as 4-(pent-1-yn-1-yl)-2-propylquinoline 2.35b. The 1H NMR spectra of 
the fastest running fraction A (red spectrum, Figure 2.11) and slowest eluting fraction C 
from the column were similar (blue spectrum, Figure 2.11). 
The 1H and 13C NMR spectra of fraction A confirmed the presence of a pentynyl substituent 
and a 1-tosylindole system. Fraction A, exhibited a doublet (signal a) at δH 6.99 ppm (J = 15.8 
Hz) and a doublet of triplets (signal b) at δH 6.79 ppm (J = 15.8 and 6.5 Hz). Both chemical 
shifts and signal multiplicities were indicative of trans-alkene protons, in the case of signal b, 
additional coupling to an adjacent methylene group. When taken in conjunction with the 
integrations and multiplicities of the aliphatic proton signals these data indicated the 
presence of a but-1-enyl group i.e. CH=CHCH2CH3 unit. The absence of exchangeable 
protons was confirmed by addition of D2O (red spectrum, Figure 2.12). Therefore the 
constitution of fraction A was established as (E)-2-(but-1-en-1-yl)-3-(pent-1-yn-1-yl)-1-tosyl-
1H-indole 2.39. 
Fraction C provided the major product from the reaction and the presence of a 1-tosylindole 
core together with a pentynyl substituent was readily confirmed from the 1H and 13C NMR 
spectra. However, the side chain in fraction C was different to that of fraction A and gave 
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rise to a series of complex signals and splitting patterns. Discounting the aromatic signals 
the most downfield signal absorbed at δH 5.51 (J = 10.8, 7.2 Hz) as a doublet of triplets (x) 
corresponding to one proton. A higher field signal absorbed at at δH 3.72 ppm as a doublet(J 
= 10.8 Hz) (signal y) integrating for one proton.  
 
Figure 2.11 400 MHz 1H NMR spectra of 2.39 (fraction A) and 2.32b (fraction C) in CDCl3 
Although no signals disappeared upon addition of D2O to fraction A (red spectrum, Figure 
2.12) confirming the structure of 2.39. In fraction C however, the doublet of triplets (signal 
x) collapsed to a triplet and the doublet (signal y) disappeared completely (blue spectrum, 
Figure 2.12), so indicating that the side chain contained a -CH(OH)CH2- moiety. These data 
and the remaining aliphatic proton signals established the presence of a -CH(OH)CH2CH2CH3 





Figure 2.12 1H NMR spectra comparison of 2.39 and 2.32b after D2O shake 
The cyclisation products from treatment of 2.5b with AgOAc were thus the novel 3-
alkynylindoles 2.32b and 2.39 and the 4-alkynylquinoline 2.35b (Scheme 2.48). 
 
Scheme 2.48 
As with the formation of the 2-(α-hydroxyalkyl)indoles 2.32 (Scheme 2.47) a possible 
mechanism for the generation of the 2-buten-1-ylindole 2.39 (Scheme 2.49) involves initial 
coordination of silver(I) to the triple bond, forming the π-complex 2.40 which is then 
attacked by the nucleophilic sulfonamide function and intramolecular cyclisation via a 5-
exo-dig pathway. Subsequent protodeargenation and protonation of the alcohol, followed 
by dehydration will lead to the highly delocalised carbocation 2.41. Deprotonation of the 
aromatic species 2.42 will afford alkene 2.39. Elimination from 2.42 occurs stereospecifically 
to afford the least sterically hindered (E)-alkene. In the case of the quinoline 2.35b its 
formation proceeds by a 6-endo-dig cyclisation of the π-complex 2.40 and loss of water to 
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form the quinolinium salt 2.43, which will facilitate displacement of tosyl the group to afford 
2.35b (Scheme 2.49). 
 
Scheme 2.49 
The reaction of the dilalkynol 2.5j with AgOAc in MeCN (entry 6, Table 2.8) did not afford 
the expected indole 2.32j Scheme 2.50. After careful consideration of the 1D (1H and 13C) 
and 2D (HSQC, HMBC, NOESY) NMR spectral data of the product, its structure was found to 
be the (Z)-3-(3,3-dimethylbut-1-yn-1-yl)-2-(2,2-dimethylpropylidene)-1-tosylindolin-3-ol 
2.33j (Scheme 2.50). 
 
Scheme 2.50 
The signals of interest in the 1H spectrum of 2.33j are the 4-H aromatic proton and methine 
proton. The 4-H proton for 2.33j absorbs at δH 7.67 ppm as a doublet, whereas in the fully 
aromatic indole 2.32a 4-H is deshielded and absorbs at δH 8.20 ppm. The methine proton in 
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tosylindolin-3-ol 2.33j absorbs at δH 6.08 ppm as a singlet. However, it would be expected 
that the latter signal would be a doublet if the product from 2.5j were the indole derivative 
2.32j, due to coupling of the methine proton with the OH moiety. Another indication that 
the product was the 2-(2,2-dimethylpropylidene)indoline 2.33j accrued from comparison 
with the 13C spectra of indole alcohols 2.32a and 2.32b. These latter compounds exhibited 
signals for the benzylic side-chain [ArCH(OH)R] carbons at δC 68.38  and 68.74 ppm 
respectively. No similar resonance was observed for 2.33j. The alkylidene carbon signal 
absorbed at δC 138.58 ppm as confirmed by a correlation in the HMBC spectrum (Figure 
2.13) with the alkene proton signal at δH 6.08 ppm. These data confirmed that the C-2 side 













































Another example from this series of cyclisation reactions of 3-[2(tosylamido)phenyl]penta-
1,4-diyn-3-ols 2.5a – k with AgOAc which also provided different products to the expected 
indole was the dialkynol derivative 2.5a (entry 4, Table 2.8) Scheme 2.51. 
 
Scheme 2.51 
However, treatment of 2.5e with AgOAc in MeCN did not provide any of the α-
(trimethylsilyl)arylmethanol 2.32e. Despite their apparent simplicity, such compounds are 
generally only accessible via a Wittig-type rearrangement. For example, PhCH(OH)SiMe3 has 
only been prepared via deprotonation of PhCH2OSiMe3 with s-BuLi in THF at r.t. 
[82JOC5051]. 
The reaction of N-{2-[3-hydroxy-1,5-bis(trimethylsilyl)penta-1,4-diyn-3-yl]phenyl}-4-
methylbenzenesulfonamide 2.5e with AgOAc, gave several products that could be separated 
by flash column chromatography on silica (10% EtOAc – petroleum ether) and obtained in 
varying yields (Scheme 2.52). The order in which the products eluted (left to right) is that as 
arranged in Scheme 2.52. Of note is that the major product was the vinylsilane 2.33e’. 
The formation of 2.33e and 2.33e’ is of interest because it represents an unusual synthesis 
of an exocyclic vinylsilane. Few examples of an analogous structural motif exist. An example 
is provided by the iodolactamisation of 2-[2-(trimethylsilyl)vinyl]-N-benzylbenzamide which 






The structure of indolines 2.33e and 2.33e’ were confirmed by their 1D (1H and 13C) and 2D 
NMR spectra (HSQC and HMBC) spectra. The 1H and 13C NMR data of significant signals in 
2.33e and 2.33e’ are shown in Table 2.9. The methine proton resonances are shielded in 
comparison to that in the indoline 2.33a (δH 6.99 ppm) but similar to that of 2.33j (δH 6.08 
ppm). However the methine carbon resonances of 2.33e and 2.33e’ are shielded compared 
with that of 2.33j (δC 138.58 ppm) but similar to 2.33a (δC 124.34 ppm). The shielding of the 
1H and 13C signals seen in 2.33 and 2.33’ is probably due to the electron donating effect (+I) 
of the TMS group. 
Indoline 4-H δH (ppm) Methine Proton  
δH (ppm)  
Methine Carbon  
δC (ppm)  
2.33e 7.79 6.14 124.48 
2.33e’ 7.75 6.05 122.97 
Table 2.9 1H and 13C NMR data for 2.33e and 2.33e’ 
Comparative spectra for the four indolines generated from cyclisation of 2.5e with AgOAc 





























































To understand the nature of the cyclisation of 2.5e further – both with base (Scheme 2.32) 
and Ag(I) catalysis – indolines 2.33e and 2.33e’ were treated with 5M NaOH (2 equiv.)  in 
MeOH for 24 h (Scheme 2.53). In the case of 2.33e (A, Scheme 2.53) a quantitative yield of 
(Z)-3-ethynyl-1-tosyl-2-[(trimethylsilyl)methylene]indolin-3-ol 2.33e’ was obtained. 
However, use of excess base with 2.33e’ provided only unreacted starting material.  
 
Scheme 2.53 
The findings above provided an insight into the formation of indolines 2.27 and 2.27’. 
Consequently, it can be envisaged that the reaction proceeds with removal of one of the 
TMS groups followed by cyclisation onto the ethynyl function. The remaining alkynylsilyl 
group will be deprotected. This sequence of events will also be applicable for the base-
mediated 5-exo-dig cyclisation to 2.27 (Section 2.3, Scheme 2.32), Scheme 2.54 depicts the 






The formation of the indolines 2.33e, 2.33e’ and 2.33j from the reaction of 2.5e – j with 
AgOAc in MeCN can be postulated to proceed by the mechanism in Scheme 2.55. 
Coordination of silver(I) to the triple bond will form the π-complex (metallacyclopropenium 
ion) 2.44, which is susceptible to attack by the nucleophilic nitrogen of the sulfonamide 
function and will cyclise accordingly via a 5-exo-dig pathway. Subsequent 
protodeargenation (loss of silver by attack of a proton) will afford the corresponding 
indoline 2.33e and 2.33j. In the case where R1 = TMS the deprotection of the 
trimethylsilylethynyl group leads to 2.33e’ (Scheme2.55). 
 
Scheme 2.55 
The minor by-products from reaction of 2.5e with AgOAc in MeCN (2.27 and 2.27’, Scheme 
2.52) will procced by coordination of silver(I) to the triple bond will form the 
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metallacyclopropenium ion 2.45 which is susceptible to attack by the nucleophilic 
sulfonamide function and cyclisation via a 5-exo-dig pathway. However the vinylsilane will 
be protonated to form the carbocation 2.46 which can be stabilised by a combination of the 
β-silicon effect and electron release from the ring nitrogen. The carbocation is then 
susceptible to hydrolytic desilylation which in turn affords 2.27’, further desilylation then 
affords 2.27 (Scheme 2.56). 
 
Scheme 2.56 
Thus, these findings parallel the report by Chan et al. [12JOC7166] that treatment 3-(2-p-
tosylamidophenyl)penta-1,4-diyn-3-ols with AgOAc in MeCN, effects cyclisation via a 5-exo-
dig pathway to indolines (Scheme 2.46) and not to indoles. Formation of indolines 2.33e and 
2.33j in preference to the indoles 2.32e and 2.32j is possibly due to the presence of bulky 
groups (R1 = t-Bu and TMS) hindering attack at the cationic centre. In the case of the TMS 
derivative, protonation of the indolin-3-ol and dehydration (E1), will lead to a carbocation 
which cannot be stabilised by the β-silicon effect. Therefore, hydration of the alkene moiety 
(attack of H2O) and aromatisation is very unlikely. 
The reaction of dialkynols 2.5c, g and k with AgOAc in MeCN failed to provide any tractable 
products (entries 3, 5 and 7 respectively, Table 2.8), only complex mixtures were obtained. 
The reactions complied in Table 2.8 demonstrate that the product obtained from the 
AgOAc-mediated cyclisations of 3-[2(tosylamido)phenyl]penta-1,4-diyn-3-ols can be 




2.5 Indium(III) Promoted Cascade Cyclisation to a Furo[2,3-c]quinoline 
In common with other group 13 elements In(III) exhibits Lewis acidity, albeit softer than 
other metal trihalides [63JA3533], such as AlCl3 and BCl3, due to its larger ionic radius. This 
Lewis acidity has been exploited for a variety of applications and In(III) use in synthesis to 
access a range of products has been reviewed a number of times [00EJO2347, 03S633, 07S1, 
18OBC5733]. There are examples of In(III) reactivity towards alkynes in Scheme 2.57 and 
subsequent cyclisations to a variety of heterocycles [00EJO2347, 03S633, 07S1, 
18OBC5733]. Indium-catalysed hydroarylation of aryl propargyl ethers proceeds efficiently 
to afford a range of 4-substituted 2H-chromenes (A, Scheme 2.57), including 4-halogenated 
chromenes (R1 = Br, I) [15OBC379]. Nakamura and co-workers found that 2-alkynyl-6-
methoxysulfonanilides 2.47 upon treatment with InBr3, cyclised to indoles via a 5-endo-dig 
pathway (B, Scheme 2.57). Indium(III) also facilitated the migration of the arylsulfonyl group 
(1,3 and 1,7-migration) [07AGE2284]. Intramolecular hydroarylation of 2.48, afforded 
azepinoindoles in high yields (60 – 89%) and could be initiated in the presence of In(OTf)3 (C, 
Scheme 2.57) [13CC6803]. Surprisingly, there are no examples in the literature that describe 
the use of In(III) to cyclise propargylic alcohols, specifically analogues of 1-arylprop-2-yn-1-






Initially 2.5a was treated with indium(III) chloride in toluene at 90 °C for 20 h. TLC 
examination of the reaction mixture showed this to contain mostly unreacted starting 
material. Efforts to purify the mixture proved unsuccessful and only the starting material 
could be isolated. With this result, the reactivity of 2.5a towards an alternative indium(III) 
salt – In(OTf)3 – was investigated. Dialkynol 2.5a was treated with In(OTf)3 in DCM at room 
temperature for 2.5 h (Scheme 2.58). TLC examination again revealed the presence of 
mostly starting material, although a new faster running (non-polar) compound was also 
present. Purification of the reaction mixture by flash chromatography provided the faster 
running component, following recrystallisation from hexane – EtOAc, as a beige powder. 
The 1H NMR spectrum of this unknown compound ‘X’ showed an upfield shift of the 
aromatic protons compared to those of the indole systems but were similar to indoline 



























































Most surprising was the 13C NMR spectrum (Figure 2.16), which revealed the absence of 
acetylenic carbon signals, evidently, both alkyne moieties had participated in this indium(III) 
catalysed reaction. 
 
Figure 2.16 150 MHz 13C NMR spectrum of unknown compound ‘X’ in acetone-d6 
Two possible structures can be postulated from the NMR data, the furo[3,4-b]indole 2.49 or 
the pyrano[3,4-c]indole 2.50 which could have been derived from 2.32a via a 5-exo-dig or 6-





However, treatment of the alcohol 2.32a with In(OTf)3 in DCM failed to effect cyclisation to 
‘X’. TLC examination showed only starting material was present (Scheme 2.60). 
 
Scheme 2.60 
This finding established that neither 2.49 nor 2.50 was the product isolated from the 
reaction of 2.5a with In(OTf)3. Moreover, NMR data from similar fragments as the furo[3,4-
b]indole 2.49 and pyrano[3,4-c]indole 2.50 – (Z)-2-benzylidene-5-phenyl-2,5-dihydrofuran 
2.51 [09T1839] and 1,3-diphenyl-1H-isochromene 2.52 [17AGE5116] respectively – did not 
match the 1H data of ‘X’. The chemical shift of the 3-H proton from 1,3-diphenyl-1H-
isochromene (2.52), highlighted in red, is the only similar (δH 6.67 ppm, δC 100.4 ppm) 
aromatic resonance (Figure 2.17) [17AGE5116]. This data provided further confirmation that 




Figure 2.17 1H and 13C NMR data for (Z)-2-benzylidene-5-phenyl-2,5-dihydrofuran 2.51 [09T1839] 
and 1,3-diphenyl-1H-isochromene 2.52 [17AGE5116]  
After careful consideration, another possibility for the structure of ‘X’ is the tricyclic 4,5-
dihydrofuro[2,3-c]quinoline 2.53, NMR data for this structure is a better fit with that of 
several model compounds and structural fragments shown below (Figure 2.18) [11JOC2379, 
14CC8324, 17MI42168, 15AGE3116]. N-[Furan-2-yl(phenyl)methyl]-4-
methylbenzenesulfonamide (structure B) is particularly informative due to the similar furan 
1H and 13C shifts as well as the non-aromatic carbon 13C (C-H) shift, with structure C also 
confirming that 2-C is saturated as the 13C shift is identical. The shift of the methine proton 
in D is similar to that in ‘X’ i.e. structure 2.53. 
 
Figure 2.18 1H and 13C data for structural fragments of 2.53 
The mechanism for the formation of this novel structure 2.53 is shown in Scheme 2.61. It 
can be postulated that dehydration of 2.5a leads to the formation of a stabilised cation. 
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Hydroxide (or water) attack on one of the alkyne motifs, followed by tautomerization of this 
intermediate (2.54) produces an α,β-unsaturated ketone in a Meyer-Schuster 
rearrangement [00EJO2347, 03S633, 07S1, 16CC12147, 18OBC5733]. Indium activates the 
remaining alkyne function to attack from the carbonyl oxygen to form a conjugated 
oxonium cation 2.55, nucleophilic attack of the sulfonamide nitrogen on this alkylidene 
intermediate will effect cyclisation to 2.53. 
 
Scheme 2.61 
Reaction of indium(III) triflate with 2.5a has therefore afforded a novel furoquinoline by an 
unprecedented cascade sequence. However the yield of 2.53 from the reaction was only 
23%. In attempts to optimise the yield different solvents, catalysts and loadings were 











2.53 (%) * 
1 In(OTf)3 5 DCM r.t. 2.5 23 
2 In(OTf)3 10 DCM r.t. 2.5 0 
3 In(OTf)3  15 DCM r.t. 2.5 30 
4 In(OTf)3  2.5 DCM r.t. 2.5 15 
5 In(OTf)3  5 MeOH 60 2.5 0 
6 In(OTf)3  5 MeCN 60 2.5 0 
7 In(OTf)3  5 EtOAc 60 2.5 0 
8 In(OTf)3  5 CHCl3 60 2.5 0 
9 In(OTf)3  5 DCE 90 2.5 0 
10 In(OTf)3  5 70% EtOH aq. 90 2.5 0 
11 In(OTf)3 5 THF 66 22 0 
12a In(OTf)3 5 DCM r.t. 24 0 
13b In(OTf)3 5 DCM r.t. 24 0 
14 Ga(OTf)3 5 DCM r.t. 24 0 
15 Sc(OTf)3 10 DCM r.t. 24 0 
16 AgOAc : Sc(OTf)3 2 : 10 DCE 85 4 0 
17cd AuPPh3NTf2 2 Dry PhMe 110 20 0 
18d Au(PPh)3Cl : AgOTf 5 : 2 Dry PhMe 110 22 0 
19 Cu(OTf)2 5 DCM r.t. 24 0 
Table 2.10 Optimising conditions to 2.53, *1H NMR yields. a = 50 % w/w montmorillonite K-10 
added, b = 10 equiv. of water added, c = 1 equiv. dry MeOH added, d = reaction carried out in the 
dark 
All the yields in Table 2.10 (excluding entry 1) were derived from 1H NMR data only, by the 
appearance and integration of two distinct signals present in the spectrum of 2.53 (δH 6.67 
and 6.51 ppm, Figure 2.15). Scale may be a factor in the yields achieved, as the majority of 
the entries did not produce anything other than unreacted starting material. 
The increased catalyst loading of In(III) (entry 3, Table 2.10) was scaled up to see if 2.53 
could be isolated in a higher yield than the initial result with DCM. However at increased 
scale only 15% of 4,5-dihydrofuro[2,3-c]quinoline 2.53 could be isolated.  
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Changing the polarity of the solvent (DCM) to a more polar system (higher dielectric 
constant), could help stabilise the charged species formed (Scheme 2.61) and therefore 
increase the yield. However this modification did not enhance the reaction as envisaged. 
Other Lewis acids known for their alkynophilicity were investigated; Ga(III), Sc(III), Au(I) and 
Cu(II), [02JOC1414, 04T1959, 07AGE3140, 14AGE13532, 19OBC2663] unfortunately these 
reactions (entry 14 – 19, Table 2.10) only afforded unreacted starting material. Hence the 
conditions used initially (5 mol % In(OTf)3 in DCM) were optimal. It is possible that 
purification of the crude reaction product plays a role in the yield obtained of 2.53, thus the 
acidity of the silica used in flash column chromatography may cause degradation of the 
furoquinoline 2.53.  
Other dialkynols 2.5b and 2.5c were subjected to the conditions discussed above – In(OTf)3 
5 mol % in DCM – but in each case only starting material was obtained (Scheme 2.62). The 
reasons for this outcome are unknown and it is proposed that the phenyl dialkynol analogue 
is a ‘goldilocks’ compound, because if the phenyl rings provide a stabilising effect then the 
4-MeOC6H4 analogue 2.5c should also have afforded the corresponding furo[2,3-c]quinoline. 
 
Scheme 2.62 
The synthesis of the furoquinoline 2.53 is a remarkable result and warrants further 
investigation. Within the literature there is little work in relation to the synthesis of furo[2,3-
c]quinolines, existing examples are shown in Scheme 2.63. Yang reported the coupling of 2-
formyl-3-furanboronic acid with 2-bromonitrobenzene followed by reduction and 
deoxygenation with PBr3 which yielded furo[2,3-c]quinoline in 92% yield together with 4-
bromofuro[2,3-c]quinoline in 4% yield (A, Scheme 2.63) [89SC1001]. A one-pot reaction to 
1,2,4-trisubstituted furo[2,3-c]quinolines involved the domino reaction of ortho-
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alkynylanilines, aldehydes and an isocyanoacetamide (B, Scheme 2.63). The reactions 
provided the relevant furo[2,3-c]quinolines in fair to good yields (42 – 75%), and aryl, alkyl 
as well as electron withdrawing substituents can be introduced into the 4-position by this 
approach (derived from the aldehyde) [02AGE3633]. Scheme 2.63 C illustrates a similar 
method to afford 2-alkoxyfuro[2,3-c]quinolines 2.56 [12EJO475].  
3-Hydroxyquinoline was utilised as a starting material for the synthesis of furo[2,3-
c]quinolines by an initial iodination followed by a Sonogashira coupling, in which the Cu(I) 
also facilitates the 5-endo-dig cyclisation to 2.57 [13JME6871]. The coupling of a 3-
furanylbornic acid with 2-iodoaniline affords 2.58. Subsequent condensation with an aryl 
aldehyde in the presence of a catalyst results in the formation of the tricyclic system in a 
variant of the Pictet-Spengler reaction (E, Scheme 2.63). Both Lewis and Bønsted acids were 
employed, with iron(III) chloride found to be the most efficient (37 – 94% yield). By this 
method only 4-arylfuro[2,3-c]quinolines were synthesised, no other position of the ring 





With the novel furo[2,3-c]quinoline 2.53 being the only product obtained from the mild 
Lewis acid promoted dehydration of the sulfonamides 2.5a – 2.5c, attention now focussed 
on investigating the reactivity of 1,5-disubstituted-3-[2-(N-substituted 
sulfamoyl)phenyl]penta-1,4-diyn-3-ols (reversed sulfonamides 2.23Aa – Hb) towards 
In(OTf)3, using the conditions found to be optimum for the cyclisation of the dialkynol 2.5a 







2.6 Indium(III) Mediated Synthesis of 3,3-Di(alkynyl)-2,3-dihydro-1,2-
benzisothiazole 1,1-dioxides 
Initially a solution of the sulfonamide 2.23Aa in DCM and 5 mol % In(OTf)3 was stirred at 
room temperature (Scheme 2.64). TLC examination after 4 h showed no change, so the 
reaction mixture was left overnight. After this time the 1H NMR spectrum of the crude 
reaction product revealed quantitative conversion to the novel 1,2-benzisothiazole 1,1-
dioxide 2.59Aa. Surprisingly both 2.23Aa and 2.59Aa have identical Rf values in a range of 
solvent systems, so the reaction may proceed to completion in less than 24 h.  
 
Scheme 2.64 
The success of this novel cyclodehydration reaction prompted examination of the cyclisation 
of a range of the other reversed sulfonamides 2.23Aa – Hb to these new 3,3-di(alkynyl)-2,3-
dihydro-1,2-benzisothiazole 1,1-dioxides 2.59Aa – Hb, Scheme 2.65. The results are collated 
















1 2.23Aa Me Ph 2.59Aa 24 100 
2 2.23Ab Me C3H7 2.59Ab 5 92 
3 2.23Ba Tolyl Ph 2.59Ba 24 100 
4 2.23Bb Tolyl C3H7 2.59Bb 24 98 
5 2.23Bc Tolyl 4-MeOC6H4 2.59Bc 23 99 
6 2.23Be Tolyl TMS 2.59Be 24 27 
7 2.23Bf Tolyl CH2OMe 2.59Bf 24 0 
8 2.23Ca 3-MeC6H4 Ph 2.59Ca 24 53 
9 2.23Cb 3-MeC6H4 C3H7 2.59Cb 24 82 
10 2.23Da 2-MeOC6H4 Ph 2.59Da 22 37 
11 2.23Db 2-MeOC6H4 C3H7 2.59Db 3 63 
12 2.23Ea 3-MeOC6H4 Ph 2.59Ea 24  0 
13 2.23Eb 3-MeOC6H4 C3H7 2.59Eb 24 100 
14 2.23Ga 3-thienyl Ph 2.59Ga 24 0 
15 2.23Gb 3-thienyl C3H7 2.59Gb 24 49 
16 2.23Ha 2-naphthyl Ph 2.59Ha 24 43 
17 2.23Hb 2-naphthyl C3H7 2.59Hb 7.3 45 





Formation of 2.59Aa – Hb is the result of an E1 type elimination, facilitated by indium(III) 
coordination to the alcohol, the resulting carbocation will be highly stabilised but will be 
readily intercepted by the sulfonamide group (Scheme 2.66). 
 
Scheme 2.66 
The foregoing cyclodehydration reaction constitutes a new approach to 2,3-dihydro-1,2-
benzisothiazole 1,1-dioxides although numerous routes to these systems exist (Scheme 
2.67). For example, reduction of a 3-alkyl- or a 3-aryl-1,2-benzisothiazole 1,1-dioxide with a 
ruthenium(II) catalyst (A, Scheme 2.67) [96JA2521]. More recently, Tao and Gilbertson 
reported the Brønsted acid-mediated reductive cyclisation of an ortho-alkynyl sulfonamide 
to 2.60 (B, Scheme 2.67). It was also found that heating induces reductive cleavage of the 
sulfonamide N-substituent, resulting in the sultam 2.61 [18CC11292]. 
 
Scheme 2.67 
However, less common are routes to 3,3-disubstitued-1,2-benzisothiazole 1,1-dioxides, 
some examples are shown in Scheme 2.68. The N-ortho dilithiated benzenesulfonamides 
2.62 have been intercepted with ketones and subsequent dehydration affords the 
118 
 
corresponding 1,2-benzisothiazole 1,1-dioxides (A, Scheme 2.68) [68JOC900, 79OR1]. 
Rhodium-promoted arylation of N-sulfonyl ketimines with sodium tetraarylborates in the 
presence of L18 provided 3,3-diaryl-1,2-benzisothiazole 1,1-dioxides 2.63 with excellent 
enantioselectivity (94 – 98%) and high yields 72 – 90% (B, Scheme 2.68) [13JA971]. To date 
there is the only one example of a 3-alkynyl-2,3-dihydro-1,2-benzisothiazole 1,1-dioxide 
2.64 (Scheme 2.68) however, Arai and co-workers did not report how it was synthesised 
[13JOC4366]. Therefore the results described above (Scheme 2.65) represents a novel 




The 3,3-di(alkynyl)-2,3-dihydro-1,2-benzisothiazole 1,1-dioxides 2.59Aa – Hb were 
characterised from their NMR spectra, which exhibited acetylene carbon resonances within 
the range of δC 99.79 – 75.58 ppm and the quaternary C-3 carbon absorbed in the range of 
δC 55.33 – 58.54 ppm (Figure 2.19). The most downfield acetylene carbon resonances 
(Figure 2.19) are from 2-(p-tolyl)-3,3-bis[(trimethylsilyl)ethynyl]-2,3-dihydro-1,2-
benzoisothiazole 1,1-dioxide 2.59Be.  
The quaternary C-3 carbon exhibited the largest resonance change, being shifted upfield by 
up to 10 ppm in comparison to the starting dialkynols 2.23Aa – Hb (Section 2.1, Table 2.6). 
This shift is not surprising after removal of the OH function. However, it is significantly 
different to that of C-3 in the 3,3-diaryl-2,3-dihydro-1,2-benzisothiazole 1,1-dioxide 2.65 
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(Figure 2.19) [13JA971]. Evidently the magnetic anistopy of the alkyne units in 2.59Aa – Hb 
are responsible for this shielding.  
 
Figure 2.19 13C NMR data for 2.59Aa – Hb and a derivative 2.65 [13JA971] 
The reaction of 1,5-disubstituted-3-[2-(N-arylsulfamoyl)phenyl]penta-1,4-diyn-3-ols (2.23Bf, 
2.23Ea and 2.23Ga) with In(OTf)3 in DCM, entries 7, 12 and 14 (Table 2.11) respectively, 
provided complex mixtures from which no identifiable products could be obtained. All the 
other reversed sulfonamides gave fair to excellent yields of the 1,2-benzisothiazole 1,1-
dioxides. Where yields were poor the reaction failed to reach completion and unreacted 
starting material was recovered as the other component. 
The aromatic 4-H protons signal of 3,3-di(arylethynyl)-2,3-dihydro-1,2-benzisothiazole 1,1-
dioxides 2.59Aa – Ga and 2.59Bc are shifted further downfield than that of the 7-H protons 
(Table 2.12). However, in the 3,3-di(alkylethynyl)-2,3-dihydro-1,2-benzisothiazole 1,1-
dioxides 2.59Ab – Gb, 2.59Be and 2.59Bf a differing trend in chemical shifts emerge, the 7-H 
signals are shifted downfield (Table 2.13). An exception of this trend is provided by the 2-
(naphthalen-2-yl)-3,3-di(alkynyl)-2,3-dihydro-1,2-benzoisothiazole 1,1-dioxides 2.59Ha – b 
where the chemical shifts are opposite to that described above. When R1 = Ph (2.59Ha) 7-H 










































Table 2.12 1H NMR proton resonances of 
2.59Aa – Ga and 2.59Bc  
 Table 2.13 1H NMR proton resonances of 
2.59Ab – Gb, 2.59Be and 2.59Bf  
 
Assignments of protons signals in 2.59Aa – Hb were established by their 2D NMR spectra 
(HSQC, HMBC and COSY). Figure 2.20 and Figure 2.21 show the HMBC spectra of 2.59Aa and 
2.59Bb respectively. The HMBC spectrum 2-methyl-3,3-bis(phenylethynyl)-2,3-dihydro-1,2-
benzisothiazole 1,1-dioxide 2.59Aa (Figure 2.20) exhibits a through bond correlation 
between the 4-H proton at δH  7.90 ppm and the quaternary carbon C-3 at δC 57.01 ppm. 
The doublet at δH 7.84 ppm corresponding to 7-H shows a cross peak with the quaternary 
ring junction C-7a at δC 137.80 ppm. However, in 3,3-di(pent-1-yn-1-yl)-2-(p-tolyl)-2,3-
dihydro-1,2-benzisothiazole 1,1-dioxide 2.59Bb the shifts of the 4-H and 7-H signals are 
reversed. Thus, Figure 2.21 exhibits a cross peak between the doublet (7-H proton) at δH 
7.84 ppm and the ring junction carbon C-7a at δC 138.72 ppm. The 4-H proton resonates at 
δH 7.77 ppm and displays a through-bond correlation with the quaternary C-3 carbon at δC 
57.93 ppm. These HMBC correlations allow the distinction between the 4-H and 7-H protons 




Figure 2.20 HMBC spectrum of 2.59Aa in CDCl3 
 
Figure 2.21 HMBC spectrum of 2.59Bb in CDCl3 
 
2.7 Iodine-Mediated Cyclodehydration to 3,3-Di(alkynyl)-2,3-dihydro-1,2-
benzisothiazole 1,1-dioxides and 6-Endo-Dig Cyclisation to 1,2-
Benzisothiazolo[2,3-a]quinolines 
Other extensively used electrophilic activators that promote the cyclisation of alkynes and 
propargyl alcohols are iodine, iodine monochloride and NIS (Section 1.3) [14COS-II(4)412, 
15S1961, 16OBC7639, 16MI49730]. They not only activate alkynes to nucleophilic attack 
and accompanying cyclisation, but an iodo-group can be incorporated into the structure, 
allowing further functionalisation of the ring. 
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With a selection of the reversed sulfonamide dialkynols 2.23Aa – Hb to hand their reactivity 
towards an iodine electrophile was explored. Initially 2.23Aa was subjected to optimised 
conditions found for another set of cyclisations (see Section 3.1); and was treated with 2 
equiv. of ICl in MeCN. After 3.5 h at reflux the reaction mixture was quenched with aqueous 
sodium thiosulfate. Flash column chromatography (10% EtOAc – petroleum ether) of the 
crude material, provided 3,3-di(alkynyl)-1,2-benzisothiazole 1,1-dioxide 2.59Aa in 48% yield 
as a brown oil (Scheme 2.69), a lower yield than that achieved with In(OTf)3 in DCM (100%, 
entry 1, Table 2.11). However, this outcome is not too surprising as iodine monochloride 
(effectively I+) is a softer Lewis acid compared to In(III) [63JA3533]. 
 
Scheme 2.69 
In order to investigate the scope of this iodine-promoted cyclisation the behaviour of the N-
p-tolyl sulfonamide (2.23Ba) towards ICl was explored. Thus, treatment of 2.23Ba with ICl (2 
equiv.) in MeCN under reflux for 24 h gave a crude product that was purified by flash 
column chromatography (12% EtOAc – Pet ether). The 1H NMR spectrum of the fast eluting 
fraction revealed the presence of 17 aromatic protons (Figure 2.22), one less than in the 
starting dialkynol 2.23Ba, a high field broad singlet integrating for one proton at δH 6.68 
ppm was also present. The 13C NMR spectrum of this initial fraction showed that there was 
either only one alkyne unit intact or that both alkyne functions were in the same chemical 
environment (δC 86.82 and 83.99 ppm). In addition, a quaternary carbon signal at δC 64.97 
was present. However these signals did not match those of the acetylenic and the C-3 
quaternary carbons in the starting material 2.23Ba (δC 67.05, 86.92 and 88.80 ppm), nor in 
3,3-bis(phenylethynyl)-2-(p-tolyl)-2,3-dihydro-1,2-benzisothiazole 1,1-dioxide 2.59Ba (δC 
86.19, 84.71 and 58.58 ppm). Another signal at δC 101.43 ppm suggested the presence of an 

























































The HRMS of this unknown compound revealed a molecular ion at m/z [M+H]+ = 586.0328 
corresponding to C30H20INO2S. In order to definitely establish the constitution of this 
compound an X-ray crystal structure (Figure 2.23) was obtained and revealed the novel 
tetracyclic, 6aH-1,2-benzisothiazolo[2,3-a]quinoline structure 2.66Ba-3 (19% yield). The 
later eluting fraction from the column provided the 1,2-benzoisothiazole 1,1-dioxide 2.59Ba 
in a 36% yield (Scheme 2.70).  
 
Figure 2.23 X-Ray crystal structure of 6-iodo-3-methyl-5-phenyl-6a-(phenylethynyl)-6aH-1,2-
benzisothiazolo[2,3-a]quinoline 11,11-dioxide 2.66a-3 
 
Scheme 2.70  
A plausible mechanism for the formation of 2.66a-3 is shown in Scheme 2.71. The initial 
step involves an E1 elimination, from the alkynol facilitated by co-ordination of I+. Following 
this, nucleophilic attack on the stabilised carbocation by the sulfonamide function will 
generate 2.59Ba as an intermediate. Subsequent coordination of an iodine electrophile to 
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one of the alkyne moieties results in the formation of an iodonium ion (2.67). The latter is 
activated towards nucleophilic attack from the electron rich tolyl ring via a 6-endo-dig 
pathway, to give following completion of the SEAr sequence, the 1,2-benzisothiazolo[2,3-
a]quinoline 2.66a-3. 
 
Scheme 2.71  
Ring systems such as 2.66a-3 possessing a 2,3-fused 1,2-benzisothiazole unit are unusual. 
Indeed, only two examples of the 1,2-benzisothiazolo[2,3-a]quinoline core have been 
reported (Scheme 2.72). Thus, Kiran et al. recently described the cycloaddition of 3-styryl-
1,2-benzisothiazole 1,1-dioxide with benzyne, generated by the Kobayashi protocol, 
provided 2.68 in a 67% yield (A, Scheme 2.72) [17JOC1823]. A Ni-catalysed Mukaiyama-
Mannich reaction between 3-(ethoxycarbonyl)-1,2-benzisothizole 1,1-dioxide and a silyl enol 
ether proceeds with a high degree of enantiocontrol and high yield (99% ee, 96% yield), in 
the presence of the chiral auxiliary L2. A subsequent intramolecular SNAr reaction proceeds 
with displacement of bromide to provide the tetracycle 2.69 in an excellent yield 95% (B, 





A tricyclic core closely related to 2.66a-3 was obtained from N-allylsaccharin via a five-step 
sequence by Modolo and co-workers [09JOC1982]. The starred quaternary carbon in 
Scheme 2.73 (2.70) resonates at δC 62.70 ppm, comparable to that observed for the 
teracycle 2.66a-3 which absorbs at δC 64.97 ppm.  
 
Scheme 2.73 
Attempts to optimise the yield of 2.66a-3 investigated the use of different solvents and 













1 ICl 2 MeCN 24 36 19 
2 ICl 3 MeCN 24 45 35 
3 ICl 5 MeCN 24 36 33 
4 I2 3 MeOH 24 100 0 
Table 2.14 Optimisation of iodocyclisation conditions to 2.66a-3 
Use of molecular iodine (entry 4, Table 2.14) provided only the 1,2-benzisothiazole 2.59Ba in 
quantitative yield, none of the tetracycle 2.66a-3 was observed. Cyclisation to the latter 
proved to be most efficient with 3 equiv. ICl. Use of 5 equiv. did not increase the yield. 
With the optimised iodocyclisation conditions at hand, their application to the propargyl 
alcohols 2.23Aa – Hb was evaluated (Scheme 2.74 – 2.76). The results are compiled in Table 





Entry R R1 Dialkynol Time (h) Temp (°C) 1,2-Benzisothiazole Yield (%) Tetracycle  R3 Yield (%) 
1* Me Ph 2.23Aa 3.5 82 2.59Aa 48 N/A N/A N/A 
2 Me C3H7 2.23Ab 24 82 2.59Ab 0 N/A N/A N/A 
3 Tolyl Ph 2.23Ba 24 82 2.59Ba 45 2.66a-3 Me 35 
4 Tolyl C3H7 2.23Bb 3.5 r.t. 2.59Bb 36 2.66b-3 Me 33 
5 Tolyl 4-MeOC6H4 2.23Bc 22 82 2.59Bc 0 266c Me 0 
6 Tolyl CH2OMe 2.23Bf 1 82 2.59Bf 40 2.66f Me 0 
7 3-MeC6H4 Ph 2.23Ca 4.5 82 2.59Ca 47 2.66a Me 0 
8 3-MeC6H4 C3H7 2.23Cb 1.5 82 2.59Cb 75 2.66b Me 0 
9 2-MeOC6H4 Ph 2.23Da 3 82 2.59Da 0 2.71a OMe 0 
10 2-MeOC6H4 C3H7 2.23Db 21 82 2.59Db 0 2.71b OMe 0 
11 3-MeOC6H4 Ph 2.23Ea 21 82 2.59Ea 0 2.71a OMe 0 
12 3-MeOC6H4 C3H7 2.23Eb 21 82 2.59Eb 54 2.71b OMe 0 





Entry R R1 Dialkynol Time (h) Temp (°C) 1,2-Benzisothiazole Yield (%) Tetracycle  Yield (%) 
1 3-thienyl Ph 2.23Ga 2.5 r.t. 2.59Ga 0 2.72a 0 
2 3-thienyl C3H7 2.23Gb 1.5 82 2.59Gb 0 2.72b 0 







Entry R R1 Dialkynol Time (h) Temp (°C) 1,2-Benzisothiazole Yield (%) Tetracycle  Yield (%) 
1 2-naphthyl Ph 2.23Ha 1.5 82 2.59Ha 0 2.73a 0 
2 2-naphthyl C3H7 2.23Hb 1.5 82 2.59Hb 0 2.73b 0 
Table 2.17 Attempted iodocyclisations of dialkynols 2.23Ha – b with ICl
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The majority of reactions, summarised in the entries in Table 2.15 – 2.17 gave complex 
mixtures from which no identifiable products could be isolated. Only N-p-tolyl (R1 = Ph and 
C3H7 analogues) entries 3 and 4 (Table 2.15) gave the corresponding 1,2-
benzisothiazolo[2,3-a]quinoline (2.66a-3 and 2.66b-3). It is surprising that the reversed 
sulfonamides with N-(3-thienyl) units (2.23Ga – b) entries 13 and 14 (Table 2.16) failed to 
give tractable products, as both the C-2 and C-5 positions on the 3-thienyl derivatives are 
activated for electrophilic attack.  
Moreover, dialkynols 2.23Ea – b should also be activated to attack from electrophiles in the 
ortho (to the nitrogen) position on the aromatic ring, due to the methoxy group being 
ortho/para directing (Scheme 2.77). It would be expected that cyclisation of 2.23Ea – b 
would afford the 1,2-benzisothiazolo[2,3-a]quinolines 2.71a – b-2 as these would be the 
least hindered products. 
 
Scheme 2.77 
Another interesting result from these ICl cyclisations is the formation of the 3,3-bis(3-
methoxyprop-1-yn-1-yl)-2-(p-tolyl)-2,3-dihydro-1,2-benzisothiazole 1,1-dioxide 2.59Bf (entry 6, 
Table 2.15). When the reversed sulfonamide 2.23Bf was treated with In(OTf)3; which proved 
to be highly effective in the dehydration and cyclisation of the dialkynols 2.23Aa – Hb, none 
of the corresponding 1,2-benzisothiazole (2.59Bf) was isolated (Scheme 2.78). The reasons 
for this are not known, it could be postulated that the alkynyl unit being terminated with a 
methoxymethyl group will change the reactivity of the species towards certain Lewis acids, 





In order to verify the intermediacy of 3,3-di(alkynyl)-1,2-benzisothiazole 1,1-dioxides 2.59Ba 
– Hb in the formation of 1,2-benzisothiazolo[2,3-a]quinoline 2.66a – c, e and 2.71a – 2.73b, 
it was thought that addition of an iodine electrophile to preformed 2.59Ba – Hb in a 
separate reaction would also give 2.66a – c, e and 2.71a – 2.73b. Accordingly, treatment of 
2.59Ba with 3 equiv. of ICl in MeCN at reflux was investigated. After 24 h TLC examination 
showed that the reaction had gone to completion and work-up provided 2.66a-3 in an 
excellent yield (91%, entry 1, Table 2.18), thereby reinforcing the suggested mechanism in 
Scheme 2.71. The reactivity of 2.59Ba – Hb towards the optimised conditions (3 equiv. ICl in 
MeCN) were investigated as shown in Schemes 2.79 and 2.80, the results are collated in 





Entry R R1 1,2-Benzisothiazole Time (h) Temp (°C) Tetracycle  R3 Yield (%) 
1 Tolyl Ph 2.59Ba 24 82 2.66a-3 Me 91 
2 Tolyl C3H7 2.59Bb 21 82 2.66b-3 Me 40 
3 Tolyl 4-MeOC6H4 2.59Bc 4 82 2.66f Me 0 
4 3-MeC6H4 Ph 2.59Ca 22 82 2.66a Me 0 
5 3-MeC6H4 C3H7 2.59Cb 22 82 2.66b Me 0 
6 2-MeOC6H4 C3H7 2.59Db 22 82 2.71b OMe 0 
7 3-MeOC6H4 Ph 2.59Ea 5 82 2.71a OMe 0 
8 3-MeOC6H4 C3H7 2.59Eb 1 82 2.71b-2 OMe 41 





Entry R1 R2 1,2-Benzisothiazole Time (h) Temp (°C) Tetracycle Yield (%) 
1 3-thienyl C3H7 2.59Gb 3 82 2.72b 0 
2 2-naphthyl Ph 2.59Ha 24 82 2.73a 0 
3 2-naphthyl C3H7 2.59Hb 24 82 2.73b 0 
Table 2.19 Attempted iodocyclisations of 3,3-di(alkynyl)-1,2-benzisothiazole 1,1-dioxides 2.59Gb – Hb  
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Unfortunately the 3,3-di(alkynyl)-1,2-benzisothiazole 1,1-dioxides 2.59Ca – b R = 3-MeC6H4, 
R1 = Ph and C3H7 (entries 4 and 5, Table 2.18) and 2.59Ha – b R = 2-naphthyl, R1 = Ph and 
C3H7 (entries 2 and 3, Table 2.19) provided only starting material from the reaction with ICl 
in MeCN. The other substrates failed to yield any identifiable products and afforded only 
complex mixtures. The 1,2-benzisothiazolo[2,3-a]quinolines 2.66a-3 and 2.66b-3 (entries 1 
and 2, Table 2.18), furnished higher yields from this stepwise sequence in comparison to the 
one-pot reaction Scheme 2.74 (entries 3 and 4, Table 2.15).  
The 1,2-benzisothiazolo[2,3-a]quinoline 2.71b-2 was isolated in 41% yield (entry 8, Table 
2.18); as discussed previously (Scheme 2.77) the 3-MeOC6H4  group should be significantly 
more reactive in the ortho positions of the aromatic ring to electrophilic attack from the 
alkyne derived iodonium ion. The 2-methoxy-1,2-benzisothiazolo[2,3-a]quinoline 2.71b-2 
isolated from treatment of 2.59Eb with ICl was found to be the expected regioisomer 
(Scheme 2.81). Cyclisation having occurred at the least hindered position ortho to nitrogen 
(i.e. para to OMe). None of the alternative regioisomer (the 1-methoxy derivative) arising 
from SEAr ortho to the methoxy group was observed. 
 
Scheme 2.81 
The structure of 2.71b-2 was confirmed by the 1H NMR spectrum (Figure 2.24), and 




Figure 2.24 400 MHz 1H NMR spectrum of 2.71b-2 in CDCl3 
The reaction of reversed sulfonamides 2.23Aa – Hb and/or the 3,3-di(alkynyl)-1,2-
benzisothiazole 1,1-dioxides 2.59Aa – Hb with ICl in MeCN provides a pathway to the novel 
ring system 1,2-benzisothiazolo[2,3-a]quinoline 2.66a – b and 2.71a – 2.73b. Iodocyclisation 
of a pre-formed 3,3-di(alkynyl)-1,2-benzisothiazole 1,1-dioxides appears to offer the most 
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Chapter 3 Electrophilic Cyclisations of 3-Arylpenta-1,4-diyn-3-ols via 
6-Endo-dig or 6-Exo-dig Pathways 
3.1 Iodocyclisations of 3-[2-(Arenesulfonamido)phenyl]penta-1,4-diyn-3-ols 
to 4-Alkynyl-3-iodoquinoline and Derivatives 
Iodine-mediated electrophilic cyclisations of alkynes have been exploited to generate a wide 
variety of different heterocycles (cf. Scheme 1.4). A significant advantage of this approach is 
that many of the resulting rings will possess an iodo substituent, allowing the further 
functionalisation or annulation of the ring. A number of reviews covering iodocyclisation 
reactions are available [14COS-II(4)412, 14MI251, 15S1961, 16OBC7639, 16MI49730]. 
Molecular iodine has been utilised to promote the cyclisation of 2-
(tosylamino)phenylpropynols to afford 3-iodoquinolines. If nitromethane was used as the 
solvent the yields were poor. However, when replaced with methanol high yields (40 – 99%) 
of the 3-iodoquinoline were obtained (Scheme 3.1) [11OL2598]. 
 
Scheme 3.1 
To date, no example of the iodocylisations of alkynols in which R1 = alkynyl have been reported. 
In the present work, initial experiments therefore focused on the behaviour of 1,5-
disubstituted-3-[2-(arenesulfonylamido)phenyl]penta-1,4-diyn-3-ols 2.5 – 2.8 towards an 
electrophilic iodine source (iodenium ion I+). It is pertinent to note that both 5-exo-dig (3.1) 
and 6-endo-dig (3.2) pathways are possible from the iodonium ion intermediate X affording 





Preliminary work showed that when 2.5a was treated with iodine in refluxing MeOH 
(Scheme 3.3), a good yield of iodoquinoline 3.2a could be obtained (66%) [16UP1]. The 
product was characterised by its 1H and 13C NMR spectra (Figure 3.1) as well as by HMRS 
that exhibited a molecular ion at m/z [M+H]+ = 432.0245 corresponding to C23H14IN.  
 
Scheme 3.3 
Various quinolines with similar structural features to 3-iodo-2-phenyl-4-
(phenylethynyl)quinoline 3.2a are shown in Scheme 3.4. 3-Iodoquinolines in Scheme 3.4 A 
and B have different 1H NMR aromatic resonances for the benzo ring protons of the 
quinoline compared with those in 3.2a (Figure 3.1). However, 1H NMR data for 4-
phenylethynylquinoline in C Scheme 3.4 reveals that upon incorporation of an alkyne unit in 
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the 4-postion of the quinoline, the peri proton (5-H) is deshielded and moves downfield in 
comparison to 8-H. The 1H NMR resonance for the 5-H proton on 3-iodo-2-phenyl-4-
(phenylethynyl)quinoline 3.2a (δH 8.39 ppm, Figure 3.1) is therefore similar to that of the 4-
phenylethynyl quinoline shown in C Scheme 3.3 (δH 8.38 ppm). The quaternary 3-C-I 13C 
NMR resonance of quinoline 3.2a (δC 102.29 ppm) is comparable to that reported for 2,4-
diphenyl-3-iodoquinoline δC 98.5ppm (B, Scheme 3.4) and for a number of other 2-
substituted-3-iodo-4-phenylquinoline derivatives for which 3-C-I carbon resonates in the 
region of δC 100.2 – 101.6 ppm (D, Scheme 3.4). Addition of substituents to the quinoline 
ring clearly changes the shift of the 13C NMR 3-C-I carbon resonance, as that in the 3-
iodoquinoline (A, Scheme 3.4) is shielded by nearly 10 ppm in comparison to the 2,4-


















On repeating treatment of 2.5a with iodine in refluxing MeOH (Scheme 3.3) was found that 
unfortunately the yield of 3.2a was not as high nor as reproducible as previously achieved 
[16UP1]. However, an additional minor product was isolated by flash column 
chromatography from the reaction mixture. Both 1D and 2D NMR analysis (COSY, HSQC and 
HMBC) as well as HMRS confirmed the constitution of the product. The latter exhibited a 
molecular ion at m/z [M+H]+ = 306.1285 corresponding to C23H15N. The compound was 
found to be the 2-phenyl-4-(phenylethynyl)quinoline 2.35a but was only isolated in very low 
yields (6% - Table 3.1). 
Formation of 2.35a, as described in Section 2.4 (Scheme 2.44) is generated via a Meyer-




To establish whether acidic conditions would effect cyclisation of the dialkynol 2.5a to 2-
phenyl-4-(phenylethynyl)quinoline 2.35a, the former was treated with TsOH in toluene at 
100 °C for 19 h (Scheme 3.6). The 1H NMR spectrum of the crude material indicated that 
2.35a had indeed been formed and was 90% pure, however attempts to effect purification 
by column chromatography resulted in degradation. Nevertheless, this result confirmed that 






Reddy et al. found that iodocyclisation (I2) of alkynols to 3-iodoquinolines also afforded 2,4-
substiuted quinolines (3.3) in up to 30% yield (Scheme 3.7). They did not allude to the 
formation of the latter but it is envisaged to proceed via a Meyer-Schuster rearrangement. 
It was found that high yields (70 – 90%) of the quinoline 3.3 could be obtained by treatment 
of the 1-(2-aminophenyl)propynols with PPTS [12MI3986]. 
 
Scheme 3.7 
In efforts to optimise the yield of 3-iodo-2-phenyl-4-(phenylethynyl)quinoline 3.2a from 
dialkynol 2.5a different solvents and positive iodine sources were investigated (Scheme 3.8); 
as well as the addition of base which should supress the acidic formation of the parent 







Entry I+ source Equiv. Solvent Time (h) Temp (°C) Base Equiv. Yield of 3.2a (%) Yield of 2.35a (%) 
1 I2 2 MeOH 4.83 65  –   –  25 6 
2 I2 2 DCM 26.0 r.t. –  –  0 0 
3 I2 2 MeOH 2.0 65 –  –  26 1 
4 I2 2 Dry MeOH 1.5 65 –  –  31 0 
5 I2 3 Dry MeOH 1.0 65 –  –  55  0 
6 I2 3 MeNO2 1.5 80 –  –  25 8  
7 I2 2 Dry MeOH 4.0 65 Na2HPO4 2 0 0 
8 I2 3 Dry MeCN 3.5 60 Na2HPO4 3 10 0 
9a I2 3 Dry MeOH 5.0 65 NaHCO3 3 11  0 
10 I2 3 MeNO2 1.5 80 NaHCO3 3 17  0 
11 NIS 3 H2O:Me2CO 4.67 100 –  –  0 0 
12 NIS 3 MeNO2 1.0 100 –  –  0 0 
13a NIS 3 Dry MeOH 2.0 65 –  –  7  0 
14 NIS 3 MeCN 48.0 r.t. –  –  0 0 
15 ICl 2 MeCN 1.0 r.t. –  –  60 0 
16 ICl 2 MeNO2 1.0 r.t. –  –  24 0 
17 ICl 2 DCM 1.0 r.t. –  –  18 0 
18 ICl 2 Toluene 5.0 r.t. –  –  0 0 
19 ICl 2.5 MeCN 0.67 r.t. –  –  35 0 
20 ICl 1.5 MeCN 24.0 r.t. –  –  19 7 
Table 3.1 Optimisation of conditions for the iodocyclisation of 2.5a to 3.2a. a = 3,6-diiodo-2-phenyl-4-(phenylethynyl)quinoline 3.4a also isolated 
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With elemental iodine the use of dry solvents did not increase the yield of 3-iodoquinoline 
3.2a substantially, nor decrease the yield of the quinoline 2.35a. However, increasing molar 
equivalents of the electrophile did exert a positive benefit (entry 5, Table 3.1). 
Iodocyclisations in which iodine was used in the absence of base (entries 1 – 6, Table 3.1), 
generated 2-phenyl-4-(phenylethynyl)quinoline 2.35a (TLC) but separation from the 3-
iodoquinoline 3.2a was not always achievable, due to very similar Rf values in various 
solvent systems. 
Treatment of 2.5a with of I2 and Na2HPO4 (entries 7 and 8, Table 3.1) produced very 
complex reaction mixtures, it was thought that the base strength of Na2HPO4 may have an 
adverse influence, therefore a weaker base (NaHCO3) was employed. A less complex 
reaction mixture was obtained, however yields of the desired compound 3.2a were still low. 
Although, as predicted no 2-phenyl-4-(phenylethynyl)quinoline 2.35a appeared to be 
present (TLC).   
Interestingly, with NaHCO3 and I2 in dry MeOH (entry 9, Table 3.1) in addition to 3-iodo-2-
phenyl-4-(phenylethynyl)quinoline 3.2a, a faster running product was also isolated by flash 
column chromatography (5% EtOAc – hexane). This unknown material readily crystallised 
and when washed with cold hexane, produced white needles. The 1H NMR spectrum of the 
compound exhibited a doublet at δH 8.75 ppm (J5-7  = 1.9 Hz) and a doublet of doublets at δH 
8.00 ppm (J7-8  = 8.8 Hz, J7-5  = 1.9 Hz), which implied that the quinoline benzo moiety was 
now substituted (Figure 3.2). Indeed, ESI-HRMS confirmed the constitution as a diiodinated 
species (3.4a) with a molecular ion at m/z [M+H]+ = 557.9207 corresponding to C23H13I2N. 
Furthermore, the 13C NMR spectrum exhibited high field signals in the region characteristic 
for an aromatic C-I bond, δC 102.90 ppm for the 3-C-I and at δC 100.03 ppm for another sp2 
C-I. These shifts are similar to those reported by Zhang for 3,6-diiodo-2,4-diphenylquinoline 
(δC 99.58 and 93.31 ppm, Scheme 3.10) [17OBC6901]. The diiodoquinoline was assigned the 
structure 3.4a (Figure 3.2, 3,6-disubstituted) due to the electron releasing effect of the 
sulfonamide nitrogen at the para position in 2.5a (Scheme 3.9), the yield of 3.4a was 4% and 




Figure 3.2 400 MHz 1H NMR spectra comparison of quinolines 3.2a and 3.4a in CDCl3 
The mechanism for the formation of 3,6-diiodoquinoline 3.4a is envisaged to be 
electrophilic aromatic substitution (SEAr) of the benzo ring with an iodine electrophile, 
followed by the activation of the triple bond and subsequent cyclisation to the quinoline 
3.4a (Scheme 3.9). 
 
Scheme 3.9 
Electrophilic cyclisation of dialkynol 2.5a with NIS was also explored. As this positive iodine 
source has been reported to be highly effective for the synthesis of several heterocycles via 
iodocyclisation including but not limited to quinolines, indoles and dihydrofurans [14MI251, 
19S1841]. Zhang et al. achieved good yields of 3-iodo-2,4-diphenylquinoline from an N-
phenyl propargylamine with NIS in 1,4-dioxane, together with trace amounts of 3,6-diiodo-






Chan and co-workers found that with NIS in dry MeNO2 at reflux, 1-(2-
tosylamidophenyl)prop-2-yn-1-ol in which R1 ≠ H would cyclise easily to diiodomethyl-
indolin-2-ones, but at ambient temperature when R1 = H iodomethylene-indolin-3-ones 
were be obtained. However, when non-distilled solvent was used 3-phenyl-1-tosyl-1H-
indole-2-carbaldehyde was produced (A, Scheme 3.11) [13CEJ1978]. Similar behaviour was 
observed from treatment of the propynols with NIS in H2O – acetone, this reaction also 
tolerated R1 = H (B, Scheme 3.11) [13T7471]. 
 
Scheme 3.11 
Reactions of the dialkynol 2.5a with NIS were not successful in a variety of solvents (entries 
11 – 14, Table 3.1), providing little (7%, entry 13, Table 3.1) or no 3-iodoquinoline 3.2a. 
Interestingly, NIS in dry MeOH (entry 13, Table 3.1) also provided the 3,6-diiodoquinoline 
3.4a in 14% yield. This finding is in line with that of Zhang et al. from the cyclisation of N-
phenyl propargylamines with NIS in MeOH (Scheme 3.10) [17OBC6901]. We did not find 4-
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alkynyl-3,6-diiodoquinoline 3.4a to be generated in the same high yields as those reported 
by Zhang et al. for the 2,4-diaryl-3,6-diiodoquinoline (59 – 76% yield). The N-phenyl 
propargylamines are much more electron rich than the 1,5-disubstituted-3-[2-
(benzenesulfonylamido)phenyl]penta-1,4-diyn-3-ol 2.5a used in this work.  
 
Scheme 3.12 
Since NIS was not a favourable electrophile for the cyclisation of 2.5a (entries 11 – 14, Table 
3.1), the highly electrophilic species ICl was employed. With only a few papers describing its 
use as an electrophilic initiator to synthesise quinoline derivatives from arylacetylenes, 
arylpropynones and (most relevant) propynol derivatives (Scheme 3.17) [05OL763, 
06JOC1626, 06OL243, 10JOC1266, 10T1177]. Iodine monochloride has found more 
extensive use for cyclisations leading to chromone and isocoumarins and the use of ICl to 
initiate electrophilic cyclisation has been reviewed [15S1961].  
Thus treatment of dialkynol 2.5a with ICl (2 equiv.) in acetonitrile (entry 15, Table 3.1) 
resulted in a rapid reaction and TLC indicated that after 1 h only a small amount of starting 
material remained. The mixture was purified by flash column chromatography. The initial 
fractions afforded TsCl whilst the main fractions provided a solid that was further purified by 
recrystallisation from EtOH – EtOAc to give 3-iodo-2-phenyl-4-(phenylethynyl)quinoline 3.2a 
in 60% yield. With this being the highest yield achieved in the optimisation studies other 
1,5-disubstituted-3-[2-(benzenesulfonylamido)phenyl]penta-1,4-diyn-3-ols 2.5 – 2.8 
possessing a variety of substituents on the alkyne and benzenesulfonyl moieties, were then 
subjected to treatment with ICl in acetonitrile (Method A, Scheme 3.13, Table 3.2). 
Unfortunately, exposure of the N-[2-(6-hydroxyundeca-4,7-diyn-6-yl)phenyl]-4-
methylbenzenesulfonamide 2.5b to ICl in MeCN provided a complex mixture that could not 
be purified by flash column chromatography. Consequently, alkylacetylene-derived 
dialkynols (2.5b, d, g, j, k and 2.6b, 2.7b) were subjected to the ‘next best’ option in the 
screening procedure (Table 3.1), I2 (3 equiv.) in MeOH at reflux (Method B, Scheme 3.13), 
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which allowed access to the 2-alkyl-4-alkynyl-3-iodoquinolines in yields ranging from 12 – 
63% (Table 3.2). 
 
Scheme 3.13 
Entry R R1 Dialkynol Method Time (h) Product Yield (%) 
1 Me Ph 2.5a A 1.0 3.2a 60 
2 Me C3H7 2.5b B 1.0 3.2b 46 
3 Me 4-MeOC6H4 2.5c A 1.0 3.2c 40 
4 Me C4H9 2.5d B 1.5 3.2d 63 
5 Me Me 2.5g B 2.25 3.2g 26 
6 Me t-Bu 2.5j B 1.25 3.2j 0 
7 Me (CH3)C=CH2 2.5k B 1.25 3.2k 0 
8 OMe Ph 2.6a A 1.0 3.2a 63 
9 OMe C3H7 2.6b B 0.83 3.2b 50 
10a NO2 Ph 2.7a A 1.0 3.2a 32 
11 NO2 C3H7 2.7b B 19.0 3.2b 12 
12 H Ph 2.8a A 2.0 3.2a 41 





(entry 10, Table 3.2) reacted with ICl in MeCN to also afford the 3,6-diiodoquinoline 3.4a in 
18% yield (Scheme 3.14) and was the only dialkynol to do so under the optimised 
conditions. This observation can be ascribed to the diminished nucleophilicity of the 
sulfonamide nitrogen and subsequent slowing of its addition to the iodonium cation, 
allowing competitive electrophilic iodination of the aromatic ring. 
 
Scheme 3.14 
Dialkynols 2.5j and 2.5k (entries 6 and 7, Table 3.2) provided complex mixtures and no 
identifiable products could be isolated from these reactions. Dialkynols 2.5j and 2.5k were 
also subjected to Method A conditions (2 equiv. ICl in MeCN, r.t. for 24 h) but again only a 
complex mixture was obtained. However, with these two exceptions the other dialkynols 
provided access to a range of 4-alkynyl-3-iodoquinolines (Table 3.2). 
Of the novel 4-alkynyl-3-iodoquinolines 3.2, Figure 3.3 shows the ranges of 1H and 13C NMR 
resonances for 5-H – 8-H protons and for the 3-C carbon. The 3-C-I carbon bond is shielded 
in comparison to the normal range for an aromatic carbon (δC 120 – 160) due to the heavy-
atom effect of the iodine substituent [98CEJ118, 16JTC199]. The 1H NMR ranges of the 
benzo ring protons are similar to those reported by Batsyts et al. for 4-




Figure 3.3 1H and 13C NMR shifts of 4-alkynyl-3-iodoquinolines 3.2a – g  
Iodocylisations of 1,5-disubstituted-3-[2-(benzenesulfonylamido)phenyl]penta-1,4-diyn-3-
ols 2.5 – 2.8 followed the expected trend; the benzenesulfonyl group containing the 
electron donating methoxy group (2.6a – b) provided better yields of 4-alkynyl-3-
iodoquinolines in a faster time (entries 8 and 9, Table 3.2), whereas the dialkynols 
possessing the electron withdrawing 4-nitrobenzenesulfonyl group (2.7a – b) provided 
lower yields of 4-alkynyl-3-iodoquinolines and required a longer reaction time (entries 10 
and 11, Table 3.2). 
It is surprising that ICl did not react cleanly with the alkyl-terminated dialkynols 2.5b, d, g, j 
and k as it is a better electrophile than iodine, due to the permanent dipole that exists and  
which facilitates electrophilic attack [07JOC977, 14MI251]. The phenyl ring will impart some 
stability to the intermediate iodonium ion, as in the strain-free ring-opened form, the vinyl 
carbocation X, there will be conjugation with the aryl group (Scheme 3.15) [93TL8205]. 
However, when the aryl substituent is replaced with an alkyl group only inductive 
stabilisation of the cation is possible. Presumably the lower yields of the 2-alkyl-4-alkynyl-3-
iodoquinolines 3.2b, d, g, j and k, compared to those of the 2-aryl-4-alkynyl-3-iodoquinoline 






The mechanism for the formation of the 4-alkynyl-3-iodoquinolines 3.2 proceeds via an 
iodonium intermediate which was initially suggested by Larock and co-workers for the 
iodocyclisation of 1-(2-methoxyphenyl)prop-2-yn-1-ols to 3-iodochromones [06JOC1626], 
and subsequently for quinolines from 1-(2-tosylamindophenyl)prop-2-yn-1-ols by Ali and co-
workers [11OL2598]. Overall, the reaction sequence can be envisaged as proceeding by anti-
attack of the electrophile and the nitrogen on the alkyne moiety via a 6-endo-dig pathway 
to produce the intermediate quinolinium salt, which then dehydrates to afford the N-
tosylquinolinium salt. Subsequent elimination of the arenesulfonyl moiety will be facile, to 
afford the product 3.2 (Scheme 3.16). When iodine monochloride is used the 
benzenesulfonyl chloride is isolated, it is expected that in the cases when molecular iodine is 
used TsOH will be lost. 
 
Scheme 3.16 
The 4-alkynyl-3-iodoquinolines (3.2a – g) obtained in this work are all novel compounds and 
as such represent a missing series of novel functionalised quinolines. Both the alkyne and 
the iodo functions allow the ring to be further elaborated, giving access to more complex 
heterocyclic systems via annulation reactions. With only a handful of literature examples of 
substituted 3-iodoquinolines and, as to date, only three papers accessing them via 
propargylic alcohols exist (A, B and C, Scheme 3.17) [11OL2598, 12MI3986, 17EJO4600]. In 
reaction D Scheme 3.17, no external iodine electrophile was utilised to afford the 3-
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iodoquinoline. A copper(II) catalysed tandem reaction of diaryliodonium salts, nitriles and 1-
haloalkynes afforded 2,4-disubstitued-3-haloquinolines with varying substituents, both aryl 
and alkyl groups are tolerated (D, Scheme 3.17) [16ASC2332]. Ramanathan and Liu utilised a 
similar set of starting materials to synthesise 2,4-disubstitued-3-iodoquinolines, from 
aryldiazonium salts with 1-iodoalkynes (E, Scheme 3.17) [17T4317]. 1-Azido-2-(2-
propynyl)benzene cyclised with ICl in nitromethane at r.t. to afford 3-iodo-2-arylquinoline 
after the loss of N2, only two examples were reported with this method (F, Scheme 3.17) 
[10JOC1266]. The majority of the other 3-iodoquinolines reported in the literature have 
been synthesised from the iodocyclisation of alkynylanilines (G – K, Scheme 3.17), with 
varying iodine electrophiles and solvents [04JOC8251, 05OL763, 10T1177, 17JOC4625, 
17JOC11727, 17OBC6901]. Simple diazotisation of 3-aminoquinoline and substitution with 
KI afforded the 3-iodo-3-phenylquinoline (L, Scheme 3.17) [12S290]. The N-
methylquinolinium salt (M, Scheme 3.17) was also afforded after the iodocyclisation of a 









The foregoing work demonstrated the successful iodocyclisation of 1,5-disubstituted-3-[2-
(benzenesulfonylamido)phenyl]penta-1,4-diyn-3-ols 2.5 – 2.8 to novel 4-alkynyl-3-
iodoquinolines 3.2. Subsequent investigations were directed to exploring the regiochemical 
preferences in the iodocyclisations of the unsymmetrical dialkynols 2.19 with the optimised 
conditions; iodine monochloride in MeCN (Method A) or with elemental iodine in refluxing 












1 Ph C3H7 2.19Ab A 4.3 3.5Ab-X 14 3.5Ab-Y 31 
2 Ph C3H7 2.19Ab B 1 3.5Ab-X 0 3.5Ab-Y 15 
3 Ph 4-MeOC6H4 2.19Ac A 0.75 3.5Ac-X 0 3.5Ac-Y 32 
4 Ph CH2OMe 2.19Af A 2 3.5Af-X 0 3.5Af-Y 0 
5 Ph Me 2.19Ag B 1.5 3.5Ag-X 8 3.5Ag-Y 17 
6 Ph t-Bu 2.19Aj A 0.75 3.5Aj-X 19 3.5Aj-Y 0 
7 Ph (CH3)C=CH2 2.19Ak A 19 3.5Ak-X 0 3.5Ak-Y 0 
8 Ph H 2.19Ai A 1.5 3.5Ai-X 0 3.5Ai-Y 0 
9 4-MeOC6H4 C3H7 2.19Cb B 1.25 3.5Cb-X 28 3.5Cb-Y 0 
10 4-MeOC6H4 CH2OMe 2.19Cf B 2.3 3.5Cf-X 0 3.5Cf-Y 0 
11 4-MeOC6H4 H 2.19Ci A 1.5 3.5Ci-X 0 3.5Ci-Y 0 
Table 3.3 Yields from the iodocyclisations of unsymmetrical dialkynols 2.19
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It was difficult to isolate any pure products from the majority of the reactions because the 
compounds produced possessed very similar Rf values. In some cases, complex mixtures 
were produced from which no identifiable products could be isolated. 
3-Iodo-4-(phenylethynyl)-2-propylquinoline 3.5Ab-Y (entry 1 and 2, Table 3.3) was 
characterised by both 1D and 2D NMR (COSY, HSQC, HMBC) spectra, with the 1H NMR data 
of 3-iodo-4-(pent-1-yn-1-yl)-2-propylquinoline 3.2b providing a useful comparison. The 
similarity of the CH2 splitting pattern and the chemical shift of the C-2 propyl group in 
quinoline 3.2b (δH 3.19 ppm, red spectrum, Figure 3.4), are comparable to that seen in 
3.5Ab-Y (δH 3.25 ppm, blue spectrum, Figure 3.4). Moreover, the HMBC spectrum of 3-iodo-
4-(phenylethynyl)-2-propylquinoline 3.5Ab-Y shows a correlation between the CH2 protons 
of the 2-propyl group and the resonance corresponding to the 3-C carbon at δC 100.38 ppm 
(Figure 3.5). Surprisingly, the major isomer from the cyclisation of 2.19Ab was the 2-
propylquinoline 3.5Ab-Y, using either Method A or Method B (entry 1 and 2, Table 3.3). The 
iodocylisation did not provide the 2-phenylquinoline 3.5Ab-X as the major isomer. The latter 
would be expected because the phenyl ring should impart a stabilising effect on the 
intermediate iodonium ion (Scheme 3.15). The difference in the yields obtained maybe due 
to the difficulties in separating the two isomers (Scheme 3.19).  
An indication that the cyclisation proceeds via cyclisation onto the more stabilised iodonium 
ion intermediate was obtained by consideration of the other entries in the table which gave 
the expected major isomer 3.5Ac-Y, 3.5Aj-X and 3.5Cb-X (Table 3.3, entries 3, 6, and 9, 
respectively). Thus, 2.19Ac provided the 3-iodo-2-(4-methoxyphenyl)quinoline 3.5Ac-Y 
exclusively. In a similar manner 2.20Aj and 2.20Cb provided the 2-aryl-3-iodoquinoline as 






Figure 3.4 400 MHz 1H NMR spectra comparison of 3.2a and 3.5Ab-Y in CDCl3 
 
Figure 3.5 HMBC spectrum of 3.5Ab-Y  
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The quinolines 3.5Ag-X, 3.5Ag-Y and 3.5Aj-X (entry 5 and 6, Table 3.3) were also 
characterised by their 1D and 2D NMR (COSY, HSQC, HMBC) spectra. In the case of 3-iodo-2-
phenyl-4-(prop-1-yn-1-yl)quinoline 3.5Ag-X (entry 5, Table 3.3) the alkynyl-linked methyl 
group exhibits a similar 1H NMR chemical shift (δH 2.36 ppm) to the starting material 2.19Ag 
(δH 1.92 ppm, Figure 3.6). Moreover, the 13C NMR shift of the methyl carbon in 3.5Ag-X (δC 
5.18 ppm) is strongly shielded due to the anisotropic effect of the alkyne unit, thus 
confirming the structure as 3.5Ag-X.  
On the other hand, the next fraction (3.5Ag-Y) obtained from the iodocyclisation of 2.19Ag 
exhibits a significant downfield shift of the methyl group both in the 1H NMR (δH 3.03 ppm) 
and the 13C NMR resonance (δC 31.20 ppm) as shown in Figure 3.6, in comparison to the 
starting material 2.19Ag (δH 1.92 ppm and δC 2.64 ppm), implying that the methyl group is 
no longer shielded by the anisotropic effect of the alkyne, therefore supporting to the 
structure 3-iodo-2-methyl-4-(phenylethynyl)quinoline 3.5Ag-Y. Moreover, the HMBC 
spectrum of 3.5Ag-Y exhibits a correlation between the 2-methyl protons (δH 3.03 ppm) and 
the quaternary 3-C carbon (δC 100.90 ppm). The 1H and 13C NMR chemical shifts for the 
methyl groups in quinolines 3.5Ag-X and 3.5Ag-Y are nearly identical those that of the 
isomeric 3-iodo-2-methyl-4-(prop-1-yn-1-yl)quinoline 3.2g (Figure 3.6), further confirming 
each assigned structure of quinolines 3.5Ag-X and 3.5Ag-Y (Figure 3.6). 
The iodocyclisation reaction of dialkynol 2.19Ag and molecular iodine in refluxing MeOH 
(entry 5, Table 3.3) provided the unexpected major isomer 2-methylquinoline 3.5Ag-Y in a 
higher yield. As discussed previously this could be due to the difficulties in purifying the 
reaction mixture. 
 
Figure 3.6 1H and 13C NMR chemical shift comparison of 2.19Ag, 3.5Ag-X, 3.5Ag-Y and 3.2g 
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Of all the iodocyclisation products obtained from the unsymmetrical dialkynols (Table 3.3) 
the most challenging to characterise was that obtained form 2.19Ac in which the two alkyne 
units are terminated by different aryl groups. Clearly the cyclisation could afford either the 
2-phenylquinoline 3.5Ac-X or the 2-(4-methoxyphenyl) derivative 3.5Ac-Y (Scheme 3.20). It 
was anticipated that the latter would be generated preferentially because of the greater 
nucleophilicity of the (4-methoxyphenyl)ethynyl group towards ICl compared to the 
phenylethynyl functions. In addition, the enhanced stability of the iodonium cation bearing 
an electron donating 4-methoxyphenyl group (c.f. Scheme 3.15) should also assist in 
directing the cyclisation. 
 
Scheme 3.20 
Thus exposure of 2.19Ac to ICl in MeCN afforded a single 3-iodoquinoline derivative in 32% 
yield (entry 3, Table 3.3). The constitution of this compound was established as the 
expected product i.e. 3-iodo-2-(4-methoxyphenyl)-4-(phenylethynyl)quinoline 3.5Ac-Y by 
comparison of its 1H NMR spectrum, firstly with that of the 3-iodo-2-(4-methoxyphenyl)-4-
(pent-1-yn-1-yl)quinoline 3.5Cb-X which revealed that the 1H NMR shifts of the 2-(4-
methoxyphenyl) protons (red boxes, B, Figure 3.7, δH 7.57 ppm and 7.01 ppm) are similar to 
that found in 3.5Ac-Y (red boxes, A, Figure 3.7, δH 7.60 ppm and 7.02 ppm). Furthermore 
the 1H NMR resonances for the phenyl unit in 3-iodo-4-(phenylethynyl)-2-propylquinoline 
3.5Ac-Y (green boxes, A, Figure 3.7) have similar chemical shifts to that for quinoline 3.5Ab-
Y (green boxes, C, Figure 3.7), further confirming the assignment of entry 3 (Table 3.3) to 




Figure 3.7 1H NMR spectra comparison of 3-iodoquinolines 3.5Ac-Y with 3.5Cb-X and 3.5Ab-Y in 
CDCl3 
Ali et al. reported the preparation of 3-iodo-2-(4-methoxyphenyl)-4-phenylquinoline 3.6 
(Scheme 3.21) [11OL2598]. The 1H NMR absorptions for the 2-(4-methoxyphenyl) unit (δH 
7.60 ppm and 7.01 ppm) are nearly identical to those of 3.5Ac-Y (δH 7.60 ppm and 7.02 




In summary, synthesis of the 3-iodoquinolines 3.5 from the unsymmetrical dialkynols 2.19 
proved to be less successful than those from their symmetrical counterparts 2.5 – 2.8 that 
give the 4-alkynyl-3-iodoquinolines 3.2. Some examples of quinolines 3.5 provided very low 
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yields or an intractable mixture of products. Clearly future optimisation of the reaction is 
required.  
3.2 Silver(I) Mediated Cyclisations of [3-2-(Sulfamoyl)phenyl]penta-1,4-diyn-
3-ols to 1,2-Benzothiazine 1,1-dioxides and Derivatives 
Since the 1960s there has been sustained interest in 1,2-benzothiazines and especially their 
1,1-dioxides, following the discovery of the non-steroidal anti-inflammatory oxicams, of 
which three representatives are shown below.  
 
Traditional routes to 1,2-benzothiazine 1,1-dioxides involve the intramolecular Claisen 
condensation of sulfonamides derived from methyl 2-(chlorosulfonyl)benzoate and α-amino 
carbonyl compounds. The base-promoted ring expansion of N-(acylmethyl) saccharins 
provides access to 3-acyl-4-hydroxy-1,2-benzothiazine 1,1-dioxides. These and related 
approaches have been reviewed [81AHC(28)73, 20MRO148]. Developments in the 
chemistry and synthetic routes to 1,2-benzothiazines have been reviewed more recently 
[18SC3033]. Some of the recent syntheses of the ring system are outlined in Section 1.5.4 
and below. This section describes a novel means to construct the 1,2-benzothiazine 1,1-
dioxide nucleus. 
As discussed in Section 2.2 there are few aryl (di)alkynols in which the aryl ring is substituted 
with a primary, secondary or tertiary sulfamoyl group i.e. -SO2NH2, -SO2NHR or -SO2NR2 
respectively. Indeed, the only examples are arylacetylenes possessing an ortho-sulfamoyl 
group, whilst compounds containing a 1-(2-sulfamolyphenyl)prop-2-yn-1-ol unit e.g. 3.7 
have not been reported previously (cf. Section 2.2). Silver(I)-mediated cyclisations of (2-
sulfamoylphenyl)acetylenes (2-alkynylbenzenesulfonamides) have been shown to afford 






Other more expensive metal catalysts have been utilised for the formation of 1,2-
benzothiazine 1,1-dioxides and complexes of palladium(0) and rhodium(III) have proved 
particularly useful [18SC3033]. Reddy and co-workers produced a range of sultams (A, 
Scheme 3.23) utilising a Pd(0) catalyst generated in situ from [PdCl2(PPh3)2], to activate the 
triple bond of N-(phenylsulfonyl)propargylamines to attack from a range of nucleophiles 
[16ASC1625]. Pham, Ye and Cramer synthesised a range of 1,2-benzothiazines (B, Scheme 
3.23) from a Rh(III)-mediated oxidative C-H activation-alkynylation reaction of N-
acetylbenzenesulfonamides. It was found that low or stoichiometric loadings of copper(I) 
were unfavourable and that to minimise acetyl group cleavage, molecular oxygen was 





The present project has demonstrated that silver(I) salts are effective for the cyclisation of 
the tosylamidophenyl dialkynols 2.5 to afford indoles 2.32 and indolines 2.33 (Section 2.4) 
via a 5-exo-dig pathway. Clearly the isomeric sulfamoylphenyldialkynols (reversed 
sulfonamides) 2.23Aa – Hb could not cyclise in the same manner and upon π-complexation 
with Ag(I) would be activated to ring closure via either 6-exo-dig or 7-endo-dig pathways 
(Scheme 3.24). Both pathways are favoured under Baldwin’s rules [76CC734, 16CMS487]. 
The cyclisations potentially constitute a novel means to construct the 1,2-benzothiazine 





Initially the dialkynol 2.23Aa was treated with AgOAc (5 mol %) in MeCN at reflux overnight. 
Purification of the reaction mixture by flash chromatography (10% EtOAc – hexane) 
provided a complex minor component in the initial fractions. However, the major final 
fraction exhibited a very different 1H NMR spectrum to that of the starting material (blue 
spectrum, Figure 3.8). The benzo ring signals are shifted upfield (red spectrum, Figure 3.8) 
compared with that of the starting material, furthermore the N-Me group signal is shifted 
downfield and appears as a singlet, consistent with formation of a cyclisation product 
(Figure 3.8). Coupling of the NH proton with the methyl group (JNHMe = 5.3 Hz) is a distinctive 




Figure 3.8 400 MHz 1H NMR spectra comparison of 2.23Aa to unknown fraction in CDCl3 
There are three potential cyclisation products from the cyclisation of dialkynol 2.23Aa 
(Scheme 3.25). Coordination of Ag(I) to the alkyne activates it to nucleophilic attack from 
the sulfonamide nitrogen; the cyclisation pathway could then proceed via 6-exo or 7-endo-
dig pathways to give six membered (3.9Aa) or seven membered (3.10Aa) rings respectively 
(Scheme 3.25). Furthermore, the benzylic enynol 3.9Aa could also undergo a 1,3-allylic 
alcohol isomerization (1,3-AAI) [07TL8505] to give the isomeric 1,2-benzothiazine system 





If the reaction had furnished 3.11Aa it would be expected that two doublets with a geminal 
coupling would be present in the 1H spectrum (as there was for indole 3.32a), corresponding 
to the alcohol and the benzylic CH protons. However, the absence of these signals discount 
structure 3.11Aa. Moreover, it was considered less likely that the major product was the 
seven-membered 1,2-benzothiazepine ring 3.10Aa because of the less favoured 
conformation the substituents must adopt for the cyclisation to proceed.  
Of the possible structures, the 1,2-benzothiazine 1,1-dioxide 3.9Aa, resulting from a 6-exo-
dig cyclisation, would appear to be the most probable. It was considered likely that the 
product will process (Z)-stereochemistry as interactions of the benzylidene moiety and the 
benzothiazine C-4 substituents in the intermediate silver(I) species 3.12 will be minimised. 
Furthermore, the 6-exo-dig cyclisation will proceed via an anti-addition of the sulfonamide 






The constitution of 1,2-benzothiazine 1,1-dioxide 3.9Aa was established by examination of 
the NOESY spectrum (Figure 3.9), which revealed a through-space interaction between the 
benzylidene CH signal (δH 7.49 ppm) and the OH signal (δH 3.42 ppm). The latter signal also 
exhibited a correlation with that of the apparent doublet at δH 8.10 ppm, thus providing 
confirmation that the most deshielded signal corresponds to the 5-H proton (cf. Section 2.2, 
Figure 2.2). Further evidence in support of the (Z)-stereochemistry of 3.9Aa was provided by 
the cross-peak (Figure 3.9) corresponding to an interaction between the ortho-Ph protons 
(δH 7.47 ppm) of the benzylidene unit and the Me protons (δH 3.12 ppm).  
 
Figure 3.9 NOESY spectrum of 3.9Aa 
Both 1,2-benzothiazine 1,1-dioxide 3.9Aa and 1,2-benzothiazepine 1,1-dioxide 3.10Aa 
structures are novel, and additional derivatives were required not only to confirm the 
structure of 3.9Aa but also to investigate the scope and limitations of these cyclisation 
reactions. Consequently, the reactivity of a range of reversed sulfonamides 2.23Aa – Hb 
towards AgOAc in MeCN was examined, Scheme 3.27. The results of these cyclisations are 











1 Me Ph 2.23Aa 24 3.9Aa 48 3.10Aa 0 
2ab Me C3H7 2.23Ab 20 3.9Ab 12b 3.10Ab 7 
3 Tolyl Ph 2.23Ba 3 3.9Ba 78 3.10Ba 0 
4 Tolyl C3H7 2.23Bb 1 3.9Bb 82 3.10Bb 0 
5 Tolyl 4-MeOC6H4 2.23Bc 23 3.9Bc 62 3.10Bc 0 
6c Tolyl TMS 2.23Be 2 3.9Be 61 3.10Be 0 
7 Tolyl CH2OMe 2.23Bf 20 3.9Bf 86 3.10Bf 0 
8 3-MeC6H4 Ph 2.23Ca 4 3.9Ca 72 3.10Ca 0 
9 3-MeC6H4 C3H7 2.23Cb 1.5 3.9Cb 59 3.10Cb 0 
10 2-MeOC6H4 Ph 2.23Da 2 3.9Da 86 3.10Da 0 
11 2-MeOC6H4 C3H7 2.23Db 2 3.9Db 61 3.10Db 0 
12 3-MeOC6H4 Ph 2.23Ea 3 3.9Ea 96 3.10Ea 0 
13 3-MeOC6H4 C3H7 2.23Eb 3 3.9Eb 80 3.10Eb 0 
14 3-thienyl C3H7 2.23Gb 3.7 3.9Gb 70 3.10Gb 11 
15 2-naphthyl Ph 2.23Ha 3 3.9Ha 75 3.10Ha 0 
16 2-naphthyl C3H7 2.23Hb 3 3.9Hb 84 3.10Hb 0 
Table 3.4 Yields from the AgOAc cyclisation of reversed sulfonamides 2.23Aa – Hb. a = 3-(1-Hydroxybutyl)-2-methyl-4-(pent-1-yn-1-yl)-2H-1,2-benzothiazine 
1,1-dioxide 3.11Ab also obtained from this reaction. b = yield from 1H NMR spectrum c = 4-Hydroxy-3-methylene-2-(p-tolyl)-4-[(trimethylsilyl)ethynyl]-3,4-
dihydro-2H-1,2-benzothiazine 1,1-dioxide 3.9Be’ also obtained from the reaction
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The reaction of 2-(6-hydroxyundeca-4,7-diyn-6-yl)-N-methylbenzenesulfonamide 2.23Ab 
AgOAc in MeCN (entry 2, Table 3.4) provided a mixture of compounds that could only be 
separated with difficulty by extensive flash column chromatography. However, it proved 
possible to identify three novel compounds (Scheme 3.28). The major fraction from flash 
column chromatography, was identified as an inseparable mixture of 1,2-benzothiazine 1,1-
dioxide 3.9Ab and starting material 2.23Ab (in several solvents). The yield quoted (12%, 
Table 3.4) is from integration ratios in the 1H NMR spectrum. (Z)-3-Butenylidene-1,2-
benzothiazin-4-ol 3.9Ab (Scheme 3.28) was identified on the basis of its 1H NMR spectrum 
which exhibited a triplet at δH 6.64 ppm (J = 7.3 Hz). The constitution of this material was 
also confirmed by LC-MS with a molecular ion at m/z [M+H]+ = 333.1391 corresponding to 
C18H22NO3S.  
A faster running (less polar) component was isolated and identified as the 7-endo-dig 
product the 1,2-benzothiazepine 1,1-dioxide 3.10Ab (7%, Scheme 3.28). The 1H NMR 
spectrum exhibited two singlets at δH 5.77 and 5.34 ppm corresponding to the 4-H and OH 
protons respectively (Figure 3.10). The absence of allylic coupling between the C-3 propyl 
group and the 4-H is noteworthy (Figure 3.10). HRMS also provided additional support for 







Figure 3.10 400 MHz 1H NMR spectrum of 1,2-benzothiazepine 1,1-dioxide 3.10Ab in CDCl3 
Another non-polar orange oil was also obtained from attempted purification of the reaction 
mixture (entry 2, Table 3.4) and identified as 3-(1-hydroxybutyl)-2-methyl-4-(pent-1-yn-1-
yl)-2H-1,2-benzothiazine 1,1-dioxide 3.11Ab (15% yield, Scheme 3.28). This compound is 
thought to be formed during repeated chromatographic purification during which the 1,2-
benzothiazin-4-ol 3.9Ab is protonated by the acidic silica gel. Subsequent dehydration will 
generate the highly delocalised carbocation 3.13 which is susceptible to nucleophilic attack 
(SN1) from water to afford 3.11Ab (Scheme 3.28). The latter was characterised by its 1H 
NMR spectrum which exhibited a multiplet for the side-chain methine proton centred at δH 
5.18 ppm. The adjacent OH proton appeared as a doublet (JCH-OH = 5.2 Hz) at δH 2.59 ppm. 





Lei and co-workers synthesised the (1-hydroxyethyl)-1,2-benzothiazine 1,1-dioxides 3.14 
and 3.15, by anodic oxidation of an N-heteroaryl sulfonamide and but-3-yn-2-ol in an 
undivided cell (Scheme 3.29). However, NMR data was only reported for the major isomer 
3.14 [20GC1548]. There are no other similar model compounds to 3-hydroxy-1,2-
benzothiazine 1,1-dioxide (3.11Ab) in the literature to date. 
 
Scheme 3.29 
1,2-Benzothiazepines are relatively uncommon. Synthetic routes to this ring system are 
highlighted in Scheme 3.26 and often involve numerous steps or employ specialist 
photochemical equipment [80CJC369, 08SC3662, 11JME716, 13JCD4410, 17OCF14, 
17OL6020, 19JOC3871]. Sulfonamide 3.16 (A, Scheme 3.30) was reductively 
cyclodehydrated to 1,2-benzothiazepines with high ee (91 – 99%) [15MI106866574]. 2-
Azidothiochromone 1,1-dioxides upon irradiation in acetophenone undergoes a ring 
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expansion affording 3.17 in an 81% yield (B, Scheme 3.30) [80CJC369]. 1,2-Benzothiazin-3-
ones undergo a ring expansion in the presence of a strong base (C, Scheme 3.30) 
[08SC3662]. Ganguly and co-workers found that the readily available N-allylsulfonamides 
3.18 undergo a radical chain cyclisation to saturated 1,2-benzothiazepine-1,1-diones (D, 
Scheme 3.30) [11JME7176]. The palladium(II)-catalysed reaction of 2-
alkynylbenzensulfonamides and 2-alkynylvinyl bromide were employed to synthesise 6H-
benzo[f ]cyclopenta[d][1,2]thiazepine 5,5-dioxides (E, Scheme 3.30) in high yields (56 – 99%) 
[13JCD4410]. Wen used a rhodium(III) complex to catalyse the C-H functionalisation of 
sulfoximines with enones to afford 1,2-benzothiazepine 1-oxides 3.19 (F, Scheme 3.30) 
[17OL6020]. Figueroa et al. obtained the 1,2-benzothiazepin-5-one 1,1-dioxide 3.20 from a 
photochemically induced ring expansion of sodium saccharin with phenylacetylene (G, 
























Although 7-endo-dig cyclisations are known, they are still relatively scarce. A SciFinder 
search uncovered 65 references. An example of a 7-endo-dig cyclisation pertinent to the 
present project is illustrated in Scheme 3.31. The Ag(I)-catalysed cyclisation of the 2-(2-
alkynylphenyl)amino-1,4-naphthoquinones 3.21 to benzo[b]naptho[2,3-f]azepine-6,11-
diones proceeds in excellent yields (69 – 99%) [18OBC5483]. 
 
Scheme 3.31 
The AgOAc-mediated ring closure of the 3-(N-methylsulfamoylphenyl)pentadiynols 2.23Aa –
b provided an entry to novel 1,2-benzothiazine 1,1-dioxides albeit in fair yields (entries 1 
and 2, Table 3.4). It was of interest to explore the scope of the influence of the alkyne 
groups upon the outcome of the reaction. To this end, the Ag-mediated cyclisation was 
extended to the range of 3-[2-(N-tolylsulfamoyl)phenyl]penta-1,4-diyn-3-ol derivatives. 
Thus, the dialkynols 2.23Ba – f cyclised efficiently to afford the corresponding 2-(4-
methylphenyl)-1,2-benzothiazine 1,1-dioxides 3.9Ba – f in yields ranging from 61 – 82% 
(entries 3 – 7, Table 3.4). All of the products were obtained as yellow or orange oils after 
flash column chromatography and the cyclisation was successful with alkynes possessing 
either alkyl or aryl terminal groups. 
In the case of the sulfamoyl dialkynol 2.23Be the cyclisation proceeded rapidly (2 h) to 
afford 3.9Be in 61% yield (entry 6, Table 3.4). In addition, a small amount of a compound 
identified as the desilylation product as 3.9Be’ (Scheme 3.32) was also obtained in 2% yield. 
The structure of the latter was confirmed by the 1H NMR spectrum, which exhibited two 
doublets at δH 5.82 and 4.76 ppm (2J = 1.8 Hz) corresponding to the alkenic protons. The 
constitution of 3.9Be’ was also confirmed by HRMS with which exhibited a molecular ion at 





The N-aryl group in 2.23 was also varied to give three additional compound series of 1,2-
benzothiazine 1,1-dioxides 3.9C – E (entries 8 – 13, Table 3.4) (Scheme 3.33), of which the 
latter were obtained in generally high yields (59 – 96%). A near quantitative yield was 




Replacement of the N-aryl substituent in dialkynols 2.23B – E with a 3-thienyl unit provided 
the N-heteroarylsulfonamide 2.23Gb. In this case, silver-mediated cyclisation proceeded 
readily to give the 2-(3-thienyl)-1,2-benzothiazine 1,1-dioxide 3.9Gb in 70% yield, together 
with a small amount of the 7-endo-dig cyclisation product 3.10Gb (Scheme 3.34). The latter 
was characterised from its 1H and 13C NMR spectra, the former exhibited a singlet at δH 5.91 
ppm for the 4-H proton together with an OH signal at δH 5.43 ppm. The presence of alkyne 
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carbon signals at δC 89.00 and 82.06 ppm confirmed the presence of the pentynyl group, 
whilst the quaternary 5-C signal resonated at δC 72.89 ppm. 
 
Scheme 3.34 
The 2-methyl- and 2-(3-thienyl)-1,2-benzothiazepine 1,1-dioxides 3.10Ab and 3.10Gb 
isolated from 2.23Ab and 2.23Gb respectively (entries 2 and 14, Table 3.4) contained 
impurities, further attempts to purify these compounds began to result in degradation (1H 
NMR). The indication seemed to be that both the 1,2-benzothiazepines were unstable in 
ambient conditions (air and light). It is noteworthy that 1,2-benzothiazepine formation (i.e. 
7-endo-dig cyclisation) was only observed from the undecadiynols 2.23Ab and 2.23Gb, a 
feature that merits further investigation. 
Within the literature there are no 1,2-benzothiazepine 1,1-dioxides analogous to 3.10Ab 
and 3.10Gb. However, the chemical shift of the 4-H protons in these examples are 
remarkably close to those in the 2-benzazepin-1-ones 3.22 and 3.23 that contain an 





Cyclisations of N-(2-naphthyl)sulfonamide 2.23H (entries 15 and 16, Table 3.4) proceeded 
straightforwardly to afford the 2-(2-naphthyl)-1,2-benzothiazine 1,1-dioxides 3.9Ha – b in 
high yields. 
Characterisation data for the compounds prepared merit some consideration. The 
benzylidene (methine) proton (CH) of benzothiazines 3.9Aa – Ha and 3.9Bc (Table 3.5), are 
in some cases shifted downfield by as much as 1 ppm in comparison to the 3-alkylidene-1,2-
benzothiazines 3.9Ab – Hb and 3.9Be – f (Table 3.6). There does not appear to be any 
examples of 3-alkylidene-1,2-benzothiazin-4-ols or -4-ones in the literature for comparison 
with the data in Table 3.6. However, in the series 3.9Ab – 3.9Hb and 3.9Be – f, shielding of 
the alkenic hydrogen stems from a combination of the inductive effect of the alkyl group 
and the absence of a geminal anisotropic group. 
Whilst the NOESY spectrum for 1,2-benzothiazine 1,1-dioxide 3.9Aa (Figure 3.9) established 
a (Z)-configuration it is worth noting that the chemical shift of the benzylidene proton (δH 
7.49 ppm, δC 131.06 ppm) is also in accord with these of the (Z)-3-benzylidene-2-methyl-2H-
1,2-benzothiazine-4-(3H)-one 1,1-dioxide derivative 3.24 obtained by Asharaf and co-
workers. The latter (3.24) was obtained from a ketone and arylaldehyde in a base-catalysed 
aldol condensation (Scheme 3.36) [18JME282]. It was observed that electron donating 
substituents in the benzylidene group resulted in shielding of the methine proton signal, 
whereas the latter was deshielded when an electron withdrawing substituent was present. 
However, the chemical shift differences between the derivatives of 3.24 were small (δH 7.77 
– 7.62 ppm, ΔδH 0.15 ppm). A similar small difference was observed here between 3.9Ba (δH 





The coupling constants (Table 3.6) of the methine proton and the CH2 in the 3-alkylidene 
series 3.9Ab – Hb and 3.9Be – f along with the similarity of the 13C shift of the methylidene 
carbon in both the 3-arylidene- and 3-alkylidene-1,2-benzothiazines (Tables 3.5 and 3.6 
respectively) is noteworthy; on the basis of this data and the probable reaction mechanism 
(Scheme 3.37) (Z)-stereochemistry is also assigned to the 3-alkylidene-1,2-benzothiazines 
3.9Ab – Hb and 3.9Be – f. 
 










1 Me 3.9Aa 8.10 7.87 7.49 131.06 
2 Tolyl 3.9Ba 8.24 7.79 7.57 131.86 
3 Tolyl 3.9Bc 8.22 7.79 7.51 131.48 
4 3-MeC6H4 3.9Ca 8.26 7.84 7.59 131.89 
5 2-MeOC6H4 3.9Da 8.30 7.84 7.64 130.22 
6 3-MeOC6H4 3.9Ea 8.26 7.84 7.61 132.26 
7 2-naphthyl 3.Ha 8.23 7.89 –a  –a 
Table 3.5 1H and 13C NMR shifts for aryl substituted 1,2-benzothiazine 1,1-dioxides 3.9Aa – Ha and 

















1 Me 3.9Ab 7.94 7.77 6.64 7.3 136.24 
2 Tolyl 3.9Bb 8.13 7.77 6.62 7.3 134.96 
3 Tolyl 3.9Be 8.16 7.73 6.91 – 134.70 
4 Tolyl 3.9Bf 8.14 7.79 6.67 5.6 131.38 
5 3-MeC6H4 3.9Cb 8.11 7.79 6.62 7.3 135.06 
6 2-MeOC6H4 3.9Db 8.15 7.77 6.62 7.4 133.74 
7 3-MeOC6H4 3.9Eb 8.11 7.78 6.64 7.3 135.52 
8 3-thienyl 3.9Gb 8.07 7.80 6.67 7.3 135.81 
9 2-naphthyl 3.9Hb 8.15 7.84 6.68 7.2 135.35 
Table 3.6 1H and 13C NMR shifts for alkyl substituted 1,2-benzothiazine 1,1-dioxide 3.9Ab – 3.9Hb 
and 3.9Be – f 
The 6-exo-dig and 7-endo-dig cyclisation pathways are depicted in Scheme 3.37. At present 
it is unclear why there was competition from the latter pathway with two of the dialkynol 
substrates. Further investigation of this aspect is clearly merited. The cyclisation of the 
sulfamoyl dialkynols 2.23Aa – Hb under Ag(I) catalysis represents a new route to 1,2-
benzothiazine 1,1-dioxides. 
The proposed mechanism for the synthesis of 1,2-benzothiazine 1,1-dioxides 3.9Aa – Hb 
and 1,2-benzothiazepine 1,1-dioxides 3.10Ab and 3.10Gb, via path a and path b 
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respectively. Both routes are envisaged to start from silver coordination to the triple bond 
by π-complexation [15CSR8124, 19MI1] which activates the triple bond to attack from the 
nucleophilic sulfonamide nitrogen. Cyclisation can occur via path a (6-exo-dig) or b (7-endo-
dig), followed by protodeargentation and proton removal from the quaternary nitrogen (by 


























Chapter 4 Ring Functionalisations and Annulations   
4.1 Functionalisation of the 3-Alkynylindol-3-ol Ring System 
With the aim of exploiting the multifunctional nature of the ring systems prepared during 
the course of this project (Sections 2.0 and 3.0), the 3-alkynyl-2-methyleneindol-3-ols (2.27, 
2.30A-C and 2.33a) and the 4-alkynyl-3-iodoquinoline 3.2a – c were subjected to a selection 
of reactions which will be discussed in this chapter. Initially chosen because it has multiple 
motifs which can be easily manipulated, was the 2-methyleneindoline 2.27.  
One way in which 2.27 can potentially be elaborated utilises the embedded alkynol function 
in a cyclocondensation reaction with 2-naphthol as shown below (Scheme 4.1). 
 
Scheme 4.1 
Montmorillonite has been utilised to catalyse the formation of naphthopyran derivatives in 
high yields (66 – 98%) from the cyclocondensation of 1,1-diaryl-2-propyn-1-ols and 2-
naphthol (A, Scheme 4.2) [14MI1081]. Montmorillonite K-10 is an inexpensive, green, 
heterogenous clay catalyst, which over the past 30 years has found numerous uses in the 
catalysis of many reaction types [19EROS1]. It can also be used as a support for a variety of 
metal salts [18MI1249]. Yaragorla and Khan found that when alkynols and 2-naphthol were 
heated with p-TsOH (neat), the naphthopyran 4.1 could be isolated; the reaction could also 
be driven to the rearrangement product 4.2 in fair to excellent yields (58 – 98%) (B, Scheme 
4.2) [18OBC7920]. Naphtho[1,2-b]pyrans have been synthesised from the acid catalysed 
reaction of propyn-1-ols and 1-naphthols to give 4.3 (C, Scheme 4.2). The (E)-4-[3,3-
bis(aryl)allylidene]naphthalen-1(4H)-ones 4.4 were also isolated as intense red dyes, their 
formation was rationalised by SEAr of 1-naphthol by a propargylic-allenic cation to give a 4-
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allenylnaphthol derivative, which undergoes a subsequent [1,7]-H shift [03EJO1220]. Kim 
and co-workers utilised 3-alkynyl-3-hydroxyindoline-2-ones 4.5 as a substrate in the Lewis 
acid-catalysed condensation with 2-naphthols (D, Scheme 4.2). 3-(Naphthofuranyl)-2-
oxindoles were obtained in fair to good yields (45 – 78%) [16TL4280]. 
 
Scheme 4.2  
Another way in which the novel 3-alkynylindol-3-ol ring system 2.27 could be exploited is via 
the dehydration and subsequent interception of the cation with a nucleophile (Scheme 4.3). 
The addition of a 1,3-dicarbonyl nucleophile to a propargylic cation (formed by 
dehydration), under metal catalysis or acidic (Brønsted and Lewis acid) conditions affords a 
functionalised alkyne that has been shown to cyclise under either basic or acidic conditions. 





Thus, 1,3-diphenylprop-2-yn-1-ol underwent easy nucleophilic addition of a 1,3-dicarbonyl 
compound in the presence of a Lewis acid. The corresponding intermediate compound 4.6 
undergoes base-catalysed cyclisation to substituted furans (A, Scheme 4.4) [10S3715]. 2-
Propynyl-1,3-dicarbonyl compounds 4.7 undergo cyclisation in the presence of base to yield 
dihydrofuran derivatives 4.8 (B, Scheme 4.4) in excellent yields (76 – 93%) [14EJO4999]. 
Dhiman et al. found that 1,2,3-trisubstituted cyclopenta[b]indoles 4.9 could be obtained in a 
one-pot reaction from propargylic alcohols via an initial formation of indole 4.10 in the 
presence of a Au(I) catalyst with a basic co-catalyst. Subsequent addition of a 1,3-dicarbonyl 
compound to 4.10 in the presence of a Brønsted acid generates the indole dicarbonyl 
compound 4.11. The latter underwent an intramolecular Friedel-Crafts type reaction to give 
the tricyclic heterocycle 4.9 (C, Scheme 4.4). Both intermediates were isolated to provide 
evidence for the reaction mechanism [15CC557]. A Cu(I) catalysed tandem cyclisation and 
addition reaction was observed when 1-(2-amidophenyl)propynol derivatives were treated 
with a range of 1,3-dicarbonyl nucleophiles (D, Scheme 4.4). The corresponding indoline 
intermediate 4.12 could also be isolated in the absence of a nucleophile in 92% yield (when 
PG = Ts, R = Me and R1 = H). Addition of the nucleophile to the pre-formed indoline, also 
proceeded smoothly with the Cu(I) catalyst. Nucleophilic addition to indoline 4.12 was also 
successful when p-TsOH (1 equiv.) was used as the catalyst but gave much lower yields of 
the indole 4.13 (when PG = Ts, R = Me and R1 = H). However, p-TsOH alone did not initiate 




Scheme 4.4  
Initially indoline 2.27 was subjected to a variety of reaction conditions, some of which were 
adapted, from literature examples (Scheme 4.5) [12JOC7166, 16TL4280, 17TL21, 17TL4094]. 
These include; dehydration and interception with a nucleophile (i, Scheme 4.5), 
cyclocondensation with 2-naphthol (iv, v, Scheme 4.5), 1,3-AAI (vi, Scheme 4.5) and 
oxidative rearrangement (vii, Scheme 4.5). Surprisingly and disappointingly no tractable 
products could be isolated from any of these reactions, only very complex mixtures were 
obtained, suggesting that 3-ethynyl-2-methylene-1-tosylindol-3-ol 2.27 is highly reactive and 
undergoes multiple reactions and/or degradation. The 1H NMR spectrum of the crude 
product from reaction (i) in Scheme 4.5 indicated that no starting material was present, but 
purification was not possible due to the complexity of the mixture (TLC). Thus, the mixture 
was carried forward into the next reaction and treated under basic conditions (ii, iii, Scheme 
4.5). However, no characterisable products could be isolated from exposure to either K2CO3 
in MeCN or to DBU in MeCN.  
All efforts to effect a cyclocondensation with 2-naphthol were unsuccessful (iv and v, 
Scheme 4.5), as were attempts to induce 1,3-AAI to the isomeric 2-(hydroxymethyl)indole 
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(vi, Scheme 4.5). Although Chan reported that 3-phenyl-2-methylene-1-tosylindol-3-ol 
undergoes an iodination rearrangement to 3-(iodomethyl)-3-phenyl-1-tosyloxindole with 




Due to the complexity of the mixtures obtained from the reactions of 3-ethynyl-2-
methylene-1-tosylindolin-3-ol 2.27 shown in Scheme 4.5, no other reactions with this 
substrate were attempted.  
In view of these disappointing results investigations were extended to the 2-
benzylideneindoline 2.33a with the rationale that the additional phenyl group would 
stabilise intermediates formed in the reactions. Thus 2.33a and acetylacetone (in DCE) in 
the presence of an acid catalyst (Montmorillonite K-10) was refluxed for 2h; after filtration 
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though Celite, the 1H NMR spectrum of the crude material showed the reaction had gone to 
completion (100% yield). After consideration of 1D NMR spectra (1H and 13C), the isolated 
product was not the expected indoline but the indole 4.14a (Scheme 4.6).  
 
Scheme 4.6 
The 1H NMR spectrum of 3-{phenyl[3-(phenylethynyl)-1-tosyl-1H-indol-2-yl]methyl}pentane-
2,4-dione 4.14a is shown in Figure 4.1. Neither this nor the 13C NMR spectrum exhibit any 
peaks corresponding to the enol tautomer, which is in line with similar compounds reported 
in the literature [07OL727, 19OBC2663]. Interestingly, the doublets corresponding to the 
vicinal sp3 hydrogens absorb over a close range, δH 6.10 and 5.95 ppm (3J = 12.06 Hz).  
 
Figure 4.1 400 Mhz 1H NMR spectrum of 4.14a in CDCl3 
The proton signals for 4.14a (Figure 4.1) were assigned from examination of the NOESY 
spectrum (Figure 4.2). The stronger though-space interaction between the doublet at δH 
6.10 ppm and the phenyl protons established distinction between the vicinal protons. The 
doublet at δH 5.95 ppm displayed an interaction with the two methyl groups (δH 2.19 and 
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1.97 ppm) of the diketone unit. The high field aromatic proton doublet (δH 7.08 ppm), 
integrating for two protons, shows a correlation with the tosyl methyl group protons (δH 
2.28 ppm). Comparison of the 1H NMR shifts with those of some model compounds is 
instructive (Scheme 4.7). 
 
Figure 4.2 NOESY spectrum of 4.14a 
Song and co-workers reported the vicinal sp3 hydrogens in indole 4.15 (Scheme 4.7) 
absorbed at δH 4.64 and 3.44 ppm [19OBC2663]. The 3-(1,3-diphenylprop-2-yn-1-
yl)pentane-2,4-dione 4.16a exhibits two doublets at δH 4.67 and 4.23 ppm with a coupling 
constant of 3J = 10.9 Hz. The downfield shift of the methine proton signals seen in 4.14a 
compared to the model compounds in Scheme 4.7, is presumably due to the combined 
influence of the adjacent alkyne moiety along with the anisotropic indole and phenyl groups 
deshielding the protons. The vicinal proton shifts in the 1,3-diketones 4.16a – c exhibit 





The indole 4.14a can be envisaged as being generated from the nucleophilic addition of the 
enolic nucleophile to the benzylic cation derived from the 2-benzylideneindol-3-ol 2.33a 
(Scheme 4.9). Consequently 4.14a should also be accessible from the indolyl alcohol 2.32a, 
under identical conditions. In order to verify this proposal, the latter was also treated with 
acetylacetone in DCE in the presence of K-10. Gratifyingly, under these conditions the 3-






The formation of the indole 4.14a from indoline 2.33a can be rationalised by the initial 
protonation and elimination of water (E1) followed by generation of the benzylic cation 4.17 
(Scheme 4.9). This cation (4.17) will also be formed from dehydration (E1) of the indolyl 
alcohol 2.32a, after protonation, the nucleophilic centre of the 1,3-diketone will then attack 
the cation leading to 4.14a in which aromaticity is retained (Scheme 4.9). 
 
Scheme 4.9  
With 3-{phenyl[3-(phenylethynyl)-1-tosyl-1H-indol-2-yl]methyl}pentane-2,4-dione 4.14a to 
hand it was subjected to basic conditions (K2CO3, DBU and Cs2CO3). However, in each case 
only starting material was recovered from the reaction and none of the cyclisation products 
were observed (i – iii, Scheme 4.10). Consequently, it was envisaged the triple bond of 4.14a 
may require additional activation to nucleophilic attack from the enol or enolic OH. 
Therefore, a variety of electrophilic activators – I+, Ag(I) and In(III) –  were employed along 
with K2CO3 in MeCN (iv – viii, Scheme 4.10). Again, only starting material was isolated from 
these reactions. More work is required to define the scope and limitations of this reaction, 
use of a wider range of solvents may increase the amount of enol tautomer [85JOC1216] 





All of the attempted base-catalysed intramolecular cyclisations of 3-{phenyl[3-
(phenylethynyl)-1-tosyl-1H-indol-2-yl]methyl}pentane-2,4-dione 4.14a were unsuccessful 
(Scheme 4.10). No further indoles and/or indolines were investigated as substrates for 
intramolecular alkyne cyclisations. 
4.2 Annulations of 4-Alkynyl-3-iodoquinolines: Synthesis of Pyrrolo[2,3-
c]quinolines 
Pyrrolo[2,3-c]quinolines which can be obtained from marine bacteria (Ohtaekwangia 
kribbensis, Mooreia alkaloidigena, and Catalinimonas alkaloidigena), have attracted interest 
because of their varied biological activities [11TL3186]. Recently discovered 
Marinoquinolines A – K (Scheme 4.11) [11JNP603, 18JME5547] have been found to exhibit 
anti-bacterial and cytotoxic properties and a number also exhibit anti-malarial activity.  
 






Aplidiopsamine A and Trigonoine B are two more pyrrolo[2,3-c]quinoline structures. 
Aplidiopsamine A has been obtained from the Australian ascidian, Aplidiopsis confluata 
[10JOC8291]. Whilst Trigonoine B has been isolated from four plant species native to China 
Trigonostemon thyrsoideus, Trigonostemon huangmosu, Trigonostemon lii, and 
Trigonostemon filipes [11TL3186]. These compounds also exhibit interesting biological 
activities (Aplidiopsamine A anti-malarial and Trigonoine B weak anti-HIV activities).  
 
It is therefore surprising that relatively little attention has been paid to the total synthesis of 
these compounds. Only Aplidiopsamine A and Marinoquinolines (A to F and K) have been 
synthesised. The approaches are outlined in Scheme 4.12 [12AGE10610, 12OL5804, 
12OL5808, 12TL1271, 12TL4836, 13SL461, 15JOC957, 18ACR1784, 18JME5547, 19MI35068, 
20OL2215, 20JOC650].  
Aplidiopsamine A was synthesised in a five-step sequence, 21% overall yield (A, Scheme 
4.12). Halide displacement from the bromoacetamide intermediate 4.18 could also be 
employed with a variety of other nucleophiles to obtain, following cyclodehydration, other 
pyrrolo[2,3-c]quinoline derivatives [12OL5808]. Marinoquinoline A was synthesised in a high 
yield over three steps via Pd-mediated cyclisation of the imine from 2-acetyl-1-
phenylsulfonylpyrrole and 2-iodoaniline. The protected pyrrolo[2,3-c]quinoline 4.19 
obtained could be further elaborated to Aplidiopsamine A (B, Scheme 4.12) [12OL5804]. 
Willis et al. utilised an Ullman cross-coupling reaction of pyrrole-2-carbaldehyde 4.20 and 2-
bromonitrobenzene. Subsequent treatment with MeLi was followed by oxidation of the 
secondary alcohol and reductive cyclisation with magnesium, afforded Marinoquinoline A in 
four steps in 85% overall yield (C, Scheme 4.12) [12AJO160]. Yamaoka and co-workers 
achieved the total syntheses of Marinoquinolines A and C and Aplidiopsamine A [15JOC957] 
by initially assembling the arene-ynamide 4.21 from a series of coupling reactions 
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[05OL3681]. The latter was then subjected to a Brønsted acid (Tf2NH) mediated cyclisation 
affording pyrrolo[2,3-c]quinolines in high yields (73 – 90%). Interestingly, it was found that 
weaker acids lowered the product yield. For Aplidiopsamine A, arene-ynamide 4.21 could be 
transformed in a one-pot reaction to 4.22 from which halide displacement with adenine 
afforded Aplidiopsamine A in a final 90% yield (D Scheme 4.12). Yamaoka and co-workers 
extended this reaction to synthesise different (hetero)areno[2,3-c]quinolines [15JOC957]. 
Marinoquinolines A – C were synthesised from an initial Knoevenagel condensation, 
followed by the reduction of the nitro moiety and subsequent acylation of ethyl-2-
aminocinnamate (E, Scheme 4.12). The α,β-unsaturated ester was then subjected to 
cyclocondensation with TosMIC to obtain pyrrole 4.23 which underwent a Morgan-Walls 
reaction to give Marinoquinolines A – C in excellent yields (85 – 92%) [12TL1271]. Schwalm 
and Correia synthesised Marinoquinolines A, B, C and E among other 3H-pyrrolo[2,3-
c]quinolines, using different aldehydes to vary the substituent in the C-4 position, from the 
Pictet-Spengler reaction of 2-(1H-pyrrol-3-yl)aniline 4.24 with aldehydes followed by 
aromatization (F, Scheme 4.12) [12TL4836]. Most recently Banwell and co-workers 
synthesised the widest range of Marinoquinolines (A – F and K) via 3-tosyl-3H-pyrrolo[2,3-
c]quinoline 5-oxide 4.25 using a range of conditions (G, Scheme 4.12). The N-oxide 4.25 was 
prepared by a Pd-catalysed Ullmann coupling of 3-iodo-1-tosylpyrrole-2-carbaldehyde with 






























The earliest reported synthesis of 3H-pyrrolo[2,3-c]quinoline involved the high temperature 
cyclodehydration of 3-formamido-4-methylquinoline under vacuum in the presence of P4O10 
from which the reaction gave low yields [49MC607]. Later work investigated the indolisation 
of 3-hydrazino-2-phenylquinoline with butanone in conc. HCl [57JCS3722]. In 1976 Parrick 
and Wilcox reported the synthesis of 3H-pyrrolo[2,3-c]quinolines via a Fischer indole 
synthesis by heating 3-hydrazino-2-methylquinoline 4.26 with either cyclohexanone or 
butanone in the presence of acetic acid. Routes to pyrrolo[2,3-b] and pyrrolo[3,2-
c]quinolines were also proposed (A, Scheme 4.13) [76J(P1)2121]. A cascade reaction 
involving the copper(II)-mediated reductive amination of quinoline-3-boronic acid with di-
tert-butyl azodicarboxylate afford 3-hydrazinequinoline in situ. When conducted in the 
presence of 2-phenylacetaldehyde the Fischer indolisation product, 1-phenyl-3H-
pyrrolo[2,3-c]quinoline was obtained in 61% yield (B, Scheme 4.13) [12TL564].  
3-Substituted-3H-pyrrolo[2,3-c]quinolin-4(5H)-ones were obtained in moderate to excellent 
yields (45 – 99%) from a Pd(II)-catalysed domino amination-hydroamination sequence, 
starting from 3-bromo-4-trifloxyquinolin-2(1H)-ones 4.27 (C, Scheme 4.13) [14JOC9628]. 
Interestingly, in the case where R1 = Me, R2 = H, R3 = Ph and R4 = c-C6H11 only the amination 
product, 3-(cyclohexylamino)-1-methyl-4-(phenylethynyl)quinolin-2(1H)-one, was isolated in 
69% yield, the reasons for this were not explained. It was also found that 1-methyl-3-nitro-
4-trifloxy-2-quinolone 4.28 readily undergoes Sonogashira coupling with aliphatic alkynes 
and selective metal-acid reduction provide access to the corresponding 4-alkynyl-3-amino-
quinolones. The latter are smoothly hydroaminated upon treatment with PdCl2 (10 mol %) 
in DMF to 2-alkyl-3H-pyrrolo[2,3-c]quinoline-4-(5H)-ones. However, access to the 2-aryl 
derivatives was only possible via initial formation of 4.29 and Sonogashira coupling with an 
aryl iodide (D, Scheme 4.13) [13OBC7334].  
Other routes to pyrrolo[2,3-c]quinoline-4-(5H)-ones include nucleophilic addition of the 
TosMIC anion to 3-(acylmethylene)oxindoles (E, Scheme 4.13) [02T9179, 13T10836]. None 
of the routes outlined in C, D or E has been adapted for the synthesis of fully unsaturated 
pyrrolo[2,3-c]quinolines. In addition to the routes to the aromatic tricycles outlined in A and 
B Scheme 4.13 which are of limited scope other syntheses include: The Hemetsberger indole 
synthesis has been adapted to access pyrrolo[2,3-c]quinolines. Thus, condensation of 2-
arylquinoline-4-carbaldehydes with ethyl azidoacetate proceeds readily at low temperature, 
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on warming to 0 °C expulsion of N2 occurs with concomitant cyclisation to the tricycle (F, 
Scheme 4.13) [93S225]. 
The parent 3H-pyrrolo[2,3-c]quinoline system has been generated via a domino Pd-
catalysed α-arylation-condensation reaction of 3-amino-4-bromoquinoline with 
acetaldehyde (G, Scheme 4.13) [09ARK(vi)174]. More recently the bicyclisation of 2-
methyleneaminochalcones 4.30 and an imine in the presence of a base and oxidant (H, 
Scheme 4.13), affords the corresponding pyrrolo[2,3-c]quinolines in varying yields (35 – 
84%) [17OL6712]. 
The Bartoli reaction is applicable to nitroquinolines and treatment of 2-chloro-3-
nitroquinoline with 5 equiv. of vinylmagnesium bromide affords the 4-
chloropyrroloquinolines in 49% yield (I, Scheme 3.14). Halide displacement by a variety of 
primary and secondary amines proceeds in high yields [18MI5386]. 2-Isocyanochalcones are 
1,5-bielectrophiles and condensation with the anion of nitromethane generates a 3-nitro-
1,4-dihydroquinoline. Reductive cyclisation of the latter also proceeds with 
dehydrogenation to the aromatic tricycle (J, Scheme 4.13) [18ASC1870]. Nucleophilic 
addition of enaminoesters to 2-azidochalcones under oxidative condations affords an 
intermediate pyrrole, from which a Staudinger-aza-Wittig reaction effects ring closure to 


























Buchwald et al. reported a copper-promoted domino amidation-hydroamidation sequence 
Scheme 4.14, to synthesise a range of pyrroles and pyrazoles. Copper(I) iodide was used as a 
pre-catalyst in place of a palladium species. Initial copper(I)-mediated amidation of an 
haloenyne 4.31 was followed by an intramolecular hydroamidation of the alkyne 4.32 
affording both pyrroles and indoles in good yields (52 – 91%). Pyrazoles result from the use 
of tert-butyl carbazate (Boc-NHNH2) [06AGE7079]. 
 
Scheme 4.14 
There are many other examples in the literature of this domino amination-hydroamination 
reaction [05T11311, 09ASC1064, 11CC6936, 12JOC8191, 15TL86, 17TL3407]. The metal-
initiated amination of alkenes and alkynes has been reviewed [98CRV675] as well as the 
metal-mediated hydroamination of alkenes and alkynes [19MI1b]. 4-Alkynyl-3-
iodoquinolines 3.2 have the same structural fragment (shown in red, Scheme 4.15) as the 
examples in Scheme 4.13 and 4.14. Thus, employing a domino amination-hydroamination 
reaction on these substrates could furnish pyrrolo[2,3-c]quinolines, thereby providing a 
possible new route to Marinoquinolines (Scheme 4.11) and derivatives. This approach would 
also provide pyrrolo[2,3-c]quinolines with substituents in both the 2- and the 4-position of 
the ring system, to date there are only three examples of pyrrolo[2,3-c]quinolines 






The isomeric 1H-pyrrolo[3,2-c]quinoline 4.33 (A, Scheme 4.16) has been synthesised in a 
similar manner to that proposed in Scheme 4.15 (i.e. the amination of a haloquinoline and 
the intramolecular hydroamination of an adjacent alkyne). The requisite 3-alkynylquinoline 
was synthesised by initial SNAr displacement of chloride with PhNH2 followed by a 
Sonogashira coupling of phenylacetylene with the 4-anilino-3-iodoquinoline. Under these 
conditions a domino hydroamination also occurred to afford 4.33. The reaction was 
undertaken in a reversed manner (B, Scheme 4.16) to confirm the intermediacy of the 3-
alkynyl-4-aminoquinoline 4.34 in the reaction [10T6040]. 
 
Scheme 4.16 
In the light of the foregoing studies, initial experiments to access the pyrrolo[2,3-
c]quinolines system utilised conditions reported by Buchwald (Scheme 4.14) and were first 
applied to 3-iodo-2-phenyl-4-(phenylethynyl)quinoline 3.2a. The latter was treated with 
tert-butyl carbamate in the presence of CuI (5 mol %), DMEDA (20 mol %) and Cs2CO3 in THF 
(Scheme 4.17). The mixture was stirred at 75 °C for 24 h, after this time the solution was 
evaporated to give a brown solid, that was purified by column chromatography (10% EtOAc 
– hexane). Unfortunately, the product and starting material co-eluted. Multiple attempts to 
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purify the mixture were unsuccessful, including the use of preparative TLC; signs of 
additional products resulting from degradation of the mixture became evident (1H NMR).  
 
Scheme 4.17 
Consequently, an alternative set of conditions to effect the Buchwald-Hartwig amination 
were employed, a modified method based on that from Wang et al. (Scheme 4.13) 
[14JOC9628] was adopted. Under these conditions we were delighted to observe that the 
domino amination-hydroamination of 3.2a afforded 2,4-diphenyl-3-(p-tolyl)-3H-pyrrolo[2,3-
c]quinoline 4.35Aa in a fair yield (21%), along with an orange solid subsequently identified 
as the amination product 4.36Aa; both of these compounds are novel (Scheme 4.18). 
 
Scheme 4.18 
A distinct singlet for the pyrrole proton (1-H) is present at δH 7.33 ppm in the 1H NMR 
spectrum of 4.35Aa (Figure 4.3) with a corresponding 13C resonance at δC 102.23 ppm. The 
2,4-diphenyl-3-(p-tolyl)-3H-pyrrolo[2,3-c]quinoline structure was also confirmed by HRMS 
which exhibited a molecular ion at m/z [M+H]+ = 411.1859 corresponding to C30H22N2. The 
aromatic protons for 4.35Aa (Figure 4.3) were assigned with the aid of 2D NMR spectra 
(HSQC, HMBC and NOESY). The NOESY spectrum shows a through-space interaction 
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between the 1-H and 9-H protons and thus established that the latter resonates at δH 8.32 
(Figure 4.4). Furthermore, the phenyl rings can be distinguished by the HMBC NMR 
spectrum, which shows an interaction between the phenyl c-ring ortho protons (4-postion) 
and the 4-C carbon (Figure 4.4). Moreover, and interaction between 1-H proton and the 
phenyl a-ring protons (2-position) with the quaternary 2-C carbon HMBC spectrum (Figure 
4.4) leads to the assignments shown in Figure 4.3. 
 




Figure 4.4 NOESY and HMBC spectra of 4.35Aa 
The structure of the 3-aminoquinoline 4.36Aa was confirmed by its 1H NMR and 13C NMR 
spectra. The former exhibited the presence of a broad singlet at δH 6.03 ppm for the amine 
proton (Figure 4.5), additionally two quaternary carbon resonances at δC 106.29 and 83.99 
ppm indicated the presence of acetylenic carbons. The assignments of protons in Figure 4.5 
were confirmed by 2D NMR experiments (COSY, HSQC, HMBC and NOESY). A through-space 
interaction (NOESY) is observed (Figure 4.6) between the NH proton and the protons ortho 
to the NH in the tolyl ring. In addition, there is an interaction between the NH and phenyl c-
ring ortho protons which absorb at δH 7.76 ppm (Figure 4.6). From these observations, the 
NOESY and the COSY spectra can be fully interpreted to assign all of the other phenyl ring 




Figure 4.5 400 MHz 1H NMR spectrum of 4.36Aa in CDCl3 
 
Figure 4.6 NOESY and COSY spectra of 4.36Aa 
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The resonances for the 1-H position are similar to those of Marinoquinoline A (4-methyl-3H-
pyrrolo[2,3-c]quinoline) which exhibits resonances at δH 7.12 ppm and δC 102.04 ppm 
(Scheme 4.19) [11JNP603]. A feature observed in 4.35Aa is the 7-H and 8-H protons absorb 
over a very small range (δH 7.65 and 7.59 ppm), which is also a feature in Marinoquinoline A 
(Scheme 4.19).  
The 1H NMR signals for the benzo ring protons in aminoquinoline 4.36Aa differ to those 
found in 3-anilinoquinoline 4.37 (Scheme 4.19) [06T6258]. Of importance are the shifts of 
the 5-H and 8-H protons in 2-phenyl-4-(phenylethynyl)-N-(p-tolyl)quinolin-3-amine 4.36Aa, 
in which the 5-H proton absorbs at δH 8.30 ppm and 8-H at δH 8.11 ppm. However, as 
described in Section 3.1, Scheme 3.3 the C-4 alkyne moiety in the quinoline ring imparts a 
pronounced deshielding effect on the (peri) 5-H proton. The phenyl ring protons of the 
amine 4.37 are deshielded compared with those observed in 4.36Aa (δH 7.01 ppm and 6.80 






With the initial success of the Pd-catalysed amination-(hydroamination) reaction with p-
toluidine the reaction of 3-iodo-2-phenyl-4-(phenylethynyl)quinoline 3.2a towards a range 
of amines or amides was investigated Scheme 4.20. The results of these reactions are 
documented in Table 4.1. In many cases the 3-aminoquinoline was the major product from 
the reaction and in every case eluted first on purification by column chromatography (non-
polar). 
The reaction was also extended to 3-iodo-4-(pent-1-yn-1-yl)-2-propylquinoline 3.2b and to 
3-iodo-2-(4-methoxyphenyl)-4-[(4-methoxyphenyl)ethynyl]quinoline 3.2c. In each case the 
amination-hydroamination reaction was investigated with p-toluidine and with aniline as 







Entry  Iodoquinoline 
R1 
Amine or Amide Pyrrolo[2,3-c]quinolines Pyrrolo[2,3-









4.35Aa 21 7.33 4.36Aa 38 6.03 
2 Ph 
 
4.35Ab 74 7.41 4.36Ab 3 7.18 
3 Ph 
 
4.35Ac 0 – 4.36Ac 0 – 
4 Ph 
 
4.35Ad 35 7.52 4.36Ad 40 6.92 
5 Ph 
 
4.35Ae 0 – 4.36Ae 60 4.72 
6 Ph 
 
4.35Af 20 7.58 4.36Af 35 7.92 
7 Ph 
 
4.35Ag 0 – 4.36Ag 0 – 





















4.35Ba 0 – 4.36Ba 0 – 
2 C3H7 
 
4.35Bb 0 – 4.36Bb 0 – 
3 4-MeOC6H4 
 
4.35Ca 40 7.25 4.36Ca 0 – 
4 4-MeOC6H4 
 
4.35Cb 37 7.27 4.36Cb 20 6.04 
Table 4.2 Yields of 4.35B – C and 4.36B – C from amination-hydroamination reaction of 4-alkynyl-3-iodoquinoline 3.2b – c 
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The Pd-catalysed amination of 3.2a with p-toluidine provided a mixture of the 
pyrroloquinoline 4.35Aa and the 3-aminoquinoline 4.36Aa in which the latter predominated 
(entry 1, Table 4.1). Separation of the two compounds was readily accomplished by flash 
column chromatography on silica with 10% EtOAc – pet ether. Under these conditions the 3-
aminoquinoline 4.36Aa eluted first from the column. When aniline was coupled with 3.2a, 
2,3,4-triphenyl-3H-pyrrolo[2,3-c]quinoline 4.35Ab was obtained in excellent yield (74%, 
entry 2, Table 4.1), together with a trace amount of the corresponding 3-aninoquinoline 
4.36Ab. However, near equal yields of both products 4.35Ad and 4.36Ad were obtained 
from the coupling of 3.2a with p-anisidine (entry 4, Table 4.1). Although the electron 
deficient 4-trifluoromethylaniline coupled to 3.2a to furnish modest yields of both the 
pyrroloquinoline 4.35Af and the aminoquinoline 4.36Af, the latter was obtained in slightly 
higher yield (entry 6, Table 4.1). 
Amination of 3.2a with benzylamine provided exclusively the 3-(benzylamino)quinoline 
derivative 4.36Ae; none of the pyrroloquinoline 4.35Ae was observed (entry 5, Table 4.1). It 
is difficult to rationalise the outcome of this latter hydroamination, that failed to provide 
any of the pyrroloquinoline, whilst the coupling of 3.2a with aniline (a less nucleophilic 
amine) furnished the pyrroloquinoline 4.35Ab in excellent yield. Attempts to effect Pd-
catalysed amidation of the 3-iodoquinoline 3.2a with either tert-butyl carbamate or with 
tert-butylsulfinamide were unsuccessful (entries 3 and 7 respectively, Table 4.1), these 
reactions are considered in more detail on page 224.  
Efforts to accomplish the amination-hydroamination reaction with 3-iodo-4-(pent-1-yn-1-yl)-
2-propylquinoline 3.2b with either aniline or p-toluidine were unsuccessful and failed to 
afford tractable products (entry 1 and 2, Table 4.2). In contrast the Pd-mediated coupling of 
3-iodo-2-(4-methoxyphenyl)-4-(4-methoxyphenylethynyl)quinoline 3.2c with both amines 
was successful, p-toluidine provided the pyrroloquinoline 4.35Ca as the only isolable 
product in 40% yield (entry 3, Table 4.2). Whereas, amination with aniline afforded both the 
pyrroloquinoline 4.35Cb and a somewhat lower yield of the 3-anilino-quinoline 4.36Cb 
(entry 4, Table 4.2). 
Pyrrolo[2,3-c]quinolines 4.35A – C and N-substituted-4-alkynylquinolin-3-amines 4.36A – C 
were characterised by all the usual physical techniques. Interestingly the melting points of 
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the pyrroloquinolines 4.35A – C were on average 50 °C higher than the 3-aminoquinolines 
4.36A – C.  
The 1H NMR spectrum of 2,4-diphenyl-3-(p-tolyl)pyrrolo[2,3-c]quinoline 4.35Aa (cf. Figure 
4.3) is shown in Figure 4.7 along with those of the analogues 4.35Ab, 4.35Ad and 4.35Af. A 
notable characteristic of the spectra in that the 1-H signal resonances fall within the range 
δH 7.58 – 7.25 ppm. Although a contribution to these differences can be attributed to 
solvent effects, particularly noteworthy is the deshielding of the 1-H signal in the 
trifluoromethyl analogue 4.35Af (δH 7.58 ppm) compared to the 3-(p-anisyl)pyrroloquinoline 
4.35Ad (δH 7.52 ppm), presumably a consequence of the electron withdrawing substituent 
in the former. 
An interesting feature of the 1H spectra of the pyrroloquinolines 4.35Ab, 4.35Ad and 4.35Af 
is that all display non-first order splitting of the signals for the 6-H and 9-H protons and 
these together with 7-H and 8-H form part of an AA’XX’ system. Clearly this feature cannot 
be attributed to solvent effects because of the similarity of the spectra of 4.35Ab (in CD2Cl2) 
with 4.35Ad and 4.35Af (both in acetone-d6). In contrast, the 6-H and 9-H signals in the 3-(p-
tolyl)pyrroloquinoline 4.35Aa both have first order-like appearance, giving rise to 
broadened double doublets (Figure 4.7, see also Figure 4.3). A similarity of all the 
pyrroloquinoline 4.35A 1H spectra is the narrow range in which the (superimposed) signals 
for 7-H and 8-H resonate (ca. δH 7.58 – 7.71 ppm) and this is also the case for the 
corresponding protons i.e. 6-H and 7-H in the aminoquinolines 4.36A (Figure 4.8). Within 
this series the quinoline 5-H and 8-H protons appear as a broadened double doublet and are 
the most deshielded signals (cf. Figures 4.5 and 4.6). Deshielding of the anilino-substituted 
protons is observed with 2-phenyl-4-(phenylethynyl)-N-[4-
(trifluoromethyl)phenyl]quinoline-3-amine 4.36Af in which the ring protons ortho to the CF3 
group are deshielded and resonate at δH 7.50 ppm, a shift of ca. 0.5 ppm compared to those 
in the tolyl derivative 4.36Aa.  
The 3-(benzylamino)quinoline 4.36Ae exhibits a broadened signal at δH 4.48 ppm which also 
displays partial splitting by virtue of coupling with the NH proton and because they are also 























































































































Formation of both N-substituted-4-(alkynyl)quinolin-3-amines 4.36A – C and the 
pyrrolo[2,3-c]quinolines 4.35A – C can be postulated to proceed by two competing catalytic 
cycles. Formation of N-substituted-4-(alkynyl)quinolin-3-amines 4.36A – C is proposed to 
involve a Buchwald-Hartwig amination as shown in catalytic cycle A (Scheme 4.22). The 
cycle has been adapted for 4.36A – C from the review by Dorel et al. for Pd-mediated 
amination with a bidentate ligand (in this case Xantphos) [00JA4618, 19AGE17118]. 
Aminoquinoline 4.36A – C will then enter the next catalytic cycle B, in which hydroamination 
takes place. Palladium(II) will coordinate with the π-electrons of the triple bond, activating it 
to attack from the amino nitrogen to give the palladium complex 4.38 [02JA764]. Following 
protodemetalation, aided by acetic acid, the corresponding pyrrolo[2,3-c]quinolines 4.35A – 
C will be obtained. 
 
Scheme 4.22 
Surprisingly, 4-alkynyl-3-iodoquinolines 3.2b (R1 = C3H7) did not work with the amination-
hydroamination conditions used (Scheme 4.21, entries 3 and 4, Table 4.2), with no 
identifiable products isolated from the reactions. As with the synthesis of the 3-
iodoquinoline 3.2b, different conditions are possibly needed for the alkyl substituted 
derivatives (Section 3.1, Scheme 3.13, page 151). Moreover when R1 = 4-MeOC6H4 (3.2c) the 
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yields of pyrrolo[2,3-c]quinolines 3.35Ca – b were higher than 4-alkynyl-3-aminoquinoline 
3.36Ca – b which is different to that seen for the phenyl derivatives (R1 = Ph) 3.35Aa – f. 
Evidently changing the substituents on the alkyne unit significantly affects the reactivity of 
the compound. 
The use of amines possessing readily cleavable N-protecting groups can be envisaged to 
allow access to a free NH i.e. an N-3-unsubstuted 3H-pyrrolo[2,3-c]quinoline. Thus, 
benzylamine was an obvious choice. The reaction proceeded smoothly with 3.2a to afford 
the aminoquinoline 4.36Ae in a good yield (60%, entry 5, Table 4.1), this was the only Pd-
mediated amination reaction in the series to produce an oil. With the N-protected 
compound to hand the removal of the Bn group and possible domino-hydroamination of the 
4-alkynyl-3-aminoquinoline 4.36Ae was attempted (A, Scheme 4.23) [05OL2361, 
15OBC11046]. Thus, treatment of the latter with Pd/C and ammonium formate, which acts 
as a hydrogen source, in MeOH was attempted. Unfortunately, no tractable products could 
be isolated from the reaction. These conditions were taken from the hydrogenolysis 
depicted in B Scheme 4.23, in which the benzyl group was removed with ease to afford the 
indole derivative 4.39 in 71% yield. Another set of conditions attempted for the 
deprotection of the benzyl group from 4.36Ae, was the use of NIS in DCM reported by 
Grayson and Davies (C Scheme 4.23) [05OL2361]. In the case of the latter conditions, it was 
hoped that along with benzyl deprotection the alkynophilicity of NIS would activate the 
triple bond to hydroamination and possible retention of an iodine substituent in the 
subsequent 3H-pyrrolo[2,3-c]quinoline structure (1-postion). However the use of NIS also 
failed to provide the desired 3H-pyrrolo[2,3-c]quinoline, with only starting material being 





Due to unsuccessful attempts to deprotect of the benzyl group from aminoquinoline 4.36Ae 
attention turned to accessing 3-benzyl-2,4-diphenyl-3H-pyrrolo[2,3-c]quinoline 3.35Ae by 
an alternative means. As discussed in D Scheme 4.13 (v), PdCl2 in DMF has been shown to be 
effective in the hydroamination of 4-alkynyl-3-amino-2-quinolones to afford 3H-pyrrolo[2,3-
c]quinolin-4(5H)-ones [13OBC7334]. Thus, N-benzyl-2-phenyl-4-(phenylethynyl)quinolin-3-
amine 4.36Ae was treated with PdCl2 (10 mol %) in DMF for 2 h (Scheme 4.24), following 
purification of the crude mixture by flash column chromatography (10 % EtOAc – pet ether) 
a fast eluting fraction was isolated as a yellow oil. On inspection of the 1H NMR spectrum 
the fraction was found to be 3-benzyl-2,4-diphenyl-3H-pyrrolo[2,3-c]quinoline 4.35Ae in a 
60% yield. It can be postulated that the hydroamination mechanism is similar to that with 
Pd(OAc)2 (Scheme 4.22, cycle B); palladium(II) will coordinate with the π-electrons of the 
triple bond, activating it to attack from the amino nitrogen to give the palladium complex X. 
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Following protodemetalation, aided by HCl, 3-benzyl-2,4-diphenyl-3H-pyrrolo[2,3-





The 1H NMR spectrum of 4.35Ae has similar features and chemical shifts to the other 
pyrrolo[2,3-c]quinolines 4.35Aa – f; for example overlapping of the 7-H and 8-H protons, the 
1-H proton resonance at δH 7.33 ppm which is identical to that in 4.35Aa. However, a 
striking difference is the high field doublet at δH 6.11 ppm, integrating for two protons 
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corresponding to the benzyl group ortho protons (blue circle, Figure 4.9). The remarkable 
upfield shift is a consequence of the proximity of the benzylic ortho protons to the adjacent 
phenyl substituents at C-2 and C-4. Either, or both of these aryl groups will adopt an 
orthogonal disposition to the N-benzyl group, so exposing the ortho protons to an 
anisotropic shielding region. Similar structural fragments to 4.35Ae possessing either C- or 
N- linked benzyl groups do no exhibit such high field signals for their aromatic protons 
(Scheme 4.26) [11JNP603, 17JOC4435, 20SL1613]. It is noteworthy that the aromatic proton 
signals in benzylamine for 4.36Ae (pink and green circles, Figure 4.9) are in the range of δH 
7.20 – 7.39 ppm (CDCl3), those in 4.35Ae are shielded by 1 ppm compared to the amine 
substrate.  
 





Donohoe and co-workers showed that β-carboline 4.40 undergoes benzyl deprotection in a 
high yield (88%) with excess AlCl3 in PhMe at room temperature (Scheme 4.27) 
[17JOC4435]. Thus, pyrrolo[2,3-c]quinoline 4.35Ae was dissolved in dry PhMe and added to 
a suspension of excess AlCl3 (6 equiv.) in dry PhMe at 0 °C. The mixture was stirred for 30 
minutes, after which it was allowed to warm to room temperature and stirred overnight. 
After quenching with aq. NaHCO3 and isolation with EtOAc the 1H NMR spectrum revealed 
only starting material (4.35Ae) was present (Scheme 4.27). The use of alternative protected 
amines or ammonia surrogates was therefore sought. 
 
Scheme 4.27 
Attempts to couple tert-butyl carbamate (BocNH2) with 3-iodoquinoline 3.2a (entry 3, Table 
4.1) were unsuccessful and only starting material could be isolated from the reaction 
mixture. BocNH2 has been utilised extensively in palladium-catalysed C-N coupling reactions, 
which has been reviewed by Buchwald and Ruiz-Castillo [16CRV12564]. An alternative 
means to access an N-unsubstituted pyrroloquinoline was to employ tert-butylsulfinamide 
(t-BuSONH2) because it has been utilised as an ammonia surrogate in the synthesis of 2-
arylindoles (A, Scheme 4.28) [11TL5625]. However use of tert-butylsulfinamide was also 
unsuccessful and only starting material was isolated from the reaction mixture (entry 7, 
Table 4.1), even when the reaction was attempted using the same conditions reported by 
Sivakumar and co-workers (B, Scheme 4.27). It is possible that the failure of tert-
butylsulfinamide to couple with 3.2a is a consequence of the substrate being an iodo-
compound. The palladium(0)-catalysed reaction of tert-butylsulfinamide with aryl halides (C, 
225 
 
Scheme 4.28) shows a significant difference in yields by changing the halide. Aryl bromides 
appear to couple most efficiently [12JOC4454]. 
 
Scheme 4.28 
Iodo-compounds are known to not react as successfully in the C-N forming reactions 
[09JA5766] in comparison to other halide substrates (bromides or chlorides). Buchwald and 
co-workers suggest the poor yields from aryl iodides in C-N bond formations is due to the 
iodide salt generation competing with the amine binding to the Pd(II) oxidative addition 
complex (X, Scheme 4.29) or iodide binding with the amino Pd(II) complex slowing the rate 
of reductive elimination (Y, Scheme 4.29). Of note is that these studies were carried out 
using different reactions conditions [09JA5766] to those described here. Therefore the use 
of an amide instead of an amine and the substrate being an iodo compound may be the 
reasons for the failure of BocNH2 and t-BuSONH2 to afford the corresponding amidation 







Another simple way in which the 4-alkynyl-3-iodoquinoline structure could be functionalised 
or extended is by application in a Suzuki, Heck or Sonogashira coupling. Some examples of 
iodoquinolines subjected to these coupling reactions are shown in Scheme 4.30 
[11JOC1163, 11OL2598, 17EJO4600, 17OBC6901, 18EJO1863]. Interestingly when 2,4-
diiodo-3-phenylquinoline was subject to Heck or Sonogashira coupling conditions with 






















3-Iodo-2-phenyl-4-(phenylethynyl)quinoline 3.2a was coupled with phenylboronic acid in 
the presence of Pd(PPh3)4 and K2CO3 in a PhMe : EtOH mixture (50 : 50) and stirred at reflux 
for 22 h. After an aqueous work-up and purification by flash column chromatography (8% 
EtOAc – hexane) the 4-alkynyl-2,3,-diphenylquinoline 4.41a was obtained as a white powder 
in 68% yield.  
 
Scheme 4.31 
The 2,3-diphenyl-4-(phenylethynyl)quinoline 4.41a was characterised by its 1H and 13C NMR 
spectra; the appearance of five extra aromatic protons corresponding to the new phenyl 
ring (1H) as well as the disappearance of the C-3 quaternary carbon signal i.e. C-I (δC 102.29 
ppm) were confirmative. The 1H NMR spectrum of 2,3-diphenyl-4-(phenylethynyl)quinoline 
4.41a shows an upfield shift of all of the phenyl protons in comparison to those of the 
starting material 3.2a (Figure 4.10). 
 
Figure 4.10 400 MHz 1H NMR spectra; comparison of 3.2a and 4.41a in CDCl3 
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It was envisaged that the alkyne moiety may undergo activation from treatment with an 
iodine electrophile thus rendering it susceptible to subsequent nucleophilic attack from the 
phenyl ring (Scheme 4.32), as observed for the cyclisation of 3,3-bis(phenylethynyl)-2-(p-
tolyl)-2,3-dihydro-1,2-benzisothiazole 1,1-dioxide 2.59Ba to 6-iodo-2-methyl-5-phenyl-6a-
(phenylethynyl)-6aH-1,2-benzisothiazolo[2,3-a]quinoline 11,11-dioxide 2.66a-3, Section 2.7, 
Scheme 2.71.  
 
Scheme 4.32 
Consequently, 4.41a was dissolved in MeCN and following addition of 3 equiv. of ICl, the 
mixture was stirred at reflux overnight. After quenching the mixture with aqueous sodium 
thiosulfate, the resultant solid was washed with pentane. However the orange solid isolated 
was found to be neither of the two possible teracycles (Scheme 4.32) but the novel 
dihalogenated species 4.42a (92% yield, Scheme 4.33). Confirmation of the presence of two 
halogen functions was established by HMRS that exhibited a molecular ion at m/z [M+H]+ = 





Further confirmation that iodochlorination had occurred on the triple bond was derived 
from the upfield shift of the 5-H proton in comparison to the starting material (Figure 4.11). 
Assignment of the proton shift was determined by consideration of the 2D NMR data 
(HSQC) Figure 4.12 and with the aid of known 13C shifts for other quinoline derivatives (see 
Section 3.1). 
 
Figure 4.11 1H NMR spectra comparison of 4.41a and 4.42a 
 
Figure 4.12 HSQC spectrum of 4.42a 
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The trans-dihalo product will be formed in preference to the cis isomer due to the 
intermediacy of an iodonium intermediate 4.43, which only enables attack of chloride on 
the opposite face (Scheme 4.34) [03JOC10175, 07MI1000]  
 
Scheme 4.34 
Recently Zeng et al. reported the regio- and stereoselective synthesis of dihaloalkenes from 
in situ generated ICl and various alkynes (Scheme 4.35) [20MI1018]. In all cases it was found 
that the trans isomer was the major or exclusive isomer obtained. The reason for the 
regioselectivity of the reaction was ascribed to addition of the chloride nucleophile to the 
most stabilised carbocation centre (neighbouring group stabilisation).  
 
Scheme 4.35 
In the case of 4.43 the most stable carbocation would be that adjacent to the phenyl ring, in 
comparison to the carbon adjacent to the quinoline ring which is electron deficient and 
therefore would exert a lesser stabilising effect. Consequently the structure is assigned as 
shown i.e. (E)-4-(2-chloro-1-iodo-2-phenylvinyl)-2,3-diphenylquinoline (Scheme 4.32). 
However, to fully ascertain the structure of 4.42a and its regio- and stereochemistry a X-ray 
crystal structure would be required. 
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The results above clearly demonstrated the ease with which an iodonium ion can be 
generated from 4-alkynyl-2,3-diphenylquinoline 4.41a. It was envisioned that the presence 
of a more electron rich 3-C aryl group may facilitate iodocarbocylisations shown in Scheme 
4.32. 
Accordingly, 4-tolylboronic acid was employed in the Suzuki coupling with 3.2a, to give 
4.41b in a 70% yield (Scheme 4.36). The constitution of 2-phenyl-4-(phenylethynyl)-3-(p-
tolyl)quinoline 4.41b was confirmed by 1H and 13C NMR spectra and by HRMS that exhibited 
a molecular ion at m/z [M+H]+ = 396.1739 corresponding to C30H21N. Addition of the methyl 
group in the para position of the aromatic ring should increase the overall electron density 
in the ring and thus facilitate the cyclisation (Scheme 4.32). Unfortunately, subsequent 
reaction with ICl in refluxing MeCN provided only unreacted starting material (Scheme 
4.36). The reasons for this outcome are not clear and further work is required to understand 






























Chapter 5 Conclusions  
5.1 Chapter 2 Conclusions 
• The synthesis of novel 3-(2-arenesulfonamidophenyl)penta-1,4-diyn-3-ols has been 
accomplished from addition of alkynyllithium reagents to methyl 2-
(arenesulfonamido)benzoates in varying yields (11 – 90%). The electron density and 
thus nucleophilicity of the sulfonamide group could be attenuated by the nature of the 
arenesulfonyl function. Both electron rich and electron-deficient sulfonamides were 
prepared.  
• The synthesis of novel 3-(2-tosylamidophenyl)penta-1,4-diyn-3-ols possessing 
unsymmetrical alkyne-terminal groups was readily accomplished in varying yields (28 – 
88%) from the reaction of 3-aryl-1-(2-tosylamidophenyl)prop-2-yn-1-ones with 
alkynyllithiums or with HC≡CMgBr. The propynones could be accessed directly from 
the Weinreb amide, N-methoxy-N-methyl-2-(tosylamido)benzamide and an 
alkynyllithium reagent.  
• The synthesis of N-arylsaccharins was achieved from a Chan-Lam-(Evans) coupling of 
arylboronic acids with saccharin. Subsequent addition of an alkynyllithium reagent 
resulted in an addition-ring opening-addition sequence giving access to the novel 1,5-
disubstituted-3-[2-(N-arylsulfamoyl)phenyl]penta-1,4-diyn-3-ols in varying yields (42 – 
98%). 
• Attempts to effect a base-mediated double desilylation of 1,5-bis(trimethylsilyl)-3-(2-
tosylamidophenyl)penta-1,4-diyn-3-ol afforded, unexpectedly, a novel 3-ethynyl-2-
methylene-1-tosylindolin-3-ol. A mechanism has been proposed to account for this 
transformation (Schemes 2.32 and 2.54) 
o This base-mediated 5-exo-dig ring closure was applicable to a range of 1-alkyl- or 1-
aryl- 5-trimethylsilyl-3-(2-tosylamidophenyl)penta-1,4-diyn-3-ols as well as the 5-
desilyl-derivatives. Both series of dialkynols provided high yields of 3-alkynyl-2-
methylene-1-tosylindolin-3-ols and six examples were prepared. 




• Silver-catalysed cyclisation (AgNO3 on silica) of 1,5-diphenyl-3-(2-
tosylamidophenyl)penta-1,4-diyn-3-ol underwent a 5-exo-dig cyclisation to the novel 
(Z)-2-benzylidene-3-(phenylethynyl)-1-tosylindolin-3-ol in quantitative yield. 
o The stereochemistry of (Z)-2-benzylidene-3-(phenylethynyl)-1-tosylindolin-3-ol was 
established by examination of 2D NMR spectra, primarily the NOESY spectrum. 
o A related, stereospecific 5-exo-dig cyclisation of 1,3-diphenyl-1-[2-
(tosylamido)phenyl]prop-2-yn-1-ol with AgOAc to 2-benzylidene-3-phenyl-1-
tosylindolin-3-ol has been reported by Chan and co-workers (Scheme 2.42) 
[12CEJ2666]. 
• Attempts to affect the cyclisation of other 3-(2-tosylamidophenyl)penta-1,4-diyn-3-ols 
with AgNO3 proved unsuccessful. 
• Treatment of 3-(2-tosylamidophenyl)penta-1,4-diyn-3-ols with silver(I) acetate brought 
about a 5-exo-dig cyclisation and subsequent isomerisation to afford the novel 
phenyl[3-(phenylethynyl)-1-tosyl-1H-indol-2-yl]methanol in quantitative yield. 
o Exposure of 6-(2-tosylamidophenyl)undeca-4,7-diyn-6-ol to AgOAc initiated 
multiple reaction pathways. The major product was characterised as 1-[3-(pent-1-
yn-1-yl)-1-tosyl-1H-indol-2-yl]butan-1-ol. The minor products were identified as the 
dehydration product (E)-2-but-1-en-1-yl-3-pentyn-1-yl-1-tosyl-1H-indole together 
with 4-pentyn-1-yl-2-propylquinoline from a 6-endo-dig pathway. All three 
products are novel. 
o However when the alkyne termini in 3-(2-tosylamidophenyl)penta-1,4-diyn-3-ols 
were substituted with TMS or tert-Bu groups, cyclisation did not procced to the 
expected 2-(α-hydroxyalkyl)indoles. Instead the (Z)-2-(trimethylsilylmethylene)- or 
(Z)-2(2,2-dimethylpropylidene)- derivatives of the 3-alkynyl-1-tosylindolin-3-ols 
were isolated. A plausible mechanism for these conversions has been postulated 
(Scheme 2.55). It is proposed that the presence of bulky groups hinders attack of 
water on the vinylic carbocation intermediate. 
• Indium(III) triflate induced a remarkable and unexpected cascade cyclisation of 1,5-
diphenyl-3-(2-tosylamidophenyl)penta-1,4-diyn-3-ol to the novel the 2,4-diphenyl-1-
tosyl-4,5-dihydrofuro[2,3-c]quinoline. It is proposed that an initial Meyer-Schuster 
rearrangement is followed by a 5-exo-dig cyclisation of an enynone from which a 6-
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endo-trig ring closure ultimately ensues. Optimisation studies revealed that yields 
were maximised with 5 mol % In(OTf)3in DCM at r.t.  
o This novel cyclisation pathway was only applicable to 1,5-diphenyl-3-(2-
tosylamidophenyl)penta-1,4-diyn-3-ol and none of the other 3-(2-
tosylaminophenyl)penta-1,4-diyn-3-ol derivatives provided analogous, isolatable 
products. 
• Treatment of 1,5-disubstituted-3-[2-(N-arylsulfamoyl)phenyl]penta-1,4-diyn-3-ols with 
indium(III) triflate initiated dehydration (via an E1 pathway) and subsequent cyclisation 
to afford novel 2-aryl-3,3-di(alkynyl)-2,3-dihydro-1,2-benzisothiazole 1,1-dioxides in 
fair to high yields (37 – 100%). This cyclodehydration reaction could also be 
accomplished, but in lower yields, by treatment with iodine monochloride. 
o Iodine monochloride also induced cyclisation of 1,5-disubstituted-3-[2-(N-
arylsulfamoyl)phenyl]penta-1,4-diyn-3-ols to a novel 1,2-benzisothiazolo[2,3-
a]quinoline that was characterised by X-ray crystallography. It was found that 2-
aryl-3,3-di(alkynyl)-2,3-dihydro-1,2-benzisothiazole 1,1-dioxides were 
intermediates of the reaction and a plausible mechanism for this unusual 
iodocyclisation reaction has been described (Scheme 2.71). 
o 1,2-Benzisothiazolo[2,3-a]quinolines could be generated from both a stepwise 
manner utilising preformed 2-aryl-3,3-di(alkynyl)-2,3-dihydro-1,2-benzisothiazole 
1,1-dioxides and in a one-pot domino reaction from 1,5-disubstituted-3-[2-(N-











5.2 Chapter 3 Conclusions 
• Treatment of 1,5-diphenyl-3-(2-tosylamidophenyl)penta-1,4-diyn-3-ol with molecular 
iodine in refluxing MeOH initiates cyclisation via a 6-endo-dig pathway to afford the 
novel 3-iodo-2-phenyl-4-(phenylethynyl)quinoline in 25% yield. 
o Optimisation studies revealed that 2 equiv. ICl in MeCN at r.t. gave the best results 
providing the 3-iodoquinoline in 60% yield. (Table 3.1). 
o However when 6-(2-p-tosylamidophenyl)undeca-4,7-diyn-6-ol was treated with ICl 
in MeCN the reaction provided complex mixtures. Therefore, for the alkyl-
terminated dialkynol derivatives molecular iodine (3 equiv.) in refluxing MeOH was 
used. 
• Changing the electron density of the sulfonamide nitrogen affected the reaction rate 
and yields of the 4-alkynyl-3-iodo-2-substituted quinolines. 
o With an electron withdrawing 4-nitrophenylsulfonyl group, lower yields and slower 
reactions times were observed. In contrast, the more electron donating (4-
methoxyphenylsulfonyl group provided higher yields of products and faster 
reaction rates were achieved.  
• 3-(2-Tosylamidophenyl)penta-1,4-diyn-3-ols possessing unsymmetrical alkyne-terminal 
groups also underwent the 6-endo-dig cyclisation to 4-alkynyl-3-iodoquinolines, 
however only poor yields were achieved and many reactions failed to give any 
tractable products. 
• 1,5-Disubstituted-3-[2-(N-arylsulfamoyl)phenyl]penta-1,4-diyn-3-ols underwent a 
silver-catalysed 6-exo-dig cyclisation to (Z)-3-alkylidene-4-alkynyl-2-aryl- and (Z)-4-
alkynyl-2-aryl-3-arylidene- derivatives of 1,2-benzothiazin-4-ol 1,1-dioxides. Some 
sixteen examples were prepared in fair to excellent yields (30 – 96%). This reaction 
represents a novel means to assemble the 1,2-benzothiazine system. 
o The reaction was stereospecific giving the (Z)-isomer exclusively, the 
stereochemistry of the products was established from the 1D and 2D NMR (1H and 
NOESY) spectra. 
o 2-(6-Hydroxyundeca-4,7-diyn-6-yl)-N-methylbenzenesulfonamide and 2-(6-
hydroxyundeca-4,7-diyn-6-yl)-N-(thiophen-3-yl)benzenesulfonamide also cyclised 
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via a 7-endo-dig pathway to yield small amounts of the novel 1,2-benzothiazepine 

























5.3 Chapter 4 Conclusions 
• A variety of reactions with 3-ethynyl-2-methylene-1-tosylindolin-3-ol (dehydration and 
interception with a nucleophile, cyclocondensation with 2-naphthol, 1,3-AAI and 
oxidation reactions) to extend the functionality of the ring system gave no tractable 
products (Scheme 4.5). 
o When (Z)-2-benzylidene-3-(phenylethynyl)-1-tosylindolin-3-ol was treated with 
acetylacetone under acidic conditions facile dehydration and interception with the 
nucleophilic enolate tautomer was achieved in quantitative yield to afford 3-
{phenyl[3-(phenylethynyl)-1-tosyl-1H-indol-2-yl]methyl}pentane-2,4-dione. 
o However when the indole-linked 1,3-dione was subjected to basic conditions, 
cyclisation did not ensue. External electrophilic π-bond activators – Ag(I), In(III) and 
sources of I+ – also failed to initiate cyclisation. Further work is needed to establish 
the scope and limitations of the reaction (Scheme 4.10). 
• Palladium(0)catalysed coupling of 4-alkynyl-3-iodquinolines with various aniline 
derivatives and with benzylamine afforded both the amination [4-(alkynyl)quinolin-3-
amine] and hydroamination (pyrrolo[2,3-c]quinoline) products. With many of the 
couplings affording the former, 4-(alkynyl)quinolin-3-amines as the major product. 
Formation of the pyrrolo[2,4-c]quinolines is of interest as it enables access to novel 
analogues of the biologically active marinoquinolines. 
o The Pd-medaiated amination reaction was also attempted with ammonia 
surrogates (tert-butyl carbamate and tert-butyl sulfinamide) but only starting 
material was isolated from these reactions. 
o In a separate reaction N-benzyl-2-phenyl-4-(phenylethynyl)quinolin-3-amine with 
PdCl2 in DMF effected the hydroamination cyclisation to 3-benzyl-2,4-diphenyl-3H-
pyrrolo[2,3-c]quinoline in 60% yield.  
o Attempts to deprotect the 3-benzyl-2,4-diphenyl-3H-pyrrolo[2,3-c]quinoline to 
achieve access to the N-unsubstituted 2,4-diphenyl-3H-pyrrolo[2,3-c]quinoline by 
dealkylation with excess AlCl3 provided futile and only starting material was 
isolated. 
o 4-Pentyn-1-yl-2-propylquinoline did not afford any amination-hydroamination 



















Chapter 6 Experimental 
6.1 Equipments and Reagents 
Unless otherwise stated, reagents were used as supplied. Reagents were purchased from 
Alfa Aesar, Fluorochem, TCI, Fisher and Sigma Aldrich.  
NMR spectra were recorded on a Bruker Avance 400 spectrometer (1H 400 MHz and 13C 100 
MHz), unless otherwise stated. Coupling constants are given in Hz. Accurate mass 
measurements were obtained from the IPOS Mass Spectrometry Service at The University of 
Huddersfield. Single crystal studies were recorded on a Bruker D8 Venture with Dual IμS 
Microfocus Sources using Mo and/or Cu radiation. The temperature of data collection was 
150 K.  
Melting points were determined in capillary tubes, using a Stuart SMP10 melting point 
apparatus, and are uncorrected. FT-IR spectra were recorded on a Nicolet 380 Spectrum 
Spotlight system, equipped with a diamond probe ATR attachment (neat sample). TLC was 
performed on Merck TLC Aluminium sheets, silica gel 60 F254 using a range of eluent 
systems of differing polarity. Flash Chromatographic separations were performed on 
Aldrich, 35-70 μ, 60 Å silica gel, according to the literature procedure [78JOC2923]. When 
stated flash column chromatography separations were performed using Biotage® Isolera 4 
Automated Purification System equipped with Biotage® Snap Ultra Biotage® HP-Sphere™ 25 
μm cartridges.  
6.2 Chapter 2.0 Experimental 
6.2.1 Synthesis of 2-Sulfonamido- Benzoic Acid Derivatives  




Under an inert (N2) atmosphere methyl 2-aminobenzoate (9.71 mL, 75.0 mmol, 1.0 equiv.) 
was dissolved in DCM (75 mL). Pyridine (7.28 mL, 90.0 mmol, 1.2 equiv.) was added 
dropwise over 10 minutes and the solution stirred for 60 minutes. Toluene-4-sulfonyl 
chloride (17.2 g, 90.0 mmol, 1.2 equiv.) dissolved in DCM (100 mL) was added dropwise over 
10 minutes and the reaction mixture was stirred at r.t. overnight. After this time the mixture 
was quenched with 2M HCl, diluted with DCM (approx. 100 mL). The organic phase was 
separated, washed with water and brine, dried (Na2SO4) and evaporated to give white 
crystals. The crude material was recrystallised from MeOH to give the title compound as 
white crystals (18.6 g, 81%) m.p. 113 – 114 °C (lit. m.p. 113 °C [04H(63)1113]). 
δH (CDCl3) 10.62 (1H, s, NH), 7.91 (1H, dd, J = 8.0, 1.6 Hz, 2-H), 7.74 (2H, d, J = 8.2 Hz, o-Ar-H), 
7.68 (1H, dd, J = 8.0, 1.6 Hz, 5-H), 7.47 – 7.42 (1H, m, 4-H), 7.22 (2H, d, J = 8.2 Hz, m-Ar-H), 
7.05 – 7.01 (1H, m, 3-H), 3.88 (3H, s, CO2Me), 2.36 (3H, s, Ar-Me). δc 168.31 (C=O), 143.93 
(qC), 140.52 (qC), 136.43 (qC), 134.50 (CH), 131.17 (CH), 129.64 (CH), 127.29 (CH), 122.83 
(CH), 118.97 (CH), 115.81 (qC), 52.48 (CH3), 21.54 (CH3). 
νmax/cm-1: 3131 b (NH), 1687 s (CO2R), 1587 s (C=C), 1492 s (CH3), 1316 s (SO2), 1256 s 
(CO2R), 1088 s (SO2). 
Synthesis of methyl 2-[(4-methoxyphenyl)sulfonamido]benzoate (2.4b) 
 
Under an inert (N2) atmosphere methyl 2-aminobenzoate (3.15 mL, 24.2 mmol, 1.0 equiv.) 
was dissolved in chloroform (20 mL). Pyridine (5.85 mL, 72.6 mmol, 3.0 equiv.) was added 
dropwise over 10 minutes and the solution stirred for 60 minutes. 4-
Methoxybenzenesulfonyl chloride (5.00 g, 24.2 mmol, 1.0 equiv.) dissolved in chloroform 
(30 mL) was added dropwise over 15 minutes and stirred at r.t. overnight. After this time 
the mixture was quenched with 2M HCl, diluted with chloroform (approx. 30 mL). The 
organic phase was separated, washed with water and brine, dried (Na2SO4) and evaporated 
to give a light red oil. On standing the oil crystallised and subsequent recrystallisation from 
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EtOH to give the title compound as white crystals (4.85 g, 62%) m.p. 80 – 82 °C (lit. m.p. 81 – 
85 °C [75USP3920687]). 
δH (CDCl3) 10.58 (1H, s, NH), 7.91 (1H, dd, J = 7.9, 1.5 Hz, 2-H), 7.81 (2H, m, o-Ar-H), 7.68 (1H, 
dd, J = 7.9, 1.5 Hz, 5-H), 7.47 – 7.43 (1H, m, 4-H), 7.05 – 7.01 (1H, m, 3-H), 6.90 – 6.87 (2H, 
m, m-Ar-H), 3.88 (3H, s, CO2Me), 3.82 (3H, s, O-Me). δc 168.29 (C=O), 163.11 (qC), 140.62 
(qC), 134.49 (CH), 131.16 (CH), 131.01 (CH), 129.47 (CH), 122.76 (CH), 119.02 (CH), 115.82 
(qC), 114.15 (CH), 55.58 (CH3), 52.47 (CH3). 
νmax/cm-1: 3137 b (NH), 1682 s (CO2R), 1588 s (C=C), 1490 s (CH3), 1255 s (CO2R), 1152 s 
(SO2), 1087 s (SO2). 
Synthesis of methyl 2-[(4-nitrophenyl)sulfonamido]benzoate (2.4c) 
 
Under an inert (N2) atmosphere methyl 2-aminobenzoate (2.70 mL, 21.4 mmol, 1.0 equiv.) 
was dissolved in DCM (30 mL). Pyridine (1.70 mL, 21.4 mmol, 1.0 equiv.) was added 
dropwise over 10 minutes and the solution was stirred for 60 minutes. 4-
Nitrobenzenesulfonyl chloride (5.00 g, 21.4 mmol, 1.0 equiv.) dissolved in DCM (30 mL) was 
added dropwise over 20 minutes and stirred at r.t. overnight. After this time the mixture 
was quenched with 2M HCl, diluted with DCM (approx. 30 mL). The organic phase was 
separated, washed with water and brine, dried (Na2SO4) and evaporated to give a red solid. 
The crude material was recrystallised from EtOH to give the title compound as yellow 
needles (4.97 g, 71%) m.p. 152 – 153 °C (lit. m.p. 154.9 – 155.7 °C [13MOL6883]). 
δH (CDCl3) 10.82 (1H, s, NH), 8.29 – 8.25 (2H, m, m-Ar-H), 8.05 – 8.01 (2H, m, o-Ar-H), 7.95 
(1H, dd, J = 8.0, 1.5 Hz, 2-H), 7.73 (1H, dd, J = 8.0, 1.5 Hz, 5-H), 7.53 – 7.49 (1H, m, 4-H), 7.13 
– 7.09 (1H, m, 3-H), 3.88 (3H, s, CO2Me). δc 168.35 (C=O), 150.24 (qC), 145.03 (qC), 139.55 
(qC), 134.83 (CH), 131.48 (CH), 128.55 (CH), 124.27 (CH), 123.90 (CH), 119.36 (CH), 116.26 
(qC), 52.73 (CH3). 
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νmax/cm-1: 3108 b (NH), 1698 s (CO2R), 1600 s (C=C), 1586 w (NO2), 1526 s (CH3), 1349 s 
(NO2), 1313 s (SO2), 1265 s (CO2R), 1088 s (SO2). 
Synthesis of methyl 2-(phenylsulfonamido)benzoate (2.4d) 
 
Under an inert (N2) atmosphere methyl 2-aminobenzoate (9.80 mL, 75.0 mmol, 1.0 equiv.) 
was dissolved in DCM (75 mL). Pyridine (18.2 mL, 225 mmol, 3.0 equiv.) was added dropwise 
over 10 minutes and solution stirred for 60 minutes. Benzenesulfonyl chloride (12.5 mL, 
97.5 mmol, 1.3 equiv.) dissolved in DCM (40 mL) was added dropwise over 5 minutes and 
stirred at r.t. overnight. After this time the mixture was quenched with 2M HCl, diluted with 
DCM (approx. 100 mL). The organic phase was separated, washed with water and brine, 
dried (Na2SO4) and evaporated to give white crystals. The crude material was recrystallised 
from MeOH to give the title compound as white crystals (15.3 g, 70%) m.p. 105 – 106 °C (lit. 
m.p. not quoted [06BMC5562]). 
δH (CDCl3) 10.65 (1H, s, NH), 7.91 (2H, dd, J = 8.0, 1.4 Hz, 2-H), 7.86 – 7.84 (2H, m, o-Ar-H) 
7.70 (1H, app. d, 5-H), 7.75 – 7.41 (4H, m, Ar-H), 7.06 – 7.02 (1H, m, 3-H), 3.87 (3H, s, 
CO2Me). δc 168.29 (C=O), 140.36 (qC), 139.36 (qC), 134.53 (CH), 133.03 (CH), 131.17 (CH), 
129.01 (CH), 127.25 (CH), 123.03 (CH), 119.22 (CH), 116.00 (qC), 52.51 (CH3). 
νmax/cm-1: 3157 b (NH), 1681 s (CO2R), 1582 s (C=C), 1489 s (CH3), 1315 s (SO2), 1265 s 
(CO2R), 1087 s (SO2). 




Anthranilic acid (5.00 g, 36.46 mmol, 1 equiv.) and toluene-4-sulfonyl chloride (8.32 g, 43.6 
mmol, 1.2 equiv.) was suspended in water (400 mL). To this NaOH (1.50 g, 37.5 mmol, 1.0 
equiv.) was added portion wise over 10 minutes and the solution was stirred at r.t. 
overnight. After this time the mixture was filtered and washed with water, the crude 
material was used without further purification (8.80 g, 83%) m.p. 200 – 202 °C (literature 
m.p. 112 °C. [07JME1219]). 
Synthesis of 2-[(4-methylphenyl)sulfonamide]benzoyl chloride (2.13) 
 
Under an inert (N2) atmosphere 2-[(4-methylphenyl)sulfonamide]benzoic acid (8.72 g, 29.9 
mmol, 1.0 equiv) was suspended in anhydrous DCM (100 mL). Oxalyl chloride (3.80 mL, 44.3 
mmol, 1.5 equiv) was added dropwise to the cold solution (0 °C), a catalytic amount of DMF 
was then added to the solution. The solution was stirred at r.t. for 2 h. After this time the 
mixture was evaporated to give the title compound as an off white solid. The crude material 
was used without further purification (8.30 g, 90%) m.p. 115 – 117 °C (literature m.p. 117 – 
118 °C. [14MI435]). 
6.2.2 Synthesis of N-[2-(3-Hydroxy-penta-1,4-diyn-3-yl)phenyl]benzenesulfonamides 
General Method for Synthesis of N-[2-(3-Hydroxy-penta-1,4-diyn-3-
yl)phenyl]benzenesulfonamides 
Method A: Under an inert (N2) atmosphere n-BuLi (3.5 equiv.) was added to a cold (-75 °C) 
solution of the appropriate alkyne (X mmol, 3.5 equiv.) in anhydrous THF (approx. 100 mL). 
A solution of the appropriate sulfonamide (Y mmol, 1.0 equiv.) in anhydrous THF (approx. 60 
mL) was added dropwise to the cold (0 °C) solution and the mixture was allowed to warm to 
r.t. and stirred for 1 h. After this time the mixture was quenched with aqueous NH4Cl and 
diluted with EtOAc. The organic phase was separated, dried (Na2SO4) and evaporated to give 
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the crude material which was purified by recrystallisation or by flash column 
chromatography. The following compounds were synthesised by this method. 
Method B: Under an inert (N2) atmosphere 1-bromo-1-propene (X mmol, 3.5 equiv.) was 
added to a cold (-75 °C) solution of LDA 3.5 equiv. (DIPA, 2.1 equiv. and n-BuLi, 3.5 equiv.) in 
anhydrous THF (approx. 50 mL) and was stirred for 3 h. A solution of the appropriate 
sulfonamide (Y mmol, 1.0 equiv.) in anhydrous THF (approx. 30 mL) was added dropwise to 
the cold (0 °C) solution and the mixture was allowed to warm to r.t. and stirred for 1 h. After 
this time the mixture was quenched with aqueous NH4Cl and diluted with EtOAc. The 
organic phase was separated, dried (Na2SO4) and evaporated to give the crude material 
which was purified by recrystallisation or by flash column chromatography. The following 




Using Method A from phenylacetylene (69.0 mmol) and methyl 2-[(4-
methylphenyl)sulfonamido]benzoate (19.7 mmol) to give a yellow oil. The product 
crystallised on standing. The crude material was then recrystallised from hexane – EtOAc to 
give the title compound as an off white powder (7.99 g, 85%) m.p. 137 – 138 °C; HRMS 
found [M+Na]+ = 500.1287; C30H23NO3SNa [M+Na]+ requires = 500.1291. 
δH (CDCl3) 8.66 (1H, s, NH), 7.91 (1H, dd, J = 7.9, 1.5 Hz, 2-H), 7.79 (2H, d, J = 8.3 Hz, o-Ar-H), 
7.60 (1H, app. d, 5-H), 7.53 – 7.51 (4H, m, Ph-H), 7.41 – 7.33 (6H, m, Ph-H), 7.30 – 7.27* (1H, 
m, 3-H), 7.08 – 7.01 (3H, m, Ar-H), 3.34 (1H, s, OH), 2.28 (3H, s, Ar-Me). δc 143.63 (qC), 
136.89 (qC), 135.93 (qC), 132.01 (CH), 130.05 (CH), 129.52 (CH), 129.28 (CH), 128.41 (CH), 
128.06 (qC), 127.89 (CH), 127.52 (CH), 123.24 (CH), 121.42 (qC), 119.23 (CH), 87.01 (qC), 
86.87 (qC), 66.27 (qC), 21.52 (CH3). 
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νmax/cm-1: 3409 b (OH), 3282 w (NH), 2981 w (Ar-H), 1583 s (C=C), 1488 s (CH3), 1326 s (SO2), 
1087 s (R-OH), 1012 s (SO2). 
*Overlapping with CDCl3 signal 
N-[2-(6-Hydroxyundeca-4,7-diyn-6-yl)phenyl]-4-methylbenzenesulfonamide (2.5b) 
 
Using Method A from 1-pentyne (23.0 mmol) and methyl 2-[(4-
methylphenyl)sulfonamido]benzoate (6.57 mmol) to give a yellow oil. The product 
crystallised on standing. The crude material was then recrystallised from hexane – EtOAc to 
give the title compound as a beige powder (2.09 g, 78%) m.p. 88 – 89 °C; HRMS found 
[M+Na]+ = 432.1589; C24H27NO3SNa [M+Na]+ requires = 432.1589. 
δH (CDCl3) 8.51 (1H, s, NH), 7.81 (2H, d, J = 8.3 Hz, o-Ar-H), 7.77 (1H, dd, J = 7.9, 1.5 Hz, 2-H), 
7.50 (1H, dd, J = 7.9, 1.5 Hz, 5-H), 7.24 – 7.19 (3H, m, Ar-H), 7.00 (1H, app. t, 3-H), 2.80 (1H, 
s, OH), 2.37 (3H, s, Ar-Me), 2.26 (4H, t, J = 7.3 Hz, CH2), 1.59 (4H, sxt, J = 7.3 Hz, CH2), 1.00 
(6H, t, J = 7.3 Hz, CH3). δc 143.60 (qC), 137.18 (qC), 135.74 (qC), 129.64 (CH), 129.53 (CH), 
128.99 (qC), 127.64 (CH), 127.48 (CH), 123.07 (CH), 119.20 (CH), 87.79 (qC), 79.40 (qC), 65.36 
(qC), 21.71 (CH2), 21.55 (CH3), 20.82 (CH2), 13.59 (CH3). 
νmax/cm-1: 3400 b (OH), 3285 m (NH), 2963 w (Ar-H), 2932 w (CH2, CH3), 2871 w (CH2, CH3), 











Using Method A from 1-ethynyl-4-methoxybenzene (34.5 mmol) and methyl 2-[(4-
methylphenyl)sulfonamido]benzoate (9.86 mmol) to give the title compound as a golden 
powder (4.77 g, 90%) m.p. 132 – 134 °C; HRMS found [M+Na]+ = 560.1491; C32H27NO5SNa 
[M+Na]+ requires = 560.1502. 
δH (CDCl3) 8.68 (1H, s, NH), 7.90 (1H, dd, J = 7.9, 1.4 Hz, 2-H), 7.79 (2H, d, J = 8.3 Hz, Ar-H), 
7.56 (1H, dd, J = 7.9, 1.4 Hz, 5-H), 7.46 (4H, d, J = 8.8 Hz, Ar-H), 7.28 – 7.24* (1H, m, 4-H), 
7.07 – 7.03 (3H, m, Ar-H, 3-H), 6.87 (4H, d, J = 8.8 Hz, Ar-H),  3.83 (6H, s, O-Me), 2.30 (3H, s, 
Ar-Me). δc 160.28 (qC), 143.58 (qC), 136.94 (qC), 133.59 (CH), 133.57 [2 X C (qC)(CH)], 129.88 
(CH), 129.53 (CH), 127.85 (qC), 127.55 (CH), 123.17 (CH), 119.14 (CH), 114.02 (CH), 113.50 
(qC), 86.85 (qC), 86.00 (qC), 66.27 (qC), 55.36 (CH3), 21.54 (CH3).  
νmax/cm-1: 3383 b (OH), 3273 w (NH), 2228 s (C≡C), 1604 s (C=C), 1399 w (CH3), 1307 w 
(SO2), 1174 s (R-OH), 1154 s (SO2). 
*Overlapping with CDCl3 signal 
N-[2-(7-Hydroxytrideca-5,8-diyn-7-yl)phenyl]-4-methylbenzenesulfonamide (2.5d) 
 
Using Method A from 1-hexyne (69.0 mmol) and methyl 2-[(4-
methylphenyl)sulfonamido]benzoate (19.7 mmol) to give the title compound as off white 
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crystals (7.71 g, 89%) m.p. 80 – 82 °C; HRMS found [M+Na]+ = 460.1926; C26H31NO3SNa 
[M+Na]+ requires = 460.1917. 
δH (CDCl3) 8.54 (1H, s, NH), 7.81 (2H, d, J = 8.3 Hz, o-Ar-H), 7.77 (1H, dd, J = 7.9, 1.5 Hz, 2-H), 
7.50 (1H, dd, J = 7.9, 1.5 Hz, 5-H), 7.24 – 7.19 (3H, m, Ar-H), 7.00 (1H, app. t, 3-H), 2.80 (1H, 
s, OH), 2.37 (3H, s, Ar-Me), 2.26 (4H, t, J = 7.3 Hz, CH2), 1.59 (4H, sxt, J = 7.3 Hz, CH2), 1.00 
(6H, t, J = 7.3 Hz, CH3). δc 143.60 (qC), 137.18 (qC), 135.74 (qC), 129.64 (CH), 129.53 (CH), 
128.99 (qC), 127.64 (CH), 127.48 (CH), 123.07 (CH), 119.20 (CH), 87.79 (qC), 79.40 (qC), 65.36 
(qC), 21.71 (CH2), 21.55 (CH3), 20.82 (CH2), 13.59 (CH3). 
νmax/cm-1: 2956 m (Ar-H), 2930 m (CH2, CH3), 2871 m (CH2, CH3), 1599 s (C=C), 1494 w (CH2), 




Using Method A from (trimethylsilyl)acetylene (34.6 mmol) and methyl 2-[(4-
methylphenyl)sulfonamido]benzoate (9.89 mmol) to give a red oil. The product crystallised 
on standing. The crude material was purified by flash column chromatography (30% EtOAc – 
hexane) to give the title compound as an off white powder (1.80 g, 39%) m.p. 138 – 140 °C 
decomp; HRMS found [M+Na]+ = 463.1304; C24H27NO3SNa [M+Na]+ requires = 463.1298. 
δH (CDCl3) 8.34 (1H, s, NH), 7.82 (2H, d, J = 8.3 Hz, o-Ar-H), 7.80 (1H, dd, J = 8.0, 1.3 Hz, 2-H), 
7.41 (1H, app. d, 5-H), 7.25 – 7.20* (3H, m, Ar-H), 7.02 (1H, app. t, 3-H), 2.38 (3H, s, Ar-Me), 
0.24 (18H, s, Si-Me3). δc 143.71 (qC), 137.17 (qC), 135.81 (qC), 129.97 (CH), 129.63 (CH), 
127.86 (CH), 127.68 (qC), 127.51 (CH), 123.23 (CH), 119.53 (CH), 102.21 (qC), 92.62 (qC), 
65.33 (qC), 21.57 (CH3), -0.44 (Si-Me3). 
νmax/cm-1: 3373 b (OH), 3285 m (NH), 2962 w (CH3), 1586 s (C=C), 1494 s (CH3), 1325 s (SO2), 
1149 s (R-OH), 1090 s (SO2). 
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*Overlapping with CDCl3 signal 
N-[2-(4-Hydroxyhepta-2,5-diyn-4-yl)phenyl]-4-methylbenzenesulfonamide (2.5g) 
 
Using Method B from 1-bromo-1-propene (22.9 mmol) and methyl 2-[(4-
methylphenyl)sulfonamido]benzoate (6.55 mmol) to give the title compound as a white 
powder (0.36 g, 16%) m.p. 140 °C decomp; HRMS found [M+Na]+ = 376.0973; C20H19NO3SNa 
[M+Na]+ requires = 376.0978. 
δH (CDCl3) 8.51 (1H, s, NH), 7.81 (2H, d, J = 8.3 Hz, o-Ar-H), 7.75 (1H, dd, J = 7.9, 1.4 Hz, 2-H), 
7.52 (1H, app. d, 5-H), 7.24 – 7.20 (3H, m, m-Ar-H, 4-H), 7.01 (1H, app. t, 3-H), 2.37 (3H, s, 
Ar-Me), 1.92 (6H, s, Me). δc 143.64 (qC), 137.20 (qC), 135.73 (qC), 129.69 (CH), 129.53 (CH), 
128.96 (qC), 127.65 (CH), 127.48 (CH), 123.16 (CH), 119.31 (CH), 83.56 (qC), 78.31 (qC), 65.40 
(qC), 21.55 (CH3), 3.91 (CH3). 
νmax/cm-1: 3392 b (OH), 3244 m (NH), 2921 w (CH3), 1597 s (C=C), 1406 w (CH3), 1319 s (SO2), 




Using Method A from 3,3-dimethyl-1-butyne (5.74 mmol) and methyl 2-[(4-
methylphenyl)sulfonamido]benzoate (1.64 mmol) to give the title compound as a white 
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solid (0.56 g, 79%) m.p. 138 – 140 °C decomp; HRMS found [M+Na]+ = 460.1915; 
C26H31NO3SNa [M+Na]+ requires = 460.1917. 
δH (CDCl3) 8.50 (1H, s, NH), 7.82 (2H, d, J = 8.2 Hz, o-Ar-H), 7.75 (1H, dd, J = 7.9, 1.5 Hz, 2-H), 
7.40 (1H, dd, J = 7.9, 1.5 Hz, 5-H), 7.24 – 7.17 (3H, m, m-Ar-H, 4-H), 7.00 (1H, td, J = 7.9, 1.5 
Hz, 3-H), 2.82 (1H, s, OH), 2.37 (3H, s, Ar-Me), 1.28 (18H, s, Me3). δc 143.61 (qC), 137.33 (qC), 
135.78 (qC), 129.61 (CH), 129.55 (CH), 129.21 (qC), 127.60 (CH), 127.45 (CH), 123.01 (CH), 
119.22 (CH), 95.54 (qC), 78.00 (qC), 64.98 (qC), 30.50 (CH3), 27.60 (qC), 21.56 (CH3). 
νmax/cm-1: 3409 b (OH), 3263 m (NH), 2964 m (CH3), 2866 w (Ar-H), 2240 w (C≡C), 1599 s 




Using Method A from 2-methyl-1-buten-3-yne (11.5 mmol) and methyl 2-[(4-
methylphenyl)sulfonamido]benzoate (3.27 mmol) to give the title compound as a yellow 
solid (0.86 g, 65%) m.p. 138 – 139 °C; HRMS found [M+K]+ = 444.1368; C24H23NO3SK [M+K]+ 
requires = 444.1030. 
δH (CDCl3) 8.49 (1H, s, NH), 7.85 (2H, d, J = 8.3 Hz, o-Ar-H), 7.77 (1H, dd, J = 7.9, 1.5 Hz, 2-H), 
7.49 (1H, app. d, 5-H), 7.27 – 7.23 (3H, m, m-Ar-H, 4-H), 7.04 (1H, app. t, 3-H), 5.47 (2H, s, 
CH2), 5.39 (2H, s, CH2), 2.39 (3H, s, Ar-Me), 1.96 (6H, s, Me). δc 143.70 (qC), 137.04 (qC), 
135.84 (qC), 129.92 (CH), 129.62 (CH), 128.04 (qC), 127.73 (CH), 127.54 (CH), 127.30 (CH), 
125.47 (qC), 124.18 (CH2), 123.12 (CH), 119.13 (CH), 87.88 (qC), 85.92 (qC), 65.89 (qC), 22.99 
(CH3), 21.56 (CH3). 
νmax/cm-1: 3370 b (OH), 3288 m (NH), 2917 w (CH3), 1602 s (C=C), 1493 s (CH3),  1335 s (SO2), 






Using Method A from phenylacetylene (21.8 mmol) and methyl 2-[(4-
methoxyphenyl)sulfonamido]benzoate (6.22 mmol) to give an orange oil. The product 
crystallised on standing, which was then recrystallised from hexane – EtOAc to give the title 
compound as an off white powder (2.16 g, 70%) m.p. 126 °C decomp; HRMS found [M+Na]+ 
= 516.1230; C30H23NO4SNa [M+Na]+ requires = 516.1240. 
δH (CDCl3) 8.64 (1H, s, NH), 7.91 (1H, dd, J = 7.8, 1.2 Hz, 2-H), 7.85 – 7.82 (2H, m, o-Ar-H), 
7.61 (1H, dd, J = 7.8, 1.2 Hz, 5-H), 7.53 – 7.51 (4H, m, Ph-H), 7.41 – 7.33 (6H, m, Ph-H), 7.29 – 
7.28 (1H, m, 4-H), 7.06 (1H, td, J = 7.8, 1.2 Hz, 3-H), 6.69 – 6.66 (2H, m, m-Ar-H), 3.73 (3H, s, 
O-Me), 3.31 (1H, s, OH). δc 162.93 (qC), 135.96 (qC), 132.01 (CH), 131.30 (qC), 130.04 (CH), 
129.75 (CH), 129.27 (CH), 128.43 (CH), 128.04 (qC), 127.89 (CH), 123.18 (CH), 121.44 (qC), 
119.13 (CH), 114.00 (CH), 87.09 (qC), 86.82 (qC), 66.27 (qC), 55.44 (CH3). 
νmax/cm-1: 3413 b (OH), 3305 w (NH), 1596 s (C=C), 1489 s (CH3), 1329 w (SO2), 1148 s (SO2), 
1093 s (R-OH), 748 s (Ph-H), 689 s (Ph-H). 
N-[2-(6-Hydroxyundeca-4,7-diyn-6-yl)phenyl]-4-methoxybenzenesulfonamide (2.6b) 
 
Using Method A from 1-pentyne (21.8 mmol) and methyl 2-[(4-
methoxyphenyl)sulfonamido]benzoate (6.22 mmol) to give a yellow oil. The product 
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crystallised on standing, the resultant solid was washed with hexane to give the title 
compound an orange solid (1.87 g, 73%) m.p. 84 – 85 °C; HRMS found [M+Na]+ = 448.1541; 
C24H27NO3SNa [M+Na]+ requires = 448.1553. 
δH (CDCl3) 8.49 (1H, s, NH), 7.87 – 7.83 (2H, m, o-Ar-H), 7.77 (1H, dd, J = 7.9, 1.5 Hz, 2-H), 
7.51 (1H, dd, J = 7.9, 1.5 Hz, 5-H), 7.24 – 7.19 (1H, m, 4-H), 7.00 (1H, app. t, 3-H), 6.91 – 6.87 
(2H, m, m-Ar-H), 3.82 (3H, s, O-Me), 2.87 (1H, s, OH), 2.27 (4H, t, J = 7.2 Hz, CH2), 1.59 (4H, 
sxt, J = 7.2 Hz, CH2), 1.00 (6H, t, J = 7.2 Hz, CH3). δc 162.94 (qC), 135.77 (qC), 131.66 (qC), 
129.65 (CH), 129.62 (CH) 127.65 (CH), 123.05 (CH), 119.22 (CH), 114.03 (CH), 87.77 (qC), 
79.44 (qC), 65.35 (qC), 55.54 (CH3), 21.72 (CH2), 20.82 (CH2), 13.59 (CH3). 
νmax/cm-1: 3407 b (OH), 3287 m (NH), 2963 w (Ar-H), 2932 w (CH2, CH3), 2840 w (CH2, CH3), 




Using Method A from phenylacetylene (20.9 mmol) and methyl 2-[(4-
nitrophenyl)sulfonamido]benzoate (5.98 mmol) to give an orange oil. The product 
crystallised on trituration with hexane – EtOAc, which was then recrystallised from hexane – 
EtOAc to give the title compound as a fine orange powder (0.31 g, 10%) m.p. 180 °C 
decomp; HRMS found [M+Na]+ = 531.0967; C29H20N2O5SNa [M+Na]+ requires = 531.0985. 
δH [(CD3)2CO] 10.16 (1H, s, NH), 8.12 – 8.10 (2H, m, m-Ar-H), 7.92 – 7.90 (2H, m, o-Ar-H), 
7.70 (1H, dd, J = 7.6, 1.5 Hz, 2-H), 7.55 (1H, app. d, 5-H), 7.48 – 7.45 (4H, m, Ph-H), 7.39 – 
7.36 (6H, m, Ph-H), 6.97 (1H, m, 4-H), 6.62 (1H, app. t, 3-H). δc 153.57 (qC), 148.08 (qC), 
147.17 (qC), 131.45 (CH), 131.23 (qC), 128.41 (CH), 128.25 (CH), 127.95 (CH), 127.82 (CH), 
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126.30 (CH), 123.28 (qC), 122.94 (CH), 118.93 (CH), 117.17 (CH), 92.19 (qC), 82.23 (qC), 67.53 
(qC). 
νmax/cm-1: 1593 m (C=C), 1532 s (NO2), 1439 s (CH3), 1362 s (NO2), 1287 s (SO2), 1234 s (R-
OH), 1099 m (SO2).  
N-[2-(6-Hydroxyundeca-4,7-diyn-6-yl)phenyl]-4-nitrobenzenesulfonamide (2.7b) 
 
Using Method A from 1-pentyne (20.8 mmol) and methyl 2-[(4-
nitrophenyl)sulfonamide]benzoate (5.95 mmol) to give an orange oil. The product 
crystallised on standing and the crude material was recrystallised from hexane – EtOAc to 
give a brick red powder. From the liquor subsequent recrystallised from EtOH(aq) to give the 
title compound as straw crystals (total = 0.29 g, 11%) m.p. 100 – 101 °C; HRMS found 
[M+Na]+ = 463.1304; C24H27NO3SNa [M+Na]+ requires = 463.1298. 
δH [(CD3)2CO] 9.38 (1H, s, NH), 8.43 – 8.39 (2H, m, m-Ar-H), 8.23 – 8.19 (2H, m, o-Ar-H), 7.81 
(1H, dd, J = 7.9, 1.5 Hz, 2-H), 7.58 (1H, app. d, 5-H), 7.29 (1H, app. t, 4-H), 7.08 (1H, td, J = 
7.9, 1.5 Hz, 3-H), 6.78 (1H, s, OH), 2.24 – 2.20 (4H, m, CH2), 1.53 (4H, sxt, J = 7.2 Hz, CH2), 
0.98 (6H, t, J = 7.2 Hz, CH3). δc 145.71 (qC), 135.44 (qC), 130.55 (qC), 129.31 (CH), 128.82 (CH), 
127.81 (CH), 124.35 (CH), 123.51 (CH), 118.64 (CH), 86.19 (qC), 80.18 (qC), 64.96 (qC), 21.61 
(CH2), 20.12 (CH2), 12.79 (CH3). 
νmax/cm-1: 2961 w (CH2, CH3), 2871 w (CH2, CH3), 1594 m (C=C), 1528 s (NO2), 1477 s (CH2), 









Using Method A from phenylacetylene (69.0 mmol) and methyl 2-
(phenylsulfonamido)benzoate (19.7 mmol) to give an orange oil. The product crystallised on 
standing, which was then recrystallised from hexane – EtOAc to give the title compound as a 
white powder (6.19 g, 65%) m.p. 127 – 128 °C; HRMS found [M+Na]+ = 486.1134; 
C29H21NO3SNa [M+Na]+ requires = 486.1134. 
δH (CDCl3) 8.69 (1H, s, NH), 7.93 – 7.90 (3H, m, Ar-H), 7.58 (1H, dd, J = 8.0, 1.0 Hz, 5-H), 7.55 
– 7.52 (4H, m, Ph-H), 7.43 – 7.33 (7H, m, Ar-H), 7.30 – 7.24 (4H, m, Ar-H), 7.07 (1H, td, J = 
8.0, 1.0 Hz, 3-H). δc 139.96 (qC), 135.82 (qC), 132.85 (CH), 132.02 (CH), 130.08 (CH), 129.31 
(CH), 128.89 (CH), 128.42 (CH), 128.14 (qC), 127.92 (CH), 127.47 (CH), 123.37 (CH), 121.37 
(qC), 119.27 (CH), 86.96 (qC), 86.94 (qC), 66.28 (qC). 
νmax/cm-1: 3344 b (OH), 3224 m (NH), 2230 w (C≡C), 1583 s (C=C), 1324 s (SO2), 1148 s (R-
OH), 1107 s (SO2). 
Prop-2-yn-1-yl 2-[(4-methylphenyl)sulfonamide]benzoate (2.14) 
 
Under and inert N2 atmosphere n-BuLi (3.5 equiv.) was added to a cold (-75 °C) solution of 
propargyl alcohol (0.96 mL, 11.3 mmol, 3.5 equiv.) in anhydrous THF (approx. 50 mL). A 
solution of 2-[(4-methylphenyl)sulfonamide]benzoyl chloride (1.00 g, 3.23 mmol, 1.0 equiv.) 
in anhydrous THF (approx. 20 mL) was added dropwise to the cold (0 °C) solution and the 
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mixture was allowed to warm to r.t. and stirred for 1 h. After this time the mixture was 
quenched with aqueous NH4Cl and diluted with EtOAc. The organic phase was separated, 
dried (Na2SO4) and evaporated to give the title compound as a cream powder (0.75 g, 70%) 
m.p. 150 – 151 °C; HRMS found [M+Na]+ = 352.0613; C17H15NO4SNa [M+Na]+ requires = 
352.0613. 
δH (CDCl3) 10.43 (1H, s, NH), 7.96 (1H, dd, J = 8.0, 1.5 Hz, 2-H), 7.74 (2H, d, J = 8.2 Hz, o-Ar-H), 
7.69 (1H, app. d, 5-H), 7.49 – 7.45 (1H, m, 4-H), 7.22 (2H, d, J = 8.2 Hz, m-Ar-H), 7.07 – 7.03 
(1H, m, 3-H), 4.86 (2H, d, J = 2.5 Hz, CH2), 2.55 (1H, d, J = 2.5 Hz, CH), 2.37 (3H, s, Ar-Me), 
1.59 (1H, s, OH). δc 167.03 (qC), 143.99 (qC), 140.75 (qC), 136.37 (qC), 134.95 (CH), 131.38 
(CH), 129.68 (CH), 127.32 (CH), 122.89 (CH), 119.08 (CH), 115.16 (qC), 77.23 (qC), 75.62 (CH), 
52.90 (CH2), 21.56 (CH3). 
νmax/cm-1: 3273 s (C≡C-H), 3171 w (CH2), 1683 s (RCO2R), 1597 s (C=C), 1490 s (CH3), 1326 s 
(SO2), 1153 s (SO2), 1084 s (R-OH). 
6.2.3 Synthesis of Ynones 
2-Amino-N-methoxy-N-methylbenzamide (2.20) 
 
N,O-Dimethylhydroxylamine hydrochloride (7.29 g, 74.5 mmol, 1.5 equiv.) was dissolved in 
90% EtOH(aq) (60 mL). Triethylamine (10.4 mL, 74.5 mmol, 1.5 equiv.) was added dropwise 
over 10 minutes and the solution stirred for 10 minutes at r.t., a solution of isatoic 
anhydride (8.13 g, 49.8 mmol, 1.0 equiv.) in 90% EtOH(aq) (50 mL) was added portion-wise 
over 20 minutes. The mixture was then refluxed for 2 h. After this time the mixture was 
poured onto equal volumes of ice and saturated aqueous Na2CO3 and the EtOH was 
removed under reduced pressure. The aqueous solution was diluted with EtOAc (approx. 
100 mL). The organic phase was separated, washed with brine, dried (Na2SO4) and 
evaporated to give dark orange oil. The crude material was purified by flash column 




δH (CDCl3) 7.36 (1H, app. d, Ar-H), 7.21 – 7.16 (1H, m, Ar-H), 6.71 – 6.67 (2H, m, Ar-H), 4.64 
(2H, s, NH2), 3.60 (3H, s, O-Me), 3.35 (3H, s, N-Me). δc 170.03 (qC), 146.78 (qC), 131.43 (CH), 
129.21 (CH), 117.25 (qC), 116.87 (CH), 116.68 (CH), 61.12 (CH3), 34.35 (CH3). 
N-Methoxy-N-methyl-2-[(4-methylphenyl)sulfonamide]benzamide (2.21) 
 
Under an inert (N2) atmosphere, 2-amino-N-methoxy-N-methylbenzamide (5.74 g, 31.9 
mmol, 1.0 equiv.) was dissolved in pyridine (40 mL) and to this toluene-4-sulfonyl chloride 
(7.59 g, 39.6 mmol, 1.3 equiv.) was added in one portion. The mixture was refluxed 
overnight. Then cooled and diluted with EtOAc and washed with 2M HCl. The organic phase 
was separated, washed with water and brine, dried (Na2SO4) and evaporated to give dark 
orange oil. The crude material was purified by flash column chromatography (10% EtOAc – 
hexane) to give an orange oil which crystallised on trituration with ether to afford the title 
compound as an off-white solid (7.50 g, 70%) m.p. 109 – 110 °C (lit m.p. not quoted 
[16JOC2930]). 
δH (CDCl3) 8.96 (1H, s, NH), 7.70 – 7.65 (3H, m, 2-H, o-Ar-H), 7.48 (1H, app. d, 5-H), 7.40 – 
7.36 (1H, m, 4-H), 7.22 (2H, d, J = 8.1 Hz, m-Ar-H), 7.10 – 7.06 (1H, m, 3-H), 3.19 (6H, s, O-
Me, N-Me), 2.35 (3H, s, Ar-Me). δc 167.85 (qC), 143.65 (qC), 136.87 (qC), 136.73 (qC), 131.72 
(CH), 129.58 (CH), 129.21 (CH), 127.31 (CH), 123.75 (CH), 123.23 (qC), 122.87 (CH), 60.94 
(CH3), 33.69 (CH3), 21.48 (CH3). 
νmax/cm-1: 3166 b (NH), 2937 w (CH3), 1616 s (C=O), 1594 s (C=C), 1450 w (CH3), 1334 s (SO2), 
1157 s (SO2). 
General Method for Synthesis of Ynones 
Under and inert (N2) atmosphere n-BuLi (2.2 equiv.) was added to a cold (-75 °C) solution of 
an acetylene derivative (X mmol, 2.2 equiv.) in anhydrous THF (50 – 100 mL). The solution 
was warmed to 0 °C and N-methoxy-N-methyl-2-[(4-methylphenyl)sulfonamide]benzamide 
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(Y mmol, 1.0 equiv.) in anhydrous THF (15 – 30 mL) was added dropwise to the solution. 
When addition was complete the mixture was allowed to warm to r.t. and stirred for 1 h. 
After this time the mixture was quenched with aqueous NH4Cl and diluted with EtOAc. The 
organic phase was separated, dried (Na2SO4) and evaporated. The following were 
synthesised by this method. 
1-[2-(4-Toluenesulfonamido)phenyl]-3-phenylprop-2-yn-1-one (2.17A) 
 
From phenylacetylene (39.5 mmol) and N-methoxy-N-methyl-2-[(4-
methylphenyl)sulfonamide]benzamide (17.9 mmol) to give an orange oil which on 
trituration with ether gave the title compound as a bright yellow solid (3.76 g, 56%) m.p. 
138 – 140 °C (lit m.p. 149 – 152 °C [16AGE7737]). 
δH (CDCl3) 11.25 (1H, s, NH), 8.28 (1H, app. d, 2-H), 7.78 (2H, d, J = 8.2 Hz, o-Ar-H), 7.73 (1H, 
app. d, 5-H), 7.67 (2H, d, J = 8.2 Hz, m-Ar-H), 7.53 – 7.49 (2H, m, Ar-H), 7.45 – 7.42 (2H, m, 
Ar-H), 7.24 (2H, d, J = 8.0 Hz, Ar-H), 7.13 (1H, app. t, 3-H), 2.36 (3H, s, Ar-Me). δc 180.51 
(C=O), 144.08 (qC), 140.94 (qC), 136.46 (qC), 135.73 (CH), 134.77 (CH), 133.11 (CH), 131.22 
(CH), 129.76 (CH), 128.80 (CH), 127.33 (CH), 122.62 (CH), 122.49 (qC), 118.42 (CH), 95.27 
(qC), 86.61 (qC), 21.56 (CH3). 
νmax/cm-1: 3056 w (NH), 2202 m (C≡C), 1706 s (C=O), 1591 s (C=C), 1449 s (CH3), 1363 s 





From 1-pentyne (15.8 mmol) and N-methoxy-N-methyl-2-[(4-
methylphenyl)sulfonamide]benzamide (7.18 mmol) to give an orange oil which on 
trituration with ether gave the title compound as a baby pink solid (1.62 g, 66%) m.p. 93 – 
94 °C; HRMS found [M+H]+ = 341.1072; C19H20NO3S [M+H]+ requires = 342.1158. 
δH (CDCl3) 11.25 (1H, s, NH), 8.18 (1H, dd, J = 7.9, 1.5 Hz, 2-H), 7.76 (2H, d, J = 8.2 Hz, o-Ar-H), 
7.68 (1H, app. d, 5-H), 7.49 – 7.45 (1H, m, 4-H), 7.23 (2H, d, J = 8.2 Hz, m-Ar-H), 7.08 (1H, 
app. t, 3-H), 2.48 (2H, t, J = 7.2 Hz, CH2), 2.37 (3H, s, Ar-Me), 1.69 (2H, sxt, J = 7.2 Hz, CH2), 
1.07 (3H, t, J = 7.2 Hz, CH3). δc 180.80 (C=O), 144.01 (qC), 140.85 (qC), 136.48 (qC), 135.50 
(CH), 134.93 (CH), 129.72 (CH), 127.31 (CH), 122.47 (CH), 122.38 (qC), 118.21 (CH), 99.08 
(qC), 79.55 (qC), 21.56 (CH3), 21.26 (CH2), 21.24 (CH2), 13.64 (CH3). 
νmax/cm-1: 3272 w (NH), 2980 w (CH2, CH3), 2214 m (C≡C), 1604 s (C=C), 1175 s (SO2). 
N-{2-[3-(4-Methoxyphenyl)propioloyl]phenyl}-4-methylbenzenesulfonamide (2.17C) 
 
From 1-ethynyl-4-methoxybenzene (39.5 mmol) and N-methoxy-N-methyl-2-[(4-
methylphenyl)sulfonamide]benzamide (17.9 mmol) to give an orange oil which on 
trituration with ether gave the title compound as a bright yellow solid (4.83 g, 66%) m.p. 
163 – 165 °C (lit m.p. 134 – 136 °C [16AGE7737]). 
δH (CDCl3) 11.31 (1H, s, NH), 8.26 (1H, dd, J = 8.0, 1.5 Hz, 2-H), 7.77 (2H, d, J = 8.1 Hz, o-Ar-H), 
7.71 (1H, app. d, 5-H), 7.64 – 7.60 (2H, m, o-Ar-H), 7.52 – 7.47 (1H, m, 4-H), 7.23 (2H, d, J = 
8.1 Hz, m-Ar-H), 7.15 – 7.11 (1H, m, 3-H), 6.96 – 6.92 (2H, m, m-Ar-H), 3.87 (3H, s, O-Me), 
2.35 (3H, s, Ar-Me). δc 180.52 (C=O), 162.10 (qC), 144.03 (qC), 140.82 (qC), 136.46 (qC), 135.47 
(CH), 135.27 (qC), 135.28 (CH), 134.64 (CH), 129.74 (CH), 127.31 (CH), 122.62 (qC), 122.60 
(CH), 118.47 (CH), 114.55 (CH), 111.33 (qC), 96.70 (qC), 86.78 (qC), 55.52 (CH3), 21.56 (CH3). 




6.2.4 Synthesis of Unsymmetrical N-[2-(3-Hydroxy-penta-1,4-diyn-3-
yl)phenyl]benzenesulfonamides 
General Method for the Synthesis of Unsymmetrical N-[2-(3-Hydroxy-penta-1,4-diyn-3-
yl)phenyl]benzenesulfonamides 
Method A: Under an inert (N2) atmosphere n-BuLi (2.1 equiv.) was added to a cold (-75 °C) 
solution of the appropriate alkyne (X mmol, 2.1 equiv.) in anhydrous THF (50 – 100 mL). The 
solution was warmed to 0 °C and 1-[2-(4-toluenesulfonamido)phenyl]-3-phenylprop-2-yn-1-
one derivative (Y mmol, 1 equiv.) in anhydrous THF (30 – 60 mL) was added dropwise to the 
solution. When the addition was complete the mixture was allowed to warm to r.t., then 
stirred for 1 h. After this time the mixture was quenched with aqueous NH4Cl and diluted 
with EtOAc. The organic phase was separated, dried (Na2SO4) and evaporated to give crude 
material which was purified by recrystallisation or washing with cold hexane. The following 
were synthesised by this method. 
Method B: Under an inert (N2) atmosphere ethynylmagnesium bromide (2.1 equiv., 0.5M in 
THF) was added to a warm (40 °C) solution of 1-[2-(4-toluenesulfonamido)phenyl]-3-
phenylprop-2-yn-1-one derivative (X mmol, 1 equiv.) in anhydrous THF (30 mL). The solution 
was refluxed until the reaction was complete by TLC. After this time the mixture was 
allowed to cool and was quenched with aqueous NH4Cl and diluted with EtOAc. The organic 
phase was separated, dried (Na2SO4) and evaporated to give crude material which was 
purified by flash column chromatography (10% EtOAc – pet ether, unless otherwise stated). 
The following were synthesised by this method. 
Method C: Under an inert (N2) atmosphere 1-bromo-1-propene (X mmol, 2.5 equiv.) was 
added to a cold (-75 °C) solution of LDA 2.5 equiv. (DIPA, 1.1 equiv. and n-BuLi, 2.5 equiv.) in 
anhydrous THF (approx. 50 mL) and was stirred for 3 h. The solution was warmed to 0 °C 
and 1-[2-(4-toluenesulfonamido)phenyl]-3-phenylprop-2-yn-1-one derivative (Y mmol, 1 
equiv.) in anhydrous THF (30 mL) was added dropwise to the solution. When the addition 
was complete the mixture was allowed to warm to r.t. and then stirred for 1 h. After this 
time the mixture was quenched with aqueous NH4Cl and diluted with EtOAc. The organic 
phase was separated, dried (Na2SO4) and evaporated to give crude material which was 
261 
 





Using Method A from 1-pentyne (8.40 mmol) and 1-[2-(4-toluenesulfonamido)phenyl]-3-
phenylprop-2-yn-1-one (4.00 mmol) to give the title compound as an orange solid (1.52 g, 
86%) m.p. 127 – 129 °C; HRMS found [M+Na]+ = 466.1452; C27H25NO3SNa [M+Na]+ requires = 
466.1447. 
δH (CDCl3) 8.59 (1H, s, NH), 7.84 (1H, dd, J = 7.9, 1.5 Hz, 2-H), 7.79 (2H, d, J = 8.2 Hz, o-Ar-H), 
7.55 (1H, dd, J = 7.9, 1.5 Hz, 5-H), 7.50 – 7.47 (2H, m, Ph-H), 7.37 – 7.31 (3H, m, Ph-H), 7.26 – 
7.22* (1H, m, 4-H), 7.10 (1H, d, J = 7.9 Hz, m-Ar-H), 7.03 (1H, td, J = 7.9, 1.5 Hz, 3-H), 3.13 
(1H, s, OH), 2.32 – 2.28 (5H, m, Ar-Me, CH2), 1.62 (2H, sxt, J = 7.3 Hz, CH2), 1.03 (3H, t, J = 7.3 
Hz, CH3). δc 143.61 (qC), 137.00 (qC), 135.84 (qC), 131.96 (CH), 129.83 (CH), 129.52 (CH), 
129.11 (CH), 128.53 (qC), 128.35 (CH), 127.78 (CH), 127.50 (CH), 123.14 (CH), 121.59 (qC), 
119.17 (CH), 88.74 (qC), 87.64 (qC), 85.91 (qC), 78.91 (qC), 65.80 (qC), 21.70 (CH2), 21.53 (CH3), 
20.88 (CH2), 13.63 (CH3).  
νmax/cm-1: 3348 b (OH), 3254 m (NH), 2968 w (Ar-H), 2931 w (CH2, CH3), 2871 w (CH2, CH3), 
2359 w (C≡C), 1597 s (C=C), 1490 s (CH2), 1324 s (SO2), 1150 s (SO2), 1087 s (R-OH). 








Using Method A from 1-ethynyl-4-methoxybenzene (8.40 mmol) and 1-[2-(4-
toluenesulfonamido)phenyl]-3-phenylprop-2-yn-1-one (4.00 mmol) to give the title 
compound as an off white powder (1.75 g, 86%) m.p. 139 – 140 °C decomp; HRMS found 
[M+Na]+ = 530.1395; C31H25NO4SNa [M+Na]+ requires = 530.1397. 
δH (CDCl3) 8.65 (1H, s, NH), 7.90 (1H, dd, J = 7.8, 1.4 Hz, 2-H), 7.79 (2H, d, J = 8.3 Hz, o-Ar-H), 
7.58 (1H, app. d, 5-H), 7.54 – 7.51 (2H, m, Ph-H), 7.49 – 7.45 (2H, m, o-Ar-H), 7.41 – 7.34 (3H, 
m, Ph-H), 7.29 – 7.25* (1H, m, 4-H), 7.08 – 7.04 (3H, m, m-Ar-H, 3-H), 6.89 – 6.86 (2H, m, m-
Ar-H), 3.83 (3H, s, O-Me), 3.20 (1H, s, OH), 2.29 (3H, s, Ar-Me). δc 160.33 (qC), 143.60 (qC), 
136.91 (qC), 135.91 (qC), 133.58 (CH), 132.00 (CH), 129.97 (CH), 129.52 (CH), 129.22 (CH), 
128.40 (CH), 128.22 (qC), 127.86 (CH), 127.53 (CH), 123.20 (CH), 121.50 (qC), 119.17 (CH), 
114.03 (CH), 113.40 (qC), 87.19 (qC), 86.65 (qC), 85.74 (qC), 78.91 (qC), 66.23 (qC), 55.37 (CH3), 
21.53 (CH3). 
νmax/cm-1: 3402 b (OH), 3274 s (NH), 2224 s (C≡C), 1604 s (C=C), 1324 s (SO2), 1153 s (SO2), 
1089 s (R-OH). 










Using Method A from methyl propargylic ether (2.79 mmol) and 1-[2-(4-
toluenesulfonamido)phenyl]-3-phenylprop-2-yn-1-one (1.33 mmol) to give the title 
compound as a golden powder (0.45 g, 73%) m.p. 141 °C decomp; HRMS found [M+Na]+ = 
468.1238; C26H23NO4SNa [M+Na]+ requires = 468.1240. 
δH [(CD3)2CO] 9.19 (1H, s, NH), 7.87 – 7.83 (3H, m, 2-H, o-Ar-H), 7.56 (1H, app. d, 5-H), 7.50 – 
7.48 (2H, m, Ph-H), 7.45 – 7.42 (3H, m, Ph-H), 7.31 – 7.24 (3H, m, 4-H, m-Ar-H), 7.06 (1H, 
app. t, 3-H), 4.21 (2H, ABq, J = 16.1 Hz, CHaHb), 3.35 (3H, s, O-Me), 2.22 (3H, s, Ar-Me). δc 
143.86 (qC), 137.36 (qC), 136.43 (qC), 131.64 (CH), 129.60 (CH), 129.56 (CH), 129.23 (CH), 
128.64 (CH), 128.47 (qC), 127.66 (CH), 127.43 (CH), 122.77 (CH), 121.72 (qC), 118.05 (CH), 
88.04 (qC), 85.19 (qC), 84.85 (qC), 82.54 (qC), 65.39 (qC), 59.20 (CH2), 56.89 (CH3), 20.49 (CH3). 
νmax/cm-1: 3255 b (OH), 2361 m (C≡C), 2342 m (C≡C), 1597 s (C=C), 1490 s (CH2), 1335 s (SO2), 






Using Method C from 1-bromo-1-propene (12.3 mmol) and 1-[2-(4-
toluenesulfonamido)phenyl]-3-phenylprop-2-yn-1-one (5.86 mmol) to give an orange oil 
which on trituration with hexane – EtOAc gave the title compound as an a pale pink solid 
(0.31 g, 28%) m.p. 127 °C decomp; HRMS found [M+Na]+ = 438.1128; C25H21NO3SNa [M+Na]+ 
requires = 438.1134. 
δH [(CD3)2CO] 9.24 (1H, s, NH), 7.85 – 7.81 (3H, m, 2-H, o-Ar-H), 7.77 (1H, dd, J = 8.2, 1.1 Hz, 
5-H), 7.49 – 7.46 (2H, m, Ph-H), 7.44 – 7.40 (3H, m, Ph-H), 7.29 – 7.23 (3H, m, m-Ar-H, 4-H), 
7.03 (1H, td, J = 8.2, 1.1 Hz, 3-H), 2.32 (3H, s, Ar-Me), 1.92 (3H, s, Me). δc 143.82 (qC), 137.45 
(qC), 136.35 (qC), 131.60 (CH), 129.57 (CH), 129.33 (CH), 129.09 (CH), 128.62 (CH), 127.69 
(CH), 127.42 (CH), 122.69 (CH), 121.91 (qC), 117.90 (CH), 88.67 (qC), 84.55 (qC), 82.83 (qC), 
78.42 (qC), 65.40 (qC), 20.49 (CH3), 2.64 (CH3). 
νmax/cm-1: 3392 b (OH), 3255 m (NH), 2980 w (CH3), 2336 w (C≡C), 1597 s (C=C), 1489 s (CH3), 




Using Method A from 3,3-dimethyl-1-butyne (2.79 mmol) and 1-[2-(4-
toluenesulfonamido)phenyl]-3-phenylprop-2-yn-1-one (1.33 mmol) to give the title 
compound as a yellow oil (0.54 g, 88%); HRMS found [M+K]+ = 496.1339; C28H27NO3SK 
[M+K]+ requires = 496.1343. 
δH (CDCl3) 8.60 (1H, s, NH), 7.84 – 7.79 (3H, m, 2-H, o-Ar-H), 7.53 – 7.47 (3H, m, 5-H, Ph-H), 
7.39 – 7.31 (3H, m, Ph-H), 7.26 – 7.22* (1H, m, 4-H), 7.10 (2H, d, J = 7.9 Hz, m-Ar-H), 7.01 
(1H, td, J = 7.8, 1.2 Hz, 3-H), 3.09 (1H, s, OH), 2.31 (3H, s, Ar-Me), 1.32 (9H, s, Me3). δc 143.60 
(qC), 137.05 (qC), 135.85 (qC), 131.95 (CH), 129.80 (CH), 129.55 (CH), 129.06 (CH), 128.62 
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(qC), 128.35 (CH), 127.72 (CH), 127.49 (CH), 123.11 (CH), 121.70 (qC), 119.15 (CH), 96.65 (qC), 
87.75 (qC), 85.71 (qC), 65.60 (qC), 30.54 (CH3), 27.71 (qC), 21.53 (CH3). 
νmax/cm-1: 3392 b (OH), 3269 m (NH), 2968 w (CH3), 2235 w (C≡C), 2205 w (C≡C), 1598 s 
(C=C), 1492 s (CH3), 1332 s (SO2), 1153 s (SO2), 1092 s (R-OH). 




Using Method A from 2-methyl-1-buten-3-yne (12.3 mmol) and 1-[2-(4-
toluenesulfonamido)phenyl]-3-phenylprop-2-yn-1-one (5.85 mmol) to give the title 
compound as a straw solid (0.90 g, 76%) m.p. 120 – 123 °C; HRMS found [M+K]+ = 480.1038; 
C27H23NO3SK [M+K]+ requires = 480.1030. 
δH [(CD3)2CO] 7.85 – 7.83 (3H, m, o-Ar-H, 2-H), 7.54 (1H, app. d, 5-H), 7.51 – 7.48 (2H, m, Ph-
H), 7.45 – 7.40 (3H, m, Ph-H), 7.27 (1H, app. t, 4-H), 7.22 (2H, d, J = 8.1 Hz, m-Ar-H), 7.04 (1H, 
app. t, 3-H), 5.41 – 5.39 (2H, m, CH2), 2.87 (1H, s, OH) 3.31 (3H, s, Ar-Me), 1.92 (3H, s, CH3). 
δc 143.76 (qC), 137.52 (qC), 136.66 (qC), 131.65 (CH), 129.59 (CH), 129.49 (CH), 129.19 (CH), 
128.63 (CH), 127.60 (CH), 127.38 (CH), 125.92 (qC), 123.18 (CH2), 122.68 (CH), 121.80 (qC), 
118.04 (CH), 88.17 (qC), 87.09 (qC), 86.65 (qC), 85.14 (qC), 65.67 (qC), 22.48 (qC), 22.27 (CH3), 
20.51 (CH3). 
νmax/cm-1: 3655 m (OH), 3388 m (NH), 3256 w (Ar-H), 2980 s (C=C-H), 2889 s (CH3), 2202 w 
(C≡C), 1594 s (C=C), 1491 s (CH3), 1327 s (SO2), 1153 s (SO2), 1090 s (R-OH), 997 s (C=CH2), 







Using Method B ethynylmagnesium bromide (5.61 mmol) and N-[2-(hex-2-ynoyl)phenyl]-4-
methylbenzenesulfonamide (2.67 mmol) to give the title compound as an orange oil (0.69 g, 
65%); HRMS found [M+Na]+ = 424.0990; C24H19NO3SNa [M+Na]+ requires = 424.0978. 
δH (CDCl3) 8.78 (1H, s, NH), 7.85 (1H, dd, J = 1.4, 7.9 Hz, 2-H), 7.80 (2H, d, J = 8.0 Hz, o-Ar-H), 
7.61 (1H, dd, J = 1.4, 7.9 Hz, 5-H), 7.48 – 7.45 (2H, m, Ph-H), 7.35 – 7.26* (4H, m, Ph-H, 4-H), 
7.09 – 7.02 (3H, m, m-Ar-H, 3-H), 4.48 (1H, s, OH), 2.78 (1H, s, CH), 2.27 (3H, s, Ar-Me). δc 
143.80 (qC), 136.85 (qC), 135.87 (qC), 131.99 (CH), 130.05 (CH), 129.57 (CH), 129.26 (CH), 
128.39 (CH), 128.02 (qC), 127.89 (CH), 127.53 (CH), 123.40 (CH), 121.36 (qC), 119.42 (CH), 
86.87 (qC), 86.65 (qC), 82.03 (qC), 75.25 (CH), 65.55 (qC), 21.52 (CH3).  
νmax/cm-1: 3279 b (OH), 2227 w (C≡C), 1598 s (C=C), 1490 s (CH3), 1328 s (SO2), 1153 s (SO2), 
1089 s (R-OH), 753 s (Ph-H), 689 s (Ph-H). 
*Overlapping with CDCl3 signal 
N-[2-(3-Hydroxyocta-1,4-diyn-3-yl)phenyl]-4-methylbenzenesulfonamide (2.19Bi) 
 
Using Method B ethynylmagnesium bromide (6.15 mmol) and N-[2-(hex-2-ynoyl)phenyl]-4-
methylbenzenesulfonamide (2.93 mmol) to give a brown oil. The crude material was 
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purified by flash column chromatography to give the title compound as yellow oil (0.57 g, 
64%); HRMS found [M+Na]+ = 390.1133; C24H19NO3SNa [M+Na]+ requires = 390.1134. 
δH (CDCl3) 8.64 (1H, s, NH), 7.80 – 7.76 (3H, m, o-Ar-H, 2-H), 7.56 (1H, dd, J = 7.7, 1.1 Hz, 5-
H), 7.25 – 7.18 (3H, m, 4-H, m-Ar-H), 7.00 (1H, td, J = 7.7, 1.1 Hz, 3-H), 3.92 (1H, s, OH), 2.66 
(1H, s, CH), 2.32 (3H, s, Ar-Me), 2.23 (2H, t, J = 7.2 Hz, CH2), 1.56 (2H, sxt, J = 7.2 Hz, CH2), 
0.97 (3H, t, J = 7.2 Hz, CH3). δc 143.78 (qC), 137.00 (qC), 135.75 (qC), 129.86 (CH), 129.57 (CH), 
128.45 (qC), 127.78 (CH), 127.51 (CH), 123.32 (CH), 119.43 (CH), 88.68 (qC), 82.56 (qC), 78.60 
(qC), 74.29 (CH), 65.11 (qC), 21.64 (CH2), 21.53 (CH3), 20.77 (CH2), 13.60 (CH3). 
νmax/cm-1: 3278 b (OH), 2970 s (CH2, CH3), 2236 s (C≡C), 1599 s (C=C), 1493 s (CH2), 1331 s 




Using Method A from 1-pentyne (5.19 mmol) and 1-[2-(4-toluenesulfonamido)phenyl]-3-
phenylprop-2-yn-1-one (2.47 mmol) to give the title compound as an white solid (0.87 g, 
74%) m.p. 122 – 123 °C; HRMS found [M+K]+ = 512.1310; C28H27NO4SK [M+K]+ requires = 
512.1292. 
δH (CDCl3) 8.57 (1H, s, NH), 7.85 – 7.89 (3H, m, 2-H, Ar-H), 7.53 (1H, dd, J = 8.2, 1.0 Hz, 5-H), 
7.45 – 7.41 (2H, m, Ar-H), 7.24* (1H, td, J = 8.2, 1.0 Hz, 4-H), 7.13 (2H, d, J = 8.1 Hz, Ar-H), 
7.03 (1H, td, J = 8.2, 1.0 Hz, 3-H), 6.88 – 6.84 (2H, m, Ar-H), 3.83 (3H, s, O-Me), 2.98 (1H, s, 
OH), 2.33 – 2.29 (5H, m, Ar-Me, CH2), 1.62 (2H, sxt, J = 7.3 Hz, CH2), 1.03 (3H, t, J = 7.3 Hz, 
CH3). δc 160.21 (qC), 143.59 (qC), 137.04 (qC), 135.81 (qC), 133.52 (CH), 129.76 (CH), 129.53 
(CH), 128.68 (qC), 127.75 (CH), 127.52 (CH), 123.12 (CH), 119.15 (CH), 113.98 (CH), 113.57 
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(qC), 88.56 (qC), 86.36 (qC), 86.15 (qC), 79.04 (qC), 65.81 (qC), 55.35 (CH3), 21.71 (CH2), 21.55 
(CH3), 20.88 (CH2), 13.63 (CH3).  
νmax/cm-1: 3386 b (OH), 3230 m (NH), 2960 w (Ar-H), 2935 w (CH2, CH3), 2872 w (CH2, CH3), 
2229 w (C≡C), 1605 s (C=C), 1440 s (CH2), 1325 s (SO2), 1153 s (SO2), 1089 s (R-OH). 




Using Method A from methyl propargylic ether (2.79 mmol) and 1-[2-(4-
toluenesulfonamido)phenyl]-3-phenylprop-2-yn-1-one (1.33 mmol) to give the title 
compound as a golden powder (0.45 g, 73%) m.p. 141 °C decomp; HRMS found [M+Na]+ = 
468.1238; C26H23NO4SNa [M+Na]+ requires = 468.1240. 
δH [(CD3)2CO] 9.19 (1H, s, NH), 7.87 – 7.83 (3H, m, 2-H, o-Ar-H), 7.56 (1H, app. d, 5-H), 7.50 – 
7.48 (2H, m, Ph-H), 7.45 – 7.42 (3H, m, Ph-H), 7.31 – 7.24 (3H, m, 4-H, m-Ar-H), 7.06 (1H, 
app. t, 3-H), 4.23 (2H, ABq, J = 15.8 Hz, CHaHb), 3.35 (3H, s, O-Me), 2.22 (3H, s, O-Me). δc 
143.86 (qC), 137.36 (qC), 136.43 (qC), 131.64 (CH), 129.60 (CH), 129.56 (CH), 129.23 (CH), 
128.64 (CH), 128.47 (qC), 127.66 (CH), 127.43 (CH), 122.77 (CH), 121.72 (qC), 118.05 (CH), 
88.04 (qC), 85.19 (qC), 84.85 (qC), 82.54 (qC), 65.39 (qC), 59.20 (CH2), 56.89 (CH3), 20.49 (CH3). 
νmax/cm-1: 3255 b (OH), 2980 m (CH2, CH3), 2233 m (C≡C), 1606 s (C=C), 1340 s (SO2), 1184 s 








Using Method B ethynylmagnesium bromide (5.19 mmol) and N-{2-[3-(4-
methoxyphenyl)propioloyl]phenyl}-4-methylbenzenesulfonamide (2.47 mmol) to give a 
brown oil. The crude material was purified by flash column chromatography (15% acetone – 
pet ether) and recrystallisation from hexane – EtOAc to give the title compound as white 
needles (0.68 g, 64%) m.p. 108 – 110 °C; HRMS found [M+Na]+ = 454.1083; C25H21NO4SNa 
[M+Na]+ requires = 454.1083. 
δH (CDCl3) 8.58 (1H, s, NH), 7.83 (1H, dd, J = 7.9, 1.5 Hz, 2-H), 7.79 (2H, d, J = 8.3 Hz, o-Ar-H), 
7.60 (1H, dd, J = 7.9, 1.5 Hz, 5-H), 7.42 (2H, d, J = 8.3 Hz, o-Ar-H), 7.30 – 7.24* (1H, m, 4-H), 
7.14 (2H, d, J = 8.3 Hz, m-Ar-H), 7.04 (1H, td, J = 7.9, 1.5 Hz, 3-H), 6.85 (2H, d, J = 8.3 Hz, m-
Ar-H), 3.81 (3H, s, Ar-Me), 3.53 (1H, s, OH), 2.76 (1H, s, CH), 2.32 (3H, s, O-Me). δc 160.35 
(qC), 143.71 (qC), 136.99 (qC), 135.83 (qC), 133.57 (CH), 130.08 (CH), 129.54 (CH), 127.95 (qC), 
127.82 (CH), 127.53 (CH), 123.37 (CH), 119.56 (CH), 114.04 (CH), 113.19 (qC), 87.14 (qC), 
85.38 (qC), 82.05 (qC), 75.08 (CH), 65.62 (qC), 55.37 (CH3), 21.54 (CH3).  
νmax/cm-1: 3295 b (OH), 3287 s (C≡C-H), 2226 s (C≡C), 1604 s (C=C), 1322 s (SO2), 1153 s 
(SO2), 1087 (R-OH). 
*Overlapping with CDCl3 signal 
6.2.5 Synthesis of N-Substituted Saccharins  




Sodium saccharin (4.00 g, 19.5 mmol, 1.0 equiv.) was dissolved in DMF (100 mL). 
Iodomethane (4.50 mL, 68.3 mmol, 3.5 equiv.) was added dropwise and the solution was 
stirred at 100 °C overnight. After this time the mixture was quenched with water and 
filtered [17CC901] to give the title compound as a white solid (2.73 g, 63%) m.p. 134 – 135 
°C (literature m.p. 130 – 131 °C [51JOC1582]). 
δH (CDCl3) 8.09 – 8.07 (1H, m, 4-H), 7.96 – 7.94 (1H, m, 7-H), 7.90 – 7.82 (2H, m, 5-H, 6-H), 
3.28 (3H, s, Me). δc 158.74 (C=O), 137.63 (qC), 134.69 (CH), 134.36 (CH), 127.62 (qC), 125.16 
(CH), 121.02 (CH), 23.27 (CH3). 
νmax/cm-1: 3095 w (Ar-H), 2980 w (CH3), 1735 s (C=O), 1594 s (C=C), 1468 s (CH3), 1311 s 
(SO2), 1055 s (SO2). 
General Method for the Synthesis of N-Aryl Substituted Saccharins  
Saccharin (X mmol, 1.0 equiv.) and an appropriate boronic acid (Y mmol, 2.0 equiv.) was 
suspended in DCM (10 – 15 mL/g). To this pyridine (Y mmol, 2.0 equiv.) and then Cu(OAc)2 
(Y mmol, 2.0 equiv.) were added, the reaction mixture was stirred at r.t. for 48 h. After this 
time the mixture was quenched with water and diluted with DCM (approx. 100 mL). The 
mixture was acidified with HCl and filtered. The organic phase was separated, dried (Na2SO4) 
and evaporated to give the title compound. The following were synthesised by this method 
[98TL2933]. 
2-(p-Tolyl)benzo[d]isothiazol-3(2H)-one 1,1-dioxide (2.25B) 
 
From p-tolylboronic acid (0.22 mol) to give the title compound as a white solid (28.4 g, 95%) 
m.p. 200 °C (literature m.p. 210 – 212 °C [15CEJ5332]). 
δH (CDCl3) 8.16 (1H, app. d, 4-H), 8.00 (1H, app. d, 7-H), 7.90 – 7.82 (2H, m, 5-H, 6-H), 7.41 
(2H, d, J = 8.3 Hz, o-Ar-H), 7.36 (2H, d, J = 8.3 Hz, m-Ar-H), 3.28 (3H, s, Ar-Me). δc 158.52 
(C=O), 140.53 (qC), 137.67 (qC), 135.01 (CH), 134.41 (CH), 130.63 (CH), 128.64 (CH), 127.31 
(qC), 125.78 (qC), 125.62 (CH), 121.26 (CH), 21.36 (CH3). 
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νmax/cm-1: 1730 s (C=O), 1613 w (C=C), 1402 s (CH3), 1310 s (SO2), 1159 s (SO2). 
2-(m-Tolyl)benzo[d]isothiazol-3(2H)-one 1,1-dioxide (2.25C) 
 
From m-tolylboronic acid (65.5 mmol) to give the title compound as a beige solid which was 
recrystallised from EtOH – EtOAc to give a white powder (4.35 g, 59%) m.p. 149 – 150 °C 
(literature m.p. not quoted [14CEJ14321]). 
δH (CDCl3) 8.16 (1H, app. d, 4-H), 8.00 (1H, app. d, 7-H), 7.95 – 7.86 (2H, m, 5-H, 6-H), 7.46 – 
7.42 (1H, m, Ar-H), 7.34 – 7.33 (3H, m, Ar-H), 2.43 (3H, s, Ar-Me). δc 158.46 (C=O), 140.14 
(qC), 137.66 (qC), 135.05 (CH), 134.44 (CH), 131.04 (CH), 129.71 (CH), 129.29 (CH), 128.47 
(qC), 127.26 (qC), 125.79 (CH), 125.63 (CH), 121.26 (CH), 21.35 (CH3).  
νmax/cm-1: 1721 s (C=O), 1602 s (C=C), 1455 w (CH3), 1333 s (SO2), 1179 s (SO2). 
2-(2-Methoxyphenyl)benzo[d]isothiazol-3(2H)-one 1,1-dioxide (2.25D) 
 
From 2-methoxyphenylboronic acid (0.11 mol) to give the title compound as a beige solid 
(7.56 g, 48%) m.p. 184 – 185 °C (literature m.p. not quoted [17SYN2000]). 
δH (CDCl3) 8.17 – 8.14 (1H, m, 4-H), 8.04 – 7.99 (1H, m, 7-H), 7.94 – 7.87 (2H, m, 5-H, Ar-H), 
7.55 – 7.48 (2H, m, 6-H, Ar-H), 7.13 – 7.08 (2H, m, Ar-H), 3.84 (3H, s, O-Me). δc 158.52 (C=O), 
140.53 (qC), 137.67 (qC), 135.01 (CH), 134.41 (CH), 130.63 (CH), 128.64 (CH), 127.31 (qC), 
125.78 (qC), 125.62 (CH), 121.26 (CH), 21.36 (CH3). 
νmax/cm-1: 3094 w (Ar-H), 2945 w (CH3), 1734 s (C=O), 1593 m (C=C), 1499 s (CH3), 1323 s 





2-(3-Methoxyphenyl)benzo[d]isothiazol-3(2H)-one 1,1-dioxide (2.25E) 
 
From 3-methoxyphenylboronic acid (32.8 mmol) to give the title compound as a golden 
powder (3.90 g, 82%) m.p. 170 – 172 °C (literature m.p. 207 – 209 °C [15CEJ5332]). 
δH (CDCl3) 8.16 (1H, app. d, 4-H), 8.00 (1H, app. d, 7-H), 7.95 – 7.87 (2H, m, 5-H, 6-H), 7.47 – 
7.43 (1H, m, Ar-H) 7.13 (1H, app. d, Ar-H), 7.07 – 7.06 (2H, m, Ar-H), 3.35 (3H, s, O-Me). δc 
160.61 (C=O), 158.34 (qC), 137.32 (qC), 135.10 (CH), 134.47 (CH), 130.55 (CH), 129.61 (qC), 
127.18 (qC), 125.67 (CH), 121.25 (CH), 120.74 (CH), 116.31 (CH), 113.96 (CH), 55.34 (CH3). 
νmax/cm-1: 1721 s (C=O), 1602 m (C=C), 1509 s (CH3), 1333 s (SO2), 1179 s (SO2). 
2-(Thiophen-3-yl)benzo[d]isothiazol-3(2H)-one 1,1-dioxide (2.25G) 
 
From 3-thienylboronic acid (10.9 mmol) to give the title compound as a red solid (0.94 g, 
65%) m.p. 170 – 172 °C (literature m.p. 173 – 175 °C [15CEJ5332]). 
δH (CDCl3) 8.16 (1H, app. d, 4-H), 8.01 (1H, app. d, 7-H), 7.96 – 7.86 (2H, m, 5-H, 6-H), 7.72 
(1H, m, Ar-H), 7.50 (1H, dd, J = 3.2, 5.2 Hz, Ar-H), 7.35 (1H, dd, J = 1.2, 5.2 Hz, Ar-H). δc 
157.80 (C=O), 137.32 (qC), 135.15 (qC), 134.61 (CH), 127.06 (qC),  126.44 (CH), 125.62 (CH), 
124.73 (CH), 122.27 (CH), 121.31 (CH). 
νmax/cm-1: 3093 w (Ar-H), 1716 s (C=O), 1593 m (C=C), 1332 s (SO2), 1175 s (SO2). 




From 2-naphthelene boronic acid (65.5 mmol) to give the title compound as a beige solid 
which was recrystallised from EtOH – EtOAc to give a beige powder (8.77 g, 87%) m.p. 184 – 
185 °C (literature m.p. 219 – 221 °C [15CEJ5332]). 
δH (CDCl3) 8.18 (1H, app. d, 4-H), 8.09 (1H, app. s, Ar-H), 8.01 (2H, d, J = 8.3 Hz, Ar-H), 7.95 – 
7.86 (4H, m, Ar-H), 7.61 – 7.54 (3H, m, Ar-H). δc 158.60 (C=O), 137.71 (qC), 135.15 (CH), 
134.52 (CH), 133.62 (qC), 133.49 (qC), 130.05 (CH), 128.43 (CH), 128.23 (CH), 127.89 (CH), 
127.55 (CH), 127.26 (qC), 126.98 (CH), 126.09 (qC), 125.68 (CH), 125.40 (CH), 121.31 (CH). 
νmax/cm-1: 1739 s (C=O), 1504 w (C=C), 1329 s (SO2), 1182 s (SO2). 
6.2.6 Synthesis of 3-[2-(Aminosulfamoyl)phenyl]penta-1,4-diyn-3-ols 
General Method for the Synthesis of 3-[2-(Aminosulfamoyl)phenyl]penta-1,4-diyn-3-ols 
Under an inert (N2) atmosphere n-BuLi (2.5 M, 2.5 equiv.) was added to a cold (-75 °C) 
solution of the appropriate alkyne (X mmol, 2.5 equiv.) in anhydrous THF (approx. 100 mL). 
A solution of the appropriate N-substituted saccharin (Y mmol, 1.0 equiv.) in anhydrous THF 
(approx. 60 mL) was added dropwise to the cold (0 °C) solution and the mixture was allowed 
to warm to r.t. and stirred for 1 h. After this time the mixture was quenched with aqueous 
NH4Cl and diluted with EtOAc. The organic phase was separated, dried (Na2SO4) and 
evaporated to give the crude material which was purified by recrystallisation or by washing 
with cold hexane. The following compounds were synthesised by this method. 
2-(3-Hydroxy-1,5-diphenylpenta-1,4-diyn-3-yl)-N-methylbenzenesulfonamide (2.23Aa) 
 
From phenylacetylene (12.9 mmol) and 2-methylbenzo[d]isothiazol-3(2H)-one 1,1-dioxide 
(5.07 mmol) to give the title compound as an off white solid (1.99 g, 98%) m.p. 145 – 146 °C; 
HRMS found [M+Na]+ = 424.0981; C24H19NO3SNa [M+Na]+ requires = 424.0978. 
274 
 
δH (CDCl3) 8.44 (1H, dd, J = 7.9, 1.1 Hz, 2-H), 8.16 (1H, dd, J = 7.9, 1.1 Hz, 5-H), 7.67 (1H, td, J 
= 7.9, 1.1 Hz, 3-H), 7.58 – 7.52 (5H, m, 4-H, Ph-H), 7.40 – 7.32 (6H, m, Ph-H), 5.95 (1H, s, OH), 
5.63 (1H, app. s, NH), 2.62 (3H, d, J = 5.3 Hz, Me). δc 139.82 (qC), 135.50 (qC), 133.28 (CH), 
132.29 (CH), 131.89 (CH), 130.65 (CH), 129.33 (CH), 129.12 (CH), 128.51 (CH), 121.39 (qC), 
88.54 (qC), 86.61 (qC), 67.02 (qC), 29.74 (CH3).  
νmax/cm-1: 3413 b (OH), 3320 m (NH), 2233 w (C≡C), 1489 m (C=C), 1372 w (CH3), 1325 s 
(SO2), 1164 s (R-OH), 1045 s (SO2), 751 s (Ph-H), 688 s (Ph-H). 
2-(6-Hydroxyundeca-4,7-diyn-6-yl)-N-methylbenzenesulfonamide (2.23Ab) 
 
From 1-pentyne (12.7 mmol) and 2-methylbenzo[d]isothiazol-3(2H)-one 1,1-dioxide (5.07 
mmol) to give the title compound as an orange oil (1.64 g, 97%); HRMS found [M+Na]+ = 
356.1304; C18H23NO3SNa [M+Na]+ requires = 356.1291. 
δH (CDCl3) 8.28 (1H, dd, J = 7.9, 1.1 Hz, 2-H), 8.10 (1H, dd, J = 7.9, 1.1 Hz, 5-H), 7.60 (1H, td, J 
= 7.9, 1.1 Hz, 3-H), 7.49 (1H, td, J = 7.9, 1.1 Hz, 4-H), 5.68 (1H, q, J = 5.2 Hz, NH), 5.51 (1H, s, 
OH), 2.62 (3H, d, J = 5.2 Hz, Me), 2.29 (4H, t, J = 7.1 Hz, CH2), 1.59 (4H, sxt, J = 7.1 Hz, CH2), 
1.00 (6H, t, J = 7.1 Hz, CH3). δc 140.70 (qC), 135.00 (qC), 132.98 (CH), 131.92 (CH), 130.71 
(CH), 128.59 (CH), 87.23 (qC), 81.04 (qC), 66.29 (qC), 29.69 (CH3), 21.70 (CH2), 20.85 (CH2), 
13.55 (CH3).  
νmax/cm-1: 3413 b (OH), 3315 b (NH), 2965 m (Ar-H), 2934 w (CH2, CH3), 2873 w (CH2, CH3), 










From (trimethylsilyl)acetylene (11.2 mmol) and 2-methylbenzo[d]isothiazol-3(2H)-one 1,1-
dioxide (5.07 mmol) to give the title compound as a brown solid (1.36 g, 68%) m.p. 71 – 73 
°C; HRMS found [M+Na]+ = 416.1140; C18H27NO3SSi2Na [M+Na]+ requires = 416.1142. 
δH (CDCl3) 8.18 (1H, dd, J = 7.9, 1.2 Hz, 2-H), 7.91 (1H, dd, J = 7.9, 1.2 Hz, 5-H), 7.45 (1H, td, J 
= 7.9, 1.2 Hz, 3-H), 7.35 (1H, td, J = 7.9, 1.2 Hz, 4-H), 5.79 (1H, s, OH), 5.70 (1H, q, J = 5.2 Hz, 
NH), 2.42 (3H, d, J = 5.2 Hz, Me), 0.19 (18H, s, Si-Me3). δc 138.55 (qC), 135.19 (qC), 133.25 
(CH), 132.26 (CH), 130.73 (CH), 129.07 (CH), 92.14 (qC), 87.10 (qC), 66.30 (qC), 29.43 (CH3), -
0.29 (Si-Me3). 
νmax/cm-1: 3342 b (NH), 2960 m (CH3), 2167 w (C≡C), 1315 m (SO2), 1160 s (R-OH). 
2-(3-Hydroxy-1,5-diphenylpenta-1,4-diyn-3-yl)-N-(p-tolyl)benzenesulfonamide (2.23Ba) 
 
From phenylacetylene (9.15 mmol) and 2-(p-tolyl)benzo[d]isothiazol-3(2H)-one 1,1-dioxide 
(3.66 mmol) to give the title compound as an pale orange powder (1.40 g, 80%) m.p. 145 – 
147 °C; HRMS found [M+Na]+ = 500.1291; C30H23NO3SNa [M+Na]+ requires = 500.1291. 
δH (CDCl3) 8.45 (1H, dd, J = 7.9, 1.1 Hz, 2-H), 7.68 (1H, dd, J = 7.9, 1.1 Hz, 5-H), 7.61 – 7.56 
(6H, m, 3-H, Ph-H), 7.38 – 7.28 (7H, m, Ph-H, 4-H, NH), 6.97 (2H, d, J = 8.3 Hz, m-Ar-H), 6.90 
(2H, d, J = 8.3 Hz, o-Ar-H), 6.10 (1H, s, OH), 2.25 (3H, s, Ar-Me). δc 139.34 (qC), 136.48 (qC), 
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135.46 (qC), 133.36 (CH), 133.19 (qC), 132.37 (CH), 131.91 (CH), 130.33 (CH), 129.78 (CH), 
129.39 (CH), 128.55 (CH), 128.30 (CH), 124.15 (CH), 121.29 (qC), 88.80 (qC), 86.92 (qC), 67.05 
(qC), 20.93 (CH3). 
νmax/cm-1: 3400 b (OH), 3268 w (NH), 2224 w (C≡C), 1508 s (C=C), 1436 w (CH3), 1325 s (SO2), 
1159 s (R-OH), 1163 s (SO2). 
2-(6-Hydroxyundeca-4,7-diyn-6-yl)-N-(p-tolyl)benzenesulfonamide (2.23Bb) 
 
From 1-pentyne (9.15 mmol) and 2-(p-tolyl)benzo[d]isothiazol-3(2H)-one 1,1-dioxide (3.66 
mmol) to give the title compound as a pale yellow powder (1.13 g, 76%) m.p. 102 – 103 °C; 
HRMS found [M+Na]+ = 432.1608; C24H27NO3SNa [M+Na]+ requires = 432.1604. 
δH (CDCl3) 8.31 (1H, dd, J = 7.9, 1.0 Hz, 2-H), 7.71 (1H, s, NH), 7.59 (1H, dd, J = 7.9, 1.0 Hz, 5-
H), 7.52 (1H, td, J = 7.9, 1.0 Hz, 3-H), 7.23 (1H, td, J = 7.9, 1.0 Hz, 4-H), 7.99 (2H, d, J = 8.2 Hz, 
m-Ar-H), 6.90 (2H, d, J = 8.2 Hz, o-Ar-H), 5.83 (1H, s, OH), 2.33 (4H, t, J = 7.0 Hz, CH2), 2.27 
(3H, s, Ar-Me), 1.66 – 1.57 (4H, m, CH2), 1.02 (6H, t, J = 7.0 Hz, CH3). δc 140.07 (qC), 136.56 
(qC), 135.06 (qC), 133.34 (qC), 133.10 (CH), 132.01 (CH), 130.39 (CH), 129.75 (CH), 128.45 
(CH), 124.38 (CH), 87.62 (qC), 81.44 (qC), 66.28 (qC), 21.71 (CH2), 20.95 (CH3), 20.91 (CH2), 
13.60 (CH3).  
νmax/cm-1: 3405 b (OH), 3264 m (NH), 2955 m (Ar-H), 2933 m (CH2, CH3), 2870 w (CH2, CH3), 










From 1-ethynyl-4-methoxybenzene (27.5 mmol) and 2-(p-tolyl)benzo[d]isothiazol-3(2H)-one 
1,1-dioxide (11.0 mmol) to give the title compound as a pale orange powder (5.50 g, 93%) 
m.p. 145 – 146 °C; HRMS found [M+Na]+ = 560.1505; C32H27NO5SNa [M+Na]+ requires = 
560.1507. 
δH (CDCl3) 8.44 (1H, dd, J = 7.8, 1.1 Hz, 2-H), 7.64 (1H, app. d, 5-H), 7.57 (1H, td, J = 7.9, 1.1, 
Hz, 3-H), 7.50 (4H, m, Ar-H), 7.28* (1H, td, J = 7.8, 1.1 Hz, 4-H), 6.96 (2H, d, J = 8.2 Hz, m-Ar-
H), 6.90 – 6.85 (6H, m, o-Ar-H, Ar-H), 6.10 (1H, s, NH), 3.81 (6H, s, O-Me), 2.24 (3H, s, Ar-
Me). δc 160.37 (qC), 139.68 (qC), 136.44 (qC), 135.34 (qC), 133.45 (CH), 133.32 (CH), 133.25 
(qC), 132.33 (CH), 130.33 (CH), 129.75 (CH), 128.75 (CH), 124.17 (CH), 114.18 (CH), 113.30 
(qC), 87.78 (qC), 86.92 (qC), 67.06 (qC), 55.35 (CH3), 20.93 (CH3). 
νmax/cm-1: 3291 b (OH), 2955 w (NH), 2226 w (C≡C), 1605 s (C=C), 1456 w (CH3), 1390 w 
(SO2), 1164 s (R-OH), 1029 s (SO2). 






From (trimethylsilyl)acetylene (27.5 mmol) and 2-(p-tolyl)benzo[d]isothiazol-3(2H)-one 1,1-
dioxide (11.0 mmol) to give the title compound as an orange oil (3.27 g, 63%); HRMS found 
[M+Na]+ = 492.1464; C24H31NO3SSi2Na [M+Na]+ requires = 492.1455. 
δH (CDCl3) 8.38 (1H, app. d, 2-H), 7.92 (1H, s, NH), 7.54 (1H, td, J = 7.7, 1.1 Hz, 3-H), 7.49 (1H, 
app. d, 5-H), 7.24* (1H, app. t, 4-H), 7.01 (2H, d, J = 8.2 Hz, m-Ar-H), 6.99 (2H, d, J = 8.2 Hz, o-
Ar-H), 6.24 (1H, s, OH), 2.27 (3H, s, Ar-Me), 0.25 (18H, s, Si-Me3). δc 138.41 (qC), 137.51 (qC), 
135.62 (qC), 133.80 (CH), 133.40 (qC), 132.82 (CH), 130.84 (CH), 130.24 (CH), 129.33 (CH), 
125.63 (CH), 105.25 (qC), 93.09 (qC), 66.83 (qC), 21.49 (CH3), 0.00 (Si-Me3). 
νmax/cm-1: 3420 w (OH), 3261 w (NH), 2960 m (CH3), 1509 s (C=C), 1334 m (SO2), 1163 s (R-
OH), 1053 m (SO2). 
*Overlapping with CDCl3 signal 
2-(4-Hydroxy-1,7-dimethoxyhepta-2,5-diyn-4-yl)-N-(p-tolyl)benzenesulfonamide (2.23Bf) 
 
From methyl propargyl ether (9.15 mmol) and 2-(p-tolyl)benzo[d]isothiazol-3(2H)-one 1,1-
dioxide (3.66 mmol) to give the title compound as a beige powder (0.99 g, 66%) m.p. 110 – 
111 °C; HRMS found [M+K]+ = 452.0930; C22H23NO5SK [M+K]+ requires = 452.0937. 
δH (CDCl3) 8.29 (1H, app. d, 2-H), 7.95 (1H, s, NH), 7.55 – 7.50 (2H, m, 5-H, 3-H), 7.24* (1H, 
app. t, 4-H), 7.04 – 6.97 (4H, m, Ar-H), 6.28 (1H, s, OH), 4.27 (4H, ABq, J = 15.7 Hz, CHaHb), 
3.41 (6H, s, Me), 2.29 (3H, s, Ar-Me). δc 138.62 (qC), 136.46 (qC), 136.06 (qC), 133.15 (qC), 
133.10 (CH), 132.59 (CH), 129.74 (CH), 129.62 (CH), 128.87 (CH), 124.60 (CH), 85.84 (qC), 
82.84 (qC), 65.72 (qC), 60.15 (CH2), 58.47 (CH3), 20.97 (CH3).  
νmax/cm-1: 3386 b (OH), 3281 m (NH), 2939 w (CH2, CH3), 2824 w (CH2, CH3), 1508 s (C=C), 
1434 w (CH2), 1394 w (CH3), 1328 m (SO2), 1167 s (R-OH), 1093 s (SO2). 





From phenylacetylene (18.3 mmol) and 2-(m-tolyl)benzo[d]isothiazol-3(2H)-one 1,1-dioxide 
(7.32 mmol) to give the title compound as an orange powder (3.28 g, 94%) m.p. 178 – 180 
°C; HRMS found [M+Na]+ = 500.1291; C30H23NO3SNa [M+Na]+ requires = 500.1297. 
δH (CDCl3) 8.44 (1H, dd, J = 7.9, 1.2 Hz, 2-H), 7.74 (1H, dd, J = 7.9, 1.2 Hz, 5-H), 7.61 – 7.56 
(6H, m, 3-H, Ph-H), 7.40 – 7.29 (7H, m, Ph-H, 4-H), 7.05 – 7.02 (1H, m, m-Ar-H), 6.93 – 6.91 
(1H, m, o-Ar-H), 6.82 – 6.80 (2H, m, Ar-H), 6.04 (1H, s, NH), 2.19 (3H, s, Ar-Me). δc 139.43 
(qC), 139.24 (qC), 135.85 (qC), 135.59 (qC), 133.36 (CH), 132.27 (CH), 131.92 [2 X C (CH)], 
130.36 (CH), 129.34 (CH), 128.93 (CH), 128.88 (CH), 128.54 [2 X C (CH)], 127.11 (CH), 124.30 
(CH), 121.33 (qC), 120.36 (CH), 88.82 (qC), 86.90 (qC), 67.08 (qC), 21.23 (CH3). 
νmax/cm-1: 3383 b (OH), 3292 m (NH), 2224 s (C≡C), 1608 w (C=C), 1385 s (CH3), 1326 s (SO2), 
1169 s (SO2), 1155 s (R-OH), 729 w (Ph-H), 688 s (Ph-H). 
2-(6-Hydroxyundeca-4,7-diyn-6-yl)-N-(m-tolyl)benzenesulfonamide (2.23Cb) 
 
From 1-pentyne (18.3 mmol) and 2-(m-tolyl)benzo[d]isothiazol-3(2H)-one 1,1-dioxide (7.32 
mmol) to give the title compound as a pale pink powder (2.51 g, 84%) m.p. 117 – 118 °C; 
HRMS found [M+Na]+ = 432.1607; C24H27NO3SNa [M+Na]+ requires = 432.1610. 
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δH (CDCl3) 8.31 (1H, dd, J = 7.9, 1.3 Hz, 2-H), 7.72 (1H, s, NH), 7.64 (1H, dd, J = 7.9, 1.3 Hz, 5-
H), 7.52 (1H, td, J = 7.9, 1.3 Hz, 3-H), 7.24 (1H, td, J = 7.9, 1.3 Hz, 4-H), 7.08 (1H, app. t, m-Ar-
H), 6.96 – 6.94 (1H, m, o-Ar-H), 6.89 (1H, app. s, o-Ar-H), 6.81 – 6.79 (1H, m, p-Ar-H), 5.76 
(1H, s, OH), 2.33 (4H, t, J = 7.1 Hz, CH2), 2.25 (3H, s, Ar-Me), 1.63 (4H, sxt, J = 7.3 Hz, CH2), 
1.03 (6H, t, J = 7.3 Hz, CH3). δc 140.16 (qC), 139.21 (qC), 136.01 (qC), 135.19 (qC), 133.10 (CH), 
131.90 (CH), 130.41 (CH), 128.89 (CH), 128.41 (CH), 127.27 (CH), 124.72 (CH), 120.84 (CH), 
87.59 (qC), 81.46 (qC), 66.31 (qC), 21.71 (CH2), 21.27 (CH3), 20.91 (CH2), 13.57 (CH3).  
νmax/cm-1: 3403 b (OH), 3278 m (NH), 2961 w (Ar-H), 2932 w (CH2, CH3), 2870 w (CH2, CH3), 




From phenylacetylene (8.65 mmol) and 2-(2-methoxyphenyl)benzo[d]isothiazol-3(2H)-one 
1,1-dioxide (3.46 mmol) to give the title compound as a golden powder (1.09 g, 59%) m.p. 
133 – 135 °C; HRMS found [M+Na]+ = 516.1248; C30H23NO4SNa [M+Na]+ requires = 516.1240. 
δH [(CD3)2CO] 8.45 (1H, app. d, 2-H), 7.91 (1H, dd, J = 7.9, 0.9 Hz, 5-H), 7.72 (1H, td, J = 7.9, 
0.9 Hz, 3-H), 6.91 (1H, app. t, Ar-H), 6.85 (1H, app. d, Ar-H), 7.59 – 7.53 (5H, m, Ar-H, Ph-H), 
7.49 – 7.40 (7H, m, 4-H, Ph-H), 7.06 (1H, td, J = 7.9, 1.4 Hz, Ar-H), 3.56 (3H, s, O-Me). δc 
150.74 (qC), 140.17 (qC), 137.51 (qC), 133.08 (CH), 131.61 (CH), 131.43 (CH), 129.73 (CH), 
129.05 (CH), 128.58 (CH), 128.57 (CH), 126.56 (qC), 125.55 (CH), 122.43 (CH), 122.16 (qC), 
120.65 (CH), 111.22 (CH), 89.63 (qC), 85.31 (qC), 66.41 (qC), 55.21 (CH3).   
νmax/cm-1: 3411 w (OH), 3243 w (NH), 2221 w (C≡C), 1596 w (C=C), 1447 m (CH3), 1259 m 






From 1-pentyne (8.65 mmol) and 2-(2-methoxyphenyl)benzo[d]isothiazol-3(2H)-one 1,1-
dioxide (3.46 mmol) to give the title compound as a red oil (1.08 g, 74%); HRMS found 
[M+Na]+ = 448.1562; C24H27NO4SNa [M+Na]+ requires = 448.1553. 
δH (CDCl3) 8.29 (1H, dd, J = 7.9, 1.0 Hz, 2-H), 7.95 (1H, s, NH), 7.58 (1H, dd, J = 7.9, 1.5 Hz, Ar-
H), 7.52 (1H, dd, J = 7.9, 1.0 Hz, 5-H), 7.45 (1H, td, J = 7.9, 1.0 Hz, 3-H), 7.19 (1H, td, J = 7.9, 
1.0 Hz, 4-H), 7.11 (1H, td, J = 7.9, 1.5 Hz, Ar-H), 6.95 (1H, td, J = 7.9, 1.5 Hz, Ar-H), 6.65 (1H, 
app. d, Ar-H), 5.83 (1H, s, OH), 3.36 (3H, s, O-Me), 2.32 (4H, t, J = 7.1 Hz, CH2), 1.61 (4H, sxt, J 
= 7.1 Hz, CH2), 1.03 (6H, t, J = 7.1 Hz, CH3). δc 151.59 (qC), 140.74 (qC), 136.17 (qC), 132.77 
(CH), 131.10 (CH), 129.98 (CH), 127.99 (CH), 126.89 (CH), 125.80 (CH), 125.41 (CH), 121.07 
(CH), 110.74 (CH), 87.17 (qC), 80.88 (qC), 66.15 (qC), 55.31 (CH), 21.88 (CH3), 21.74 (CH2), 
20.95 (CH2), 13.59 (CH3). 
νmax/cm-1: 3435 w (OH), 3253 w (NH), 2963 m (Ar-H), 2934 m (CH2, CH3), 2872 w (CH2, CH3), 





From (trimethylsilyl)acetylene (17.3 mmol) and 2-(2-methoxyphenyl)benzo[d]isothiazol-
3(2H)-one 1,1-dioxide (6.91 mmol) to give the title compound as a brown solid (2.08 g, 62%) 
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m.p. 138 – 139 °C; HRMS found [M+Na]+ = 508.1404; C24H31NO4SSi2Na [M+Na]+ requires = 
508.1404. 
δH (CDCl3) 8.34 (1H, app. d, 2-H), 8.02 (1H, s, NH), 7.57 – 7.50 (2H, m, 3-H, Ar-H), 7.42 (1H, 
app. d, 5-H), 7.22 – 7.15 (2H, m, 4-H, Ar-H), 7.01 – 6.97 (1H, m, Ar-H), 6.68 – 6.65 (1H, m, Ar-
H), 6.12 (1H, s, OH), 3.31 (3H, s, O-Me), 0.25 (18H, s, Si-Me3). δc 152.27 (qC), 138.92 (qC), 
136.39 (qC), 132.81 (CH), 131.26 (CH), 129.87 (CH), 128.24 (CH), 127.63 (CH), 127.49 (CH), 
124.87 (qC), 121.03 (CH), 104.00 (qC), 91.87 (qC), 66.32 (qC), 54.99 (CH3), -0.50 (Si-Me3). 
νmax/cm-1: 3424 w (OH), 3219 b (NH), 2961 m (CH3), 1598 s (C=C), 1325 m (SO2), 1157 s (R-




From phenylacetylene (13.0 mmol) and 2-(3-methoxyphenyl)benzo[d]isothiazol-3(2H)-one 
1,1-dioxide (5.18 mmol) to give the title compound as a beige powder (2.16 g, 84%) m.p. 
150 – 152 °C; HRMS found [M+Na]+ = 516.1244; C30H23NO4SNa [M+Na]+ requires = 516.1245. 
δH (CDCl3) 8.43 (1H, dd, J = 7.9, 1.0 Hz, 2-H), 7.91 (1H, app. d, 5-H), 7.63 (1H, s, NH), 7.61 – 
7.56 (5H, m, 3-H, Ph-H), 7.40 – 7.30 (7H, m, 4-H, Ar-H), 7.04 (1H, app. t, Ar-H), 6.66 – 6.62 
(2H, m, Ar-H), 6.56 (1H, dd, J = 8.0, 1.1 Hz, Ar-H), 5.96 (1H, s, OH), 3.67 (3H, s, O-Me). δc 
160.16 (qC), 139.43 (qC), 137.16 (qC), 133.44 (CH), 132.27 (CH), 131.92 (CH), 130.40 (CH), 
129.84 (CH), 129.40 (CH), 128.94 (CH), 128.71 (qC), 128.55 (CH), 128.29 (CH), 121.30 (qC), 
115.34 (CH), 112.16 (CH), 109.02 (CH), 88.78 (qC), 86.90 (qC), 67.08 (qC), 55.30 (CH3).   
νmax/cm-1: 3404 b (OH), 3271 w (NH), 2229 w (C≡C), 1606 w (C=C), 1488 m (CH3), 1392 s 





From 1-pentyne (13.0 mmol) and 2-(3-methoxyphenyl)benzo[d]isothiazol-3(2H)-one 1,1-
dioxide (5.18 mmol) to give the title compound as an orange powder (1.63 g, 74%) m.p. 84 – 
85 °C; HRMS found [M+Na]+ = 448.1555; C24H27NO4SNa [M+Na]+ requires = 448.1558. 
δH (CDCl3) 8.29 (1H, dd, J = 1.0, 7.9 Hz, 2-H), 7.98 (1H, s, NH), 7.69 (1H, dd, J = 7.9, 1.0 Hz, 5-
H), 7.52 (1H, td, J = 7.9, 1.0 Hz, 3-H), 7.26* (1H, td, J = 7.9, 1.0 Hz, 4-H), 7.10 – 7.05 (1H, m, 
Ar-H), 6.69 – 6.68 (2H, m, Ar-H), 6.56 (1H, app. d, Ar-H), 5.69 (1H, s, OH), 3.73 (3H, s, O-Me), 
2.33 (4H, t, J = 7.1 Hz, CH2), 1.62 (4H, sxt, J = 7.1 Hz, CH2), 1.03 (6H, t, J = 7.1 Hz, CH3). δc 
160.15 (qC), 140.20 (qC), 137.34 (qC), 135.08 (qC), 133.16 (CH), 131.90 (CH), 130.46 (CH), 
129.79 (CH), 128.48 (CH), 115.75 (CH), 112.13 (CH), 109.56 (CH), 87.62 (qC), 81.43 (qC), 66.33 
(qC), 55.33 (CH), 21.70 (CH2), 20.90 (CH2), 13.57 (CH3). 
νmax/cm-1: 3402 b (OH), 3254 m (NH), 2963 m (Ar-H), 2932 m (CH2, CH3), 2871 w (CH2, CH3), 
2235 w (C≡C), 1606 m (C=C), 1491 s (CH2), 1394 m (CH3), 1327 s (SO2), 1169 s (R-OH), 1109 s 
(SO2). 






From phenylacetylene (18.9 mmol) and 2-(thiophen-3-yl)benzo[d]isothiazol-3(2H)-one 1,1-
dioxide (7.54 mmol) to give the title compound as a brown solid (1.49 g, 42%) m.p. 107 °C 
decomp; HRMS found [M+Na]+ = 492.0699; C27H19NO3S2Na [M+Na]+ requires = 492.0698. 
δH (CDCl3) 8.43 (1H, dd, J = 8.0, 1.2 Hz, 2-H), 7.80 (1H, app. d, 5-H), 7.72 (1H, s, NH), 7.61 (1H, 
td, J = 8.0, 1.2 Hz, 3-H), 7.59 – 7.55 (2H, m, Ph-H), 7.50 – 7.47 (3H, m, Ph-H), 7.41 – 7.30 (6H, 
m, Ph-H, 4-H), 7.12 – 7.10 (1H, m, Ar-H), 6.83 (1H, dd, J = 3.0, 1.3 Hz, Ar-H), 6.74 (1H, dd, J = 
5.0, 1.3 Hz, Ar-H), 5.95 (1H, s, OH). δc 139.42 (qC), 135.33 (qC), 133.87 (qC), 133.53 (CH), 
132.35 (CH), 131.90 (CH), 130.42 (qC), 128.98 (CH), 128.73 (CH), 128.58 (CH), 128.30 (CH), 
125.56 (CH), 123.94 (CH), 115.74 (CH), 88.66 (qC), 86.87 (qC), 67.05 (qC). 
νmax/cm-1: 3415 w (OH), 3275 w (NH), 2235 w (C≡C), 1597 w (C=C), 1488 s (R-OH), 1277 m 
(SO2), 1155 w (SO2), 776 s (Ph-H), 670 s (Ph-H). 
2-(6-Hydroxyundeca-4,7-diyn-6-yl)-N-(thiophen-3-yl)benzenesulfonamide (2.23Gb) 
 
From 1-pentyne (18.9 mmol) and 2-(thiophen-3-yl)benzo[d]isothiazol-3(2H)-one 1,1-dioxide 
(7.54 mmol) to give the title compound as a light brown solid (2.19 g, 69%) m.p. 87 – 88 °C; 
HRMS found [M+Na]+ = 424.1016; C21H23NO3S2Na [M+Na]+ requires = 424.1011. 
δH (CDCl3) 8.30 (1H, dd, J = 7.9, 1.1 Hz, 2-H), 7.86 (1H, s, NH), 7.72 (1H, dd, J = 7.9, 1.1 Hz, 5-
H), 7.55 (1H, td, J = 8.0, 1.2 Hz, 3-H), 7.29 (1H, td, J = 8.0, 1.2 Hz, 4-H), 7.15 – 7.13 (1H, m, Ar-
H), 6.85 (1H, dd, J = 4.0, 1.3 Hz, Ar-H), 6.80 (1H, dd, J = 4.0, 1.3 Hz, Ar-H), 5.65 (1H, s, OH), 
2.32 (4H, t, J = 7.3 Hz, CH2), 1.61 (4H, sxt, J = 7.3 Hz, CH2), 1.02 (6H, t, J = 7.3 Hz, CH3). δc 
140.21 (qC), 134.94 (qC), 134.10 (qC), 133.25 (CH), 131.97 (CH), 130.49 (CH), 128.51 (CH), 
125.50 (CH), 124.22 (CH), 116.19 (CH), 87.57 (qC), 81.30 (qC), 66.31 (qC), 21.71 (CH2), 20.88 
(CH2), 13.59 (CH3). 
νmax/cm-1: 3393 b (OH), 3234 m (NH), 2963 m (Ar-H), 2904 w (CH2, CH3), 2869 w (CH2, CH3), 






From phenylacetylene (24.3 mmol) and 2-(naphthalen-2-yl)benzo[d]isothiazol-3(2H)-one 
1,1-dioxide (9.70 mmol) to give a beige powder which was recrystallised (EtOAc – pentane) 
to give the title compound as a beige powder (4.88 g, 98%) m.p. 166 – 168 °C; HRMS found 
[M+Na]+ = 536.1301; C33H23NO3SNa [M+Na]+ requires = 536.1300. 
δH (CDCl3) 8.43 (1H, dd, J = 8.0, 1.2 Hz, 2-H), 7.86 (1H, s, NH), 7.74 – 7.72 (2H, m, Ar-H, 5-H), 
7.65 – 7.53 (7H, m, Ar-H, 3-H), 7.47 (1H, d, J = 2.1 Hz, Ar-H), 7.44 – 7.33 (8H, m, Ar-H), 7.23 
(1H, td, J = 8.0, 1.2 Hz, 4-H), 7.17 (1H, dd, J = 8.7, 2.1 Hz, Ar-H), 5.99 (1H, s, OH). δc 139.46 
(qC), 135.54 (qC), 133.51 (qC), 133.45 (CH), 133.43 (qC), 132.21 (CH), 131.94 (CH), 131.58 (qC), 
130.45 (CH), 129.42 (CH), 129.20 (CH), 129.00 (CH), 128.57 (CH), 127.63 (CH), 127.60 (CH), 
126.61 (CH), 125.88 (CH), 122.43 (CH), 121.32 (qC), 121.06 (CH), 88.85(qC), 86.96 (qC), 67.16 
(qC). 
νmax/cm-1: 3387 b (OH), 3270 m (NH), 3055 w (Ar-H), 2226 s (C≡C), 1598 w (C=C), 1373 m 





From 1-pentyne (24.3 mmol) and 2-(naphthalen-2-yl)benzo[d]isothiazol-3(2H)-one 1,1-
dioxide (9.70 mmol) to give the title compound as yellow flakes (3.85 g, 89%) m.p. 127 – 128 
°C; HRMS found [M+Na]+ = 468.1601; C27H27NO3SNa [M+Na]+ requires = 468.1610. 
δH (CDCl3) 8.30 (1H, dd, J = 7.9, 1.1 Hz, 2-H), 7.99 (1H, s, NH), 7.77 – 7.75 (1H, m, Ar-H), 7.71 
– 7.67 (2H, m, Ar-H), 7.64 (1H, dd, J = 7.9, 1.1 Hz, 5-H), 7.50 – 7.41 (4H, m, Ar-H), 7.21 – 7.14 
(2H, m, Ar-H, 4-H), 5.72 (1H, s, OH), 2.35 (4H, t, J = 7.3 Hz, CH2), 1.64 (4H, sxt, J = 7.3 Hz, 
CH2), 1.04 (6H, t, J = 7.3 Hz, CH3). δc 140.21 (qC), 135.13 (qC), 133.67 (qC), 133.47 (qC), 133.16 
(CH), 131.85 (CH), 131.68 (qC), 130.52 (CH), 129.16 (CH), 128.54 (CH), 127.65 (CH), 127.63 
(CH), 126.62 (CH), 125.93 (CH), 122.79 (CH), 121.48 (CH), 87.68 (qC), 81.40 (qC), 66.40 (qC), 
21.70 (CH2), 20.94 (CH2), 13.59 (CH3). 
νmax/cm-1: 3405 b (OH), 3261 m (NH), 2961 m (Ar-H), 2933 w (CH2, CH3), 2870 w (CH2, CH3), 
2219 w (C≡C), 1602 w (Ar-H), 1453 w (CH2), 1353 m (CH3), 1322 s (SO2), 1162 s (R-OH), 1110 
s (SO2). 
6.2.7 General Method for Synthesis of 3-Alkynyl-2-methylene-1-tosylindolin-3-ols  
 
Scheme 6.1 
To a cold (0 °C) solution of N-[2-(3-hydroxy-1,5-disubstituted-1,4-diyn-3-yl)phenyl]-4-
benzenesulfonamide derivative (X mmol, 1 equiv.) in MeOH (10 – 80 mL) was added 5M 
NaOH (Y equiv.) dropwise. The mixture was brought to r.t. and stirred for 0.5 – 24 h (Table 
5.1). After this time, the reaction mixture was diluted with water and EtOAc. The organic 
phase was separated, dried (Na2SO4) and evaporated. The following were synthesised by 




Entry R1 Dialkynol Time (h) Base equiv. Product Yield (%) 
1 TMS 2.5e 0.25 28.3 2.27 100 
2 Ph 2.19Ae 24 11.2 2.30A 76 
3 Ph 2.19Ai 1 59.5 2.30A 70* 
4 C3H7 2.19Be 24 10.1 2.30B 62 
5 C3H7 2.19Bi 0.5 5.0 2.30B 91 
6 4-MeOC6H4 2.19Ce 24 22.9 2.30C 40 
7 4-MeOC6H4 2.19Ci 24 60.4 2.30C 77 
Table 6.1 Base mediated cyclisation to 2.27 and 2.30. *By 1H NMR 
3-Ethynyl-2-methylene-1-tosylindolin-3-ol (2.27) 
 
Entry 1 (Table 6.1) to give the title compound as a brown oil; HRMS found [M+Na]+ = 
348.0661; C18H15NO3SNa [M+Na]+ requires = 348.0665. 
δH (CDCl3) 7.84 (1H, app. d, 4-H), 7.57 (2H, d, J = 8.2 Hz, o-Ar-H), 7.45 (1H, app. d, 7-H), 7.42 – 
7.37 (1H, m, 5-H), 7.20 – 7.15 (3H, m, 6-H, m-Ar-H), 5.90 (1H, d, J = 2.0 Hz, CH), 5.46 (1H, d, J 
= 2.0 Hz, CH), 2.55 (1H, s, CH), 2.32 (3H, s, Ar-Me), 2.21 (1H, s, OH). δc 149.73 (qC), 144.82 
(qC), 140.81 (qC), 133.64 (qC), 132.20 (qC), 130.98 (CH), 129.49 (CH), 127.427 (CH), 125.66 
(CH), 124.44 (CH), 116.89 (CH), 102.41 (CH2), 82.21 (qC), 74.68 (CH), 72.13 (qC), 21.59 (CH3).  
νmax/cm-1: 3498 s (OH), 3284 w (C≡C-H),1658 w (C=C), 1597 s (C=C), 1353 s (SO2), 1164 s (R-





From entries 2 or 3 (Table 6.1) to give the title compound as an orange oil; HRMS found 
[M+Na]+ = 424.0979; C24H19NO3SNa [M+Na]+ requires = 424.0978. 
δH [(CD3)2CO] 7.78 (1H, app. d, 4-H), 7.61 (2H, d, J = 8.3 Hz, o-Ar-H), 7.47 (1H, dd, J = 7.8, 0.9 
Hz, 7-H), 7.40 – 7.36 (1H, m, 5-H), 7.32 – 7.29 (3H, m, Ph-H), 7.23 – 7.16 (5H, m, Ph-H, 6-H, 
m-Ar-H), 5.78 (1H, d, J = 1.7 Hz, CH), 5.65 (1H, s, OH), 5.41 (1H, d, J = 1.7 Hz, CH), 2.17 (3H, s, 
Ar-Me). δc 151.30 (qC), 144.96 (qC), 140.45 (qC), 134.16 (qC), 133.96 (qC), 131.53 (qC), 131.44 
(CH), 130.21 (CH), 129.51 (CH), 128.71 (CH), 128.45 (CH), 127.45 (CH), 125.39 (CH), 124.71 
(CH), 115.95 (CH), 99.70 (CH2), 89.36 (qC), 85.24 (CH), 72.16 (qC), 20.47 (CH3).  
νmax/cm-1: 3387 s (OH), 2222 w (C≡C), 1658 w (C=C), 1597 s (C=C), 1355 s (SO2), 1167 s (R-
OH), 1089 w (SO2), 1020 m (C=CH2), 938 m (C=CH2). 
2-Methylene-3-(pent-1-yn-1-yl)-1-tosylindolin-3-ol (2.30B) 
 
From entries 4 or 5 (Table 6.1) to give the title compound as a red oil; HRMS found [M-
H2O+H]+ = 350.1213; C21H20NO2S [M-H2O+H]+ requires = 350.1205. 
δH (CDCl3) 7.84 (1H, app. d, 4-H), 7.58 (2H, d, J = 8.3 Hz, o-Ar-H), 7.44 (1H, dd, J = 7.5, 0.9 Hz, 
7-H), 7.37 (1H, app. t, 5-H), 7.19 – 7.14 (3H, m, 6-H, m-Ar-H), 5.86 (1H, d, J = 1.9 Hz, CH), 5.44 
(1H, d, J = 1.9 Hz, CH), 2.32 (3H, s, Ar-Me), 2.11 (2H, t, J = 7.2 Hz, CH2), 1.99 (1H, s, OH), 1.46 
(2H, sxt, J = 7.1 Hz, CH2), 0.91 (3H, t, J = 7.2 Hz, CH3). δc 150.49 (qC), 144.65 (qC), 140.65 (qC), 
133.78 (qC), 133.19 (qC), 130.62 (CH), 129.42 (CH), 127.48 (CH), 125.54 (CH), 124.36 (CH), 
116.80 (CH), 101.77 (CH2), 87.56 (qC), 78.99 (qC), 72.49 (qC), 21.76 (CH2), 21.58 (CH3), 20.65 
(CH2), 13.41 (CH3).  
νmax/cm-1: 3481 s (OH), 2961 w (Ar-H), 2929 w (CH2, CH3), 2871 w (CH2, CH3), 2236 w (C≡C), 
1716 w (C=C), 1598 m (C=C), 1463 s (CH2, CH3), 1355 s (SO2), 1168 s (R-OH), 1089 s (SO2), 






From entries 6 or 7 (Table 6.1) to give the title compound as an orange oil; HRMS found 
[M+Na]+ = 454.1081; C25H21NO4SNa [M+Na]+ requires = 454.1089. 
δH (CDCl3) 7.87 (1H, app. d, 4-H), 7.59 (2H, d, J = 8.2 Hz, o-Ar-H), 7.51 (1H, app. d, 7-H), 7.40 – 
7.40 (1H, app. t, 5-H), 7.24* (2H, d, J = 8.8 Hz, Ar-H), 7.19 (1H, app. t, 6-H), 7.11 (2H, d, J = 
8.2 Hz, m-Ar-H), 6.80 (2H, d, J = 8.8 Hz, Ar-H), 5.92 (1H, d, J = 1.9 Hz, CH), 3.79 (3H, s, O-Me), 
2.22 (3H, s, Ar-Me), 2.13 (1H, s, OH). δc 159.99 (qC), 150.40 (qC), 144.74 (qC), 140.70 (qC), 
133.72 (qC), 133.24 (CH), 133.05 (qC), 130.72 (CH), 129.42 (CH), 127.48 (CH), 125.64 (CH), 
124.47 (CH), 116.93 (CH), 113.90 (qC), 113.87 (CH), 102.07 (CH2), 86.48 (qC), 86.11 (CH), 
72.88 (qC), 55.32 (CH3), 21.48 (CH3).  
νmax/cm-1: 2359 w (C≡C), 1604 w (C=C), 1509 m (C=C), 1355 m (SO2), 1168 s (R-OH), 1069 m 
(SO2), 1031 w (C=CH2), 943 w (C=CH2). 
*Overlapping with CDCl3 signal 
6.2.8 Silver(I) Catalysed Cyclisations of N-[2-(3-Hydroxy-penta-1,4-diyn-3-
yl)phenyl]benzenesulfonamides 
 (Z)-2-Benzylidene-3-(phenylethynyl)-1-tosylindolin-3-ol (2.33a) 
 
To a solution of N-[2-(3-hydroxy-1,5-diphenylpenta-1,4-diyn-3-yl)phenyl]-4-
methylbenzenesulfonamide (1.00g, 2.09 mmol, 1 equiv.) in MeCN (38.3 mL/mmol) was 
added AgNO3 on silica (5 mol %, 10 % w/w) and the mixture stirred at reflux overnight. After 
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this time the reaction mixture was allowed to cool, filtered through Celite and evaporated 
to give the title compound as a brown oil (1.00 g, 100%); HRMS found [M+Na]+ = 500.1293; 
C30H23NO3SNa [M+Na]+ requires = 500.1291. 
δH [(CD3)2CO] 7.82 – 7.79 (3H, m, Ph-H, 4-H), 7.52 (1H, dd, J = 7.6, 0.8 Hz, 7-H), 7.48 – 7.44 
(3H, m, 5-H, o-Ar-H), 7.39 – 7.34 (7H, m, Ph-H), 7.28 – 7.24 (2H, m, Ph-H, 6-H), 7.00 (2H, d, J 
= 8.1 Hz, m-Ar-H), 6.94 (1H, s, CH), 5.51 (1H, s, OH), 2.05* (3H, s, Ar-Me). δc 144.44 (qC), 
143.13 (qC), 141.43 (qC), 136.60 (qC), 136.13 (qC), 133.76 (qC), 131.64 (CH), 129.83 (CH), 
129.73 (CH), 128.94 (CH), 128.73 (CH), 128.71 (qC), 128.48 (CH), 127.75 (CH), 127.47 (CH), 
126.44 (CH), 124.46 (CH), 122.49 (qC), 121.74 (CH), 118.570 (CH), 89.04 (qC), 85.70 (qC), 
73.41 (qC), 20.39 (CH3). 
νmax/cm-1: 3526 w (OH), 1595 m (C=C), 1355 s (SO2), 1162 s (R-OH), 1087 w (SO2), 770 s (Ph-
H), 690 s (Ph-H). 
*Overlapping with (CD3)2CO signal 
General Method for the AgOAc-Mediated Cyclisation of N-[2-(3-Hydroxy-penta-1,4-diyn-3-
yl)phenyl]benzenesulfonamides 
To a solution of N-[2-(3-hydroxy-1,5-disubstituted-1,4-diyn-3-yl)phenyl]-4-
benzenesulfonamide derivative (1.0 equiv.) in MeCN (38.3 mL/mmol) was added AgOAc (5 
mol %) and the mixture stirred at reflux overnight. After this time the reaction mixture was 
allowed to cool, filtered through Celite and evaporated. The residue was purified by flash 






methylbenzenesulfonamide (2.09 mmol) to give the title compound as a brown oil (1.00 g, 
100%); HRMS found [M+Na]+ = 500.1298; C30H23NO3SNa [M+Na]+ requires = 500.1291. 
δH [(CD3)2CO] 8.20 (1H, app. d, 4-H), 7.73 – 7.71 (3H, m, 7-H, o-Ar-H), 7.57 – 7.55 (2H, m, Ph-
H), 7.49 – 7.42 (3H, m, Ph-H, 6-H), 7.39 – 7.33 (6H, m, Ph-H, 5-H), 7.29 – 7.26 (3H, m, m-Ar-
H, Ph-H), 6.95 (1H, d, J = 7.1 Hz, CH), 5.19 (1H, d, J = 7.1 Hz, OH), 2.32 (3H, s, Ar-Me). δc 
145.79 (qC), 145.63 (qC), 142.45 (qC), 135.81 (qC), 135.08 (qC), 131.43 (CH), 130.07 (qC), 
129.97 (CH), 128.48 (CH), 128.44 (CH), 128.07 (CH), 127.22 (CH), 126.96 (CH), 126.53 (CH), 
126.00 (CH), 124.52 (CH), 123.17 (qC), 120.00 (CH), 115.18 (CH), 106.70 (qC), 97.26 (qC), 
80.52 (qC), 68.38 (CH), 20.58 (CH3). 
νmax/cm-1: 3519 w (OH), 3062 w (Ar-H), 2922 w (CH3), 1709 s (C=C), 1596 m (C=C), 1362 s 
(SO2), 1168 s (R-OH), 1087 s (SO2), 749 s (Ph-H), 690 s (Ph-H). 
1-[3-(Pent-1-yn-1-yl)-1-tosyl-1H-indol-2-yl]butan-1-ol (2.32b) 
 
From N-[2-(6-hydroxyundeca-4,7-diyn-6-yl)phenyl]-4-methylbenzenesulfonamide (2.44 
mmol). From flash column chromatography (5% EtOAc – hexane) to give the title compound 
as an orange oil (0.62 g, 62%); HRMS found [M+Na]+ = 500.1298; C30H23NO3SNa [M+Na]+ 
requires = 500.1291. 
δH (CDCl3) 8.06 (1H, app. d, 4-H), 7.71 (2H, d, J = 8.4 Hz, o-Ar-H), 7.55 (1H, app. d, 7-H), 7.32 – 
7.23* (2H, m, 6-H, 5-H), 7.13 (2H, d, J = 8.4 Hz, m-Ar-H), 5.51 (1H, dt, J = 10.8, 7.1 Hz, CH), 
3.72 (1H, d, J = 10.8 Hz, OH), 2.49 (2H, t, J = 7.2 Hz, CH2), 2.26 (3H, s, Ar-Me), 2.16 – 2.10 (2H, 
m, CH2), 1.68 (2H, sxt, J = 7.2 Hz, CH2), 1.08 (3H, t, J = 7.2 Hz, CH3), 0.98 – 0.86 (5H, m, CH3, 
CH2). δc 145.25 (qC), 145.16 (qC), 136.06 (qC), 135.02 (qC), 130.21 (qC), 129.87 (CH), 126.59 
(CH), 125.63 (CH), 124.15 (CH), 120.11 (CH), 114.99 (CH), 107.07 (qC), 99.27 (qC), 71.52 (qC), 




νmax/cm-1: 3544 w (OH), 2959 w (Ar-H), 2932 w (CH2, CH3), 2871 w (CH2, CH3), 1597 w (C=C), 
1451 s (CH2, CH3), 1364 s (SO2), 1172 s (R-OH), 1088 s (SO2). 
*Overlapping with CDCl3 signal 
(E)-2-(But-1-en-1-yl)-3-(pent-1-yn-1-yl)-1-tosyl-1H-indole (2.39) 
 
From N-[2-(6-hydroxyundeca-4,7-diyn-6-yl)phenyl]-4-methylbenzenesulfonamide (2.44 
mmol). From flash column chromatography (5% EtOAc – hexane) to give the title compound 
as a brown oil (0.16 g, 17%); HRMS found [M+Na]+ = 414.1497; C24H25NO2SNa [M+Na]+ 
requires = 414.1498. 
δH (CDCl3) 8.19 (1H, app. d, 4-H), 7.60 (2H, d, J = 8.3 Hz, o-Ar-H), 7.53 (1H, app. d, 7-H), 7.32 – 
7.24* (2H, m, 5-H, 6-H), 7.13 (2H, d, J = 8.4 Hz, m-Ar-H), 6.99 (1H, d, J = 15.8 Hz, CH), 6.79 
(1H, dt, J = 15.8, 6.5 Hz, CH), 2.47 (2H, t, J = 7.2 Hz, CH2), 2.41 – 2.33 (2H, m, CH2), 2.30 (3H, 
s, Ar-Me), 1.65 (2H, sxt, J = 7.2 Hz, CH2), 1.18 (3H, t, J = 7.4 Hz, CH3), 1.08 (3H, t, J = 7.2 Hz, 
CH3). δc 144.85 (qC), 140.69 (CH), 140.03 (qC), 135.69 (qC), 135.43 (qC), 131.27 (qC), 129.59 
(CH), 126.73 (CH), 125.15 (CH), 124.06 (CH), 119.77 (CH), 118.24 (CH), 115.14 (CH), 104.29 
(qC), 97.02 (qC), 73.35 (qC), 26.69 (CH2), 22.26 (CH2), 21.86 (CH2), 21.56 (CH3), 13.64 (CH3), 
13.40 (CH3). 
νmax/cm-1: 2962 w (Ar-H), 2931 w (CH2, CH3), 2872 w (CH2, CH3), 1682 w (C=C), 1597 w (C=C), 
1450 s (CH2, CH3), 1370 s (SO2), 1171 s (R-OH), 1088 s (SO2), 965 w (trans CH=CH). 









From N-[2-(6-hydroxyundeca-4,7-diyn-6-yl)phenyl]-4-methylbenzenesulfonamide (2.44 
mmol). From flash column chromatography (5% EtOAc – hexane) to give the title compound 
as an orange oil (0.04 g, 8%); HRMS found [M+H]+ = 238.1604; C17H20N [M+H]+ requires = 
238.1590. 
δH (CDCl3) 8.22 (1H, app. d, 5-H), 8.04 (1H, app. d, 8-H), 7.70 – 7.66 (1H, m, 7-H), 7.54 – 7.50 
(1H, m, 6-H), 7.36 (1H, s, CH), 2.93 – 2.89 (2H, m, CH2), 2.56 (2H, t, J = 7.3 Hz, CH2), 1.89 – 
1.70 (4H, m, CH2), 1.13 (3H, t, J = 7.3 Hz, CH3), 1.01 (3H, t, J = 7.3 Hz, CH3). δc 162.30 (qC), 
147.67 (qC), 130.78 (qC), 129.63 (CH), 129.01 (CH), 126.63 (qC), 126.05 (CH), 125.80 (CH), 
123.95 (CH), 99.83 [2 X C (qC)], 41.01 (CH2), 23.24 (CH2), 22.10 (CH2), 21.76 (CH2), 14.01 
(CH3), 13.69 (CH3).  





methylbenzenesulfonamide (4.26 mmol). From flash column chromatography (5% EtOAc – 
hexane) to give the title compound as a white powder (0.22 g, 11%) m.p. 164 – 165 °C; 
HRMS found [M+H]+ = 470.1635; C24H32NO3SSi2 [M+H]+ requires = 470.1636. 
δH (CDCl3) 7.79 (1H, app. d, 4-H), 7.42 – 7.38 (4H, m, o-Ar-H, 7-H, 5-H), 7.20 (1H, app. t, 6-H), 
7.09 (2H, d, J = 8.1 Hz, m-Ar-H), 6.14 (1H, s, CH), 2.29 (3H, s, Ar-Me), 1.08 (1H, s, OH), 0.33 (9H, 
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s, Si-Me3), 0.15 (9H, s, Si-Me3). δc 153.22 (qC), 144.67 (qC), 141.71 (qC), 134.25 (qC), 133.37 (qC), 
130.55 (CH), 129.27 (CH), 128.12 (CH), 126.43 (CH), 124.61 (CH), 124.43 (CH), 119.14 (CH), 
103.48 (qC), 91.76 (qC), 74.15 (qC), 21.57 (CH3), 0.29 (Si-Me3). 
νmax/cm-1: 3438 m (OH), 2951 w (Ar-H), 2898 w (CH3), 1644 s (C=C), 1599 s (C=C), 1340 s 
(SO2), 1166 s (R-OH), 1092 s (SO2). 
 (Z)-3-Ethynyl-1-tosyl-2-[(trimethylsilyl)methylene]indolin-3-ol (2.33e’) 
 
From N-{2-[3-hydroxy-1,5-bis(trimethylsilyl)penta-1,4-diyn-3-yl]phenyl}-4-
methylbenzenesulfonamide (4.26 mmol). From flash column chromatography (5% EtOAc – 
hexane) to give the title compound as a brown powder (0.88 g, 64%) m.p. 64 – 65 °C; HRMS 
found [M+H]+ = 398.1239; C21H24NO3SSi [M+H]+ requires = 398.1241. 
δH (CDCl3) 7.75 (1H, app. d, 4-H), 7.40 – 7.34 (4H, m, o-Ar-H, 7-H, 5-H), 7.16 (1H, app. t, 6-H), 
7.05 (2H, d, J = 8.2 Hz, m-Ar-H), 6.05 (1H, s, CH), 2.43 (1H, s, OH), 2.26 (3H, s, Ar-Me), 0.32 (9H, 
s, Si-Me3). δc 153.69 (qC), 144.56 (qC), 141.38 (qC), 134.44 (qC), 133.49 (qC), 130.46 (CH), 129.24 
(CH), 128.31 (CH), 126.47 (CH), 124.40 (CH), 122.95 (CH), 119.04 (CH), 82.45 (qC), 74.57 (CH), 
73.40 (qC), 21.56 (CH3), 0.11 (Si-Me3). 
νmax/cm-1: 3561 w (OH), 3286 w (C≡C-H), 2951 w (Ar-H), 1640 s (C=C), 1598 s (C=C), 1359 s 




methylbenzenesulfonamide (4.26 mmol). From flash column chromatography (5% EtOAc – 
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hexane) to give the title compound as a brown oil (0.01 g, 1%); HRMS found [M+H]+ = 
398.1243; C21H24NO3SSi [M+H]+ requires = 398.1241. 
δH (CDCl3) 7.84 (1H, app. d, 4-H), 7.58 (2H, d, J = 8.3 Hz, o-Ar-H), 7.45 (1H, app. d, 7-H), 7.41 – 
7.37 (1H, m, 5-H), 7.20 – 7.15 (3H, m, 6-H, m-Ar-H), 5.89 (1H, d, J = 2.0 Hz, CH), 5.47 (1H, d, J 
= 2.0 Hz, CH), 2.32 (3H, s, Ar-Me), 0.13 (9H, s, Si-Me3). δc 149.93 (qC), 144.75 (qC), 140.88 (qC), 
133.74 (qC), 132.48 (qC), 130.84 (CH), 129.47 (CH), 127.45 (CH), 125.57 (CH), 124.56 (CH), 




methylbenzenesulfonamide (2.29 mmol). From flash column chromatography (5% EtOAc – 
hexane) to give the title compound as an off white solid (0.54 g, 54%) m.p. 125 – 126 °C; 
HRMS found [M+H]+ = 438.2102; C26H32NO3S [M+H]+ requires = 438.2098. 
δH (CDCl3) 7.67 (1H, app. d, 4-H), 7.43 – 7.36 (4H, m, o-Ar-H, 7-H, 5-H), 7.20 (1H, app. t, 6-H), 
7.09 (2H, d, J = 8.1 Hz, m-Ar-H), 6.08 (1H, s, CH), 2.29 (3H, s, Ar-Me), 1.36 (9H, s, Me3), 1.20 
(9H, s, Me3). δc 144.65 (qC), 142.42 (qC), 138.95 (qC), 138.58 (CH), 136.61 (qC), 133.40 (qC), 
130.04 (CH), 129.16 (CH), 128.66 (CH), 126.71 (CH), 124.27 (CH), 119.77 (CH), 95.79 (qC), 
77.54 (qC), 74.46 (qC), 34.37 (qC), 30.73 (Me3), 29.44 (Me3), 27.43 (qC), 21.57 (CH3). 
νmax/cm-1: 3490 w (OH), 2963 m (Ar-H), 2868 w (CH3), 1598 m (C=C), 1461 s (CH3), 1354 s 







6.2.9 Synthesis of 2,4-Diphenyl-5-tosyl-4,5-dihydrofuro[2,3-c]quinoline (2.53) 
 
To a solution of N-[2-(3-hydroxy-1,5-diphenylpenta-1,4-diyn-3-yl)phenyl]-4-
methylbenzenesulfonamide (1.00 g, 2.09 mmol, 1 equiv.) in DCM (38.3 mL/mmol) was 
added indium(III) trifluoromethanesulfonate (5 mol %), the mixture stirred at r.t. for 18 h. 
After this time the reaction mixture was filtered through Celite. The residue was purified by 
flash column chromatography (10% EtOAc – hexane) and recrystallised with EtOAc – hexane 
to give the title compound as a beige powder (0.22 g, 22%) m.p. 130 – 131 °C; HRMS found 
[M+H]+ = 478.1477; C30H24NO3S [M+H]+ requires = 478.1472. 
δH [(CD3)2CO] 7.75 – 7.73 (2H, m, Ph-H), 7.70 (1H, dd, J = 7.8, 1.2 Hz, 9-H), 7.49 – 7.45 (2H, m, 
Ph-H), 7.41 (1H, dd, J = 7.8, 1.2 Hz, 6-H), 7.38 – 7.22 (10H, m, Ph-H, 8-H, 7-H, o-Ar-H), 7.02 
(2H, d, J = 8.0 Hz, m-Ar-H), 6.95 (1H, s, Ar-H), 6.73 (1H, s, 1-H), 2.15 (3H, s, Ar-Me). δc 154.72 
(qC), 147.80 (qC), 143.91 (qC), 137.73 (qC), 134.43 (qC), 131.24 (qC), 130.28 (qC), 129.20 (CH), 
129.00 (CH), 128.85 (CH), 128.65 (CH), 128.21 (CH), 127.83 (CH), 127.70 (CH), 126.83 (qC), 
126.77 (CH), 126.69 (CH), 126.65 (CH), 123.67 (CH), 123.06 (CH), 118.53 (qC), 100.91 (CH), 
56.49 (CH), 20.36 (CH3).  













Method A: To a solution of 3-[2-(sulfamoyl)phenyl]penta-1,4-diyn-3-ols derivative (1.0 
equiv.) in MeCN (38.3 mL/mmol) was added ICl (3.0 equiv.), the mixture was stirred at the 
temperature for the time indicated in Table 5.2. After this time the reaction mixture was 
quenched with aqueous sodium thiosulfate. The organic phase was separated, dried 
(Na2SO4) and evaporated. The residue was purified by flash column chromatography or by 
recrystallisation. 









1* Me Ph 2.23Aa 3.5 82 2.59Aa 48 
2 Tolyl Ph 2.23Ba 24 82 2.59Ba 45 
3 Tolyl C3H7 2.23Bb 3.5 r.t. 2.59Bb 36 
4 Tolyl CH2OMe 2.23Bf 1 82 2.59Bf 40 
5 3-MeC6H4 Ph 2.23Ca 4.5 82 2.59Ca 47 
6 3-MeC6H4 C3H7 2.23Cb 1.5 82 2.59Cb 75 
7 3-MeOC6H4 C3H7 2.23Eb 21 82 2.59Eb 54 
Table 6.2 Cyclisation of dialkynols 2.23Aa – Eb with ICl to 2.59Aa – Eb results. * 2 equiv. of ICl used 
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Method B: To a solution of 3-[2-(sulfamoyl)phenyl]penta-1,4-diyn-3-ols derivative (1.0 
equiv.) in DCM (38.3 mL/mmol) was added indium(III) trifluoromethanesulfonate (5 mol %), 
the mixture stirred at r.t. for the time indicated in Table 5.3. After this time the reaction 
mixture was filtered through Celite and evaporated to give the title compound. The residue 
was purified by column chromatography or by recrystallisation. 






1 2.23Aa Me Ph 2.59Aa 24 100 
2 2.23Ab Me C3H7 2.59Ab 5 92 
3 2.23Ba Tolyl Ph 2.59Ba 24 100 
4 2.23Bb Tolyl C3H7 2.59Bb 24 98 
5 2.23Bc Tolyl 4-MeOC6H4 2.59Bc 23 99 
6 2.23Be Tolyl TMS 2.59Be 24 27 
7 2.23Ca 3-MeC6H4 Ph 2.59Ca 24 53 
8 2.23Cb 3-MeC6H4 C3H7 2.59Cb 24 82 
9 2.23Da 2-MeOC6H4 Ph 2.59Da 22 37 
10 2.23Db 2-MeOC6H4 C3H7 2.59Db 3 63 
11 2.23Eb 3-MeOC6H4 C3H7 2.59Eb 24 100 
12 2.23Gb 3-thienyl C3H7 2.59Gb 24 49 
13 2.23Ha 2-naphthyl Ph 2.59Ha 24 43 
14 2.23Hb 2-naphthyl C3H7 2.59Hb 7.3 45 
Table 6.3 Yields of In(OTf)3 promoted cyclisation of 2.23Aa – Hb to 2.59Aa – Hb   




From 2-(3-hydroxy-1,5-diphenylpenta-1,4-diyn-3-yl)-N-methylbenzenesulfonamide (Method 
A: 1.74 mmol, Method B: 1.25 mmol). Method A – From column chromatography (10% 
EtOAc – pet ether) to give the title compound as a brown oil (Method A: 0.32 g, 48%, 
Method B: 0.48 g, 100%); HRMS found [M+H]+ = 384.1047; C24H18NO2S [M+H]+ requires = 
384.1053. 
δH (CDCl3) 7.90 (1H, app. d, 4-H), 7.84 (1H, app. d, 7-H), 7.73 (1H, app. t, 6-H), 7.62 (1H, app. 
t, 5-H), 7.49 – 7.46 (4H, m, Ph-H), 7.38 – 7.28 (6H, m, Ph-H), 3.16 (3H, s, Me). δc 137.80 (qC), 
133.84 (CH), 133.02 (qC), 132.11 (CH), 130.43 (CH), 129.37 (CH), 128.39 (CH), 124.96 (CH), 
121.36 (CH), 121.16 (qC), 85.95 (qC), 83.29 (qC), 57.01 (qC), 25.56 (CH3).  
νmax/cm-1: 3056 w (Ar-H), 2229 w (C≡C), 1597 w (C=C), 1490 s (CH3), 1309 s (SO2), 1158 s 
(SO2), 752 s (Ph-H), 688 s (Ph-H). 
2-Methyl-3,3-di(pent-1-yn-1-yl)-2,3-dihydro-1,2-benzisothiazole 1,1-dioxide (2.59Ab) 
 
From 2-(6-hydroxyundeca-4,7-diyn-6-yl)-N-(p-tolyl)benzenesulfonamide (Method B: 3.00 
mmol) to give the title compound as an orange oil (Method B: 0.87 g, 92%); HRMS found 
[M+H]+ = 316.1368; C18H22NO2S [M+H]+ requires = 316.1375. 
δH (CDCl3) 7.77 (1H, app. d, 7-H), 7.73 (1H, app. d, 4-H), 7.68 (1H, app. t, 5-H), 7.56 (1H, app. 
t, 6-H), 3.00 (3H, s, Me), 2.20 (4H, t, J = 7.0 Hz, CH2), 1.53 (4H, sxt, J = 7.3 Hz, CH2), 0.96 (6H, 
t, J = 7.3 Hz, CH3). δc 138.91 (qC), 133.45 (CH), 132.84 (qC), 129.90 (CH), 124.65 (CH), 121.09 
(CH), 86.59 (qC), 75.58 (qC), 56.31 (qC), 25.08 (CH3), 21.70 (CH2), 20.63 (CH2), 13.37 (CH3).  
νmax/cm-1: 2964 m (Ar-H), 2934 m (CH2, CH3), 2873 w (CH2, CH3), 2241 w (C≡C), 1455 s (CH2), 





3,3-Bis(phenylethynyl)-2-(p-tolyl)-2,3-dihydro-1,2-benzisothiazole 1,1-dioxide (2.59Ba) 
 
From 2-(3-hydroxy-1,5-diphenylpenta-1,4-diyn-3-yl)-N-(p-tolyl)benzenesulfonamide 
(Method A: 2.09 mmol, Method B: 1.47 mmol). Method A – From column chromatography 
(12% EtOAc – pet ether) to give the title compound as a brown powder (Method A: 0.43 g, 
45%, Method B: 0.68 g, 100%) m.p. 130 – 131 °C; HRMS found [M+H]+ = 460.1371; 
C30H22NO2S [M+H]+ requires = 460.1366. 
δH (CDCl3) 7.96 – 7.92 (2H, m, 4-H, 7-H), 7.78 (1H, app. t, 5-H), 7.73 (2H, d, J = 8.2 Hz, o-Ar-H), 
7.68 (1H, app. t, 6-H), 7.42 – 7.40 (4H, m, Ph-H), 7.35 – 7.28 (6H, m, Ph-H, m-Ar-H), 2.43 (3H, 
s, Me). δc 140.03 (qC), 137.53 (qC), 133.67 (CH), 133.42 (qC), 132.10 (CH), 131.93 (CH), 130.44 
(CH), 130.02 (CH), 129.25 (CH), 128.91 (qC), 128.34 (CH), 125.18 (CH), 121.50 (CH), 121.32 
(qC), 86.19 (qC), 84.71 (qC), 58.58 (qC), 21.41 (CH3).  
νmax/cm-1: 3056 w (Ar-H), 2229 w (C≡C), 1597 w (C=C), 1490 s (CH3), 1311 s (SO2), 1173 s 
(SO2), 754 s (Ph-H), 688 s (Ph-H). 
3,3-Di(pent-1-yn-1-yl)-2-(p-tolyl)-2,3-dihydro-1,2-benzisothiazole 1,1-dioxide (2.59Bb) 
 
From 2-(6-hydroxyundeca-4,7-diyn-6-yl)-N-(p-tolyl)benzenesulfonamide (Method B: 1.71 
mmol) to give the title compound as a brown powder (Method B: 0.66 g, 98%) m.p. 131 – 
133 °C; HRMS found [M+Na]+ = 414.1518; C24H25NO2SNa [M+Na]+ requires = 414.1498. 
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δH (CDCl3) 7.84 (1H, app. d, 7-H), 7.77 (1H, app. d, 4-H), 7.71 (1H, app. t, 5-H), 7.62 – 7.58 
(3H, m, o-Ar-H, 6-H), 7.28 (1H, d, J = 5.2 Hz, m-Ar-H), 2.42 (3H, s, Ar-Me), 2.15 (4H, t, J = 7.3 
Hz, CH2), 1.48 (4H, sxt, J = 7.3 Hz, CH2), 0.90 (6H, t, J = 7.3 Hz, CH3). δc 139.58 (qC), 138.72 
(qC), 133.35 (CH), 133.16 (qC), 131.87 (CH), 129.94 (CH), 129.78 (CH), 129.06 (qC), 124.90 
(CH), 121.19 (CH), 87.00 (qC), 76.88 (qC), 57.93 (qC), 21.60 (CH2), 21.38 (CH3), 20.70 (CH2), 
13.46 (CH3).  
νmax/cm-1: 2965 m (Ar-H), 2935 m (CH2, CH3), 2873 w (CH2, CH3), 2235 w (C≡C), 1508 s (C=C), 





tolyl)benzenesulfonamide (Method B: 1.86 mmol) to give the title compound as a brown 
powder (Method B: 0.95 g, 99%) m.p. 140 – 141 °C; HRMS found [M+Na]+ = 542.1403; 
C32H25NO4SNa [M+Na]+ requires = 542.1402. 
δH (CDCl3) 7.96 – 7.90 (2H, m, 4-H, 7-H), 7.78 – 7.64 (4H, m, 5-H, o-Ar-H, 6-H), 7.42 – 7.40 
(4H, m, Ph-H), 7.35 – 7.30 (6H, m, Ar-H, m-Ar-H), 6.82 (2H, d, J = 8.8 Hz, Ar-H), 3.80 (6H, s, O-
Me), 2.42 (3H, s, Ar-Me). δc 160.25 (qC), 139.88 (qC), 137.96 (qC), 133.59 (CH), 133.48 [2 X C 
(CH)], 133.37 (qC), 132.13 (CH), 130.27 (CH), 129.96 (CH), 129.01 (qC), 125.21 (CH), 121.41 
(CH), 113.94 (CH), 113.40 (qC), 86.16 (qC), 83.64 (qC), 55.33 (qC), 21.41 (CH3).  
νmax/cm-1: 2952 w (Ar-H), 2840 w (CH3), 2224 w (C≡C), 1605 s (C=C), 1508 s (C=C), 1294 s 









(Method B: 2.13 mmol) to give the title compound as white crystals (Method B: 0.26 g, 27%) 
m.p. 183 °C; HRMS found [M+H]+ = 452.1335; C24H30NO2SSi2 [M+H]+ requires = 452.1538. 
δH (CDCl3) 7.72 (1H, app. d, 7-H), 7.66 (1H, app. d, 4-H), 7.59 (1H, td, J = 1.1, 7.4 Hz, 5-H), 
7.51 – 7.44 (4H, m, 6-H, o-Ar-H), 7.15 (2H, d, J = 8.1 Hz, m-Ar-H), 2.30 (3H, s, Ar-Me), 0.00 
(18H, s, Si-Me3). δc 139.98 (qC), 137.18 (qC), 133.56 (CH), 133.22 (qC), 132.36 (CH), 130.29 
(CH), 129.74 (CH), 128.67 (qC), 125.11 (CH), 121.33 (CH), 99.79 (qC), 91.59 (qC), 58.28 (qC), 
21.42 (CH3), -0.54 (Si-Me3). 





(Method A: 1.21 mmol). Flash column chromatography (10% EtOAc – hexane) to give the 
title compound as a brown powder (Method A: 0.19 g, 40%) m.p. 115 °C decomp; HRMS 
found [M+Na]+ = 418.1092; C22H21NO4SNa [M+Na]+ requires = 418.1083. 
δH (CDCl3) 7.87 (1H, app. d, 7-H), 7.82 (1H, app. d, 4-H), 7.74 (1H, td, J = 7.4, 1.1 Hz, 5-H), 
7.67 – 7.61 (3H, m, o-Ar-H, 6-H), 7.29 (1H, d, J = 8.1 Hz, m-Ar-H), 4.10 (4H, s, CH2), 3.29 (6H, 
s, CH3), 2.42 (3H, s, Ar-Me). δc 140.02 (qC), 136.98 (qC), 133.67 (CH), 133.28 (qC), 131.71 (CH), 
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130.54 (CH), 130.03 (CH), 128.69 (qC), 124.95 (CH), 121.44 (CH), 82.54 (qC), 81.83 (qC), 59.66 
(CH2), 57.84 (CH3), 21.38 (CH3). 
νmax/cm-1: 2942 m (CH2, CH3), 1507 s (C=C), 1453 s (CH2), 1373 w (CH3), 1312 s (SO2), 1178 s 
(SO2). 
3,3-Bis(phenylethynyl)-2-(m-tolyl)-2,3-dihydro-1,2-benzisothiazole 1,1-dioxide (2.59Ca) 
 
From 2-(3-hydroxy-1,5-diphenylpenta-1,4-diyn-3-yl)-N-(m-tolyl)benzenesulfonamide 
(Method A: 2.09 mmol, Method B: 0.45 mmol). Method A and B – The residue was 
recrystallised from EtOH – H2O to give the title compound as a white solid (Method A: 0.45 
g, 47%, Method B: 0.15 g, purity 75%, 53%) m.p. 140 °C decomp; HRMS found [M+Na]+ = 
482.1187; C30H21NO2SNa [M+Na]+ requires = 482.1191. 
δH (CDCl3) 7.97 – 7.91 (2H, m, 4-H, 7-H), 7.78 (1H, td, J = 7.5, 1.1 Hz, 5-H), 7.69 – 7.64 (3H, m, 
6-H, Ar-H), 7.42 – 7.38 (5H, m, Ar-H), 7.36 – 7.27 (7H, m, Ar-H), 2.41 (3H, s, Ar-Me) δc 139.15 
(qC), 137.50 (qC), 133.67 (CH), 133.46 (qC), 132.67 (CH), 131.89 (CH), 131.71 (qC),  130.57 
(CH), 130.44 (CH), 129.25 (CH), 129.05 (CH), 129.00 (CH), 128.33 (CH), 125.17 (CH), 121.48 
(CH), 121.33 (qC), 86.34 (qC), 84.75 (qC), 58.54 (qC), 21.42 (CH3).   
νmax/cm-1: 2233 m (C≡C), 1604 w (C=C), 1488 m (CH3), 1311 s (SO2), 1171 s (SO2), 784 s (Ph-
H), 690 s (Ph-H). 




From 2-(6-hydroxyundeca-4,7-diyn-6-yl)-N-(m-tolyl)benzenesulfonamide (Method A: 2.44 
mmol, Method B: 0.49 mmol). Method A - The residue was recrystallised from EtOH – H2O, 
the liquor was subject to flash column chromatography (20% Ether – pet ether) to give the 
title compound as beige crystals (Method A: 0.26 g, 75%, Method B: 0.16 g, 82%) m.p. 100 – 
101 °C; HRMS found [M+H]+ = 392.1681; C24H26NO2S [M+H]+ requires = 392.1686. 
δH (CDCl3) 7.84 (1H, app. d, 7-H), 7.78 (1H, app. d, 4-H), 7.71 (1H, td, J = 7.4, 1.1 Hz, 5-H), 
7.60 (1H, td, J = 7.4, 1.1 Hz, 6-H), 7.56 – 7.53 (2H, m, Ar-H), 7.36 (1H, app. t, Ar-H), 7.29 – 
7.27 (1H, m, Ar-H), 2.41 (3H, s, Ar-Me), 2.16 (4H, t, J = 7.2 Hz, CH2), 1.49 (4H, sxt, J = 7.2 Hz, 
CH2), 0.90 (6H, t, J = 7.2 Hz, CH3). δc 138.56 (qC), 138.71 (qC), 133.35 (CH), 133.19 (qC), 132.32 
(CH), 131.85 (qC), 130.15 (CH), 129.94 (CH), 128.77 (CH), 128.75 (CH), 124.89 (CH), 121.17 
(CH), 87.06 (qC), 76.93* (qC), 57.86 (qC), 21.59 (CH2), 21.34 (CH3), 20.70 (CH2), 13.41 (CH3).  
νmax/cm-1: 2964 m (Ar-H), 2935 m (CH2, CH3), 2872 w (CH2, CH3), 2235 w (C≡C), 1604 w (C=C), 
1454 m (CH2), 1296 s (SO2), 1176 s (SO2). 





methoxyphenyl)benzenesulfonamide (Method B: 1.01 mmol). Flash column 
chromatography (10% EtOAc – hexane) to give the title compound as a white solid (Method 
B: 0.18 g, 37%) m.p. 165 – 166 °C; HRMS found [M+Na]+ = 498.1135; C30H21NO3SNa [M+Na]+ 
requires = 498.1132. 
δH (CDCl3)(600 MHz) 7.94 (1H, app. d, 4-H), 7.92 – 7.90 (2H, m, 7-H, Ar-H), 7.76 (1H, td, J = 
7.8, 1.1 Hz, 5-H), 7.65 (1H, td, J = 7.8, 1.1 Hz, 6-H), 7.49 – 7.46 (1H, m, Ar-H), 7.41 – 7.39 (4H, 
m, Ph-H), 7.34 – 7.27 (6H, m, Ph-H), 7.09 – 7.05 (1H, m, Ar-H), 3.76 (3H, s, O-Me) δc (150 
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MHz) 160.05 (qC), 137.93 (qC), 134.99 (CH), 133.52 (CH), 131.89 (CH), 131.70 [2 X C (CH) 
(qC)], 130.25 (CH), 129.08 (CH), 128.27 (CH), 125.13 (CH), 121.58 (qC), 121.49 (CH), 120.51 
(CH), 119.56 (qC), 112.65 (CH), 85.53 (qC), 84.96 (qC), 58.31 (qC), 56.15 (CH3).   




From 2-(6-hydroxyundeca-4,7-diyn-6-yl)-N-(2-methoxyphenyl)benzenesulfonamide (Method 
B: 0.94 mmol). Trituration with acetone to give the title compound as a white crystalline 
solid (Method B: 0.24 g, 63%) m.p. 200 °C; HRMS found [M+Na]+ = 430.1449; C24H25NO3SNa 
[M+Na]+ requires = 430.1453. 
δH (CDCl3) 7.84 – 7.76 (3H, m, 7-H, Ar-H, 4-H), 7.69 (1H, app. t, 5-H), 7.58 (1H, app. t, 6-H), 
7.45 (1H, app. t, Ar-H), 7.05 – 7.02 (2H, m, Ar-H), 3.82 (3H, s, O-Me), 2.15 (4H, t, J = 7.2 Hz, 
CH2), 1.47 (4H, sxt, J = 7.2 Hz, CH2), 0.89 (6H, t, J = 7.2 Hz, CH3). δc 159.98 (qC), 139.20 (qC), 
134.92 (CH), 133.36 (qC), 133.17 (CH), 131.39 (CH), 129.74 (CH), 124.84 (CH), 121.23 (qC), 
120.34 (CH), 119.75 (qC), 112.53 (CH), 86.33 (qC), 76.80* (qC), 55.94 (CH3), 21.63 (CH2), 20.77 
(CH2), 13.44 (CH3).  
νmax/cm-1: 2966 m (Ar-H), 2936 m (CH2, CH3), 2874 w (CH2, CH3), 2235 w (C≡C), 1592 m (C=C), 
1498 s (CH2), 1298 s (SO2), 1176 s (SO2). 









From 2-(6-hydroxyundeca-4,7-diyn-6-yl)-N-(3-methoxyphenyl)benzenesulfonamide (Method 
A and B: 1.17 mmol). Method A – From column chromatography (20% EtOAc – pet ether) to 
give the title compound as a black solid (Method A: 0.26 g, 54%, Method B: 0.48 g, 100%) 
m.p. 98 – 100 °C; HRMS found [M+H]+ = 408.1634; C24H26NO3S [M+H]+ requires = 408.1635. 
δH (CDCl3) 7.84 (1H, app. d, 7-H), 7.78 (1H, app. d, 4-H), 7.72 (1H, td, J = 7.4, 1.1 Hz, 5-H), 7.9 
(1H, app. t, 6-H), 7.38 – 7.35 (2H, m, Ar-H), 7.32 – 7.31 (1H, m, Ar-H), 7.04 – 7.00 (1H, m, Ar-
H), 3.82 (3H, s, O-Me), 2.16 (4H, t, J = 7.2 Hz, CH2), 1.48 (4H, sxt, J = 7.2 Hz, CH2), 0.90 (6H, t, 
J = 7.2 Hz, CH3). δc 159.96 (qC), 138.68 (qC), 133.45 (CH), 133.20 (qC), 133.06 (qC), 130.00 
(CH), 129.50 (CH), 124.87 (CH), 123.48 (CH), 121.14 (CH), 116.55 (CH), 115.38 (CH), 87.17 
(qC), 76.88* (qC), 57.77 (qC), 55.38 (CH3), 21.59 (CH2), 20.71 (CH2), 13.43 (CH3).  
νmax/cm-1: 2965 m (Ar-H), 2934 w (CH2, CH3), 2872 w (CH2, CH3), 2237 w (C≡C), 1597 s (C=C), 
1486 s (CH2), 1303 s (SO2), 1038 s (SO2). 






From 2-(6-hydroxyundeca-4,7-diyn-6-yl)-N-(thiophen-3-yl)benzenesulfonamide (Method B: 
2.49 mmol). Flash column chromatography (10% EtOAc – pet ether) to give the title 
compound as red oil (Method B: 0.47 g, 49%); HRMS found [M+H]+ = 384.1090; C21H22NO2S2 
[M+H]+ requires = 384.1096. 
δH (CDCl3) 7.83 (1H, app. d, 7-H), 7.78 (1H, app. d, 4-H), 7.73 – 7.69 (2H, m, 5-H, Ar-H), 7.60 
(1H, td, J = 7.8, 1.1 Hz, 6-H), 7.46 – 7.44 (1H, m, Ar-H), 7.39 – 7.37 (1H, m, Ar-H), 2.16 (4H, t, J 
= 7.2 Hz, CH2), 1.48 (4H, sxt, J = 7.2 Hz, CH2), 0.90 (6H, t, J = 7.2 Hz, CH3). δc 138.44 (qC), 
133.60 (CH), 132.70 (qC), 130.05 (CH), 129.93 (qC), 127.22 (CH), 124.88 (CH), 124.68 (CH), 
123.71 (CH), 121.19 (CH), 86.98 (qC), 76.76* (qC), 57.58 (qC), 21.59 (CH2), 20.67 (CH2), 13.41 
(CH3).  
νmax/cm-1: 2962 w (Ar-H), 2932 w (CH2, CH3), 2872 w (CH2, CH3), 1453 w (CH2), 1306 s (SO2), 
1174 s (SO2). 





yl)benzenesulfonamide (Method B: 1.95 mmol). Flash column chromatography (toluene) to 
give the title compound as a brown foam (Method B: 0.41 g, 43%) m.p. 82 – 83 °C; HRMS 
found [M+Na]+ = 518.1178; C33H21NO2SNa [M+Na]+ requires = 518.1191. 
δH [(CD3)2CO] 8.51 (1H, d, J = 1.9 Hz, Ar-H), 8.22 (1H, app. d, 7-H), 8.16 (1H, app. d, 4-H), 8.11 
– 8.09 (2H, m, Ar-H), 8.06 – 7.99 (3H, m, Ar-H, 5-H, 6-H), 7.92 (1H, td, J = 7.6, 1.0 Hz, Ar-H), 
7.68 – 7.61 (2H, m, Ar-H), 7.51 – 7.48 (4H, m, Ph-H, Ar-H), 7.47 – 7.38 (6H, m, Ph-H). δc 
137.06 (qC), 134.38 (CH), 133.67 (qC), 133.62 (qC), 133.55 (qC), 131.69 (CH), 131.29 (CH), 
131.23 (CH), 129.99 (qC), 129.61 (CH), 129.02 (CH), 128.78 (CH), 128.68 (CH), 128.23 (CH), 
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127.82 (CH), 127.36 (CH), 126.80 (CH), 125.52 (CH), 121.32 (CH), 120.97 (qC), 86.37 (qC), 
84.71 (qC), 58.54 (qC).  




From 2-(6-hydroxyundeca-4,7-diyn-6-yl)-N-(naphthalen-2-yl)benzenesulfonamide (Method 
B: 2.24 mmol). Flash column chromatography (toluene) to give the title compound as a grey 
powder (Method B: 0.43 g, 45%) m.p. 93 – 94 °C; HRMS found [M+H]+ = 428.1678; 
C27H26NO2S [M+H]+ requires = 428.1686. 
δH (CD2Cl2) 8.33 (1H, app. s, Ar-H), 7.98 – 7.92 (3H, m, 4-H, Ar-H), 7.85 – 7.74 (4H, m, Ar-H, 7-
H, 5-H), 7.65 (1H, td, J = 7.7, 1.0 Hz, 6-H), 7.60 – 7.53 (2H, m, Ar-H), 2.17 (4H, t, J = 7.2 Hz, 
CH2), 1.48 (4H, sxt, J = 7.2 Hz, CH2), 0.89 (6H, t, J = 7.2 Hz, CH3). δc 138.53 (qC), 133.65 (CH), 
133.41 (qC), 133.35 (qC), 133.11 (qC), 130.84 (CH), 130.26 (CH), 129.76 (qC), 128.71 (CH), 
128.56 (CH), 128.26 (CH), 127.66 (CH), 127.04 (CH), 126.45 (CH), 125.05 (CH), 120.94 (CH), 
87.53 (qC), 76.80 (qC), 58.03 (qC), 21.77 (CH2), 20.54 (CH2), 13.18 (CH3).   
νmax/cm-1: 2961 w (Ar-H), 2932 w (CH2, CH3), 2871 w (CH2, CH3), 1511 w (Ar-H), 1463 w (CH2), 












Method A: To a solution of 3-[2-(aminosulfamoyl)phenyl]penta-1,4-diyn-3-ols derivative (1 
equiv.) in MeCN (38.3 mL/mmol) was added ICl (3 equiv.) and the mixture stirred at the 
temperature and time indicated in Table 6.4. After this time the reaction mixture was 
quenched with aqueous sodium thiosulfate. The organic phase was separated, dried 
(Na2SO4) and evaporated. The residue was purified by flash column chromatography. 
Entry R R1 Dialkynol Time (h) Temp (°C) Tetracycle  Yield (%) 
1 Tolyl Ph 2.23Ba 24 82 2.66a-3 35 
2 Tolyl C3H7 2.23Bb 3.5 r.t. 2.66b-3 33 
Table 6.4 Cyclisation of dialkynols 2.23Ba – Bb with ICl  
Method B: To a solution of 3,3-di(alkynyl)-N-(substituted)-2,3-dihydro-1,2-benzisothiazole 
1,1-dioxide (1 equiv.) in MeCN (38.3 mL/mmol) was added ICl (3 equiv.) and the mixture 
stirred at the temperature and time indicated in Table 5.5. After this time the reaction 
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mixture was quenched with aqueous sodium thiosulfate. The organic phase was separated, 
dried (Na2SO4) and evaporated. The residue was purified by flash column chromatography. 
Entry R1 R3 1,2-Benzisothiazole  Time (h) Temp (°C) Tetracycle  Yield (%) 
1 Ph 4-Me 2.59Ba 24 82 2.66a-3 91 
2 C3H7 4-Me 2.59Bb 3.5 r.t. 2.66b-3 40 
3 C3H7 3-OMe 2.59Eb 1 82 2.71b-2 41 





(Method A: 1.26 mmol, entry 1, Table 5.4) from flash column chromatography (12% EtOAc – 
pet ether). From 3,3-bis(phenylethynyl)-2-(p-tolyl)-2,3-dihydro-1,2-benzoisothiazole 1,1-
dioxide (Method B: 0.44 mmol, entry 1, Table 5.5). To give the title compound as a beige 
powder m.p. 96 – 98 °C; HRMS found [M+H]+ = 586.0328; C30H21INO2S [M+H]+ requires = 
586.0330. 
δH (CDCl3) 8.23 (1H, app. d, 7-H), 7.90 (1H, app. d, 10-H), 7.77 (1H, app. t, 8-H), 7.68 – 7.61 
(2H, m, 9-H, Ar-H), 7.54 – 7.50 (1H, m, Ar-H), 7.45 – 7.24* (9H, m, Ar-H), 7.08 – 7.06 (1H, m, 
Ar-H), 6.68 (1H, app. s, Ar-H), 2.25 (3H, s, Ar-Me). δc 144.92 (qC), 142.13 (qC), 138.06 (qC), 
137.86 (qC), 133.94 (qC), 132.12 (CH), 130.50 (CH), 130.37 (CH), 130.14 (CH), 130.05 (qC), 
129.57 (CH), 129.24 (CH), 128.99 (CH), 128.80 (CH), 128.77 (CH), 128.37 (CH), 128.32 (CH), 
128.17 (CH), 127.06 (qC), 125.35 (CH), 121.48 (qC), 121.20 (CH), 101.43 (qC), 86.82 (qC), 83.99 
(qC), 64.97 (qC), 21.35 (CH3). 
νmax/cm-1: 2980 s (C-H), 2224 w (C≡C), 1486 s (CH3), 1319 s (SO2), 1173 s (SO2), 755 s (Ph-H), 
690 s (Ph-H), 573 s (C-I). 
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From 2-(6-hydroxyundeca-4,7-diyn-6-yl)-N-(p-tolyl)benzenesulfonamide (Method A: 2.56 
mmol, entry 2, Table 5.4) from flash column chromatography (20% ether – pet ether). From 
3,3-di(pent-1-yn-1-yl)-2-(p-tolyl)-2,3-dihydro-1,2-benzisothiazole 1,1-dioxide (Method B: 
1.53 mmol, entry 2, Table 5.5). To give the title compound as an orange oil; HRMS found 
[M+H]+ = 518.0644; C24H25INO2S [M+H]+ requires = 518.0652. 
δH (CDCl3) 8.12 (1H, app. d, 7-H), 7.81 (1H, app. d, 10-H), 7.77 (1H, td, J = 7.7, 1.1 Hz, 8-H), 
7.61 (1H, td, J = 7.7, 1.1 Hz, 9-H), 7.54 (1H, d, J = 8.0 Hz, Ar-H), 7.35 (1H, app. s, Ar-H), 7.24 
(1H, d, J = 8.0 Hz, Ar-H), 2.79 (2H, t, J = 7.5 Hz, CH2), 2.44 (3H, s, Ar-Me), 2.09 (2H, t, J = 7.0 
Hz, CH2), 1.67 – 1.49 (2H, m, CH2), 1.42 (2H, sxt, J = 7.5 Hz, CH2), 0.99 (3H, t, J = 7.5 Hz, CH3), 
0.85 (3H, t, J = 7.0 Hz, CH3). δc 140.95 (qC), 138.90 (qC), 137.65 (qC), 133.98 (qC), 131.78 (CH), 
130.18 (CH), 130.04 [2 X C (CH)], 127.56 (qC), 128.62 (qC), 125.82 (CH), 125.74 (CH), 120.99 
(CH), 101.75 (qC), 87.91 (qC), 75.60 (qC), 64.72 (qC), 40.09 (CH2), 21.66 (CH2), 21.64 (CH3), 
21.33 (CH2), 20.75 (CH2), 13.84 (CH3), 13.25 (CH3). 
νmax/cm-1: 2960 m (Ar-H), 2930 m (CH2, CH3), 2871 m (CH2, CH3), 2260 w (C≡C), 1489 s (C=C), 







dioxide (Method B: 0.58 mmol, entry 3, Table 5.5) from flash column chromatography (15% 
EtOAc – pet ether) to give the title compound as a white powder; HRMS found [M+H]+ = 
534.0595; C24H25INO3S [M+H]+ requires = 534.0602. 
δH (CDCl3) 8.13 (1H, app. d, 7-H), 7.82 (1H, app. d, 10-H), 7.74 (1H, app. t, 8-H), 7.62 (1H, app. 
t, 9-H), 7.47 (1H, d, J = 8.8 Hz, Ar-H), 7.20 (1H, d, J = 2.6 Hz, Ar-H), 6.91 (1H, dd, J = 8.8, 2.6 
Hz, Ar-H), 3.89 (3H, s, O-Me), 2.76 (2H, t, J = 7.7 Hz, CH2), 2.10 (2H, t, J = 7.0 Hz, CH2), 1.64 – 
1.39 (4H, m, CH2), 0.97 (3H, t, J = 7.3 Hz, CH3), 0.85 (3H, t, J = 7.0 Hz, CH3). δc 160.17 (qC), 
140.71 [2 X C (qC)], 138.79 (qC), 133.89 (qC), 131.83 (CH), 130.18 (CH), 130.04 (CH), 126.54 
(CH), 121.90 (qC), 120.93 (CH), 114.16 (CH), 110.34 (CH), 97.83 (qC), 87.65 (qC), 75.83 (qC), 
64.71 (qC), 55.66 (CH3), 40.14 (CH2), 21.66 (CH2), 21.34 (CH2), 20.74 (CH2), 13.78 (CH3), 13.23 
(CH3). 
νmax/cm-1: 2959 m (Ar-H), 2929 m (CH2, CH3), 2870 m (CH2, CH3), 1586 s (C=C), 1462 s (CH2, 














6.3 Chapter 3 Experimental 
6.3.1 General Method for the Synthesis of 4-Alkynyl-3-iodo-quinolines 
 
Scheme 6.4 
Method A: To a solution of N-[2-(3-hydroxy-1,5-disubstituted-1,4-diyn-3-yl)phenyl]-4-
benzenesulfonamide derivative (1.0 equiv.) in MeCN (38.3 mL/mmol) was added ICl (2.0 
equiv.) in MeCN and the mixture stirred at r.t. for the time indicated in Table 6.6. After this 
time the reaction mixture was quenched with aqueous sodium thiosulfate. The organic 
phase was separated, dried (Na2SO4) and evaporated. The residue was purified by flash 
column chromatography or washed with cold hexane. 
Method B: To a solution of N-[2-(3-hydroxy-1,5-disubstituted-1,4-diyn-3-yl)phenyl]-4-
benzenesulfonamide derivative (1.0 equiv.) in MeOH (38.3 mL/mmol) was added I2 (3.0 
equiv.) and stirred at 65 °C for the time indicated in Table 5.6. After this time the reaction 
mixture was concentrated and diluted with EtOAc and quenched with aqueous sodium 
thiosulfate. The organic phase was separated, dried (Na2SO4) and evaporated. The residue 




Entry R R1 Dialkynol Method Time (h) Product Yield (%) 
1 Me Ph 2.5a A 1.0 3.2a 60 
2 Me C3H7 2.5b B 1.0 3.2b 46 
3 Me 4-OMeC6H4 2.5c A 1.0 3.2c 40 
4 Me C4H9 2.5d B 1.5 3.2d 63 
5 Me Me 2.5g B 2.25 3.2g 26 
8 OMe Ph 2.6a A 1.0 3.2a 63 
9 OMe C3H7 2.6b B 0.83 3.2b 50 
10a NO2 Ph 2.7a A 1.0 3.2a 32 
11 NO2 C3H7 2.7b B 19.0 3.2b 12 
12 H Ph 2.8a A 2.0 3.2a 41 
Table 6.6 Iodocyclisations of dialkynols 2.5 – 2.8 results. a = 3,6-diiodo-2-phenyl-4-
(phenylethynyl)quinoline 3.4a also isolated  
3-Iodo-2-phenyl-4-(phenylethynyl)quinoline (3.2a) 
 
From entries; 1, 8, 10 and 12 (Table 6.6). From column chromatography (5% ether – hexane) 
resultant material recrystallised from EtOH – EtOAc to give the title compound as off-white 
needle-like crystals m.p. 149 – 150 °C; HRMS found [M+H]+ = 432.0245 C23H15IN requires 
[M+H]+ = 432.0244. 
δH (CDCl3) 8.41 (1H, app. d, 5-H), 8.13 (1H, app. d, 8-H), 7.80 – 7.75 (3H, m, Ar-H), 7.66 – 7.62 
(3H, m, Ar-H), 7.53 – 7.44 (6H, m, Ph-H). δc 161.77 (qC), 146.60 (qC), 143.27 (qC), 137.60 (qC), 
132.04 (CH), 130.52 (CH), 129.82 (CH), 129.74 (CH), 129.21 (CH), 128.76 (CH), 128.66 (CH), 
128.05 (CH), 127.96 (CH), 127.50 (qC), 126.30 (CH), 122.17 (qC), 102.29 (qC), 99.21 (qC), 89.70 
(qC). 





From flash column chromatography (5% ether – hexane) to give the title compound as a 
pale yellow solid (0.04 g, 6%) m.p. 100 °C; HRMS found [M+H]+ = 306.1285; C23H16N [M+H]+ 
requires = 306.1204. 
δH (CDCl3) 8.37 (1H, dd, J = 8.3, 0.9 Hz, 5-H), 8.21 – 8.17 (3H, m, Ar-H), 8.08 (1H, s, 3-H), 7.79 
– 7.75 (1H, m, 7-H), 7.72 – 7.69 (2H, m, Ph-H), 7.66 – 7.60 (1H, m, 6-H), 7.57 – 7.43 (6H, m, 
Ph-H). δc 156.91 (qC), 148.23 (qC), 139.20 (qC), 132.00 (CH), 130.41 (qC), 130.13 (CH), 130.11 
(CH), 129.54 (CH), 129.35 (CH), 128.91 (CH), 128.62 (CH), 127.53 (CH), 126.91 (CH), 126.62 
(qC), 125.76 (CH), 122.34 (qC), 121.69 (CH), 98.16 (qC), 85.48 (qC). 
νmax/cm-1: 3055 w (Ar-H), 2216 m (C≡C), 1597 s (C=C), 756 s (Ph-H), 690 s (Ph-H). 
3,6-Diiodo-2-phenyl-4-(phenylethynyl)quinoline (3.4a) 
 
From entry 10 (Table 6.6). From flash column chromatography (5% EtOAc – hexane) to give 
the title compound as white needles (0.05 g, 18%) m.p. 245 – 246 °C; HRMS found [M+H]+ = 
557.9207; C23H14I2N [M+H]+ requires = 557.9210. 
δH (CDCl3) 8.75 (1H, d, J = 1.9 Hz, 5-H), 8.00 (1H, dd, J = 8.8, 1.9 Hz, 7-H), 7.82 (1H, d, J = 8.8 
Hz, 8-H), 7.78 – 7.75 (2H, m, Ph-H), 7.63 – 7.60 (2H, m, Ph-H), 7.53 – 7.45 (6H, m, Ph-H). δc 
162.36 (qC), 145.57 (qC), 142.93 (qC), 139.33 (CH), 136.48 (qC), 135.17 (CH), 132.11 (CH), 
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131.39 (CH), 129.96 (CH), 129.11 (CH), 128.94 (CH), 128.80 (qC), 128.71 (CH), 128.08 (CH), 
121.86 (qC), 102.90 (qC), 100.03 (qC), 94.01 (qC), 89.23 (qC). 
νmax/cm-1: 3061 w (Ar-H), 2205 m (C≡C), 1590 w (C=C), 759 s (Ph), 687 s (Ph), 534 m (C-I), 528 
m (C-I). 
3-Iodo-4-(pent-1-yn-1-yl)-2-propylquinoline  (3.2b) 
 
From entries; 2, 9 and 11 (Table 6.6). Flash column chromatography (6% EtOAc – hexane) to 
give the title compound as a yellow oil; HRMS found [M+H]+ = 364.0565; C17H19IN [M+H]+ 
requires = 364.0557. 
δH (CDCl3) 8.21 (1H, app. d, 5-H), 7.98 (1H, app. d, 8-H), 7.69 (1H, app. t, 7-H), 7.51 (1H, app. 
t, 6-H), 3.21 – 3.17 (2H, m, CH2), 2.65 (2H, t, J = 7.3 Hz, CH2), 1.92 – 1.76 (4H, m, CH2), 1.18 
(3H, t, J = 7.3 Hz, CH3), 1.08 (3H, t, J = 7.3 Hz, CH3). δc 162.53 (qC), 146.48 (qC), 137.76 (qC), 
129.97 (CH), 128.93 (CH), 127.53 (qC), 126.90 (CH), 126.42 (CH), 104.76 (qC), 100.69 (qC), 
81.27 (qC), 44.98 (CH2), 22.51 (CH2), 22.07 (CH2), 21.94 (CH2), 14.09 (CH3), 13.87 (CH3). 
νmax/cm-1: 3058 w (Ar-H), 2957 m (CH2, CH3), 2927 m (CH2, CH3), 2869 m (CH2, CH3), 2217 w 





From entry 3 (Table 6.6). From flash column chromatography (10% EtOAc – pet ether) to 
give the title compound as yellow needles m.p. 163 – 165 °C; HRMS found [M+H]+ = 
492.0448; C25H19INO2 [M+H]+ requires = 492.0455. 
δH (CDCl3) 8.38 (1H, dd, J = 7.6, 0.7 Hz, 5-H), 8.10 (1H, app. d, 8-H), 7.78 – 7.34 (1H, m, 7-H), 
7.72 – 7.68 (2H, m, o-Ar-H), 7.63 – 7.59 (3H, m, Ar-H, 6-H), 7.04 – 7.01 (2H, m, Ar-H), 6.98 – 
6.95 (2H, m, Ar-H), 3.89 (3H, s, O-Me), 3.88 (3H, s, O-Me). δc 160.81 (qC), 159.96 (qC), 146.65 
(qC), 137.95 (qC), 135.98 (qC), 133.68 (CH), 130.77 (CH), 130.36 (CH), 129.69 (CH), 127.63 
(CH), 127.27 (qC), 126.36 (CH), 114.33 (CH), 113.35 (CH), 102.76 (qC), 99.21 (qC), 89.06 (qC), 
55.45 (CH3), 55.39 (CH3). 
νmax/cm-1: 3058 w (Ar-H), 2833 s (CH3), 2209 s (C≡C), 1605 s (C=C), 1339 s (CH3). 
2-Butyl-4-(hex-1-yn-1-yl)-3-iodoquinoline (3.2d) 
 
From entry 4 (Table 6.6). From flash column chromatography (2% ether – hexane) to give 
the title compound as a brown oil; HRMS found [M+H]+ = 392.0882; C19H23IN [M+H]+ 
requires = 392.0870. 
δH (CDCl3) 8.20 (1H, app. d, 5-H), 7.97 (1H, app. d, 8-H), 7.69 (1H, app. t, 7-H), 7.51 (1H, app. 
t, 6-H), 3.26 – 3.19 (2H, m, CH2), 2.67 (2H, t, J = 7.0 Hz, CH2), 1.83 – 1.72 (4H, m, CH2), 1.66 – 
1.45 (6H, m, CH2), 1.10 – 0.96 (6H, m, CH3). δc 162.75 (qC), 146.56 (qC), 137.74 (qC), 129.93 
(CH), 128.95 (CH), 127.51 (qC), 126.85 (CH), 126.41 (CH), 104.84 (qC), 100.65 (qC), 81.13 (qC), 
42.89 (CH2), 31.24 (CH2), 30.44 (CH2), 22.76 (CH2), 22.20 (CH2), 19.76 (CH2), 14.02 (CH3), 
13.67 (CH3). 







From entry 5 (Table 6.6). Flash column chromatography (5% EtOAc – hexane) to give the 
title compound as a yellow solid m.p. 90 °C decomp; HRMS found [M+H]+ = 307.9938; 
C13H11IN [M+H]+ requires = 307.9931. 
δH (CDCl3) 8.23 – 8.20 (1H, m, 5-H), 7.96 (1H, app. d, 8-H), 7.72 – 7.67 (1H, m, 7-H), 7.54 – 
7.49 (1H, m, 6-H), 2.97 (3H, s, Me), 2.32 (3H, s, Me). δc 159.73 (qC), 146.43 (qC), 137.47 (qC), 
130.05 (qC), 128.76 (CH), 127.45 (CH), 126.91 (CH), 126.39 (CH), 100.64 (qC), 100.41 (qC), 
80.03 (qC), 31.33 (CH3), 5.14 (CH3).  
νmax/cm-1: 2981 s (Ar-H), 2911 m (CH3), 2217 w (C≡C), 1564 w (C=C), 1484 s (CH3), 640 s (C-I). 
6.3.2 General Method for the Synthesis of 4-Alkynyl-3-iodo-quinolines from 
Unsymmetrical Dialkynols 
Method A: To a solution of N-[2-(3-hydroxy-1,5-disubstituted-1,4-diyn-3-yl)phenyl]-4-
benzenesulfonamide derivative (1 equiv.) in MeCN (38.3 mL/mmol) was added ICl (2 equiv.) 
in MeCN and the mixture stirred at r.t. for the time indicated in Table 6.7. After this time the 
reaction mixture was quenched with aqueous sodium thiosulfate. The organic phase was 
separated, dried (Na2SO4) and evaporated. The residue was purified by flash column 
chromatography or washed with cold hexane. 
Method B: To a solution of N-[2-(3-hydroxy-1,5-disubstituted-1,4-diyn-3-yl)phenyl]-4-
benzenesulfonamide derivative (1 equiv.) in MeOH (38.3 mL/mmol) was added I2 (3 equiv.) 
and stirred at 65 °C for the times indicated in Table 6.7. After this time the reaction mixture 
was concentrated, diluted with EtOAc and quenched with aqueous sodium thiosulfate. The 
organic phase was separated, dried (Na2SO4) and evaporated. The residue was purified by 





Entry R1 R2 Dialkynol Method Time 
(h) 
Quinoline Product -X 
yield 
Quinoline Product -Y 
yield 
1 Ph C3H7 2.20Ab A 4.3 3.5Ab-X 14 3.5Ab-Y 31 
2 Ph C3H7 2.20Ab B 1 3.5Ab-X 0 3.5Ab-Y 15 
3 Ph 4-MeOC6H4 2.20Ac A 0.75 3.5Ac-X 0 3.5Ac-Y 32 
4 Ph Me 2.20Ag B 1.5 3.5Ag-X 8 3.5Ag-Y 17 
5 Ph t-Bu 2.20Aj A 0.75 3.5Aj-X 19 3.5Aj-Y 0 
6 4-MeOC6H4 C3H7 2.20Cb B 1.25 3.5Cb-X 28 3.5Cb-Y 0 







From entries; 1 and 2 (Table 6.7). From flash column chromatography (5% ether – hexane) 
to give the title compound as an orange paste; HRMS found [M+H]+ = 398.0400; C20H17IN 
[M+H]+ requires = 398.0407. 
δH (CDCl3) 8.30 (1H, dd, J = 8.3, 0.9 Hz, 5-H), 8.09 (1H, app. d, 8-H), 7.76 – 7.72 (1H, m, 6-H), 
7.61 – 7.57 (3H, m, Ph-H), 7.51 – 7.45 (3H, m, Ph-H, 7-H), 2.67 (2H, t, J = 7.1 Hz, CH2), 1.81 
(2H, sxt, J = 7.1 Hz CH2), 1.18 (3H, t, J = 7.1 Hz, CH3). δc 161.73 (qC), 146.50 (qC), 143.44 (qC), 
138.44 (qC), 130.33 (CH), 129.67 (CH), 129.15 (CH), 128.65 (CH), 127.99 (CH), 127.93 (qC), 
127.73 (CH), 126.48 (CH), 105.19 (qC), 99.05 (qC), 81.39 (qC), 22.11 (CH2), 21.92 (CH2), 13.83 
(CH3). 
νmax/cm-1: 3056 w (Ar-H), 2956 m (CH2, CH3), 2928 m (CH2, CH3), 2869 m (CH2, CH3), 2210 m 
(C≡C), 1596 w (C=C), 756 s (Ph-H), 688 s (Ph-H), 584 w (C-I). 
3-Iodo-4-(phenylethynyl)-2-propylquinoline (3.5Ab-Y) 
 
From entries; 1 and 2 (Table 6.7). From flash column chromatography (5% Ether – hexane) 
to give the title compound as a yellow solid. m.p. 107 – 108 °C; HRMS found [M+H]+ = 
398.0406; C20H17IN [M+H]+ requires = 398.0400. 
δH (CDCl3) 8.33 (1H, app. d, 5-H), 8.04 (1H, app. d, 8-H), 7.78 – 7.73 (3H, m, Ph-H, 6-H), 7.58 
(1H, app. t, 7-H), 7.48 – 7.47 (3H, m, Ph-H), 3.27 – 3.23 (2H, m, CH2), 1.90 (2H, sxt, J = 7.3 Hz 
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CH2), 1.12 (3H, t, J = 7.3 Hz, CH3). δc 162.60 (qC), 146.60 (qC), 136.87 (qC), 131.96 (CH), 130.14 
(CH), 130.62 (CH), 129.11 (CH), 128.63 (CH), 127.12 (CH), 126.23 (CH), 122.26 (qC), 102.93 
(qC), 100.85 (qC), 89.57 (qC), 44.91 (CH2), 22.51 (CH2), 14.09 (CH3). 
νmax/cm-1: 2955 m (CH2, CH3), 2869 w (CH2, CH3), 2210 m (C≡C), 1595 w (C=C), 781 s (Ph-H), 
688 s (Ph-H), 603 m (C-I). 
3-Iodo-2-(4-methoxyphenyl)-4-(phenylethynyl)quinoline (3.5Ac-Y) 
 
From entry 3 (Table 6.7). From washing the precipitate, obtained in the crude product, with 
cold hexane, to give the title compound as yellow needles (0.29 g, 32%) m.p. 125 – 126 °C; 
HRMS found [M+H]+ = 462.0356; C25H19INO2 [M+H]+ requires = 462.0349. 
δH (CDCl3) 8.38 (1H, app. d, 5-H), 8.10 (1H, app. d, 8-H), 7.77 – 7.75 (3H, m, 7-H, Ph-H), 7.62 – 
7.60 (3H, m, o-Ar-H, 6-H), 7.45 – 7.44 (3H, m, Ph-H), 7.02 (2H, d, J = 8.5 Hz, m-Ar-H), 3.89 
(3H, s, O-Me). δc 161.31 (qC), 159.99 (qC), 146.65 (qC), 137.56 (qC), 135.77 (qC), 131.98 (CH), 
130.75 (CH), 130.39 (CH), 129.72 (CH), 129.66 (CH), 128.61 (CH), 127.73 (CH), 127.32 (qC), 
126.24 (CH), 122.19 (qC), 113.34 (CH), 102.10 (qC), 99.56 (qC), 89.78 (qC), 55.36 (CH3). 
νmax/cm-1: 3061 w (Ar-H), 2980 w (Ar-H), 2840 w (CH3), 2206 m (C≡C), 1607 s (C=C), 752 s 





From entry 4 (Table 5.7). From using Biotage Isolera 4 (SNAP Ultra 10g cartridge, EtOAc – 
pet ether 10% → 100%) to give the title compound as a beige solid (0.007 g, 8%); HRMS 
found [M+H]+ = 370.0098; C18H13IN [M+H]+ requires = 370.0087. 
δH (CDCl3) 8.33 (1H, dd, J = 8.2, 0.8 Hz, 5-H), 8.11 (1H, app. d, 8-H), 7.79 – 7.75 (1H, m, 7-H), 
7.63 – 7.59 (3H, m, Ph-H), 7.53 – 7.46 (3H, m, 6-H, Ph-H), 2.36 (3H, s, Me). δc 161.72 (qC), 
146.51 (qC), 143.41 (qC), 138.39 (qC), 131.99 (qC), 130.35 (CH), 129.88 (qC), 129.67 (CH), 
129.14 (CH), 128.66 (CH), 127.99 (CH), 127.73 (CH), 126.48 (CH), 100.70 (qC), 98.97 (qC), 
80.43 (qC), 5.18 (CH3). 
3-Iodo-2-methyl-4-(phenylethynyl)quinoline (3.5Ag-Y) 
 
From entry 4 (Table 6.7). From using Biotage Isolera 4 (SNAP Ultra 10g cartridge, EtOAc – 
pet ether 10% → 100%) to give the title compound as a beige solid (0.015 g, 17%); HRMS 
found [M+H]+ = 370.0095; C18H13IN [M+H]+ requires = 370.0087. 
δH (CDCl3) 8.33 (1H, dd, J = 8.3, 0.8 Hz, 5-H), 8.02 (1H, app. d, 8-H), 7.78 – 7.74 (3H, m, Ph-H, 
7-H), 7.61 – 7.57 (1H, m, 6-H), 7.49 – 7.45 (3H, m, Ph-H), 3.03 (3H, s, Me). δc 159.83 (qC), 
146.46 (qC), 136.72 (qC), 131.99 (CH), 130.24 (CH), 129.68 (CH), 128.87 (CH), 128.64 (CH), 






From entry 5 (Table 6.7). From flash column chromatography (5% EtOAc – pet ether) to give 
the title compound as an orange paste (0.12 g, at 60% purity, 19%); HRMS found [M+H]+ = 
412.0558; C21H13IN [M+H]+ requires = 412.0564. 
δH (CDCl3) 8.26 (1H, dd, J = 8.3, 0.8 Hz, 5-H), 8.08 (1H, app. d, 8-H), 7.76 – 7.72 (1H, m, 6-H), 
7.61 – 7.45 (6H, m, Ph-H, 7-H), 1.49 (9H, s, Me3). δc 161.71 (qC), 146.49 (qC), 143.47 (qC), 
138.28 (qC), 130.31 (CH), 129.63 (CH), 129.14 (CH), 128.93 (qC), 128.64 (CH), 127.99 (CH), 
127.72 (CH), 127.69 (qC), 126.45 (CH), 112.93 (qC), 99.30 (qC), 80.17 (qC), 30.66 (CH3). 
νmax/cm-1: 3057 w (Ar-H), 2923 s (CH3), 2224 m (C≡C), 1361 m (CH3), 771 s (Ph-H), 695 s (Ph-
H), 583 m (C-I) 
3-Iodo-2-(4-methoxyphenyl)-4-(pent-1-yn-1-yl)quinoline (3.5Cb-X) 
 
From entry 6 (Table 6.7). From using Biotage Isolera 4 (SNAP Ultra 25g cartridge, EtOAc – 
pet ether 1% → 20%) to give the title compound as a brown oil (0.20 g, 28%); HRMS found 
[M+H]+ = 428.0512; C21H19INO [M+H]+ requires = 428.0506. 
δH (CDCl3) 8.28 (1H, dd, J = 8.4, 1.0 Hz, 5-H), 8.07 (1H, app. d, 8-H), 7.75 – 7.71 (1H, m, 7-H), 
7.59 – 7.55 (3H, m, o-Ar-H, 6-H), 7.03 – 6.99 (2H, m, m-Ar-H), 3.88 (3H, s, O-Me) 2.67 (2H, t, J 
= 7.3 Hz, CH2), 1.81 (2H, sxt, J = 7.3 Hz, CH2), 1.18 (3H, t, J = 7.3 Hz, CH3). δc 161.30, 159.92 
(qC), 146.58 (qC), 138.43 (qC), 135.99 (qC), 130.72 (CH), 130.25 (CH), 129.60 (CH), 127.78 (qC), 
127.54 (CH), 126.45 (CH), 113.31 (CH), 105.03 (qC), 99.46 (qC), 81.49 (qC), 55.38 (CH3) 22.11 
(CH2), 21.92 (CH2), 13.86 (CH3). 
νmax/cm-1: 2959 w (Ar-H), 2930 w (CH2, CH3), 2970 w (CH2, CH3), 2833 w (CH2, CH3), 2217 m 








To a solution of 2-(3-hydroxypenta-1,4-diyn-3-yl)-N-(substituted)benzenesulfonamide 
derivative (1 equiv.) in MeCN (38.3 mL/mmol) was added AgOAc (5 mol %) and the mixture 
stirred at reflux for the time indicated in Table 5.8. After this time the reaction mixture was 
allowed to cool, filtered through Celite and evaporated. The residue was purified by flash 




Entry R R1 Dialkynol Time (h) Product 1,2- Benzothiazine 
Yield (%) 
Product 1,2-Benzothiazepine  
Yield (%) 
1 Me Ph 2.23Aa 24 3.9Aa 48 3.10Aa 0 
2ab Me C3H7 2.23Ab 20 3.9Ab 12b 3.10Ab 7 
3 Tolyl Ph 2.23Ba 3 3.9Ba 78 3.10Ba 0 
4 Tolyl C3H7 2.23Bb 1 3.9Bb 82 3.10Bb 0 
5 Tolyl 4-MeOC6H4 2.23Bc 23 3.9Bc 62 3.10Bc 0 
6c Tolyl TMS 2.23Be 2 3.9Be 61 3.10Be 0 
7 Tolyl CH2OMe 2.23Bf 20 3.9Bf 86 3.10Bf 0 
8 3-MeC6H4 Ph 2.23Ca 4 3.9Ca 72 3.10Ca 0 
9 3-MeC6H4 C3H7 2.23Cb 1.5 3.9Cb 59 3.10Cb 0 
10 2-MeOC6H4 Ph 2.23Da 2 3.9Da 86 3.10Da 0 
11 2-MeOC6H4 C3H7 2.23Db 2 3.9Db 61 3.10Db 0 
12 3-MeOC6H4 Ph 2.23Ea 3 3.9Ea 96 3.10Ea 0 
13 3-MeOC6H4 C3H7 2.23Eb 3 3.9Eb 80 3.10Eb 0 
14 3-thienyl C3H7 2.23Gb 3.7 3.9Gb 70 3.10Gb 11 
15 2-naphthyl Ph 2.23Ha 3 3.9Ha 75 3.10Ha 0 
16 2-naphthyl C3H7 2.23Hb 3 3.9Hb 84 3.10Hb 0 
Table 6.8 Yields from the AgOAc cyclisation of reversed sulfonamides 2.23Aa – Hb. a = 3-(1-Hydroxybutyl)-2-methyl-4-(pent-1-yn-1-yl)-2H-1,2-benzothiazine 
1,1-dioxide 3.11Ab also obtained from this reaction. b = yield from 1H NMR spectrum c = 4-Hydroxy-3-methylene-2-(p-tolyl)-4-[(trimethylsilyl)ethynyl]-3,4-




benzothiazine 1,1-dioxide (3.9Aa) 
 
From 2-(3-hydroxy-1,5-diphenylpenta-1,4-diyn-3-yl)-N-methylbenzenesulfonamide (2.02 
mmol). From flash column chromatography (10% EtOAc – hexane) to give the title 
compound as a yellow powder (0.39 g, 48%) m.p. 79 – 80 °C; HRMS found [M+Na]+ = 
424.0980; C24H19NO3SNa [M+Na]+ requires = 424.0978. 
δH (CDCl3)(600MHz) 8.10 (1H, dd, J = 8.0, 1.1 Hz, 5-H), 7.87 (1H, dd, J = 8.0, 1.1 Hz, 8-H), 7.82 
– 7.81 (2H, m, Ph-H), 7.65 (1H, td, J = 8.0, 1.1 Hz, 6-H), 7.52 (1H, td, J = 8.0, 1.1 Hz, 7-H), 7.49 
(1H, s, CH), 7.48 – 7.46 (2H, m, Ph-H), 7.42 – 7.32 (6H, m, Ph-H), 3.42 (1H, s, OH), 3.12 (3H, s, 
N-Me). δc (150 MHz) 139.17 (qC), 138.22 (qC), 133.98 (qC), 133.24 (qC), 133.22 (CH), 131.67 
(CH), 131.03 (CH), 129.55 (CH), 129.52 (CH), 129.17 (CH), 129.11 (CH), 129.03 (CH), 128.65 
(CH), 128.42 (CH), 124.03 (CH), 121.49 (qC), 89.12 (qC), 87.89 (qC), 68.32 (qC), 38.38 (CH3).  
νmax/cm-1: 3433 b (OH), 1490 w (C=C), 1443 s (CH3), 1327 s (SO2), 1165 s (R-OH), 1132 m 




From 2-(6-hydroxyundeca-4,7-diyn-6-yl)-N-methylbenzenesulfonamide (3.00 mmol). From 
flash column chromatography (10% EtOAc – hexane) to give the title compound as a yellow 
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oil (0.31 g, at 40% purity by NMR, 12%); LC-MS found [M+H]+ = 333.1391; C18H23NO3S 
[M+H]+ requires = 333.1400. 
δH (CDCl3) 7.94 (1H, dd, J = 8.0, 1.0 Hz, 5-H), 7.77 (1H, dd, J = 8.0, 1.0 Hz, 8-H), 7.60 – 7.56 
(1H, m, 6-H), 7.48 – 7.44 (1H, m, 7-H), 6.64 (1H, t, J = 7.3 Hz, CH), 3.15 (3H, s, Me), 3.03 (1H, 
s, OH), 2.34 – 2.32 (2H, m, CH2), 2.26 – 2.23 (2H, m, CH2), 1.58 – 1.47 (4H, m, CH2), 0.99 – 
0.94 (6H, m, CH3). δc 138.93 (qC), 138.92 (qC), 136.19 (CH), 135.06 (qC), 134.22 (qC), 132.74 
(CH), 131.87 (CH), 130.67 (CH), 129.28 (CH), 129.05 (CH), 123.96 (CH),  88.87 (qC), 81.06 (qC), 




From 2-(6-hydroxyundeca-4,7-diyn-6-yl)-N-methylbenzenesulfonamide (3.00 mmol). From 
flash column chromatography (10% EtOAc – pet ether) to give the title compound as an 
orange oil (0.065 g, 7%); HRMS found [M+H]+ = 334.1463; C18H24NO3S [M+H]+ requires = 
334.1479. 
δH (CDCl3) 8.41 (1H, app. d, 6-H), 7.96 (1H, dd, J = 7.7, 1.2 Hz, 9-H), 7.67 (1H, td, J = 7.7, 1.2 
Hz, 7-H), 7.53 (1H, td, J = 7.7, 1.2 Hz, 8-H), 5.78 (1H, s, 4-H), 5.36 (1H, s, OH), 2.78 (3H, s, 
Me), 2.37 (2H, t, J = 7.3 Hz, CH2), 1.69 – 1.60 (4H, m, CH2), 1.26 (2H, t, J = 7.3 Hz, CH2), 1.06 
(3H, t, J = 7.3 Hz, CH3), 1.01 (3H, t, J = 7.3 Hz, CH3).  
νmax/cm-1: 3339 b (OH), 2964 m (Ar-H), 2932 m (CH2, CH3), 2874 w (CH2, CH3), 1463 m (CH2), 






3-(1-Hydroxybutyl)-2-methyl-4-(pent-1-yn-1-yl)-2H-1,2-benzothiazine 1,1-dioxide (3.11Ab) 
 
From 2-(6-hydroxyundeca-4,7-diyn-6-yl)-N-methylbenzenesulfonamide (3.00 mmol). From 
flash column chromatography (10% EtOAc – pet ether) to give the title compound as an 
orange oil (0.15 g, 15%); HRMS found [M+Na]+ = 356.1294; C18H23NO3SNa [M+Na]+ requires 
= 356.1297. 
δH (CDCl3) 7.88 (1H, app. d, 5-H), 7.82 (1H, dd, J = 7.6, 1.1 Hz, 8-H), 7.63 (1H, td, J = 7.6, 1.1 
Hz, 6-H), 7.51 (1H, td, J = 7.6, 1.1 Hz, 7-H), 5.18 (1H, m, CH), 3.28 (3H, s, Me), 2.69 (1H, d, J = 
5.2 Hz, OH), 2.48 (2H, t, J = 7.2 Hz, CH2), 1.61 – 1.84 (2H, m, CH2), 1.72 – 1.55 (4H, m, CH2), 
1.07 (3H, t, J = 7.2 Hz, CH3), 1.00 (3H, t, J = 7.4 Hz, CH3). δc 149.20 (qC), 132.56 (qC), 132.07 
(CH), 131.39 (qC), 128.59 (CH), 127.23 (CH), 122.03 (CH),  108.54 (qC), 100.61 (qC), 74.18 (qC), 
72.23 (CH), 37.63 (CH2), 35.53 (CH3), 22.14 (CH2), (CH2), 21.69 (CH2), 19.22 (CH2), 13.85 (CH3), 
13.70 (CH3).   
νmax/cm-1: 3442 b (OH), 2960 m (Ar-H), 2933 m (CH2, CH3), 2872 w (CH2, CH3), 1580 w (C=C), 
1470 m (CH2), 1336 s (SO2), 1180 s (R-OH), 1127 m (SO2). 
(Z)-3-Benzylidene-4-hydroxy-4-(phenylethynyl)-2-(p-tolyl)-3,4-dihydro-2H-1,2-
benzothiazine 1,1-dioxide (3.9Ba) 
 
From 2-(3-hydroxy-1,5-diphenylpenta-1,4-diyn-3-yl)-N-(p-tolyl)benzenesulfonamide (2.09 
mmol). From flash column chromatography (20% ether – pet ether) to give the title 
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compound as an orange oil (0.78 g, 78%); HRMS found [M+Na]+ = 500.1294; C30H23NO3SNa 
[M+Na]+ requires = 500.1291. 
δH (CDCl3) 8.24 (1H, app. d, 5-H), 7.79 (1H, app. d, 8-H), 7.68 – 7.64 (3H, m, 6-H, Ph-H), 7.57 
(1H, s, CH), 7.50 – 7.43 (3H, m, Ph-H, 7-H), 7.38 – 7.31 (2H, m, Ph-H), 7.28 – 7.18 (3H, m, Ph-
H), 7.12 (2H, d, J = 8.5 Hz, o-Ar-H), 6.86 (2H, d, J = 8.5 Hz, m-Ar-H), 4.16 (1H, s, OH), 2.12 (3H, 
s, Ar-Me). δc 141.16 (qC), 138.80 (qC), 137.11 (qC), 136.44 (qC), 134.67 (qC), 133.65 (CH), 
133.25 (CH), 131.85 (CH), 129.74 (CH), 129.42 (CH), 129.25 (CH), 129.23 (CH), 129.20 (CH), 
128.79 (CH), 128.63 (qC), 128.50 (CH), 128.25 (CH), 125.04 (CH), 124.29 (CH), 121.70 (qC), 
89.31 (qC), 88.06 (qC), 69.24 (qC), 20.85 (CH3).  
νmax/cm-1: 3432 b (OH), 2920 w (Ar-H), 1700 m (C=C), 1597 w (C=C), 1443 s (CH3), 1347 s 




From 2-(6-hydroxyundeca-4,7-diyn-6-yl)-N-(p-tolyl)benzenesulfonamide (2.44 mmol). From 
flash column chromatography (10% EtOAc – hexane) to give the title compound as an 
orange oil (0.82 g, 82%); HRMS found [M+Na]+ = 432.1612; C24H27NO3SNa [M+Na]+ requires 
= 432.1610. 
δH (CDCl3) 8.13 (1H, app. d, 5-H), 7.77 (1H, dd, J = 7.8, 1.1 Hz, 8-H), 7.64 (1H, td, J = 7.8, 1.1 
Hz, 6-H), 7.46 (1H, td, J = 7.8, 1.1 Hz, 7-H), 7.19 (2H, d, J = 8.4 Hz, o-Ar-H), 7.05 (2H, d, J = 8.4 
Hz, m-Ar-H), 6.62 (1H, t, J = 7.3 Hz, CH), 3.52 (1H, s, OH), 2.35 (2H, t, J = 7.1 Hz, CH2), 2.28 
(3H, s, Ar-Me), 2.16 – 1.98 (2H, m, CH2), 1.62 (2H, sxt, J = 7.1 Hz, CH2), 1.28 (2H, sxt, J = 7.3 
Hz, CH2), 1.02 (3H, t, J = 7.1 Hz, CH3), 0.79 (3H, t, J = 7.3 Hz, CH3). δc 141.29 (qC), 139.24 (qC), 
138.16 (qC), 136.29 (qC), 135.17 (qC), 135.00 (CH), 133.17 (CH), 129.48 (CH), 129.11 (CH), 
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128.91 (CH), 125.01 (CH), 124.15 (CH), 89.14 (qC), 80.61 (qC), 68.76 (qC), 29.32 (CH2), 21.85 
(CH2), 21.32 (CH2), 20.93 (CH3), 20.87 (CH2), 13.79 (CH3), 13.62 (CH3).  
νmax/cm-1: 3466 b (OH), 2960 w (Ar-H), 2931 m (CH2, CH3), 2871 w (CH2, CH3), 1509 w (C=C), 
1463 w (CH2), 1323 s (SO2), 1164 s (R-OH), 1127 s (SO2), 734 s (C=CH). 
(Z)-4-Hydroxy-3-(4-methoxybenzylidene)-4-[(4-methoxyphenyl)ethynyl]-2-(p-tolyl)-3,4-
dihydro-2H-1,2-benzothiazine 1,1-dioxide (3.9Bc) 
 
From 2-[3-hydroxy-1,5-bis(4-methoxyphenyl)penta-1,4-diyn-3-yl]-N-(p-
tolyl)benzenesulfonamide (1.86 mmol). From flash column chromatography (20% EtOAc – 
pet ether) to give the title compound as an orange oil (0.62 g, 62%); HRMS found [M+Na]+ = 
560.1509; C32H27NO5SNa [M+Na]+ requires = 560.1508. 
δH (CDCl3) 8.22 (1H, app. d, 5-H), 7.79 (1H, app. d, 8-H), 7.68 – 7.63 (3H, m, Ar-H, 6-H), 7.51 
(1H, s, CH), 7.47 – 7.40 (3H, m, 7-H, Ar-H), 7.19 (2H, d, J = 8.4 Hz, o-Ar-H), 6.89 (2H, d, J = 8.4 
Hz, m-Ar-H), 6.85 (2H, d, J = 8.8 Hz, Ar-H), 6.79 (2H, d, J = 8.8 Hz, Ar-H), 3.79 (3H, s, O-Me), 
3.75 (3H, s, O-Me), 2.60 (1H, s, OH), 2.14 (3H, s, Ar-Me). δc 160.17 (qC), 159.94 (qC), 139.26 
(qC), 138.72 (qC), 137.30 (qC), 136.17 (qC), 134.65 (qC), 133.51 (CH), 133.32 (CH), 131.43 [2 x 
C (CH)], 129.25 [2 X C (CH)], 129.20 (CH), 125.88 (qC), 124.71 (CH), 124.15 (CH), 114.05 (CH), 
113.80 (CH), 113.68 (qC), 88.30 (qC), 87.88 (qC), 69.22 (qC), 55.35 (CH3), 55.22 (CH3), 20.82 
(CH3).  
νmax/cm-1: 3432 b (OH), 2969 w (Ar-H), 2837 w (CH3), 1700 m (C=C), 1604 s (C=C), 1508 s 






dihydro-2H-1,2-benzothiazine 1,1-dioxide (3.9Be) 
 
From 2-[3-hydroxy-1,5-bis(trimethylsilyl)penta-1,4-diyn-3-yl]-N-(p-tolyl)benzenesulfonamide 
(2.13 mmol). From flash column chromatography (15% EtOAc – pet ether) to give the title 
compound as a straw coloured oil (0.61 g, 61%); HRMS found [M+Na]+ = 492.1459; 
C24H31NO3SSi2Na [M+Na]+ requires = 492.1461. 
δH (CDCl3) 8.16 (1H, dd, J = 7.9, 1.0 Hz, 5-H), 7.73 (1H, dd, J = 7.9, 1.0 Hz, 8-H), 7.65 (1H, td, J 
= 7.9, 1.0 Hz, 6-H), 7.44 (1H, td, J = 7.9, 1.0 Hz, 7-H), 7.27 – 7.24 (2H, m, o-Ar-H), 7.05 (2H, d, 
J = 8.1 Hz, m-Ar-H), 6.91 (1H, s, CH), 3.94 (1H, s, OH), 2.28 (3H, s, Ar-Me), 0.29 (9H, s, Si-
Me3), 0.00 (9H, s, Si-Me3). δc 154.96 (qC), 138.78 (qC), 138.60 (qC), 136.14 (qC), 134.71 (CH), 
133.97 (qC), 133.49 (CH), 129.30 (CH), 129.28 (CH), 129.20 (CH), 124.65 (CH), 124.26 (CH), 
105.68 (qC), 93.21 (qC), 69.74 (qC), 20.84 (CH3), -0.35 (CH3), -1.35 (CH3).  
νmax/cm-1: 3456 b (OH), 2958 s (CH3), 1509 s (C=C), 1356 w (SO2), 1159 m (R-OH), 1116 s 
(SO2), 723 w (CH=CH). 
4-Hydroxy-3-methylene-2-(p-tolyl)-4-[(trimethylsilyl)ethynyl]-3,4-dihydro-2H-1,2-
benzothiazine 1,1-dioxide (3.9Be’) 
 
From 2-[3-hydroxy-1,5-bis(trimethylsilyl)penta-1,4-diyn-3-yl]-N-(p-tolyl)benzenesulfonamide 
(2.13 mmol). From flash column chromatography (15% EtOAc – pet ether) to give the title 
compound as a straw coloured oil (0.02 g, 2%); HRMS found [M+H]+ = 398.1251; 
C21H24NO3SSi [M+H]+ requires = 398.1248. 
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δH (CDCl3) 8.14 (1H, dd, J = 8.0, 1.0 Hz, 5-H), 7.90 (1H, dd, J = 8.0, 1.0 Hz, 8-H), 7.70 (1H, td, J 
= 8.0, 1.0 Hz, 6-H), 7.57 (1H, td, J = 8.0, 1.0 Hz, 7-H), 7.34 – 7.31 (2H, m, o-Ar-H), 7.23 (2H, d, 
J = 8.1 Hz, m-Ar-H), 5.82 (1H, d, J = 1.8 Hz, CH), 4.76 (1H, d, J = 1.8 Hz, CH), 2.38 (3H, s, Ar-
Me), 0.25 (9H, s, Si-Me3). δC 148.96 (qC), 138.87 (qC), 136.87 (qC), 136.82 (qC), 135.86 (qC), 
134.42 (qC), 133.36 (CH), 130.44 (CH), 129.56 (CH), 128.50 (CH), 128.41 (CH), 123.30 (CH), 
107.86 (CH2), 102.94 (qC), 94.10 (qC), 69.54 (qC), 21.21 (CH3), -0.36 (CH3). 
νmax/cm-1: 3285 w (OH), 2959 m (CH2, CH3), 1509 m (C=C), 1338 w (SO2), 1165 s (R-OH), 1138 
w (SO2), 992 w (CH=CH), 842 s (CH=CH). 
(Z)-4-Hydroxy-3-(2-methoxyethylidene)-4-(3-methoxyprop-1-yn-1-yl)-2-(p-tolyl)-3,4-
dihydro-2H-1,2-benzothiazine 1,1-dioxide (3.9Bf) 
 
From 2-(4-hydroxy-1,7-dimethoxyhepta-2,5-diyn-4-yl)-N-(p-tolyl)benzenesulfonamide (2.42 
mmol) to give the title compound as a brown oil (0.86 g, 86%); HRMS found [M+Na]+ = 
436.1190; C22H23NO5SNa [M+Na]+ requires = 436.1195. 
δH (CDCl3) 8.14 (1H, dd, J = 7.9, 0.9 Hz, 5-H), 7.79 (1H, dd, J = 7.9, 0.9 Hz, 8-H), 7.66 (1H, td, J 
= 7.9, 0.9 Hz, 6-H), 7.49 (1H, td, J = 7.9, 0.9 Hz, 7-H), 7.18 (2H, d, J = 8.5 Hz, o-Ar-H), 7.07 (2H, 
d, J = 8.5 Hz, m-Ar-H), 6.67 (1H, t, J = 5.6 Hz, CH), 4.22 (2H, s, CH2), 4.04 (1H, dd, J = 14.1, 5.8 
Hz, CHaCHb), 3.99 (1H, s, OH), 3.92 (1H, dd, J = 14.1, 5.8 Hz, CHaCHb), 3.39 (3H, s, O-Me), 3.20 
(3H, s, O-Me), 3.28 (3H, s, Ar-Me). δc 141.99 (qC), 138.14 (qC), 137.45 (qC), 136.88 (qC), 
135.02 (qC), 133.48 (CH), 131.43 (CH), 129.77 (CH), 129.47 (CH), 128.83 (CH), 125.07 (CH), 
124.24 (CH), 86.09 (qC), 84.26 (qC), 68.09 (CH2), 68.07 (qC), 59.89 (CH2), 58.47 (CH3), 58.00 
(CH3), 20.95 (CH3).  
νmax/cm-1: 3346 b (OH), 2924 s (CH3), 1611 s (C=C), 1508 s (CH3), 1347 s (SO2), 1168 s (R-OH), 




benzothiazine 1,1-dioxide (3.9Ca) 
 
From 2-(3-hydroxy-1,5-diphenylpenta-1,4-diyn-3-yl)-N-(m-tolyl)benzenesulfonamide (2.09 
mmol). From flash column chromatography (20% EtOAc – hexane) and resultant solid 
recrystalised from ether – hexane to give the title compound as a white powder (0.72 g, 
72%) m.p. 160 – 161 °C; HRMS found [M+Na]+ = 500.1291; C30H23NO3SNa [M+Na]+ requires = 
500.1297. 
δH (CDCl3) 8.26 (1H, dd, J = 7.9, 1.0 Hz, 5-H), 7.84 (1H, dd, J = 7.9, 1.0 Hz, 8-H), 7.71 (1H, td, J 
= 7.9, 1.0 Hz, 6-H), 7.63 – 7.61 (2H, m, Ar-H), 7.59 (1H, s, CH), 7.56 – 7.50 (3H, m, Ar-H, 7-H), 
7.42 – 7.34 (3H, m, Ar-H), 7.28 – 7.19* (2H, m, Ar-H), 7.04 (2H, m, Ar-H), 6.98 (1H, t, J = 7.6 
Hz, Ar-H), 6.82 (1H, m, Ar-H), 3.74 (1H, s, OH), 2.13 (3H, s, Ar-Me). δc 141.11 (qC), 139.38 
(qC), 138.65 (qC), 138.39 (qC), 134.81 (qC), 133.62 (CH), 133.19 (qC), 131.82 [2 X C (CH)], 
129.65 (CH), 129.48 (CH), 129.25 (CH), 129.09 (CH), 128.69 (CH), 128.49 (CH), 128.31 (CH), 
128.14 (CH), 127.30 (CH), 125.92 (CH), 124.31 (CH), 121.98 (CH), 121.64 (qC), 89.04 (qC), 
88.25 (qC), 69.52 (qC), 21.27 (CH3).  
νmax/cm-1: 3470 b (OH), 1489 m (C=C), 1349 s (SO2), 1180 s (R-OH), 1137 s (SO2), 757 s 
(C=CH). 








benzothiazine 1,1-dioxide (3.9Cb) 
 
From 2-(6-hydroxyundeca-4,7-diyn-6-yl)-N-(m-tolyl)benzenesulfonamide (2.44 mmol). From 
flash column chromatography (15% EtOAc – pet ether) to give the title compound as a 
yellow glass-like solid (0.59 g, 59%); HRMS found [M+Na]+ = 432.1611; C24H27NO3SNa 
[M+Na]+ requires = 432.1610. 
δH (CDCl3) 8.11 (1H, dd, J = 7.9, 1.2 Hz, 5-H), 7.79 (1H, dd, J = 7.9, 1.2 Hz, 8-H), 7.64 (1H, td, J 
= 7.8, 1.2 Hz, 6-H), 7.47 (1H, td, J = 7.8, 1.2 Hz, 7-H), 7.21 – 7.21 (1H, m, Ar-H), 7.15 – 7.13 
(2H, m, Ar-H), 6.99 – 6.96 (1H, m, Ar-H), 6.62 (1H, t, J = 7.3 Hz, CH), 3.40 (1H, s, OH), 2.35 
(2H, t, J = 7.1 Hz, CH2), 2.29 (3H, s, Ar-Me), 2.16 – 1.99 (2H, m, CH2), 1.62 (2H, sxt, J = 7.1 Hz, 
CH2), 1.32 – 1.22 (2H, m, CH2), 1.02 (3H, t, J = 7.1 Hz, CH3), 0.78 (3H, t, J = 7.3 Hz, CH3). δc 
140.72 (qC), 140.59 (qC), 139.18 (qC), 138.77 (qC), 135.39 (qC), 135.02 (CH), 133.12 (CH), 
129.16 (CH), 128.79 (CH), 128.59 (CH), 127.05 (CH), 125.50 (CH), 124.05 (CH), 121.75 (CH), 
89.22 (qC), 80.58 (qC), 68.87 (qC), 29.27 (CH2), 21.84 (CH2), 21.41 (CH3), 21.27 (CH2), 20.86 
(CH2), 13.76 (CH3), 13.69 (CH3).  
νmax/cm-1: 3455 b (OH), 2961 m (Ar-H), 2933 w (CH2, CH3), 2871 w (CH2, CH3), 2233 w (C≡C), 
1605 m (C=C), 1488 m (CH2), 1319 s (SO2), 1163 s (R-OH), 1126 s (SO2), 734 s (C=CH). 
(Z)-3-Benzylidene-4-hydroxy-2-(2-methoxyphenyl)-4-(phenylethynyl)-3,4-dihydro-2H-1,2-





methoxyphenyl)benzenesulfonamide (2.03 mmol). From flash column chromatography (20% 
ether – hexane) to give the title compound as a golden foam (0.86 g, 86%); HRMS found 
[M+Na]+ = 516.1239; C30H23NO4SNa [M+Na]+ requires = 516.1246. 
δH (CDCl3) 8.30 (1H, dd, J = 8.0, 0.9 Hz, 5-H), 7.84 (1H, dd, J = 8.0, 0.9 Hz, 8-H), 7.70 (1H, td, J 
= 8.0, 0.9 Hz, 6-H), 7.64 (1H, s, CH), 7.57 – 7.54 (2H, m, Ar-H), 7.52 – 7.48 (3H, m, 7-H, Ar-H), 
7.38 – 7.34 (3H, m, Ar-H), 7.28 – 7.19* (3H, m, Ar-H), 7.06 – 7.01 (1H, m, Ar-H), 6.95 (1H, dd, 
J = 9.0, 1.6 Hz, Ar-H), 6.68 (1H, dd, J = 9.0, 1.6 Hz, Ar-H), 6.59 (1H, td, J = 9.0, 1.6 Hz, Ar-H), 
5.04 (1H, s, OH), 3.46 (3H, s, Ar-Me). δc 153.90 (qC), 139.63 (qC), 135.63 (qC), 134.04 (qC), 
133.04 (CH), 131.81 (CH), 131.57 (CH), 130.21 (CH), 129.07 (CH), 129.02 (CH), 128.94 [2 X C 
(CH)], 128.87 [2 X C (CH)], 128.68 (CH), 128.45 (CH), 128.03 (CH), 127.43 (qC), 123.22 (CH), 
122.00 (qC), 120.73 (CH), 112.30 (CH), 89.23 (qC), 87.50 (qC), 70.06 (qC), 55.44 (CH3). 
νmax/cm-1: 3399 b (OH), 1595 m (C=C), 1341 s (SO2), 1172 s (R-OH), 1131 m (SO2), 751 s (Ph-
H), 691 s (C=CH), 690 s (Ph-H). 
*Overlapping with CDCl3 signal 
(Z)-3-Butylidene-4-hydroxy-2-(2-methoxyphenyl)-4-(pent-1-yn-1-yl)-3,4-dihydro-2H-1,2-
benzothiazine 1,1-dioxide (3.9Db) 
 
From 2-(6-hydroxyundeca-4,7-diyn-6-yl)-N-(2-methoxyphenyl)benzenesulfonamide (2.56 
mmol). From flash column chromatography (20% EtOAc – pet ether) to give the title 
compound as a pink oil (0.67 g, 61%); HRMS found [M+Na]+ = 448.1550; C24H27NO4SNa 
[M+Na]+ requires = 448.1559. 
δH (CDCl3) 8.15 (1H, dd, J = 8.0, 1.0 Hz, 5-H), 7.77 (1H, dd, J = 8.0, 1.0 Hz, 8-H), 7.63 (1H, td, J 
= 8.0, 1.0 Hz, 6-H), 7.54 (1H, dd, J = 7.9, 1.6 Hz, Ar-H), 7.43 (1H, td, J = 8.0, 1.0 Hz, 7-H), 7.26 
– 7.22* (1H, m, Ar-H), 6.96 (1H, td, J = 7.9, 1.6 Hz, Ar-H), 6.86 (1H, dd, J = 7.9, 1.6 Hz, Ar-H), 
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6.62 (1H, t, J = 7.4 Hz, CH), 4.73 (1H, s, OH), 3.57 (3H, s, O-Me), 2.34 (2H, t, J = 7.2 Hz, CH2), 
2.15 – 2.08 (2H, m, CH2), 1.62 (2H, sxt, J = 7.2 Hz, CH2), 1.24 – 1.17 (2H, m, CH2), 1.02 (3H, t, J 
= 7.2 Hz, CH3), 0.77 (3H, t, J = 7.4 Hz, CH3). δc 154.48 (qC), 140.68 (qC), 140.08 (qC), 135.77 
(qC), 133.69 (CH), 132.72 (CH), 130.80 (CH), 129.05 (CH), 128.84 (CH), 128.44 (qC), 128.41 
(CH), 123.11 (CH), 121.19 (CH), 112.63 (CH), 88.40 (qC), 80.81 (qC), 60.42 (qC), 55.54 (CH3), 
29.22 (CH2), 21.92 (CH2), 21.57 (CH2), 20.90 (CH2), 13.72 (CH3), 13.65 (CH3).  
νmax/cm-1: 3444 b (OH), 2960 w (Ar-H), 2932 m (CH2, CH3), 2871 w (CH2, CH3), 1498 s (C=C), 
1459 m (CH2), 1334 s (SO2), 1123 s (R-OH), 1097 w (SO2), 742 s (C=CH). 
*Overlapping with CDCl3 signal 
(Z)-3-Benzylidene-4-hydroxy-2-(3-methoxyphenyl)-4-(phenylethynyl)-3,4-dihydro-2H-1,2-
benzothiazine 1,1-dioxide (3.9Ea) 
 
From 2-(3-hydroxy-1,5-diphenylpenta-1,4-diyn-3-yl)-N-(3-
methoxyphenyl)benzenesulfonamide (2.03 mmol). From flash column chromatography (30% 
ether – pet ether) to give the title compound as a yellow oil (0.96 g, 96%); HRMS found 
[M+Na]+ = 516.1239; C30H23NO4SNa [M+Na]+ requires = 516.1246. 
δH (CDCl3) 8.26 (1H, dd, J = 7.9, 1.0 Hz, 5-H), 7.84 (1H, dd, J = 7.9, 1.0 Hz, 8-H), 7.71 (1H, td, J 
= 7.9, 1.0 Hz, 6-H), 7.66 – 7.63 (2H, m, Ph-H), 7.61 (1H, s, CH), 7.54 – 7.49 (3H, m, Ph-H, 7-H), 
7.39 – 7.33 (3H, m, Ph-H), 7.30 – 7.21* (3H, m, Ph-H), 7.00 (1H, t, J = 8.2 Hz, Ar-H), 6.87 – 
6.85 (1H, m, Ar-H), 6.82 – 6.81 (1H, m, Ar-H), 6.58 – 6.55 (1H, m, Ar-H), 3.87 (1H, s, OH), 3.57 
(3H, s, O-Me). δc 159.53 (qC), 140.93 (qC), 140.61 (qC), 138.68 (qC), 134.98 (qC), 133.68 (CH), 
133.20 (qC), 132.25 (CH), 131.83 (CH), 129.68 (CH), 129.50 (CH), 129.26 (CH), 129.12 (CH), 
128.81 (CH), 128.48 (CH), 128.24 (CH), 124.31 (CH), 121.59 (qC), 117.39 (CH), 112.52 (CH), 
110.78 (CH), 89.09 (qC), 88.17 (qC), 69.36 (qC), 55.18 (CH3).  
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νmax/cm-1: 3445 b (OH), 1601 s (C=C), 1489 s (CH3), 1347 s (SO2), 1161 s (R-OH), 1121 m 
(SO2), 755 s (Ph-H), 731 s (C=CH), 688 s (Ph-H). 
*Overlapping with CDCl3 signal 
(Z)-3-Butylidene-4-hydroxy-2-(3-methoxyphenyl)-4-(pent-1-yn-1-yl)-3,4-dihydro-2H-1,2-
benzothiazine 1,1-dioxide (3.9Eb) 
 
From 2-(6-hydroxyundeca-4,7-diyn-6-yl)-N-(3-methoxyphenyl)benzenesulfonamide (1.39 
mmol). From flash column chromatography (20% EtOAc – hexane) to give the title 
compound as an orange oil (0.47 g, 80%); HRMS found [M+Na]+ = 448.1555; C24H27NO4SNa 
[M+Na]+ requires = 448.1559. 
δH (CDCl3) 8.11 (1H, dd, J = 7.9, 1.0 Hz, 5-H), 7.78 (1H, dd, J = 7.9, 1.0 Hz, 8-H), 7.64 (1H, td, J 
= 7.9, 1.0 Hz, 6-H), 7.47 (1H, td, J = 7.9, 1.0 Hz, 7-H), 7.15 – 7.13 (1H, m, Ar-H), 6.96 – 7.93 
(2H, m, Ar-H), 6.72 – 6.70 (1H, m, Ar-H), 6.64 (1H, t, J = 7.3 Hz, CH), 3.75 (3H, s, O-Me), 3.44 
(1H, s, OH), 2.34 (2H, t, J = 7.3 Hz, CH2), 2.18 – 2.00 (2H, m, CH2), 1.62 (2H, sxt, J = 7.3 Hz, 
CH2), 1.30 (2H, sxt, J = 7.3 Hz, CH2), 1.01 (3H, t, J = 7.3 Hz, CH3), 0.79 (3H, t, J = 7.3 Hz, CH3). 
δc 159.83 (qC), 141.75 (qC), 140.67 (qC), 139.17 (qC), 135.49 (CH), 135.22 (qC), 133.20 (CH), 
129.40 (CH), 129.20 (CH), 128.83 (CH), 124.09 (CH), 117.10 (CH), 111.96 (CH), 110.62 (CH), 
89.26 (qC), 80.54 (qC), 68.79 (qC), 55.32 (CH3), 29.30 (CH2), 21.84 (CH2), 21.30 (CH2), 20.89 
(CH2), 13.82 (CH3), 13.62 (CH3). 
νmax/cm-1: 3459 b (OH), 2960 m (Ar-H), 2932 w (CH2, CH3), 2871 w (CH2, CH3), 1601 s (C=C), 






benzothiazine 1,1-dioxide (3.9Gb) 
 
From 2-(6-hydroxyundeca-4,7-diyn-6-yl)-N-(thiophen-3-yl)benzenesulfonamide (1.25 mmol). 
From flash column chromatography (20% EtOAc – hexane) to give the title compound as an 
orange oil (0.35 g, 70%); HRMS found [M+H]+ = 402.1195; C21H24NO3S2 [M+H]+ requires = 
402.1199. 
δH (CDCl3) 8.07 (1H, app. d, 5-H), 7.80 (1H, app. d, 8-H), 7.63 (1H, app. t, 6-H), 7.48 (1H, app. 
t, 7-H), 7.18 – 7.16 (1H, m, Ar-H), 7.13 – 7.11 (1H, m, Ar-H), 7.08 (1H, dd, J = 5.1, 1.4 Hz, Ar-
H), 6.67 (1H, t, J = 7.3 Hz, CH), 3.20 (1H, s, OH), 2.31 (2H, t, J = 7.3 Hz, CH2), 2.19 – 2.17 (2H, 
m, CH2), 2.16 – 1.98 (2H, m, CH2), 1.59 (2H, sxt, J = 7.3 Hz, CH2), 1.35 (2H, sxt, J = 7.3 Hz, 
CH2), 1.00 (3H, t, J = 7.3 Hz, CH3), 0.85 (3H, t, J = 7.3 Hz, CH3). δc 139.93 (qC), 139.10 (qC), 
138.22 (qC), 135.81 (CH), 135.12 (qC), 133.16 (CH), 129.25 (CH), 128.93 (CH), 124.61 (CH), 
124.22 (CH), 123.99 (CH), 115.49 (CH), 89.19 (qC), 80.56 (qC), 68.62 (qC), 29.18 (CH2), 21.81 
(CH2), 21.39 (CH2), 20.83 (CH2), 13.83 (CH3), 13.60 (CH3).  
νmax/cm-1: 3407 b (OH), 2960 m (Ar-H), 2930 m (CH2, CH3), 2871 w (CH2, CH3), 1585 m (C=C), 
1468 w (CH2), 1390 m (CH3), 1352 s (SO2), 1177 s (R-OH), 1068 w (SO2) 766 (C=CH). 
5-Hydroxy-5-(pent-1-yn-1-yl)-3-propyl-2-(thiophen-3-yl)-2,5-dihydrobenzo[f][1,2] 




From 2-(6-hydroxyundeca-4,7-diyn-6-yl)-N-(thiophen-3-yl)benzenesulfonamide (1.25 mmol). 
From flash column chromatography (20% EtOAc – hexane) to give the title compound as an 
orange oil (0.05 g, 11%); HRMS found [M+H]+ = 402.1199; C21H24NO3S2 [M+H]+ requires = 
402.1279. 
δH (CDCl3) 8.45 (1H, app. d, 6-H), 7.68 – 7.64 (2H, m, 9-H, 7-H), 7.40 (1H, app. t, 8-H), 7.15 – 
7.12 (1H, m, Ar-H), 6.83 – 6.82 (1H, m, Ar-H), 6.72 (1H, dd, J = 5.0, 1.1 Hz, Ar-H), 5.91 (1H, s, 
4-H), 5.43 (1H, s, OH), 2.41 (2H, t, J = 7.2 Hz, CH2), 2.09 – 2.02 (1H, m, CH2), 1.96 – 1.88 (1H, 
m, CH2), 1.70 (2H, sxt, J = 7.2 Hz, CH2), 1.64 – 1.55 (2H, m, CH2), 1.09 (3H, t, J = 7.2 Hz, CH3), 
0.97 (3H, t, J = 7.2 Hz, CH3). δc 137.47 (qC), 137.03 (qC), 135.10 (qC), 134.86 (qC), 133.93 (CH), 
130.87 (CH), 128.80 (CH), 128.38 (CH), 126.24 (CH), 125.15 (CH), 122.19 (CH), 120.87 (CH), 
89.00 (qC), 82.06 (qC), 72.89 (qC), 37.68 (CH2), 21.95 (CH2), 20.99 (CH2), 20.62 (CH2), 13.75 
(CH3), 13.01 (CH3).  
νmax/cm-1: 3129 b (OH), 2962 w (Ar-H), 2927 m (CH2, CH3), 2871 w (CH2, CH3), 2207 w (C≡C) 
1631 s (C=C), 1593 w (C=C), 1465 s (CH2), 1364 m (CH2), 1329 s (SO2), 1157 s (R-OH), 1060 w 
(SO2). 
(Z)-3-Benzylidene-4-hydroxy-2-(naphthalen-2-yl)-4-(phenylethynyl)-3,4-dihydro-2H-1,2-
benzothiazine 1,1-dioxide (3.9Ha) 
 
From 2-(3-hydroxy-1,5-diphenylpenta-1,4-diyn-3-yl)-N-(naphthalen-2-
yl)benzenesulfonamide (1.95 mmol). From flash column chromatography (20% EtOAc – 
hexane) and resultant solid recrystalised from ether – hexane to give the title compound as 
a beige foam (0.75 g, 75%) m.p. 94 – 96 °C; HRMS found [M+Na]+ = 536.1297; C33H23NO3SNa 
[M+Na]+ requires = 536.1297. 
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δH  [(CD3)2CO](600 MHz) 8.23 (1H, dd, J = 8.0, 0.9 Hz, 5-H), 7.89 (1H, app. s, Ar-H), 7.84 (1H, 
dd, J = 8.0, 0.9 Hz, 8-H), 7.77 – 7.75 (1H, m, 6-H), 7.66 – 7.63 (3H, m, Ar-H), 7.61 – 7.57 (5H, 
m, Ar-H, 7-H), 7.33 – 7.24 (7H, m, Ar-H), 7.16 – 7.13 (2H, m, Ar-H), 7.07 – 7.04 (1H, m, Ar-H), 
6.66 (1H, s, OH). δc (150 MHz) 139.84 (qC), 139.39 (qC), 137.16 (qC), 135.54 (qC), 133.48 (CH), 
133.33 (qC), 133.06 (qC), 131.52 (CH), 131.28 (qC), 130.23 (CH), 129.45 (CH), 129.37 (CH), 
129.05 (CH), 128.74 (CH), 128.55 (CH), 128.53 (CH), 128.03 (CH), 127.99 (CH), 127.54 (CH), 
127.35 (CH), 126.36 (CH), 125.72 (CH), 123.57 (CH), 123.37 (CH), 122.43 (CH), 121.90 (qC), 
90.82 (qC), 86.70 (qC), 68.08 (qC). 
νmax/cm-1: 3454 w (OH), 1596 w (C=C), 1508 w (C=C), 1490 m (CH3), 1342 s (SO2), 1170 s (R-
OH), 1131 s (SO2), 753 s (Ph-H), 690 s (C=CH), 667 m (Ph-H). 
(Z)-3-Butylidene-4-hydroxy-2-(naphthalen-2-yl)-4-(pent-1-yn-1-yl)-3,4-dihydro-2H-1,2-
benzothiazine 1,1-dioxide (3.9Hb) 
 
From 2-(6-hydroxyundeca-4,7-diyn-6-yl)-N-(naphthalen-2-yl)benzenesulfonamide (2.24 
mmol). From flash column chromatography (toluene) to give the title compound as an 
orange oil (0.84 g, 84%); HRMS found [M+Na]+ = 468.1609; C27H27NO3SNa [M+Na]+ requires 
= 468.1610. 
δH (CDCl3) 8.15 (1H, dd, J = 8.0, 0.9 Hz, 5-H), 7.83 – 7.73 (5H, m, Ar-H), 7.65 (1H, td, J = 7.7, 
1.3 Hz, 6-H), 7.52 – 7.40 (4H, m, Ar-H), 6.68 (1H, t, J = 7.2 Hz, CH), 3.44 (1H, s, OH), 2.37 (2H, 
t, J = 7.0 Hz, CH2), 2.15 – 1.98 (2H, m, CH2), 1.64 (2H, sxt, J = 7.2 Hz, CH2), 1.27 (2H, sxt, J = 
7.2 Hz, CH2), 1.03 (3H, t, J = 7.1 Hz, CH3), 0.74 (3H, t, J = 7.2 Hz, CH3). δc 140.50 (qC), 139.15 
(qC), 138.05 (qC), 135.32 (CH), 133.33 (qC), 133.25 (CH), 131.50 (qC), 129.27 (CH), 128.82 
(CH), 128.74 (CH), 127.90 (CH), 127.54 (CH), 126.48 (CH), 125.94 (CH), 124.08 (CH), 123.42 
(CH), 122.44 (CH), 89.41 (qC), 80.56 (qC), 68.92 (qC), 29.30 (CH2), 21.86 (CH2), 21.31 (CH2), 
20.90 (CH2), 13.76 (CH3), 13.65 (CH3).  
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νmax/cm-1: 3453 b (OH), 2959 m (Ar-H), 2929 m (CH2, CH3), 2870 m (CH2, CH3), 2231 w (C≡C), 
1631 m (C=C), 1597 m (C=C), 1508 m (C=C), 1465 m (CH2), 1317 s (SO2), 1162 s (R-OH), 1125 
s (SO2), 732 s (C=CH). 
6.4 Chapter 4 Experimental 
6.4.1 Reactions with (Z)-2-Benzylidene-3-(phenylethynyl)-1-tosylindolin-3-ol 
3-{Phenyl[3-(phenylethynyl)-1-tosyl-1H-indol-2-yl]methyl}pentane-2,4-dione (4.14a) 
 
Under an argon atmosphere (Z)-2-benzylidene-3-(phenylethynyl)-1-tosylindolin-3-ol (0.20 g, 
0.004 mmol, 1 equiv.) was dissolved in DCE (10 mL) to this 100% w/w montmorilontite K-10 
(0.20 g) and acetylacetone (0.13 mL, 0.01 mmol, 3 equiv.) was added, and the mixture 
stirred at reflux for 2 h. After this time the reaction mixture was allowed to cool, filtered 
through Celite and evaporated to give the title compound as a brown oil (0.24 g, 100%); 
HRMS found [M+Na]+ = 582.1711; C35H29NO4SNa [M+Na]+ requires = 582.1709. 
δH (CD2Cl2) 8.04 – 8.00 (1H, m, 4-H), 7.72 – 7.70 (3H, m, Ph-H), 7.63 – 7.62 (4H, m, Ar-H, Ph-
H), 7.53 – 7.46 (3H, m, Ph-H), 7.37 – 7.29 (5H, m, Ph-H, 5-H, 6-H, 7-H), 7.15 (2H, d, J = 8.0 Hz, 
m-Ar-H), 6.08 (1H, d, J = 12.0 Hz, CH), 6.00 (1H, d, J = 12.0 Hz, CH), 2.33 (3H, s, Ar-Me), 2.23 
2.22 (3H, s, Me), 2.06 (3H, s, Me). δc 191.30 (C=O), 145.35 (qC), 144.17 (qC), 139.13 (qC), 
135.36 (qC), 135.08 (qC), 131.18 (CH), 129.55 (CH), 129.40 (CH), 128.95 (CH), 128.78 (CH), 
128.76 (CH), 127.45 (CH), 127.19 (CH), 125.51 (CH), 124.00 (CH), 122.78 (qC), 119.63 (CH), 
115.07 (CH), 97.55 (qC), 82.17 (qC), 72.74 (CH), 58.38 (qC), 43.38 (CH), 31.32 (CH3), 29.20 
(CH3), 21.25 (CH3). 
νmax/cm-1: 1729 s (C=O), 1699 s (C=O), 1597 m (C=C), 1377 s (CH3), 1352 s (SO2), 1168 s (R-




6.4.2 Reactions of 4-Alkynyl-3-iodo-quinolines 
General Method for the Synthesis of Pyrrolo[2,3-c]quinolines and 3-Amino-4-
alkynylquinolines 
Under an inert (N2) atmosphere anhydrous DMA (5 mL) was added to a mixture of 4-alkynyl-
3-iodoquinoline (1 equiv.), Pd(OAc)2 (8 mol %), potassium carbonate (1.38 mmol, 3 equiv.) 
and Xantphos (10 mol %). To this mixture was added the relevant amine (1.2 equiv.), the 
reaction mixture was heated to 80 °C and stirred for 16 h. After this time the mixture was 
cooled, diluted with EtOAc, washed with water and brine. The organic phase was separated, 
dried (Na2SO4) and evaporated, and the crude material was purified by flash column 
chromatography unless otherwise stated. Reactions that provided 3-aminoquinolines gave 
these as the fastest running compounds (non-polar) from the column. The following were 
synthesised by this method. 
2,4-Diphenyl-3-(p-tolyl)-3H-pyrrolo[2,3-c]quinoline (4.35Aa) 
 
From 3-iodo-2-phenyl-4-(phenylethynyl)quinoline (0.20 g) and p-toluidine (0.063 g). From 
column chromatography (10% EtOAc – pet ether) to give the title compound as off white 
crystals (0.04 g, 21%) m.p. 229 °C; HRMS found [M+H]+ = 411.1859; C30H23N2 [M+H]+ 
requires = 411.1863. 
δH (CDCl3) 8.32 – 8.29 (1H, m, 9-H), 8.23 (1H, app. d, 6-H), 7.66 – 7.58 (2H, m, 7-H, 8-H), 7.33 
(1H, s, 1-H), 7.25 – 7.22 (5H, m, Ph-H), 7.12 – 7.07 (3H, m, Ph-H), 7.00 – 6.95 (2H, m, Ph-H), 
6.70 – 6.65 (4H, m, Ar-H), 2.23 (3H, s, Ar-Me). δc 148.62 (qC), 143.53 (qC), 142.32 (qC), 139.14 
(qC), 137.23 (qC), 135.44 (qC), 132.25 (qC), 130.22 (qC), 129.73 [2 X C (CH)], 129.67(qC), 128.98 
(CH), 128.68 (CH), 128.66 (CH), 128.10 (CH), 127.88 (CH), 127.28 (CH), 126.80 (CH), 126.50 
(CH), 125.89 (CH), 122.68 (CH), 122.65 (qC), 102.21 (CH), 21.02 (CH3). 





From 3-iodo-2-phenyl-4-(phenylethynyl)quinoline (0.20 g) and p-toluidine (0.063 g). From 
column chromatography (10% EtOAc – pet ether) to give the title compound as a bright 
yellow powder (0.07 g, 38%) m.p. 187 – 188 °C; HRMS found [M+H]+ = 411.1860; C30H23N2 
[M+H]+ requires = 411.1863. 
δH (CDCl3) 8.33 – 8.29 (1H, m, 5-H), 8.14 – 8.10 (1H, m, 8-H), 7.74 – 7.71 (2H, m, Ph-H), 7.66 – 
7.58 (2H, m, 6-H, 7-H), 7.48 – 7.37 (3H, m, Ph-H), 7.34 – 7.26* (3H, m, Ph-H), 7.13 – 7.10 (2H, 
m, Ph-H), 7.01 (2H, d, J = 8.1 Hz, m-Ar-H), 6.80 (2H, d, J = 8.1 Hz, o-Ar-H), 6.03 (1H, s, NH), 
2.28 (3H, s, Ar-Me). δc 154.96 (qC), 144.00 (qC), 140.49 (qC), 138.44 (qC), 135.77 (qC), 131.69 
(CH), 130.95 (qC), 129.75 (CH), 129.25 (CH), 129.00 (CH), 128.87 [2 X C (CH)], 128.77 (CH), 
128.23 (CH), 128.08 (qC), 127.78 (CH), 127.42 (CH), 125.00 (CH), 122.54 (qC), 118.38 (CH), 
117.85 (qC), 106.29 (qC), 83.99 (qC), 20.65 (CH3).  
νmax/cm-1: 3391 s (NH), 3051 w (Ar-H), 2917 w (CH3), 1609 w (C=C), 1386 s (CH3), 772 s (Ph-
H), 700 s (Ph-H). 





From 3-iodo-2-phenyl-4-(phenylethynyl)quinoline (0.20 g) and aniline (50 µL). From column 
chromatography (toluene) and resulting residue washed with pentane to give the title 
compound as an orange powder (0.12 g, 74%) m.p. 163 °C; HRMS found [M+H]+ = 397.1695; 
C29H21N2 [M+H]+ requires = 397.1706. 
δH (CD2Cl2) 8.40 – 8.38 (1H, m, 9-H), 8.20 – 8.16 (1H, m, 6-H), 7.71 – 7.64 (2H, m, 7-H, 8-H), 
7.41 (1H, s, 1-H), 7.31 – 7.26 (5H, m, Ph-H), 7.16 – 7.03 (6H, m, Ph-H), 7.00 – 6.96 (2H, m, Ph-
H), 6.90 – 6.87 (2H, m, Ph-H). δc 148.43 (qC), 143.64 (qC), 142.36 (qC), 139.16 (qC), 138.15 
(qC), 132.25 (qC), 130.15 (qC), 129.69 (CH), 129.51 (CH), 129.49 (qC), 129.09 (CH), 128.86 
(CH), 128.08 (CH), 128.02 (CH), 127.89 (CH), 127.39 (CH), 127.16 (CH), 127.08 (CH), 126.41 
(CH), 125.81 (CH), 122.66 (CH), 122.57 (qC), 102.32 (CH). 
νmax/cm-1: 1498 s (C=C), 759 s (Ph-H), 694 s (Ph-H). 
N,2-Diphenyl-4-(phenylethynyl)quinolin-3-amine (4.36Ab) 
 
From 3-iodo-2-phenyl-4-(phenylethynyl)quinoline (0.20 g) and aniline (50 µL). From column 
chromatography (toluene) to give the title compound as yellow crystals (0.006 g, 3%) m.p. 
136 – 137 °C; HRMS found [M+H]+ = 397.1696; C29H21N2 [M+H]+ requires = 397.1706. 
δH [(CD3)2CO] 8.26 – 8.23 (1H, m, 5-H), 7.96 – 7.93 (1H, m, 8-H), 7.71 – 7.68 (2H, m, Ph-H), 
7.68 – 7.53 (2H, m, 6-H, 7-H), 7.18 (1H, s, NH), 7.15 – 7.12 (2H, m, Ph-H), 7.06 – 7.01 (2H, m, 
Ph-H), 6.77 – 6.74 (2H, m, Ph-H), 6.70 – 6.66 (2H, m, Ph-H). δc 156.35 (qC), 144.79 (qC), 
144.53 (qC), 139.23 (qC), 135.37 (qC), 131.69 (CH), 129.75 (CH), 129.17 (CH), 128.94 (CH), 
128.68 (CH), 128.59 (CH), 128.43 (CH), 128.23 (CH), 128.07 (CH), 127.67 (qC), 127.47 (CH), 
125.06 (CH), 122.48 (qC), 121.21 (qC), 119.68 (CH), 116.29 (CH), 105.32 (qC), 83.79 (qC).  






From 3-iodo-2-phenyl-4-(phenylethynyl)quinoline (0.20 g) and p-anisidine (0.069 g). From 
column chromatography (10% EtOAc – hexane) to give the title compound as red crystals 
(0.07 g, 35%) m.p. 195 °C; HRMS found [M+H]+ = 427.1805; C30H23N2O [M+H]+ requires = 
427.1812. 
δH [(CD3)2CO] 8.49 – 8.45 (1H, m, 9-H), 8.12 – 8.07 (1H, m, 6-H), 7.66 – 7.63 (2H, m, 7-H, 8-H), 
7.52 (1H, s, 1-H), 7.35 – 7.29 (5H, m, Ph-H), 7.18 – 7.14 (3H, m, Ph-H), 7.08 – 7.04 (2H, m, Ph-
H), 6.89 – 6.85 (2H, m, Ar-H), 6.56 – 6.52 (2H, m, Ar-H), 3.73 (3H, s, O-Me). δc 158.98 (qC), 
148.46 (qC), 143.62 (qC), 142.42 (qC), 139.55 (qC), 132.43 (qC), 130.97 (qC), 130.18 (qC), 
129.90 (qC), 129.78 (CH), 129.66 (CH), 129.55 (CH), 129.10 (CH), 128.07 (CH), 127.88 (CH), 
126.89 (CH), 126.71 (CH), 126.17 (CH), 125.72 (CH), 122.82 (CH), 122.76 (qC), 113.38 (CH), 
102.03 (CH), 54.88 (CH3). 
νmax/cm-1: 3031 w (Ar-H), 2925w (CH3), 1508 s (C=C), 1383 s (CH3), 766 s (Ph-H), 696 s (Ph-H). 
N-(4-Methoxyphenyl)-2-phenyl-4-(phenylethynyl)quinolin-3-amine (4.36Ad) 
 
From 3-iodo-2-phenyl-4-(phenylethynyl)quinoline (0.20 g) and p-anisidine (0.069 g). From 
column chromatography (10% EtOAc – hexane) to give the title compound as bright orange 
crystals (0.08 g, 40%) m.p. 131 – 132 °C; HRMS found [M+H]+ = 427.1800; C30H23N2O [M+H]+ 
requires = 427.1812. 
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δH [(CD3)2CO] 8.21 – 8.17 (1H, m, 5-H), 7.90 – 7.86 (1H, m, 8-H), 7.67 – 7.64 (2H, m, Ph-H), 
7.53 – 7.47 (2H, m, 7-H, 8-H), 7.27 – 7.19 (6H, m, Ph-H), 7.18 – 7.14 (2H, m, Ph-H), 6.92 (1H, 
s, NH), 6.76 – 6.72 (2H, m, o-Ar-H), 6.64 – 6.60 (2H, m, m-Ar-H), 3.55 (3H, s, O-Me). δc 155.34 
(qC), 154.65 (qC), 144.01 (qC), 139.23 (qC), 137.52 (qC), 136.72 (qC), 131.65 (CH), 129.70 (CH), 
129.03 (CH), 128.85 (CH), 128.56 (CH), 128.42 (CH), 128.16 (CH), 127.93 (qC), 127.52 (CH), 
127.44 (CH), 124.75 (CH), 122.64 (qC), 119.27 (CH), 117.70 (qC), 114.05 (CH), 105.29 (qC), 
83.87 (qC), 54.94 (CH3). 
νmax/cm-1: 3393 m (NH), 3056 w (Ar-H), 2926 w (CH3), 2200 m (C≡C), 1506 s (C=C), 1388 m 
(CH3), 753 s (Ph-H), 687 s (Ph-H). 
N-Benzyl-2-phenyl-4-(phenylethynyl)quinolin-3-amine (4.36Ae) 
 
From 3-iodo-2-phenyl-4-(phenylethynyl)quinoline (0.20 g) and benzylamine (60 µL). From 
column chromatography (toluene) to give the title compound as a dark orange oil (0.11 g, 
60%); HRMS found [M+H]+ = 411.1850; C30H23N2 [M+H]+ requires = 411.1863. 
δH (CDCl3) 8.24 – 8.22 (1H, m, 5-H), 8.04 – 8.02 (1H, m, 8-H), 7.75 – 7.72 (2H, m, Ph-H), 7.57 – 
7.43 (8H, m, 6-H, 7-H, Ph-H), 7.38 – 7.35 (3H, m, Ph-H), 7.28 – 7.20* (4H, m, Ph-H), 4.72 (1H, 
app. s, NH), 4.48 (2H, d, J = 4.0 Hz, CH2). δc 153.04 (qC), 142.51 (qC), 141.82 (qC), 139.73 (qC), 
139.18 (qC), 131.47 (CH), 129.64 (CH), 128.98 (CH), 128.95 (CH), 128.92 (CH), 128.69 (CH), 
128.62 (CH), 128.55 (CH), 128.21 (qC), 127.65 (CH), 127.40 (CH), 127.36 (CH), 126.59 (CH), 
124.49 (CH), 122.76 (qC), 111.89 (qC), 102.73 (qC), 84.08 (qC), 51.54 (CH2).  
νmax/cm-1: 3057 w (Ar-H), 1509 w (C=C), 1491 w (CH2), 753 s (Ph-H), 687 s (Ph-H). 






From 3-iodo-2-phenyl-4-(phenylethynyl)quinoline (0.20 g) and trifluoromethylaniline (70 
µL). From column chromatography (20% toluene – hexane) to give the title compound as 
white needles (0.04 g, 20%) m.p. 250 °C; HRMS found [M+H]+ = 465.1570; C30H20F3N2 [M+H]+ 
requires = 465.1580 
δH [(CD3)2CO](600 MHz) 8.51 – 8.47 (1H, m, 9-H), 8.15 – 8.11 (1H, m, 6-H), 7.71 – 7.66 (2H, 
m, 7-H, 8-H), 7.58 (1H, s, 1-H), 7.34 – 7.30 (7H, m, Ph-H), 7.17 – 7.11 (5H, m, Ph-H, Ar-H), 
7.05 – 7.01 (2H, m, Ar-H). δc (150 MHz) 148.00 (qC), 143.40 (qC), 142.62 (qC), 141.75 – 141.74 
(d, J = 1.4 Hz, qC), 139.26 (qC), 131.89 (qC), 130.41 (qC), 129.95 (CH), 129.80 (CH), 129.61 
(CH), 129.46 (qC) 129.04 (CH), 128.24 [2 X C (CH)], 127.12 [2 X C (CH)], 127.09 (CH), 126.71 – 
121.32 (q, J = 271.78 Hz, qC),  126.52 (CH), 126.00 (CH), 125.13 – 125.05 (q, J = 3.8 Hz, CH), 
122.92 (CH), 122.66 (qC), 102.99 (CH). 19F [(CD3)2CO](376 MHz) δF -63.14. 
νmax/cm-1: 3057 w (Ar-H), 1597 w (C=C), 753 s (Ph-H), 687 s (Ph-H). 
2-Phenyl-4-(phenylethynyl)-N-[4-(trifluoromethyl)phenyl]quinolin-3-amine (4.36Af) 
 
From 3-iodo-2-phenyl-4-(phenylethynyl)quinoline (0.20 g) and trifluoromethylaniline (70 
µL). From column chromatography (20% toluene – hexane) to give the title compound as a 
bright yellow solid (0.08 g, 35%) m.p. 184 – 185 °C; HRMS found [M+H]+ = 465.1567; 
C30H20F3N2 [M+H]+ requires = 465.1580 
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δH [(CD3)2CO](600 MHz) 8.41 (1H, dd, J = 8.2, 0.7 Hz, 5-H), 8.11 (1H, app. d, 8-H), 7.92 (1H, s, 
NH), 7.83 – 7.81 (2H, m, Ph-H), 7.80 – 7.77 (1H, m, 7-H), 7.73 – 7.71 (1H, m, 6-H), 7.50 (2H, 
d, J = 8.6 Hz, m-Ar-H), 7.43 – 7.40 (4H, m, Ph-H), 7.37 – 7.35 (2H, m, Ph-H), 7.24 – 7.23 (2H, 
m, Ph-H), 7.01 (2H, d, J = 8.6 Hz, o-Ar-H). δc (150 MHz) 157.00 (qC), 148.31 – 148.29 (q, J = 
1.0 Hz, qC), 145.54 (qC), 133.78 (qC), 131.63 (CH), 129.83 (CH), 129.48 (CH), 129.06 [2 X C 
(CH)], 129.05 (qC), 128.73 (CH), 128.51 (CH), 128.11 (CH), 127.88 – 122.52 (q, J = 269.72 Hz, 
qC), 127.66 (CH), 127.45 (qC), 126.16 – 126.08 (q, J = 3.8 Hz, CH), 125.36 (CH), 123.87 (qC), 
122.17 (qC), 120.22 – 119.58 (q, J = 32.3 Hz, qC), 114.99 (CH), 105.70 (qC), 83.64 (qC). 19F 
[(CD3)2CO](376 MHz) δF -61.47. 
νmax/cm-1: 3393 m (NH), 3052 w (Ar-H), 2207 m (C≡C), 1611 s (C=C), 1099 s (C-F), 755 s (Ph-
H), 688 s (Ph-H). 
2,4-Bis(4-methoxyphenyl)-3-(p-tolyl)-3H-pyrrolo[2,3-c]quinoline (4.35Ca) 
 
From 3-iodo-2-(4-methoxyphenyl)-4-[(4-methoxyphenyl)ethynyl]quinoline (0.25 g) and p-
toluidine (0.09 g). From column chromatography (10% EtOAc – pet ether) to give the title 
compound as off white powder (0.09 g, 40%) m.p. 238 – 239 °C; HRMS found [M+H]+ = 
471.2061; C32H27N2O2 [M+H]+ requires = 471.2074. 
δH (CDCl3) 8.29 – 8.27 (1H, m, 9-H), 8.23 – 8.21 (1H, m, 6-H), 7.63 – 7.55 (2H, m, 7-H, 8-H), 
7.25* (1H, s, 1-H), 7.13 – 7.10 (2H, m, Ar-H), 7.03 – 6.99 (2H, m, Ar-H), 6.75 – 6.72 (4H, m, 
Ar-H), 6.64 (2H, d, J = 8.3 Hz, Ar-H), 6.52 – 6.48 (2H, m, Ar-H), 3.75 (3H, s, O-Me), 3.72 (3H, s, 
O-Me), 2.23 (3H, s, Ar-Me). δc 159.27 (qC), 158.95 (qC), 148.22 (qC), 143.48 (qC), 142.32 (qC), 
136.97 (qC), 135.68 (qC), 131.65 (qC), 130.91 (CH), 130.27 (qC), 130.16 (CH), 129.54 [2 X C (qC) 
(CH)], 128.77 (CH), 128.65 (CH), 126.40 (CH), 125.64 (CH), 124.62 (qC), 122.65 (CH), 122.57 
(qC), 113.59 (CH), 112.80 (CH), 101.62 (CH), 55.33 (CH3), 55.21 (CH3), 21.02 (CH3). 
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νmax/cm-1: 1607 s (C=C), 1485 s (CH3). 
*Overlapping with CDCl3 signal 
2,4-Bis(4-methoxyphenyl)-3-phenyl-3H-pyrrolo[2,3-c]quinoline (4.35Cb) 
 
From 3-iodo-2-(4-methoxyphenyl)-4-[(4-methoxyphenyl)ethynyl]quinoline (0.16 g) and 
aniline (33 µL). From column chromatography (10% EtOAc – pet ether) to give the title 
compound as a yellow solid (0.06 g, 37%) m.p. 186 – 187 °C; HRMS found [M+H]+ = 
457.1906; C31H25N2O2 [M+H]+ requires = 457.1918. 
δH (CDCl3) 8.30 – 8.28 (1H, m, 9-H), 8.25 – 8.23 (1H, app. d, 6-H), 7.65 – 7.56 (2H, m, 7-H, 8-
H), 7.27 (1H, s, 1-H), 7.11 – 7.03 (5H, m, Ar-H), 6.98 – 6.94 (2H, m, Ph-H), 6.78 (2H, app. d, 
Ph-H), 6.76 – 6.73 (2H, m, Ar-H), 6.53 – 6.49 (2H, m, Ar-H), 3.76 (3H, s, O-Me), 3.72 (3H, s, O-
Me). δc 159.32 (qC), 158.91 (qC), 148.09 (qC), 143.62 (qC), 142.30 (qC), 138.27 (qC), 131.43 
(qC), 130.93 (CH), 130.45 (qC), 130.16 (CH), 129.47 (CH), 129.29 (qC), 129.08 (CH), 128.10 
(CH), 127.19 (CH), 126.52 (CH), 125.72 (CH), 124.52 (qC), 122.65 (CH), 122.51 (qC), 113.59 
(CH), 112.94 (CH), 101.87 (CH), 55.36 (CH3), 55.22 (CH3). 
νmax/cm-1: 2933 w (Ar-H), 2834 w (CH3), 1607 s (C=C), 1500 s (C=C), 1371 s (CH3), 756 s (Ph-










From 3-iodo-2-(4-methoxyphenyl)-4-[(4-methoxyphenyl)ethynyl]quinoline (0.16 g) and 
aniline (33 µL). From column chromatography (10% EtOAc – pet ether) to give the title 
compound as a brown solid (0.03 g, 20%) m.p. 135 – 136 °C; HRMS found [M+H]+ = 
457.1904; C31H25N2O2 [M+H]+ requires = 457.1918. 
δH (CDCl3) 8.29 (1H, dd, J = 8.0, 1.0 Hz, 5-H), 8.11 (1H, dd, J = 8.0, 1.0 Hz, 8-H), 7.71 – 7.68 
(2H, m, Ar-H), 7.66 – 7.56 (2H, m, 6-H, 7-H), 7.23 – 7.19 (2H, m, Ph-H), 7.06 – 7.03 (2H, m, 
Ar-H), 6.97 – 6.90 (3H, m, Ar-H, Ph-H), 6.86 (2H, app. d, Ph-H), 6.82 – 6.78 (2H, m, Ar-H), 6.04 
(1H, s, NH), 3.83 (3H, s, O-Me), 3.81 (3H, s, O-Me). δc 160.26 (qC), 160.21 (qC), 155.03 (qC), 
144.45 (qC), 143.26 (qC), 134.69 (qC), 133.32 (CH), 130.85 (qC), 130.28 (CH), 129.58 (CH), 
128.81 (CH), 128.05 (CH), 127.70 (qC), 127.08 (CH), 125.20 (CH), 120.85 (CH), 120.12 (qC), 
117.37 (CH), 114.53 (qC), 114.22 (CH), 113.95 (CH), 106.66 (qC), 84.00 (qC), 55.37 (CH3), 55.33 
(CH3). 
νmax/cm-1: 3390 s (NH), 2927 w (Ar-H), 2837 w (CH3), 2200 s (C≡C), 1601 s (C=C), 1510 s 
(C=C), 751 m (Ph-H), 693 m (Ph-H). 




Under an inert (N2) atmosphere N-benzyl-2-phenyl-4-(phenylethynyl)quinolin-3-amine (0.10 
g, 0.002 mmol, 1.0 equiv.) and PdCl2 (10 mol %) in 5 mL of anhydrous DMF was stirred at 
160 °C for 2 h. After this time the mixture was allowed to cool to r.t. and the solvent 
removed, the residue was purified by flash column chromatography (10% – pet ether) to 
give the title compound as a yellow oil (0.06 g, 60%); HRMS found [M+H]+ = 411.1854; 
C30H23N2 [M+H]+ requires = 411.1863. 
δH (CDCl3) 8.29 – 8.27 (1H, m, 9-H), 8.23 – 8.21 (1H, m, 6-H), 7.64 – 7.57 (2H, m, 7-H, 8-H), 
7.51 – 7.48 (2H, m, Ph-H), 7.43 – 7.37 (4H, m, Ph-H), 7.34 – 7.28 (4H, m, Ph-H), 7.26 (1H, s, 1-
H), 7.04 – 7.00 (1H, m, Ar-H), 6.96 – 6.92 (2H, m, Ar-H), 6.11 (2H, app. d, Ar-H), 5.15 (2H, s, 
CH2). δc 148.65 (qC), 145.75 (qC), 142.23 (qC), 139.62 (qC), 138.35 (qC), 132.14 (qC), 131.05 
(qC), 129.75 (CH), 129.51 (CH), 129.11 (CH), 128.91 (qC), 128.78 (CH), 128.68 (CH), 128.38 
(CH), 128.12 (CH), 127.96 (CH), 126.85 (CH), 126.60 (CH), 125.91 (CH), 125.13 (CH), 122.71 
(qC), 122.65 (CH), 102.45 (CH), 49.46 (CH2). 
νmax/cm-1: 3055 w (Ar-H), 2924 w (CH2), 1566 w (C=C), 1478 s (CH2), 769 s (Ph-H), 696 s (Ph-
H). 
General Method for the Suzuki-Miyaura Couplings of 3-Iodo-2-phenyl-4-
(phenylethynyl)quinoline 
To a mixture of degassed EtOH : PhMe (50 : 50) was added 3-iodo-2-phenyl-4-
(phenylethynyl)quinoline (0.50 g, 1.16 mmol, 1.0 equiv.), the appropriate boronic acid (2.3 
equiv.), potassium carbonate (0.38 g, 2.78 mmol, 2.4 equiv.) and Pd(PPh3)4 (2.5 mol %). The 
solution was stirred under N2 at reflux for 22 h. After this time the mixture was cooled, 
diluted with EtOAc, washed with water and brine. The organic phase was separated, dried 
(Na2SO4) and evaporated. The crude material was purified by flash column chromatography 









From phenylboronic acid (0.32 g, 2.67 mmol) to give the title compound as a yellow powder 
(0.30 g, 68%) m.p. 148 – 149 °C; HRMS found [M+H]+ = 382.1590; C29H17N [M+H]+ requires = 
382.1597. 
δH (CDCl3) 8.44 (1H, dd, J = 8.3, 0.8 Hz, 5-H), 8.22 (1H, app. d, 8-H), 7.76 – 7.72 (1H, m, 7-H), 
7.65 – 7.61 (1H, m, 6-H), 7.43 – 7.39 (2H, m, Ph-H), 7.34 – 7.29* (10H, m, Ph-H), 7.24 – 7.20 
(3H, m, Ph-H). δc 158.59 (qC), 147.09 (qC), 140.62 (qC), 138.63 (qC), 136.21 (qC), 131.86 (CH), 
131.08 (CH), 130.03 [2 X C (CH)], 129.96 (CH), 129.67 (qC), 129.17 (CH), 128.46 (CH), 127.95 
(CH), 127.84 (CH), 127.77 (CH), 127.45 (CH), 127.36 (CH), 126.62 (qC), 126.31 (CH), 122.57 
(qC), 101.99 (qC), 85.61 (qC). 
νmax/cm-1: 3055 w (Ar-H), 2208 w (C≡C), 1596 s (C=C), 755 s (Ph-H), 689 s (Ph-H). 
*Overlapping with CDCl3 signal 
2-Phenyl-4-(phenylethynyl)-3-(p-tolyl)quinoline (4.41b) 
 
From p-tolylboronic acid (0.36 g, 2.67 mmol) to give the title compound as a white powder 




δH  [(CD3)2CO] 8.51 (1H, dd, J = 8.3, 0.9 Hz, 5-H), 8.14 (1H, app. d, 8-H), 7.87 – 7.83 (1H, m, 7-
H), 7.77 – 7.73 (1H, m, 6-H), 7.47 – 7.39 (7H, m, Ar-H), 7.31 – 7.20 (7H, m, Ar-H), 2.36 (3H, s, 
Ar-Me). δc 158.43 (qC), 147.00 (qC), 140.96 (qC), 137.09 (qC), 136.17 (qC), 135.75 (qC), 131.67 
(CH), 130.87 (CH), 130.04 (CH), 129.92 (CH), 129.85 (CH), 129.40 (CH), 129.06 (qC), 128.66 
(CH), 128.39 (CH), 127.72 (CH), 127.56 (CH), 127.44 (CH), 126.28 (qC), 126.07 (CH), 122.36 
(qC), 101.57 (qC), 85.24 (qC), 20.42 (CH3). 
νmax/cm-1: 3055 w (Ar-H), 2980 w (CH3), 2208 m (C≡C), 761 s (Ph-H), 695 s (Ph-H). 
 (E)-4-(1-Chloro-2-iodo-2-phenylvinyl)-2,3-diphenylquinoline (4.42a) 
 
To a solution of 2,3-diphenyl-4-(phenylethynyl)quinoline (0.20 g, 0.55 mmol, 1 equiv.) in 
MeCN (15 mL) was added iodine monochloride (78 μL, 1.65 mmol, 3 equiv.) and the mixture 
stirred at reflux for 16 h. After this time the reaction mixture was quenched with aqueous 
sodium thiosulfate and diluted with EtOAc. The organic phase was separated, dried (Na2SO4) 
and evaporated to give a powder which was washed with pentane to give the title 
compound as an orange powder (0.26 g, 92%) m.p. 180 °C decomp; HRMS found [M+H]+ = 
544.0314; C29H1735ClIN [M+H]+ requires =544.0331. 
δH (CD2Cl2) (600 MHz) 8.29 (1H, app. d, 8-H), 8.13 (1H, app. d, 5-H), 7.87 (1H, app. t, 7-H), 
7.78 (1H, app. t, 6-H), 7.63 (2H, d, J = 7.2 Hz, Ph-H), 7.49 – 7.39 (7H, m, Ph-H), 7.35 – 7.26 
(7H, m, Ph-H). δc (150 MHz) 159.33 (qC), 147.75 (qC), 146.08 (qC), 140.55 (qC), 140.27 (qC), 
137.76 (qC), 133.95 (qC), 131.43 (qC), 130.30 (CH), 130.08 (CH), 130.02 (CH), 129.74 (CH), 
129.51 (CH), 128.74 (CH), 128.50 (CH), 127.86 (CH), 127.83 (CH), 127.75 (CH), 127.72 (CH), 
127.54 (CH), 127.36 (CH), 125.01 (CH), 122.55 (qC), 88.91 (qC).  
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Chapter 8 Appendices  
8.1 Appendices 1.0 















Compound Reference 2.66a-3 
Chemical Formula C31.50 H23 I N O2.50 S (C30 H20 I N O2 S) 
Formula Mass 614.47 







Unit cell volume/Å3 2713.0(8) 
Temperature/K 150 (2) 
Space group P -1 
No. of formula units per unit cell, Z 4 
No. of reflections measured 70093 
No. of independent reflections 26168 
Rint 0.0391 
Final R1 values (I>2σ(I)) 0.0422 
Final wR(F2) values (I>2σ(I)) 0.1001 
Final R1 values (all data) 0.0614 
Final wR(F2) values (all data) 0.1135 
Goodness of fit on F2 1.037 
Table 8.1 Crystal data for 6-Iodo-2-methyl-5-phenyl-6a-(phenylethynyl)-6aH-1,2-benzisothiazolo[2,3-






Atom 1 Atom 2 Atom 3 Angle (°)  Atom 1 Atom 2 Atom 3 Angle (°) 
N1 S1 O1 112.26  C9 C14 C13 120.38 
N1 S1 O2 109.43  C9 C14 H14 119.81 
N1 S1 C30 92.040  C13 C14 H14 119.81 
O1 S1 O2 117.21  I1 C15 C8 121.92 
O1 S1 C30 110.03  I1 C15 C16 117.70 
O2 S1 C30 113.13  C8 C15 C16 120.37 
S1 N1 C6 115.73  N1 C16 C15 109.37 
S1 N1 C16 110.97  N1 C16 C17 110.68 
C6 N1 C16 117.14  N1 C16 C25 102.90 
C2 C1 C6 118.01  C15 C16 C17 109.48 
C2 C1 C8 123.10  C15 C16 C25 115.32 
C6 C1 C8 118.79  C17 C16 C25 108.93 
C1 C2 H2 119.27  C16 C17 C18 170.78 
C1 C2 C3 121.46  C17 C18 C19 177.12 
H2 C2 C3 119.27  C18 C19 C20 121.32 
C2 C3 C4 118.69  C18 C19 C24 118.88 
C2 C3 C7 121.11  C20 C19 C24 119.78 
C4 C3 C7 120.19  C19 C20 H20 120.13 
Bond Length (Å)  Bond Length (Å)  Bond Length (Å) 
I1-C15  2.0890(16)   C7-H7C  0.9800   C19-C20  1.397(3)  
S1-O2  1.4279(18)   C8-C15  1.351(2)   C20-C21  1.387(3)  
S1-O1  1.4361(17)   C8-C9  1.489(2)   C20-H20  0.9500  
S1-N1  1.6794(13)   C9-C14  1.391(2)   C21-C22  1.384(4)  
S1-C30  1.743(2)   C9-C10  1.398(2)   C21-H21  0.9500  
N1-C6  1.430(2)   C10-C11  1.394(2)   C22-C23  1.381(4)  
N1-C16  1.485(2)   C10-H10  0.9500   C22-H22  0.9500  
C1-C2  1.403(2)   C11-C12  1.384(3)   C23-C24  1.385(3)  
C1-C6  1.404(2)   C11-H11  0.9500   C23-H23  0.9500  
C1-C8  1.476(2)   C12-C13  1.390(3)   C24-H24  0.9500  
C2-C3  1.399(2)   C12-H12  0.9500   C25-C30  1.379(2)  
C2-H2  0.9500   C13-C14  1.392(3)  C25-C26  1.390(3)  
C3-C4  1.396(2)   C13-H13  0.9500   C26-C27  1.395(3)  
C3-C7  1.511(3)   C14-H14  0.9500   C26-H26  0.9500  
C4-C5  1.391(3)  C15-C16  1.531(2)  C27-C28  1.389(4)  
C4-H4  0.9500   C16-C17  1.470(2)   C27-H27  0.9500  
C5-C6  1.388(2)   C16-C25  1.532(2)  C28-C29  1.383(4)  
C5-H5  0.9500   C17-C18  1.200(2)   C28-H28 0.9500  
C7-H7A  0.9800   C18-C19  1.436(2)  C29-C30  1.395(3)  
C7-H7B  0.9800   C19-C24  1.397(3)  C29-H29  0.9500  
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C3 C4 H4 119.50  C19 C20 C21 119.75 
C3 C4 C5 120.99  H20 C20 C21 120.13 
H4 C4 C5 119.50  C20 C21 H21 119.92 
C4 C5 H5 120.25  C20 C21 C22 120.16 
C4 C5 C6 119.49  H21 C21 C22 119.92 
H5 C5 C6 120.25  C21 C22 H22 119.89 
N1 C6 C1 119.25  C21 C22 C23 120.22 
N1 C6 C5 119.44  H22 C22 C23 119.89 
C1 C6 C5 121.27  C22 C23 H23 119.77 
C3 C7 H7A 109.47  C22 C23 C24 120.46 
C3 C7 H7B 109.47  H23 C23 C24 119.77 
C3 C7 H7C 109.47  C19 C24 C23 119.61 
H7A C7 H7B 109.47  C19 C24 H24 120.20 
H7A C7 H7C 109.47  C23 C24 H24 120.19 
H7B C7 H7C 109.47  C16 C25 C26 126.73 
C1 C8 C9 118.72  C16 C25 C30 113.83 
C1 C8 C15 119.77  C26 C25 C30 119.25 
C9 C8 C15 121.41  C25 C26 H26 120.87 
C8 C9 C10 120.97  C25 C26 C27 118.27 
C8 C9 C14 119.46  H26 C26 C27 120.87 
C10 C9 C14 119.55  C26 C27 H27 119.21 
C9 C10 H10 120.08  C26 C27 C28 121.58 
C9 C10 C11 119.84  H27 C27 C28 119.21 
H10 C10 C11 120.08  C27 C28 H28 119.69 
C10 C11 H11 119.90  C27 C28 C29 120.62 
C10 C11 C12 120.20  H28 C28 C29 119.69 
H11 C11 C12 119.90  C28 C29 H29 121.50 
C11 C12 H12 119.90  C28 C29 C30 116.99 
C11 C12 C13 120.21  H29 C29 C30 121.50 
H12 C12 C13 119.90  S1 C30 C25 110.14 
C12 C13 H13 120.09  S1 C30 C29 126.56 
C12 C13 C14 119.81  C25 C30 C29 123.27 
H13 C13 C14 120.09      
Table 8.2 Bond lengths and angles for 6-Iodo-2-methyl-5-phenyl-6a-(phenylethynyl)-6aH-1,2-




















Compound Reference 2.23Bb 
Chemical Formula C24 H25 N O3 S (C24 H27 N O3 S) 
Formula Mass 407.54 







Unit cell volume/Å3 2189.75(11) 
Temperature/K 150.0 
Space group P 1 21/c 1 
No. of formula units per unit cell, Z 4 
No. of reflections measured 23670 
Rint 0.0433 
Final R1 values (I>2σ(I)) 0.0642 
Final wR(F2) values (I>2σ(I)) 0.1589 
Final R1 values (all data) 0.1047 
Final wR(F2) values (all data) 0.1856 
Goodness of fit on F2 1.0839 
Table 8.3 Crystal data for 2-(6-Hydroxyundeca-4,7-diyn-6-yl)-N-(p-tolyl)benzenesulfonamide 2.23Bb 
Bond Length (Å)  Bond Length (Å)  Bond Length (Å) 
S1-N1 1.6311(17)  C7-H7a 0.9800  C22-C23 1.532(6) 
S1-O1 1.4345(13)  C7-H7b 0.9800  C22-C21 1.480(4) 
S1-O2 1.4323(13)  C7-H7c 0.9800  C22-H22a 0.9900 
S1-C8 1.788(2)  C8-C9 1.399(2)  C22-H22b 0.9900 
N1-H1 0.8800  C8-C13 1.413(2)  C23-C24 1.517(5) 
N1-C1 1.434(2)  C9-H9 0.9500  C23-H23a 0.9900 
O3-H3 0.8400  C9-C10 1.375(3)  C23-H23b 0.9900 
O3-C14 1.434(2)  C10-H10 0.9500  C24-H24a 0.9800 
C1-C2 1.385(3)  C10-C11 1.385(3)  C24-H24b 0.9800 
C1-C6 1.378(3)  C11-H11 0.9500  C24-H24c 0.9800 
C2-H2 0.9500  C11-C12 1.390(3)  C18-C19 1.551(14) 
C2-C3 1.384(3)  C12-H12 0.9500  C18-C17 1.332(15) 
C3-H3a 0.9500  C12-C13 1.387(3)  C18-H18 0.9500 
C3-C4 1.379(4)  C13-C14 1.544(2)  C19-H19a 0.9800 
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Atom 1 Atom 2 Atom 3 Angle (°)  Atom 1 Atom 2 Atom 3  Angle (°) 
N1 S1 O1 107.30  C11 C12 H12 118.87 
N1 S1 O2 106.35  C11 C12 C13 122.25 
N1 S1 C8 108.13  H12 C12 C13 118.88 
O1 S1 O2 118.73  C8 C13 C12 117.65 
O1 S1 C8 106.49  C8 C13 C14 124.53 
O2 S1 C8 109.44  C12 C13 C14 117.77 
S1 N1 H1 120.13  O3 C14 C13 106.58 
S1 N1 C1 119.75  O3 C14 C15 113.25 
H1 N1 C1 120.13  O3 C14 C20 108.98 
H3 O3 C14 109.47  C13 C14 C15 109.17 
N1 C1 C2 121.17  C13 C14 C20 112.03 
N1 C1 C6 119.41  C15 C14 C20 106.93 
C2 C1 C6 119.41  C14 C15 C16 175.32 
C1 C2 H2 120.39  C15 C16 C17 174.53 
C1 C2 C3 119.21  C14 C20 C21 172.90 
H2 C2 C3 120.40  H22a C22 H22b 107.91 
C2 C3 H3a 118.99  H22a C22 C23 109.22 
C2 C3 C4 122.04  H22a C22 H22c 58.660 
H3a C3 C4 118.97  H22a C22 C21 109.21 
C3 C4 C5 117.97  H22b C22 C23 109.22 
C3 C4 C7 120.84  H22b C22 H22c 51.270 
C5 C4 C7 121.19  H22b C22 C21 109.20 
C4 C5 H5 119.51  C23 C22 H22c 111.34 
C4 C5 C6 120.96  C23 C22 C21 111.98 
H5 C5 C6 119.52  H22c C22 C21 136.50 
C1 C6 C5 120.41  C22 C23 H23a 108.86 
C1 C6 H6 119.79  C22 C23 H23b 108.86 
C5 C6 H6 119.81  H23a C23 H23b 107.72 
C4 C7 H7a 109.48  H24a C24 H24b 109.47 
C4 C7 H7b 109.48  H24a C24 H24c 109.47 
C4 C7 H7c 109.47  H24a C24 H23c 143.19 
H7a C7 H7b 109.47  H24b C24 H24c 109.47 
H7a C7 H7c 109.46  H24b C24 H23c 47.810 
C4-C5 1.377(3)  C14-C15 1.485(2)  C19-H19b 0.9800 
C4-C7 1.507(3)  C14-C20 1.479(2)  C19-H19c 0.9800 
C5-H5 0.9500  C15-C16 1.188(3)  C17-H17 0.9500 
C5-C6 1.386(3)  C16-C17 1.472(13)    
C6-H6 0.9500  C20-C21 1.185(3)    
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H7b C7 H7c 109.47  H24c C24 H23c 66.050 
S1 C8 C9 114.46  H18 C18 C19 122.69 
S1 C8 C13 126.12  H18 C18 C17 122.69 
C9 C8 C13 119.42  C19 C18 C17 114.63 
C8 C9 H9 119.14  C18 C19 H19a 109.48 
C8 C9 C10 121.70  C18 C19 H19b 109.47 
H9 C9 C10 119.15  C18 C19 H19c 109.48 
C9 C10 H10 120.41  H19a C19 H19b 109.46 
C9 C10 C11 119.18  H19a C19 H19c 109.47 
H10 C10 C11 120.41  H19b C19 H19c 109.46 
C10 C11 H11 120.14  C16 C17 C18 120.55 
C10 C11 C12 119.73  C16 C17 H17 119.72 
H11 C11 C12 120.13  C18 C17 H17 119.72 
     C20 C21 C22 170.32 
Table 8.4 Bond lengths angles for 2-(6-Hydroxyundeca-4,7-diyn-6-yl)-N-(p-tolyl)benzenesulfonamide 
2.23Bb 
 
